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Abstract
Functional analysis of genomic variations associated with
emerging artemisinin resistant P. falciparum parasite
populations and human infecting piroplasmida B. microti
populations
by Ankit Dwivedi
The undergoing WHO Malaria elimination program is threatened by the emer-
gence and potential spread of the Plasmodium falciparum artemisinin resistant par-
asite. Recent reports have shown (a) SNPs in region of chromosome 13 to be under
strong recent positive selection in Cambodia, (b) presence of P. falciparum para-
site resistant and sensitive subpopulations in Cambodia, (c) the evidence that mu-
tations in the Kelch propeller domain of the k13 gene are major determinants of
artemisinin resistance in Cambodian parasite population and (d) parasite subpopula-
tions in Northern Cambodia near Thailand and Laos with mefloquine drug resistance
and carrying R539T allele of the k13 gene.
Identifying the genetic basis of resistance is important to monitor and control the
transmission of resistant parasites and to understand parasite metabolism for the de-
velopment of new drugs. This thesis focuses on analysis of P. falciparum population
structure in Cambodia and description of metabolic properties of these subpopula-
tions and gene flow among them. This could help in identifying the genetic evidence
associated to transmission and acquisition of artemisinin resistance over the country.
First, a barcode approach was used to identify parasite subpopulations using small
number of loci. A mid-throughput PCR-LDR-FMA approach based on LUMINEX
technology was used to screen for SNPs in 537 blood samples (2010 - 2011) from 16
health centres in Cambodia. Based on successful typing of 282 samples, subpopula-
tions were characterized along the borders of the country. Gene flow was described
based on the gradient of alleles at the 11 loci in the barcode. The barcode success-
fully identifies recently emerging parasite subpopulations associated to artemisinin
and mefloquine resistance.
In the second approach, the parasite population structure was defined based on
167 parasite NGS genomes (2008 - 2011) originating from four locations in Cambodia,
recovered from the ENA database. Based on calling of 21257 SNPs, eight parasite
vii
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subpopulations were described. Presence of admixture parasite subpopulation could
be supporting artemisinin resistance transmission. Functional analysis based on sig-
nificant genes validated similar background for resistant isolates and revealed PI3K
pathway in resistant populations supporting acquisition of resistance by assisting the
parasite in ring stage form.
Our findings question the origin and the persistence of the P. falciparum sub-
populations in Cambodia, provide evidence of gene flow among subpopulations and
describe a model of artemisinin resistance acquisition.
The variant calling approach was also implemented on the Babesia microti genome.
This is a malaria like syndrome, and is endemic in the North-Eastern USA. The ob-
jective was to validate the taxonomic position of B. microti as an out-group among
piroplasmida and improve the functional genome annotation based on genetic varia-
tion, gene expression and protein antigenicity. We identified new proteins involved in
parasite host interactions.
ix
Résumé
Analyse fonctionnelle des variations du génome au sein de
populations de P. falciparum résistantes à l’artémisinine et
chez le piroplasme responsable de la babésiose humaine B.
microti
par Ankit Dwivedi
Le programme d’élimination du paludisme de l’OMS est menacé par l’émergence et
la propagation potentielle de parasites de l’espèce Plasmodium falciparum résistants
à l’artémisinine. Récemment il a été montré que (a) des SNPs dans une région
du chromosome 13 subissaient une forte sélection positive récente au Cambodge,
(b) plusieurs sous-populations de parasites de P. falciparum résistants et sensibles
à l’artémisinine étaient présentes au Cambodge, (c) des mutations dans le domaine
Kelch du gène k13 sont des déterminants majeurs de la résistance à l’artémisinine
dans la population parasitaire cambodgien et (d) des parasites de sous-populations
du nord du Cambodge près de la Thaïlande et du Laos sont résistants à la méfloquine
et portent l’allèle R539T du gène de k13.
Il est donc nécessaire d’identifier la base génétique de la résistance dans le but de
surveiller et de contrôler la transmission de parasites résistants au reste du monde,
pour comprendre le métabolisme des parasites et pour le développement de nouveaux
médicaments. Ce travail a porté sur la caractérisation de la structure de la population
de P. falciparum au Cambodge et la description des propriétés métaboliques des sous-
populations présentes ainsi que des flux de gènes entre ces sous-populations. Le but
est d’identifier les bases génétiques associées à la transmission et l’acquisition de
résistance à l’artémisinine dans le pays.
La première approche par code-barre a été développée pour identifier des sous-
populations à l’aide d’un petit nombre de loci. Une approche moléculaire de PCR-
LDR-FMA multiplexée et basée sur la technologie LUMINEX a été mise au point
pour identifier les SNP dans 537 échantillons de sang (2010 - 2011) provenant de 16
centres de santé au Cambodge. La présence de sous-populations le long des frontières
du pays a été établie grâce à l’analyse de 282 échantillons. Les flux de gènes ont été
décrits à partir des 11 loci du code-barre. Le code-barre permet d’identifier les sous-
populations de parasites associées à la résistance à l’artémisinine et à la méfloquine
x
qui ont émergé récemment.
La seconde approche de caractérisation de la structure de la population de P.
falciparum au Cambodge a été définie sur la base de l’analyse de 167 génomes de
parasites (données NGS de 2008 à 2011) provenant de quatre localités au Cambodge
et récupérés à partir de la base de données ENA. Huit sous-populations de parasites
ont pu être décrites à partir d’un jeu de 21257 SNPs caractérisés dans cette étude.
La présence de sous-populations mixtes de parasite apparait comme un risque majeur
pour la transmission de la résistance à l’artémisinine. L’analyse fonctionnelle montre
qu’il existe un fond génétique commun aux isolats dans les populations résistantes et
a confirmé l’importance de la voie PI3K dans l’acquisition de la résistance en aidant
le parasite à rester sous forme de stade anneau.
Nos résultats remettent en question l’origine et la persistance des sous-populations
de P. falciparum au Cambodge, fournissent des preuves de flux génétique entre les
sous-populations et décrivent un modèle d’acquisition de résistance à l’artémisinine.
Le processus d’identification des SNPs fiables a été ensuite appliqué au génome de
Babesia microti. Ce parasite est responsable de la babésiose humain (un syndrome
de type malaria) et est endémique dans le nord-est des Etats-Unis. L’objectif était de
valider la position taxonomique de B. microti en tant que groupe externe aux piro-
plasmes et d’améliorer l’annotation fonctionnelle du génome en incluant la variabilité
génétique, l’expression des gènes et la capacité antigénique des protéines. Nous avons
ainsi identifié de nouvelles protéines impliquées dans les interactions hôte-parasite.
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Chapter 1
Introduction
The work presented in this thesis focuses on the description of parasite population
structure using whole genome sequencing data and functional annotation of the iden-
tified polymorphisms and genes. The work presented here focuses on two genomes
primarily, Plasmodium falciparum and Babesia microti. All the methods and ap-
proaches are developed for P. falciparum whole genome sequencing data analysis and
implemented on B. microti genomic data as an application of developed pipelines.
The following bibliographical sections will be mainly focused on the parasite P. fal-
ciparum and Malaria. The bibliographic sections is divided into two parts, one part
explaining the epidemiology and biology associated to the two parasites and the other
part focussing on whole genome sequencing data analysis.
1.1 Genomic Information
Proteins are the building blocks of an organism. They are functional units involved
in physiological processes. The DNA sequence encodes the genetic information of an
organism. In eukaryotes, they are encoded in protein coding (exons) and non-coding
regions (introns), which are defined stretches of DNA sequence that contain the in-
formation required to construct proteins and functional RNA molecules, respectively.
In the nucleus, the dsDNA (double stranded DNA) carrying the genetic informa-
tion goes under transcription producing premature mRNA (messenger RNA), which
is a single stranded (ss) nucleotide sequence. This premature RNA containing ex-
ons and introns undergoes splicing and the intronic part of the RNA is removed.
The intronic sequence containing non-coding regions encode for RNA molecules. The
5
6 CHAPTER 1. INTRODUCTION
spliced mRNA containing the exonic sequence is transported outside the nucleus in
the cytoplasm through nuclear pores. The mature mRNA contains the open reading
frame (ORF) encoding for the protein. This mRNA undergoes translation (5’ -> 3’)
in the presence of Ribosome and tRNAs (transfer RNAs). The nucleotide sequence is
read as three bases at a time (referred to as codon) and the tRNAs match the codon
coding for one of the 20 amino acids with three complimentary bases (anticodon).
The synthesized proteins (inactive form) folds into 3-D structure (active form) in the
presence of molecular chaperon proteins near the endoplasmic reticulum.
Starting from the dsDNA to synthesis of RNAs and proteins, different kind of
data can be recovered at each level, i.e, at DNA level (Annotation and Epigenomic
data), at RNA transcription level (Transcriptomic data), at protein translation level
(proteomic data) and phenotype level (phenomic data).
1.2 Apicomplexan Genomes
Plasmodium falciparum is a protozoa from phylum Apicomplexa. These apicomplex-
ans are eukaryotic and share many metabolic pathways with host organisms. Eu-
karyotic nuclear genomes are organized in linear chromosomes. The composition in
chromosomes is called the karyotype. The proportion between coding and non-coding
regions vary greatly among eukaryotes. Larger genomes have a small ratio of cod-
ing regions. Apicomplexa are protists. The eukaryotic genome is much larger and
complex than the prokaryotic genome. In the genome of eukaryotic organism, apart
from the protein coding genes, a large amount of sequences does not code for any
proteins and constitutes most of the DNA, thus increasing the complexity [Cooper
GM., 2000]. Many gene families exist in eukaryotic genes contributing to the large
size of the eukaryotic genome and fulfilling the requirement of increased RNA and
protein production. The size of eucaryotic genomes is explained first by the num-
ber of genes, because they have to fulfill more complex functions and the size of
the coding regions. Some eukaryotes have genomes which are smaller than bacteria
(microsporidia). Some bacteria (Streptomyces, 9 Mbp) have genome larger than B.
microti (6.5 Mbp)
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1.2.1 P. falciparum nuclear genome
The P. falciparum nuclear genome is 23 Mbp in size and dispersed throughout 14
chromosomes. The genome of P. falciparum is haploid. More than 5,500 protein
coding genes have been recognized. The size of each chromosome is in the range 0.643
- 3.29 Mbp. Around 54 % of the genome is intronic sequence [Gardner et al., 2002].
Most of the genome sequence is AT rich, which makes the genome less complex and
prone to overlapping errors. The nuclear genome contains 43 tRNAs and some rRNAs
(ribosomal RNAs) in different chromosomes. The subtelomeric region has most of
the mutations in the genome, affecting the genes involved in antigenic variation.
Three gene families rif, stevor and var were shown to be associated with antigenic
variation and were separated from the telomeres by tandem repeats of 21 bp telomere-
associated repetitive elements (TARE). The centromeric regions have more conserved
domains, with house-keeping genes. The predicted proteins in P. falciparum are
hypothetical proteins with unknown function and around 60% of the genes do not
have homology with other organisms, making the genes specific to P. falciparum.
Based on the genome ontology (GO) term analysis of the P. falciparum genome, the
products of predicted genes were associated to functions like cell invasion/adhesion,
response to external stimulus, signal transduction, cell organization and biogenesis,
stress response, transport, cell growth/maintatnance and others [Gardner et al.,
2002].
The genome of P. falciparum comprises of the nuclear genome and the two or-
ganelle genomes (Figure 1.1), mitochondrial genome (6 KB) and circular apicoplast
genome (35 KB) [Gardner et al., 2002]. The mitochondrial genome is the smallest
described so far. The nuclear genome and mitochondrial genome were described ear-
lier [Cornillot et al., 2012, Cornillot et al., 2013] and were used in the description of
apicoplast genome (Article3: Materials and Methods section).
1.2.2 P. falciparum organelle genome
Mitochondria are small double membrane organelles in the eukaryotic genome. They
are involved in oxidative phosphorylation and responsible for cellular energy by pro-
ducing ATP. The presence of this organelle is explained by endosymbiont evolution,
where a proteobacterium (prokaryotic cell) capable of oxidative mechanisms was en-
gulfed by and incorporated into a eukaryote [van Dooren et al., 2006]. Mitochondria
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genome contains 3 protein coding genes, cytochrome oxidase I (cox I), cytochrome
oxidase III (cox III) and cytochrome b (cyt b) and at least 20 rRNA sequences.
This organelle is also responsible for other metabolic functions such as apoptosis and
biosynthetic processes for synthesis of compounds required in the electron transport
chain (Figure 1.1). The genome lacks tRNA genes, genes encoding cox II and NADH
dehydrogenase which are imported from nuclear genome [van Dooren et al., 2006].
The import of proteins takes place by N-terminal leader peptide. The electron trans-
port chain functions as an electron sink, but is responsible for producing reactive
oxygen species contributing to DNA mutations. It contains proteins to tackle ox-
idative stress [Muller, 2004]. The smaller size of the genome, uniparental mode of
inheritance and lower rate of decay makes it a suitable genetic marker for evolution-
ary population studies and phylogenetic analyses [Smith, 2016]. The mitochondrial
genome organization of B. microti is different from other apicomplexa [Cornillot
et al., 2013].
The apicoplast genome is a circular DNA contained in a non-photosynthetic plas-
tid [Lim and McFadden, 2010]. The origin of this chloroplast like genome can be
traced back to algae. The gene organization is conserved between Plasmodium and
Toxoplasma. The presence of apicoplast in parasite genome is explained by secondary
endosymbiosis theory, in which eukaryotic alga was engulfed by the apicomplexan
parasite and the plastid was retained in the parasite [Funes et al., 2002]. The api-
coplast genome encodes 30 proteins and like the chloroplast in plant cells, most of
the apicolplast proteins are translated in the nucleus and then transported to the api-
coplast (Figure 1.1). The proteins are targeted using amino-terminal secretory signal
sequence followed by plastid signal peptide which takes the proteins into the plastid
[Roos et al., 1999]. The targeted proteins include housekeeping enzymes involved
in DNA replication, DNA repair, protein synthesis, protein turnover, metabolic pro-
cesses and transport activities. This organelle is associated with functions like fatty
acid synthesis, isoprenoids synthesis and heme synthesis [Gardner et al., 2002]. Fatty
acids were shown to be absent in B. microti [Cornillot et al., 2012]. The apicoplast is
essential for survival of the parasite [Roos et al., 1999]. Around 60% of the putative
apicoplast proteins are of unknown function. The unique proteins and pathways com-
pared to human biochemical pathways make apicoplast a good drug target [Preston
et al., 2014].
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Figure 1.1: Schematic representation of metabolic pathways associated to P. fal-
ciparum extrachromosomal organelles [Gardner et al., 2002]. Metabolic pathways
associated to food vacuole, mitochondria and apicoplast are shown. Glucose and
glycerol provide the major carbon sources for malaria parasites. The white squares
indicate TCA (tricarboxylic acid) cycle metabolites that may be derived from out-
side the mitochondrion. Antimalarial targets are represented by block arrows. Po-
tential drug targets are represented by grey block arrows. Transporters are grouped
by substrate specificity: inorganic cations (green), inorganic anions (magenta), or-
ganic nutrients (yellow), drug efflux and other (black). O the top the numbers in
parentheses are the number of transporter genes with similar substrate predictions.
Membrane transporters of unknown or putative subcellular localization are shown
in a generic membrane (blue bar). Abbreviations: ACP, acyl carrier protein; ALA,
aminolevulinic acid; CoA, coenzyme A; DHF, dihydrofolate; DOXP, deoxyxylulose
phosphate; FPIX2+ and FPIX3+, ferro- and ferriprotoporphyrin IX, respectively;
pABA, para-aminobenzoic acid; PEP, phosphoenolpyruvate; Pi, phosphate; PPi,
pyrophosphate; PRPP, phosphoribosyl pyrophosphate; THF, tetrahydrofolate; UQ,
ubiquinone.
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The two organelles, apicoplast and mitochondria are in close contact during the
asexual stages of the parasite due to their metabolic dependence. Many proteins in
these organelles are imported from the nuclear genome. These organelles are observed
and transmitted in the female gametocytes only and do not recombine [Okamoto
et al., 2009]. The no-recombinant nature of the organelle genomes makes it a good
target for evolutionary studies [Preston et al., 2014].
1.3 Apicomplexan infections affecting humans
Malaria is a mosquito-borne parasitic infection of the liver and red blood cells (RBCs)
in humans. It is caused by the protozoan Plasmodium. The main source of trans-
mission of malarial infection is the female Anopheles mosquito. It is one of the most
widespread parasitic diseases in the world and transmitted in more than 100 countries.
Malaria cases are predominantly observed and reported in Sub-Saharan African re-
gions, followed by South-East Asia regions, Eastern Mediterranean regions and some
South American regions (see Fig. 1.1). There are five species of the genus Plasmodium
reported that cause all malarial infections in human beings. These are P. falciparum,
P. vivax, P. ovale, P. malariae and P. knowlesi [Kantele and Jokiranta, 2011]. Most
of the infections are caused by P. falciparum and P. vivax with P. falciparum alone
accounting for the 90 percent of the death cases due to Malaria [White et al., 2014].
The death cases due to P. vivax Malaria are observed in patients with other diseases
leading to low immunity [Douglas et al., 2014]. The death cases due to Malaria are
common in all ages, but it is mostly prevalent in children [White et al., 2014, Murray
et al., 2012].
One of the most important challenges being faced today is the emergence of anti-
malarial drug resistance [White, 2008, Eastman and Fidock, 2009]. One of the reasons
is anti-malarial drug practices for long periods in specific locations. Artemisinin-
combination therapy (ACTs) is the front line treatment used to cure P. falciparum
Malaria worldwide and is the key component of global malaria elimination pro-
grams [Dondorp et al., 2011, Chotivanich et al., 2000, Douglas et al., 2012]. The
parasite population structure has evolved due to the Malaria control interventions
and the emergence of anti-malarial drug resistance has been observed. Cambodia
in the South-East Asian region is the epicenter of evolving parasites with acquired
anti-malarial drug resistance. The first clinical case of artemisinin drug resistance was
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observed near Western Cambodia and the Thailand-Myanmar border in 2008 [Noedl
et al., 2008, Dondorp et al., 2009, Phyo et al., 2012]. Emergence of artemisinin
drug resistance in this region is of major concern, as this is the same location where
resistance to earlier anti-malarial drugs Chloroquine, Sulfadoxin-Pyrimethamine and
Mefloquine [Naidoo and Roper, 2013, Sa et al., 2011, Wongsrichanalai and Meshnick,
2008] was observed in the past. In all the cases the resistance spread to different parts
of the world, specifically in areas of high transmission such as sub-Saharan Africa and
caused millions of deaths [Dondorp et al., 2009, Phyo et al., 2012]. There is a strong
need to understand the underlying mechanism of acquisition of drug resistance and
also the role played by parasite population structure in Cambodia to support this
process. To prevent the spread of artemisinin resistance parasites in South-East Asia
and Africa, it is very much necessary and urgent to detect the outbreaks of resistance
at the early stage and provide guidelines to implement prevention measures.
The main objective of this study is the characterization of P. falciparum par-
asite population structure in Cambodia and describing the metabolic properties of
the parasite subpopulations. The goal was to use the genomic and bioinformatics
approaches to describe the specific metabolic capacities of different subpopulations
and the genetic flux among them. The epidemiological knowledge of artemisinin re-
sistant parasite populations will help in identifying the genetic evidence associated to
transmission and acquisition of resistance in Cambodia.
1.3.1 Malaria: Global Review
Malaria has been eliminated from most parts of the world mainly in developed coun-
tries such as USA, Canada, Europe, and Russia. But around 40% of the world’s
population is still affected. The cases of Malaria increased significantly during the
1970s to the 1990s. The increase can be due to various reasons, such as relaxation
of control efforts, increasing antimalarial drug resistance and insecticide resistance
in the mosquito vectors [Feachem et al., 2010, Alonso et al., 2011]. Various effective
measures have been implemented since then to control Malaria cases. Many countries
have adapted Malaria elimination programs and have implemented guidelines such as
early diagnosis and effective treatment within 48 hours, rational use of anti-malarial
drugs, combination therapies and optimal dosage of anti-malarial drugs [The World
Health Organization, 2015a]. The number of malaria cases have dropped from es-
timated 262 million in 2000, to 214 million in 2015 and the number of death cases
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has reduced from estimated 839000 in 2000, to 438000 in 2015 [The World Health
Organization, 2015b].
Sub-saharan Africa is the region where the risk of Malaria transmission is highest
and around 75% of death cases due to P. falciparum malaria are children under 5
years [Snow et al., 1999]. The other regions are areas where the risk of malaria
transmission is lower. Between 2000 and 2015, the number of reported malaria cases
and the morality rate have declined significantly (>50%) globally. An increasing
number of countries are dedicated towards eradicating malaria and have adapted
malaria elimination programs. The European Region reported zero indigenous cases
of malaria in 2015. Also the central asian region reported zero cases of malaria [The
World Health Organization, 2015b]. On the other hand Venezuela has experienced
increased cases of malaria (Figure 1.3).
Figure 1.2: Map showing malaria endemic countries around the world and number of
confirmed malaria cases per 1000 of population accounted in 2013 [The World Health
Organization, 2014]. This map is created based on surveillance conducted among 97
countries and territories where malaria is endemic.
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Figure 1.3: Map showing malaria endemic countries around the world and the changes
in malaria incidence rates for the affected countries as accounted for the period 2000-
2015 [The World Health Organization, 2015b]. This map is created based on surveil-
lance conducted among 97 countries and territories where malaria is endemic.
Out of the 5 species of Plasmodium known to infect humans, P. falciparum and
P. vivax infect most of the population around the world. P. malariae and P. ovale
are less frequently observed. The species P. knowlesi is mostly found in primates and
is prevalent in south-east Asia (SEA), but can also affect humans. Even though P.
falciparum is responsible for most of the death cases due to malaria, P. vivax has the
wider geographical distribution. The reason for this distribution is the ability of P.
vivax to survive in the mosquito vector at higher altitudes and lower temperatures.
This parasite has a dormant liver stage (hypnozoites), which enables it to survive
for longer periods. The two common drugs used as the treatment against P. vivax
are chloroquine and primaquine. These two drugs eliminate the asexual blood stages
and hypnozoites, which can relapse the infection [The World Health Organization,
2014, Antony and Parija, 2016]. ACTs are used as the treatment in the areas where
chloroquine resistance is prevalent. The risk of infection due to P. vivax is low in
Africa because of the absence of Duffy antigen on the surface of RBCs in many
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human populations in Africa [Miller et al., 1976].
One of the major threats faced by the malaria elimination programs worldwide is
the emergence of antimalarial drug resistance. Understanding the mechanism of drug
resistance and identifying the molecular markers to target is essential for development
of antimalarial vaccines and planned implementation of the drugs. There is a need to
develop new tools and diagnostics using different genomic and bioinformatics tools for
the rapid identification of molecular markers associated to antimalarial drug resistance
in different scenarios. Although the precise evaluation and monitoring of malaria
worldwide is difficult, a continuous and planned surveillance is required for predicting
transmission and acquisition of antimalarial drug resistance. The containment and
treatment of the malaria cases should be dealt simultaneously.
1.3.2 Life cycle of Plasmodium falciparum
Malaria is caused by intra-erythrocytic protozoan parasites belonging to the phylum
Apicomplexa. It is the most widespread vector-borne disease caused by the parasite
species of genus Plasmodium. This parasite is transmitted to humans during the
blood feed by female Anopheles mosquitoes mostly during the night time. Out of
more than 400 Anopheles species only around 70 are potential vectors, which are
robust to environmental change, occur in high densities in tropical climates, breed
readily, and prefer humans [Sinka et al., 2012].
The sylvatic reserves of P. vivax and P. malarie exist [Ramasamy, 2014]. The
life cycle of the parasite involves multiple stages in the anopheline mosquitoes and
humans. The life cycle is complex and the parasite population in the host increases
rapidly to help in transmission and pathogenesis [Gerald et al., 2011]. Humans are the
intermediate host in the replication cycle and Anopheles mosquitoes are the definitive
hosts for sexual reproduction.
The life cycle of P. falciparum parasites can be described by four important stages
(Figure 1.4): (1) liver-stage development in humans, (2) rapid blood-stage asexual
multiplication in humans, (3) gamete development in humans and (4) Sporozoite
formation in the gut of Anopheles mosquito [Rosenberg, 2008]. The parasite number
during the life cycle stages increases greatly and rapidly during Plasmodium life cycle
stages by mitosis leading to mass cytokinesis to release the progeny [Sinden, 1991,
Gerald et al., 2011]. Figure 1.4 shows the life cycle of the parasite in the Anopheles
mosquito (definitive host) and human (intermediate host).
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Figure 1.4: Life cycle stages of the malaria parasite P. falciparum in both mosquito
and humans [Josling and Llinas, 2015]. The life cycle of the parasite in the human
host begins with inoculation of motile sporozoites into the blood stream during the
blood meal of female Anopheles mosquito. The sporozoites then travel to the liver, in-
vade a hepatocyte and multiply rapidly. After about a week, the liver schizonts burst
and release thousands of merozoites that invade the red blood cells and undergo re-
peated asexual multiplication. This asexual division is followed by the morphological
stages such as the ring stage, the trophozoite and the schizont stage. Illness starts
when total asexual parasite numbers in the circulation reach roughly 100 million.
Less than 10% of the parasites develop into male and female gametocytes and are
taken up by the Anopheles mosquito and undergo the sexual phase. This is the only
parasite form transmitted from humans to the mosquito. In gut of the mosquito the
zygote formed after fertilization develops into motile ookinete which can penetrate
the midgut and forms an oocyst. The oocyst enlarges over time and bursts liberating
sporozoites, which migrate to the salivary glands to await inoculation at the next
blood feed [Klein, 2013, White et al., 2014, Bousema et al., 2014].
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1.3.2.1 Life cycle stages in the vector
The part of the life cycle responsible for gametocytes fertilization and sporozoite
development takes place in the gut of the female Anopheles mosquito.
The Anopheles mosquitoes are the transmission vectors for the P. falciparum par-
asite causing Malaria. The mature sexual gametocyte form of the parasite is trans-
mitted to mosquitoes from humans during the blood feed. This is the only form of
the parasite capable of transmission from humans to mosquitoes and the density of
the mature gametocytes in the blood in very less [Drakeley et al., 2006].
After the transmission of the male motile and female non-motile sexual forms,
further development takes place within the midgut of the mosquito. A small number of
male gametocytes (macrogametes) fuse with the female gametocytes (microgametes)
and form a diploid zygote. These zygotes become motile ookinates that pass through
the midgut epithelial wall and form a oocyst [Sinden and Billingsley, 2001]. The
ookinates inside the oocyst undergo meiosis and produce thousands of sporozoites.
The oocysts are ruptured and thousands of infective haploid sporozoites migrate to
the salivary glands in about 24 hours [Rosenberg and Rungsiwongse, 1991, Beier,
1998, Gerald et al., 2011].
1.3.2.2 Life cycle stages in humans
The part of the life cycle with infected sporozoites responsible for liver cell invasion
and the blood stage infection takes place in human blood stream.
The female Anopheles mosquitoes transmit malaria during the human blood feed
by inoculating motile and microscopic protozoan sporozoites, few of which are able
to swim in the blood to attach themselves to the liver cells (hepatocytes) and grow
as a trophozoite (uninucleate). The parasites not reaching the liver are removed by
phagocytic cells. This step is usually fast and sporozoites takes around 30 minutes to
reach the liver cells. In the pre-erythrocytic stage or the liver stage, over the span of
7 to 15 days, these liver stage parasites undergo 13-14 rounds of differentiation and
asexual reproduction producing a schizont with up to tens of thousands of daughter
merozoites [Gerald et al., 2011].
The hepatocyte infection for P. vivax and P. ovale could last up to 9-10 months.
These two species show a slightly different life cycle within the intermediate hu-
man host. The liver-stage of these species is prolonged as few sporozoites do not
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develop immediately into schizonts and remain at an undifferentiated (uninucleate)
stage known as hypnozoite [Soulard et al., 2015]. Because of the presence of this
hypnozoite form of the parasite the relapse of malaria in a human can occur even after
several years. The factors activating the relapse are still not clearly known [Mary R.
Galinski and Esmeralda V.S. Meyer and John W. Barnwell, 2013]. There are no hyp-
nozoite forms of the parasite described for P. falciparum and P. malariae [Greenwood
et al., 2008, Tanomsing et al., 2007].
The daughter merozoites are released into the liver sinusoids (capillary vessels
of the liver forming the junction between the latter and the bloodstream) after the
hepatic schizont bursts and eventually released in the bloodstream to infect the RBCs
[Sturm et al., 2006].
The erythrocyte life cycle stages are responsible for malaria clinical symptoms
[Miller et al., 2002]. The liberated merozoites from the liver invade the erythrocytes
and asexual proliferation takes place. A single merozoite in the RBC begins as a ring
stage. This is called the ring stage as all the major organelles of the cell (nucleus,
mitochondria, apicoplast, endoplasmic reticulum and ribosomes) are organized on
the boundary of the cell with cytosolic central region. The ring stage parasites are
surrounded by parasitophorous vacuolar membrane (PVM) developed during invasion
into RBCs. The metabolic activity and the size of the ring stage parasite increase.
The growing parasite enters the trophozoite stage, consumes RBCs contents and
inserts newly derived parasite proteins to alter the membrane of the red blood cell.
At this stage a tubovesicular network (TVN) is generated between the PVM and the
host RBC membrane to import the nutrients and control the proteins and lipids of
the erythrocyte membrane [Lauer et al., 1997, Tamez et al., 2008]. The trophozoite
stage parasites then undergo DNA synthesis, mitosis and nuclear division to develop
into a schizont with around 16 to 32 merozoites. With the rupture of the RBCs the
merozoites spread and infect other RBCs. Some of the merozoites undergo 10 days
maturation and develop into sexual gametocytes (male and female) and circulate in
the blood. These gametocytes are then taken up by the mosquito during the blood
feed and developed into sporozoites. Hence, continuing the cycle.
The malaria parasite is able to multiply rapidly by mitosis at every developmental
stage. The incubation period is around 12 to 14 days from the infecting bite [Simpson
et al., 2002]. The parasite avoids the major growth regulation process of splenic
clearance by expressing the antigens on the infected erythrocyte to sequester them
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on endothelial cells [Gerald et al., 2011]. Prolonged growth periods of the parasite
support transmission and the schizont bursts support the pathogenic symptoms of
the disease.
1.3.3 Malaria Treatment
1.3.3.1 Diagnosis
The early symptoms of malaria are flu-like symptoms. These symptoms are variable
and have a incubation period of 9 days for P. falciparum and around 30 days for
P. vivax malaria. These include fever, headache, weakness, myalgia (muscle pain),
chills, dizziness, abdominal pain and diarrhea, followed by irregular occurrence of
fever, nausea, vomiting, anorexia (loss of appetite) and skin itching. These symptoms
are referred to as uncomplicated malaria systems. If not treated timely and properly
these symptoms can lead to severe malaria symptoms which can be fatal.
Clinical diagnosis of these symptoms is difficult as these symptoms are also com-
mon in case of viral and bacterial infections. This ambiguity in diagnosis of symptoms
can lead to improper use of antimalarial drugs and on the other hand improper use
of other drugs used for common infections. Even if the symptoms are identified for
malaria and antimalarial drugs are provided, it is important to have an account of
the parasite species causing the malarial infection. Improper drug use may lead to
severe malaria symptoms. Therefore, laboratory diagnosis and proper treatment is
required to cure Malaria [The World Health Organization, 2015a].
Early malaria diagnosis is required for curing the patients and for preventing
transmission of the infection. In laboratories, malaria is diagnosed using different
strategies like microscopic detection of parasites in blood, concentration techniques,
rapid diagnostic tests and molecular diagnostic methods.
The microscopic detection of the parasite is a conventional diagnosis method. It
relies on microscopic examination of Giemsa stained blood films in which the cyto-
plasm of the RBC is colored in pink and the parasite nucleus in purple. A thick
blood film is used for the confirmation of the presence of the parasite while the thin
blood films are used to identify the parasite species [Ndao, 2009]. This is the most
widely accepted and practiced method in the laboratories all over the world as it is
cheap, easy to understand and able to identify the parasite density and the species.
The drawbacks are less efficiency at low parasite densities, difficulties in identify-
1.3. APICOMPLEXAN INFECTIONS AFFECTING HUMANS 19
ing mixed infections and laborious microscopy technique, which is not suitable for
high-throughput [Tangpukdee et al., 2009].
One of the other diagnosis methods called Quantitative Buffer Coat (QBC) method
was developed to simplify parasite diagnosis and enhance the microscopic detection
of parasites. In this method the blood is collected in acridine orange dye stained
capillary tube which is centrifuged to separate the components of the blood based on
density. The presence of the parasite is confirmed using epifluorescence microscopy.
The parasite DNA appears light green and the cytoplasm orange [Clendennen et al.,
1995]. The sensitivity of this method is similar to that of a thick blood film. Although
it is fast, simple, and user-friendly, it requires specialized instrumentation and train-
ing which makes it costlier. Also, it is less efficient in determining parasite density
and species. It is more efficient for P. falciparum than the other species [Tangpukdee
et al., 2009].
In order to come over the limitations in using microscopy based technique for
malaria diagnosis, a technique based on antigen-antibody reaction was developed in
the 1990’s and is referred to as rapid diagnostic tests (RDTs). This technique relies on
immunochromatographic assays to detect malaria antigen in the patient blood flowing
along a capillary whose membrane contains specific anti-malaria antibodies. Most of
the RDTs target for detection of three parasite proteins, the histidine-rich protein
II (HRP-II) and lactate dehydrogenase (pLDH) or aldolase. The protein HRP-II is
present in the cytoplasm and membrane of the infected RBC and is specific to P. fal-
ciparum. The protein pLDH and adolase are glycolytic enzymes of genus Plasmodium
and are used to detect asexual and sexual parasites stages. These methods are less
sensitive to other Plasmodium species than P. falciparum [Tangpukdee et al., 2009].
More than 80 RDTs are available [The World Health Organization, 2015b].
These RDTs have limitations and increased specificity to P. falciparum. There-
fore, new molecular diagnostic methods with higher sensitivity have been developed.
One of the most extensively used and sensitive techniques is the Polymerase Chain
Reaction (PCR) DNA amplification process. The host DNA, parasite genome is iden-
tified by amplification of certain target genes [Singh et al., 1999]. This can be useful in
analysing genomes with low parasite levels. PCR is able to detect mutations in genes
associated with antimalarial drug resistant and mixed infections. Although PCR in-
creases diagnosis sensitivity and specificity, it is limited by complex methodologies
and high cost [Tangpukdee et al., 2009].
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Some of the other diagnosis methods are LAMP technique, microarrays, FCM
assay, Automated blood Cell Counters (ACC) and mass spectrophotometry [Tang-
pukdee et al., 2009]. These methods are labor intensive, expensive or require im-
provement to be used as laboratory diagnosis methods universally. The microscopic
techniques using blood films and the use of RDTs remain the gold standards for the
diagnosis of malaria parasites [The World Health Organization, 2015a].
1.3.3.2 Anti-malaria drugs
The antimalarial drugs made available for the treatment of malaria and controlling the
transmission, target different parasite forms at different life cycle stages. These drugs
can be classified into four groups based on the drug effect on particular parasite stage
in humans: Blood schizonticides kill asexual intra-erythrocytic stages (merozoite,
trophozoite and schizont) of the parasites; tissue schizonticides kill hepatic schizonts
before development into merozoites leading to erythrocytic invasion; hypnozoiticides
kill the hypnozoite stages of P. vivax and P. ovale for the prevention of relapsing
infection and the gametocytocides that kill the gametocyte form of the parasite to
control the transmission of the malaria infection [Schlitzer, 2007]. These drugs are
used in combination (combination therapies) with other drugs to slow down the devel-
opment of drug resistance to monotherapies. The clearance half-life and anti-malarial
action of both the drugs is different. Some of the front line therapy drugs and their
action on the parasite are described in further paragraphs.
The first antimalarial drug to be used was quinine (QN) discovered in the 1800s
and fully synthesized in 1944 [Toovey, 2004]. It is the most effective and practiced
anti-malarial drug. This drug targets the hemozoin formation in the red blood cells.
During the infection, parasite digests haemoglobin and releases free heme, which is
toxic for the cell. The parasite converts this free heme into crystal form known as
hemozoin. Quinine inhibits the formation of hemozoin, hence killing the blood-feeding
parasites [White, 1996]. In south-east Asia (SEA) it is combined with antibiotics
(clindamycin and tetracycline). It is used to treat P. falciparum malaria [Sibley,
2014]. It is mostly used for the treatment of severe malarial cases. The two other
drugs used to target hemozoin were chloroquine (CQ) and mefloquine (MQ). Mass
drug administration of the drugs led to resistance. The first case of CQ resistance
for P. falciparum malaria was observed at Thailand-Cambodia border in 1957, which
eventually spread to Africa around the 1980s [Dondorp et al., 2009]. It is used for the
1.3. APICOMPLEXAN INFECTIONS AFFECTING HUMANS 21
treatment of P. vivax, P. ovale and P. malariae malaria. Mefloquine was introduced
in the 1980s and became the first line treatment of uncomplicated malaria in SEA
after QN (Pradines Bruno et al. 2010a) in the 1990s. Since 2001 it has been widely
used in combination with artesunate in SEA [The World Health Organization, 2015a].
These three drugs (quinine, chloroquine and mefloquine) have blood schizonticides
activity. Whereas chloroquine also has gametocytocides activity in P. vivax and P.
malariae [White, 1996].
After the emergence of chloroquine drug resistance, the combination of sulfa-
doxine and pyrimethamine (SP) was used as the anti-malarial drug [Sibley, 2014].
Pyrimethamine targets the folate biosynthesis pathway by inhibiting the enzyme dihy-
drofolate reductase (DHFR). The folate derivatives are essential for DNA replication
and cell division. One of the folate derivatives, tetrahydrofolic acid is important for
the biosynthesis of amino acid. The resistance against pyramithamine was rapid after
its introduction. Therefore, it was used in combination with sulfonamide antibiotic
sulfadoxine, targeting the dihydropteroate synthase (DHPS), which catalyzes the pro-
duction of dihydropteroate required for biosynthesis of folate. This combination was
introduced in Thailand in 1967 [Wongsrichanalai et al., 2002], but resistance devel-
oped rapidly. It is used to treat P. falciparum malaria, but due to side-effects it is only
used in areas with resistance to other effective drugs. Sulfadoxin-Pyramethamine has
blood schizonticides activity. Whereas, pyramethamine also has tissue schizonticides
and hypnozoiticides activity [White, 1996].
Another drug, atovaquone with anti-malarial properties was used in combination
with proguanil. This combination affects the mitochondrial electron transport chain,
responsible for ATP synthesis. This drug combination targets the liver stage (pre-
erthrocytic) parasite forms in addition to the RBC (erythrocytic) parasite forms. The
molecular target of atovaquone is the cytochrome b (cyt b) protein encoded by Pfcytb
gene in the mitochondria [McKeage and Scott, 2003].
Artemisinin, an old medicinal Chinese herb was recognized for its rapid anti-
malarial action and was introduced in 1977 [White, 1997]. It is the fastest acting
antimalarial. The combination of artemisinin and other antimalarial drugs referred
to as Artemisinin Combination Therapies (ACTs), were recommended by the WHO
as the front line therapy for the treatment of cerebral malaria and multi-drug resistant
malaria in 2001. This drug can be used for both uncomplicated and severe P. falci-
parum malaria. The biological action of this drug on the parasite is not completely
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known. Some of the plausible modes of actions are (1) reaction of the iron (Fe2+)
from heme with artemisinin to form carbon centered free radical or reactive oxygen
species (ROS) inhibiting parasite growth leading to parasite death or (2) direct inter-
action between artemisinin and Ca2+-ATPase PfATP6, causing loss of Ca2+ pump of
parasite leading to death [Shandilya et al., 2013, Cui and Su, 2009]. A computational
approach has shown that Fe-artemisinin molecule inhibits the function of Ca2+ pump
PfATP6 through an allosteric mechanism causing death of the parasite [Shandilya
et al., 2013] (Figure 1.5). Artemisinin is used in combination with other anti-malarial
drugs. Due to less biovailability of artemisinin, three artemisinin derivatives arte-
sunate (water soluble), Artemether (lipid soluble) and dihydroartemisinin (DHA) are
mostly used combined with other drugs such as sulfadoxine-pyramethamine (SP) and
mefloquine (MQ). Artemisinin derivatives reduces the parasitemia IC50 (half maximal
inhibitory concentration) by a log fold and are eliminated rapidly. The combination
partner drugs are responsible for eliminating rest of the parasites and have a longer
half-life, thus preventing emergence of artemisinin resistant mutants [White, 2004].
Therefore, the partner drug resistance will be acquired if the parasites are able to
evade artemisisnin action. ACTs have blood schizonticides activity and targets all
the intra-erythrocytic stages of the parasite. It also prevents the development of ga-
metocytes by its action on the ring stage of the parasite and the early gametocyte
stage (I-III) [Witkowski et al., 2013]. Hence, controlling the transmission of malarial
parasite [Price et al., 1996].
Some new possible anti-malarial compounds are in pipeline, targeting multiple
life-cycle stages of the parasite and are under clinical trials. Two classes of chemical
compounds pyrazoleamides [Vaidya et al., 2014] and spiroindolones [Spillman et al.,
2013] are defined, which target and increase the sodium ion concentration inside
the blood stage P. falciparum parasite form (sexual stages) and disrupt the parasite
membrane and permeability, subsequently killing the parasite. The pyrazoleamides
affect the cation-pummping P-type ATPase (E1-E2 ATPase), and the spiroindolones
effect the cation ATPase (PfATP4). Based on whole genomic sequencing methods,
mutations in two proteins PfCDPK5 and PfATP4 are shown to be necessary for
resistance to these two compounds. Another chemical compound DDD107498 [Bara-
gana et al., 2015], was shown with anti-malarial activity against multiple life-cycle
stages. This compound has long half-life and potential for single dose treatment.
This compound also effects the transmission of parasites from the liver stage. The
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target of DDD107498 is the gene encoding P. falciparum translocation elongation
factor 2 (PfeEF2), playing a role in protein synthesis. This compound affecting mul-
tiple life-cycle stages of P. falciparum has a potential to be advanced towards clinical
trials [Baragana et al., 2015].
Figure 1.5: Possible Artemisinin mode of action and factors leading to resistance in
P. falciparum [Ding et al., 2011]. Red dots, represent the mutations in the proteins
responsible for increasing (arrow) or decreasing (inhibition line) in vitro sensitivity to
ART. The target molecules and mechanisms are in orange and the resistance factors
are in yellow.
1.3.4 Drug Resistance
In the above sections we have seen that the resistance for all of the widely used anti-
malarial drugs has been observed in most parts of the world. As each drug targets
different parasite forms and has different mode of action, understanding the resistance
mechanism is complex. Some plausible resistance pathways have been described, but
the process of acquisition of resistance is not completely understood. Some molecular
markers have been defined based on the acquired mutations in the parasite genome
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associated to the underlying drug resistance process for different drugs (Figure 1.5).
These markers have helped in understanding the resistance process and defining new
drug targets for the synthesis and recognition of new anti-malarial drugs.
For the first widely used anti-malarial drug quinine, three genes encoding trans-
porters at the digestive vacuole membrane, were shown to have mutations associated
to resistance in 2004. The identification of these genes was based on analysis of
quantitative trait locus (QTL) of genetic crosses between the reference clones HB3
(sensitive) and Dd2 (resistant). Ferdig and colleagues showed that Pfmdr-1 gene (Pf
multidrug resistance 1) on chromosome 5, Pfcrt (Pf chloroquine resistance transport)
on chromosome 7, and Pfnhe-1 (Pf Na+ / H+ exchanger-1) on chromosome 13 were
associated with reduced sensitivity to QN [Ferdig et al., 2004]. The identification of
molecular changes in the genome of the parasite treated with chloroquine was based
on analysis of genetic crosses between CQ sensitive (HB3) and resistant (Dd2) para-
site strains. This analysis identified the non-synonymous SNPs (8 mutations) in the
P. falciparum chloroquine resistance transporter encoded by the Pfcrt gene (PF3D7
0709000) on chromosome 7. The Pfcrt-K76T mutation was found in all the chloro-
quine resistant parasites [Sibley, 2014]. These results were supported by association
studies between genotype (resistant alleles) and phenotype (half maximal inhibitory
concentration (IC50)) of isolates [Ecker et al., 2012]. This Pfcrt has a transporter-like
structure at the digestive vacuole of the cell. The mutant Pfcrt (loss of the positively
charged lysine 76) has acquired the ability to transport protonated CQ out of the
digestive vacuole to the cytosol. Therefore reducing the excess CQ for heme from
the digestive vacuole [Ecker et al., 2012]. In the case of Sulfadoxine-Pyramethamine
(SP) the point mutations in the gene dihydrofolate reductase (DHFR) and dihy-
dropteroate synthase (DHPS) were seen to be associated with resistance. For the
mefloquine (MQ) resistant drugs, several studies (clinical or in vitro) have shown a
correlation between the resistance to MQ and amplification of the copy number of
Pfmdr1. This gene, similarly to Pfcrt, encodes a transporter at the digestive vacuole
membrane of the parasite [Ferreira et al., 2011].
The main focus of this study is the emergence of artemisinin resistant parasites in
the SEA region. The emergence of resistance to artemisinin appears to be currently
limited to the Mekong basin [Ashley et al., 2014]. Clinical resistance to artemisinin
in Plasmodium falciparum cases were documented at Pailin in 2009 [Dondorp et al.,
2009] in WestWestern Cambodia. Since then, other cases have been found in the
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adjacent countries such as Thailand [Phyo et al., 2012], Vietnam [Hien et al., 2012],
Burma [Kyaw et al., 2013] and Myanmar [Tun et al., 2015]. The clinical resistance
is defined as the increased parasite clearance half-life. The rate of clearance of para-
sites is based on frequent parasite counts until no more parasites are detected. The
emergence of resistance to this front line therapy worldwide is of major concern as the
locus of emergence (Thailand-Cambodia border) is same as that of the emergence of
resistance to previously used anti-malarial drugs and all the major drugs have devel-
oped resistance. All the combined therapies use artemisinin derivative [Sibley, 2014].
The resistance mechanism is not fully understood and no new anti-malarial agent is
present for the replacement/substitution of ACTs. The increased parasite clearance
half-life could evolve into true resistance, where it will not be efficient to clear the
parasites and spread of this resistance following the trajectory of resistant to previ-
ous anti-malarial drugs will result into millions of deaths. The evidence supporting
the plausible mechanisms associated to artemisinin resistance emergence in SEA are
discussed in the next section.
1.3.5 Evidences decoding artemisinin resistance in Cambo-
dia
Most of the malaria cases are due to P. falciparum and P. vivax, but all the species
have been reported to cause infections [The World Health Organization, 2015b]. Re-
sistant is mostly prevalent for P. falciparum, but cases in other species are also ob-
served. Anti-malarial drug resistance is defined as delayed parasite clearance half-life.
Cambodia is the epicenter of emergence of drug resistance. It shares its borders with
Thailand, Vietnam and Laos in the north-west, east and north, respectively. These
parasites are carried by around 25 different species of Anopheles mosquitoes in Cam-
bodia. The first cases of resistance against chloroquine, mefloquine and sulfadoxine-
pyramethamine used for the treatment of P. falciparum malaria were observed near
the Thailand-Cambodia border. Mefloquine was practiced as the main drug for the
treatment of malaria from 1993 to 2000, which lead to emergence of resistance to
mefloquine. Later it was combined with artemisinin derivative artesunate for the
treatment of malaria [Sibley, 2014].
The first clinical case of artemisinin resistance (increased IC50) was observed in
Pailin in 2009 [Dondorp et al., 2009]. This location is very close to north-western bor-
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der with Thailand, where resistance to other drugs was reported. Artesunate was used
as the monotherapy in that region for some years, which lead to the emergence of re-
sistance [Noedl et al., 2008]. Since 2009, the combined therapy of dihydroartemisinin
(DHA) and piperaquine (activity similar to chloroquine) is used for the treatment in
Cambodia [Zani et al., 2014]. This treatment is failing in Cambodia, because the par-
asite surviving artemisinin are targeted by only piperaquine, leading to piperaquine
resistance [Fairhurst, 2015].
Identifying the genetic basis of resistance is very important for developing tools to
provide aiding efforts to tackle resistance. Studies have been performed on parasite
genotypes to examine trends of recent positive selection and to identify regions of the
genome associated with artemisinin resistance.
In the early studies, based on geographical differentiation, haplotype structure
and GWAS (Genome Wide Association Study) analyses, it was shown that SNPs on
chromosome 13 are under strong selection and associated to delayed parasite clearance
half-life [Cheeseman et al., 2012, Takala-Harrison et al., 2013]. Also, a novel assay was
developed to measure the parasite clearance phenotype. Two properties of artemsinin
were recognized for this assay: (1) short half-life and (2) on the ring stage exposure to
artemisinin, the parasite is shrunk and squeezed out of the RBCs in spleen, producing
uninfected RBCs. In this assay the clinical parasite isolates were adapted to culture
and then synchronized to early ring stage. Then these ring stages were exposed to
DHA for 6 hours and then cultured for 66 hours. The parasite density was calculated
after DHA exposure [Witkowski et al., 2013]. This test is referred to as Ring Stage
Assay (RSA) and shows that the artemisinin resistance phenomenon takes place at
the early ring stage rather than other stage [Sibley, 2014].
In the early 2014, a strong molecular marker associated to artemisinin resistance
was described based on extensive genetic analysis [Ariey et al., 2014]. Resistant was
induced in Tanzanian cell lines by supplying escalating doses of artemisinin for 5
years in vitro. By comparing the resistant and sensitive parasite lines, mutations in
the propeller domain of the kelch gene called as K13 (PF3D7-1343700) in chromo-
some 13 were associated to artemisinin resistance. Out of the 17 mutations observed
in Cambodia, three mutations C580Y, Y493H and R539T showed long parasite clear-
ance half-life and elevated RSA levels. The most dominant allele C580Y, is highly
prevalent in western Cambodia. These mutations are mutually exclusive; each resis-
tance strain contains only one of the K13 alleles. Clusters of mutant K13-propeller
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alleles in Cambodia are observed where resistance is prevalent; also an increased fre-
quency of the most dominant mutant K13-propeller allele is correlated to the recent
spread of resistance in western Cambodia. These K13 alleles show different levels of
resistance and C580Y has been shown to be the most resistant among other alleles
based on mutating the wild-type strains with these mutations and calculating the
RSA levels [Straimer et al., 2015]. Kelch gene (K13) is homologous to KEAP1 gene
in humans and contains propeller domain and BTB-POZ domain [Ariey et al., 2014].
Other mutations in K13 gene have been observed with slow clearance parasite half-life
in Myanmar and C580Y mutations have been observed in the south-eastern part of
Myanmar [Tun et al., 2015]. These results support that chromosome 13 can be a re-
gion of interest and also that K13-propeller mutations can be important determinants
of artemisinin resistance. To follow these directions accurately and to build strategies
for containing resistance, there is a need of temporal and geographical distribution
data from the region of interest.
In 2013, based on population studies, existence of resistant and sensitive parasite
subpopulations was shown in Cambodia [Miotto et al., 2013]. Artemisinin resistant
populations were defined based on non-synonymous single nucleotide polymorphism
data from 825 parasite genomes originating from regions in Africa and Asia. The
resistant populations were associated to clinical resistance to artemisinin and it was
shown that the artemisisn-resistant founder subpopulations are highly differentiated
and have gone under recent expansion [Miotto et al., 2013]. Three artemisinin re-
sistant subpopulations (KH2, KH3 and KH4) and an existing ancestral population
(KH1) were described in Cambodia. Based on GWAS analysis in 2015 O. Miotto
and colleagues, showed that all the resistant populations have a similar genetic back-
ground. This analysis identified five background mutations showing that the SNP
fd-D193Y (ferredoxin) is most significantly associated with resistant founder popula-
tions followed by crt-I356T (chloroquine resistance transporter), crt-N326S, arps10 -
V127M (apicoplast ribosomal protein s10) and mdr2 -T484I (multidrug resistance 2
transporter). The mechanism with which these mutations support mutations in the
K13 gene and artemisinin resistance is not known, but these mutations are likely
to increase the fitness of the parasite to overcome artemisinin drug pressure [Miotto
et al., 2015].
These efforts have led to a suitable molecular marker of artemisinin resistance,
but still the mechanism of resistance is not understood. Some efforts have been
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made and hypothetical models associated to artemisinin resistance have been sug-
gested. In one of the transcriptional analyses it has been shown that the resistance
is associated to an unfolded protein response pathway with P. falciparum reactive
oxidative stress complex and TCP-1 ring complex (TRiC) [Mok et al., 2015]. One
of the hypotheses is that these factors repair the oxidative stress of the parasite
due to artemisinin and then the parasites continue their life cycle [Fairhurst, 2015].
The other hypothesis for the artemisinin-resistance pathway is that the artemisinin
targets the phosphatidylinositol-3-kinase (PI3K). The phosphatidylinositol-3-kinase
(PI3K) produces phosphatidylinositol-3-phosphate (PI3P) and the level of PI3P is
shown to increase when ring stages develop to schizonts. Hence PI3P is required
for the parasite growth [Mbengue et al., 2015]. The non-mutated k13 binds to the
phosphatidylinositol-3-kinase (PI3K), which is followed by polyubiquitination of K13
by an unknown ubiquitin ligase. Due to this binding the levels of PI3P remain low
in parasites. PI3K is proposed as being sensitive to artemisinin, and because of the
low PI3P levels the growth of the parasite is stopped. In the case of artemisinin resis-
tant K13, the binding does not take place increasing the levels of PI3K activity and
hence increasing the level of available PI3P. The inhibiting action of artemisinin on
PI3K does not affect the levels of PI3P available for the parasite growth. No relation
was seen in increased PI3K transcripts and parasite clearance half-life [Mok et al.,
2015]. These two hypotheses are still under validation and need more results to fully
understand the artemisinin drug resistant mechanism completely [Fairhurst, 2015].
Therefore, from all the efforts and development to understand the artemisinin
mechanism we know artemisinin resistance is based on delay in parasite clearance half-
life (> 5 hrs) and increased parasite density at the early ring stage (RSA test). SNPs
in the gene (K13) have been shown to be an effective molecular marker associated to
artemisinin resistance. Also, the resistant parasites have been shown to have increased
levels of PI3K activity and PI3P levels. The most dominant K13 allele C580Y is
prevalent in the western part of Cambodia [Fairhurst, 2015]. As the resistance process
is not fully understood, new methods and markers are required to understand the
resistance process.
In this study we try to define the parasite population structure in Cambodia and
an association with artemisisnin resistant based on the whole genome sequencing
data from the study of O. Miotto and colleagues [Miotto et al., 2013]. We try to
identify the parts of the parasite genome associated to these markers, which support
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the acquisition and transmission of artemisinin resistance in Cambodia. In the next
chapter we discuss some important DNA sequencing techniques developed over years
and mention data post-processing methods used to produce whole genome sequencing
data and for the identification of mutations.
1.3.6 Babesiosis
Babesiosis is a worldwide emerging parasite disease with malaria like symptoms.
The increasing prevalence of babesiosis has been observed in the north-eastern and
north-western USA. Human babesiosis is mainly caused by apicomplexan parasite
Babesia microti and is the first pathogen transmitted by blood transfusion. The par-
asite is mainly transmitted to humans from arthropod vector tick bites. The tick
species Ixodes scapularis is responsible for Babesia transmission in the USA. The
other Babesia species affecting humans are Babesia duncani, Babesia divergens and
Babesia venatorum [Vannier et al., 2015]. In general B. microti infects rodents, but
recent reports show that the dear population is playing an essential role in modulating
the vector population. Not much is known about the genomic structure, proteome,
drug targets, population structure and epidemiology of this parasite.
1.3.6.1 B. microti genome
The genome of B. microti has been sequenced recently. The B. microti R1 strain
genome is the reference genome for this species. The parasite was isolated from the
blood of a patient and was propagated in gerbils and hamsters [Cornillot et al.,
2012]. This strain provided a unique opportunity to probe the genome composition
of this parasite. The sequencing of B. microti genome and the first annotation was
completed in 2012 [Cornillot et al., 2012]. In 2013, a whole genome map of both
the R1 strain as well as another B. microti isolate known as the Gray strain was
completed [Cornillot et al., 2013]. More recent efforts have led to the sequencing of
several isolates from human, ticks and infected animals. In these analyses the genome
size of B. microti genome is reported between 6.3 mbp and 6.9 mbp depending on the
isolate, making it the smallest nuclear genome among other Apicomplexa [Cornillot
et al., 2012, Cornillot et al., 2013] till date. The genome consists of four chromosomes
encoding 3567 protein-coding genes, most of which are expressed during parasite
development in mammalian red blood cells. It has a G+C content of around 36%.
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The organelle genomes, mitochondria and apicoplast (in context of this thesis and
is mentioned in Chapter 4), of B. microti are also sequenced [Cornillot et al., 2013,
Garg et al., 2014]. The phylogenetic analyses revealed that B. microti represents
a new lineage within apicomplexans, which is distinct from lineages encompassing
Plasmodium species, Theileria species and Babesia bovis. Extensive 18S phylogenies,
based on sequencing data from databases, revealed that the B. microti clade is highly
diverse with host specificity among different groups [Schnittger et al., 2012].
The genome annotation of R1 isolate and subsequent metabolic pathway reconsti-
tution revealed novel antigens and several metabolic functions that could be targeted
for the development of new diagnostic tests and more effective therapies [Cornillot
et al., 2016]. The drug used for the treatment of babesiosis is atovaquone. Mutations
in the cytochrome b (cytb) gene in the mitochondrial genome are associated to ato-
vaquone drug resistnace. The other drug used is quinine. The usage of this drug is
questionable due to the side effect associated with this drug, the lack of evidence that
B. microti degrades hemoglobin and the inability of the compound to inhibit growth
of the parasite in mice, suggesting that its use for babesiosis treatment should be
reevaluated. Clindamycin and azytromycin used in combined therapies for babesiosis
and are expected to target translation in the apicoplast. Most of the immunocompe-
tent patients recover from babesiosis without the need for treatment and present only
flu-like symptoms, but some immunocompetent individuals can develop moderate to
severe disease symptoms which could also be fatal.
1.3.6.2 Symptoms
The symptoms of babesiosis are similar to diseases with flu like symptoms (inflam-
matory response). This also contributes to the misdetection of B. microti infection
with P. falciparum infection due to similarity in blood smears. B. microti is mainly
confused with lyme disease in the absence of erythema migrans (specific lyme dis-
ease rash), as both the pathogens are prevalent in the same geographical areas. The
early symptoms of B. microti infection are high fever, chills and headache followed by
malaise, fatigue, drenching sweats, muscle pains, nausea, vomiting, hypotonia, liver
problems, severe hemolytic anemia and kidney failure in moderate illness [Vannier
et al., 2015]. Severe cases are often associated with immunologically depressed indi-
viduals, either due to HIV infection or after immune suppressive medication (e.g. in
case of B-cell lymphoma). Also, splenectomy supports B. microti development, as
1.3. APICOMPLEXAN INFECTIONS AFFECTING HUMANS 31
the spleen is one of the major organs where B-cells are activated. The life cycle of
B. microti does not have any liver stage unlike P. falciparum. Also no human trans-
mission, because of low exposure to ticks and ticks bite only once. When considering
babesiosis, in addition to the blood smear more specific tests should be considered,
such as immunefluorescenceassay (IFA), which is the most common serological test,
and particularly PCR for confirmation of the diagnosis. PCR is highly sensitive in
the detection of acute babesiosis, i.e., the infections with as few as three parasites in
100 microliters of blood can yield a positive result [Persing et al., 1992, Wilson et al.,
2015]. PCR is performed with two clade specific primers design in the 18S gene such
as piroA/piroB or BAB1/BAB4. Size polymorphism is used to distinguish between
species and sequencing is used to identify group among B. microti isolates.
1.3.6.3 Diagnosis
The diagnosis of B. microti infection by detection of parasites in blood smears is chal-
lenging and inconclusive, and can lead to misdetection of babesiosis cases as malaria
cases. The detection is more challenging in infected individuals with very low levels
of parasitemia, such as asymptomatic blood donors in transfusion-associated cases or
following treatment with currently approved combination therapies. Furthermore, it
is difficult to discriminate between infections caused by P. falciparum and B. microti
based on microscopy results in patients whose travel histories cannot exclude either
parasite [Lantos and Krause, 2002]. Cross-reactivity between specific antigens of dif-
ferent hemoparasites has been previously described for B. bovis and P. falciparum
[James et al., 1987] and could also be true for B. microti. Therefore, considering
the extensive travel history of the patients, including areas endemic for the malaria
parasite, is essential for distinction between malaria and babesiosis.
Diagnosis of babesiosis is also difficult because of the diversity of symptom be-
tween patients, which can range from asymptomatic including fever to severe including
spleen disruption. The rapid growth of the parasite in patient blood is not always
observed and followed, which increases the severity of the disease and leads to hemol-
ysis and other associated complications. B. microti has been identified as a human
pathogen since the late 1960s and despite the increasing number of cases of human
babesiosis reported each year, little is known about babesiosis pathogenesis. The
current diagnostic tests and therapies are not ideal and needs to be reevaluated.
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1.3.6.4 Therapy
Most of the B. microti infected people are asymptomatic and recover naturally from
babesiosis. The treatment regime is essentially recommended for patients with active
babesiosis, which is associated with symptoms described above. The illness usually
results 1-2 weeks after administration of single course of therapy, which combines an
anti-malaria drug and an antibiotic and observation of clinical improvements after
48 hours. Current therapy regimes for treatment of human babesiosis caused by B.
microti consist of combinations of atovaquone and azithromycin for 7 to 10 days for
patients with mild to moderate disease or quinine and clindamycin for at least 6
weeks for patients with severe disease [Vannier et al., 2015]. There is a need to survey
patients at least for hemolysis and parasitemia during the complete period of drug
administration and continuation of therapy until parasitemia is cleared. As stated
earlier, some major side-effects associated to quinine have been observed, such as
shakiness, hearing deficiency or cardiac effects. Intravenous quinine treatment, which
is often performed in the early phase of infection must be associated with cardiac
profile monitoring. The capacity of the patient to support both therapy regimes
for mild and moderate scenarios should be taken into consideration. Although both
combinations are generally effective, drug failures and major side effects have been
observed [Vannier et al., 2015].
Partial or complete blood transfusion must be considered for severe babesiosis
when parasitemia levels grow over 10%, when liver or renal impairment are observed
or when patients are presenting ARD syndrome (ARDS). Patients more susceptible
to severe babesiosis are immunocomprised after cancer treatments, organ transplants
or other reasons. In the past, AIDS patients were also presenting severe babesiosis,
but the former disease is becoming rarer in the USA. Mortality rate of these patients
remains at the level of 20% even after blood transfusion. Blood transfusion remains
also a concern, as control of blood samples for the presence of Babesia parasite is still
not possible. Indeed, B. microti becomes the first pathogen transmitted by blood
transfusion in the USA. The threat of B. microti should also be taken into account
in other countries where B. microti is still not prevalent. As was exemplified by
the description of the first Australian case in a patient that receive extensive blood
transfusion after a car accident [Senanayake et al., 2012].
For patients travelling to, or residing in areas endemic for both malaria as well
as babesiosis, correct diagnosis might prove difficult, so there is a need to consider
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expertise of experienced reference centers for infectious diseases for evaluation of blood
smears. In case of doubtful diagnosis, hospital admission should be considered for
patients with more severe symptoms and an extremely detailed travel history should
be taken into consideration to distinguish between an infection with Babesia spp.
or Plasmodium spp. based on incubation period, mode of infection and presence of
vectors. Both inpatients and outpatients who have suspected babesiosis, but are not
initially treated should be closely observed over time. Recent validation of targets for
sensitive and specific B. microti assay is promising for future development of highly
sensitive and specific EIA test for babesiosis [Cornillot et al., 2016].
The cases of babesiosis are emerging worldwide and Asia could be the next area
of emergence of human babesiosis. Reports on simultaneous infection with both
apicomplexan parasites are uncommon, except near the China-Myanmar border [Zhou
et al., 2013]. Careful diagnosis of babesiosis in south-east Asia where malaria is also
endemic is important to prevent misdiagnosis of babesiosis cases as drug-resistant
malaria.
1.3.6.5 Bacterial coinfections
The tick vector Ixodes scapularis is present in north America, where Babesia microti
Anaplasma phagocytophilum (previously referred to as Ehrlichia phagocytophila) and
Borrelia burgdorferi infections are endemic. Parasite and bacteria are transmitted
from rodents to humans in the northeastern and midwestern US. Furthermore, it
is also important to emphasize that human co-infection with Babesia microti and
tick-transmitted bacteria of the genera Ehrlichia, Anaplasma or Bartonella have also
been reported in different regions of the world. Co-infections are also frequently
observed in the environment, in rodent and tick populations. Interestingly, genome
sequencing revealed the lateral transfer of a Bartonella gene encoding a putative
thiamin pyrophosphokinase into B. microti genome.
1.4 Genomic data functional analysis
1.4.1 Sequencing technologies
Sequencing provides the orderly construction of nucleotides (A, T, C and G) in a
molecule of DNA. The first DNA sequencing was produced by Fred Sanger in 1950’s,
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for which he received the Nobel prize. Later in the 1970s, Maxam and Gilbert devel-
oped methods to sequence DNA based on 2D chromatography and chemical degra-
dation [Maxam and Gilbert, 1977]. In 1977, Fred Sanger developed the chain ter-
mination method to sequence DNA, commonly referred to as the Sanger sequencing
method [Sanger et al., 1977]. This method became the most used DNA sequencing
method, as it required less chemicals and radioisotopes and was much reliable com-
pared to other methods [Van Dijk et al., 2014]. These DNA sequencing methods
are referred to as the first generation sequencing techniques. Since 1990, efforts have
been made to improve the DNA sequencing methods. New technologies producing
high-throughput data in less cost have been developed and are known as the Next
Generation Sequencing (NGS) methods. Most of these methods utilize DNA poly-
merase catalysis and nucleotide labeling techniques. Due to the growing demand of
DNA sequencing to answer important genetic level questions, platforms are continuing
their efforts to generate sequence data faster, cheaper and at higher volume [Schuster,
2008].
The first genome sequence of P. falciparum (3D7 clone; canonical reference genome)
was produced using Sanger sequencing method [Gardner et al., 2002]. The nuclear
genome of P. falciparum is around 23 megabase and comprises of 14 chromosomes,
encoding aroud 5,300 genes. Sequencing was challenging because the AT content of
this genome is very high. B. microti is a more recent genome to be sequenced using
this technique [Cornillot et al., 2012].
Development of genome sequencing technologies and platforms has helped in pro-
ducing unbiased and reliable results. Availability of whole genome sequencing data
has made possible the identification of parasite population structure and loci asso-
ciated to drug resistance [Takala-Harrison et al., 2013, Miotto et al., 2013]. Due to
the availability of large number of genome sequences from around the world, pop-
ulation genomic studies have become an important analysis tool to examine and
track the genetic variations and evolution of parasite populations locally and glob-
ally. Such information can help in following the transmission and acquisition of drug
resistance, which provides an opportunity to design guidelines to contain and eradi-
cate malaria [Carlton et al., 2015]. This section explains the basic principles involved
and the limitations of some of the widely used DNA sequencing methods.
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1.4.1.1 First generation sequencing techniques
The first generation sequencing strategies comprises the Maxam-Gilbert method and
chain-termination method developed in the 1970’s.
1.4.1.1.1 Maxam-Gilbert sequencing method
Allan M. Maxam and Walter Gilbert developed one of the first DNA sequencing
methods in 1977 [Maxam and Gilbert, 1977], for which they won a Nobel prize.
In this method terminally radioactive labeled DNA is chemically cleaved at guanine
(G), guanine + adenine (G+A), cytosine (C) and cytosine + thymine (C+T), pro-
ducing radioactive fragments of the length equal to the cleaved position from the
labeled terminal. The concentration of the chemicals used is controlled to approxi-
mately introduce one modification per molecule, which are separated using gel elec-
trophoresis. These radio labeled DNA fragments produced from the four reactions
are separated using electrophoresis through high resolution acrylamide gels. The se-
quence is inferred from the dark bands depicting the position of the radio labeled
nucleotides [Maxam and Gilbert, 1977].
This method was widely accepted as sequencing method, because of its ability to
sequence the purified DNA directly. It could sequence around 500 bp. Some of the
drawbacks of Maxam-Gilbert method were setup complexity, use of hazardous chemi-
cals, low read length for incomplete cleavage reactions and difficulty in differentiating
bands on the gel [Liu et al., 2012].
1.4.1.1.2 Chain-termination sequencing method
Frederick Sanger, developed the DNA sequencing method in 1977 based on chain-
termination inhibitors of the DNA polymerase at specific residues [Sanger et al.,
1977]. This method gained popularity from 1980s to 2000, as it required less chem-
icals and lower levels of radioactivity [Morozova and Marra, 2008]. This sequencing
method used single stranded DNA, DNA primer, DNA polymerase 1, deoxynucleoside
triphosphates (dNTPs; dATPs, dTTPs, dCTPs and dGTPs), and di-deoxynucleoside
triphosphates (ddNTPs; ddATPs, ddTTPs, ddCTPs and ddGTPs). In this method
also, four different sequencing reactions are set up to detect the four nucleotides A,
T, C and G. To each reaction ssDNA (5’ -> 3’), DNA polymerase, dNTPs and only
one of the ddNTPs were added. The DNA polymerase incorporates dNTPs comple-
mentary to the target DNA strand and stops when encountered with a ddNTP, as
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no free hydroxyl group available to react with DNA polymerase. Hence, fragments
with different sizes and same primer at the 5’ end are produced for each of the four
reactions. The different sized fragments for the four reactions are separated using
gel electrophoresis and the dark bands on the gel is descriptive of the position of the
nucleotide in the sequence.
This method provides highly accurate results for short fragments only. This
method can produce sequence reads of size 600 nucleotides on an average. The major
disadvantages of this method were non-specific primer binding and short read length.
To perform sequencing on longer DNA sequences, extension of this method known as
shotgun sequencing method was developed [Shendure and Ji, 2008].
1.4.1.1.3 Shotgun sequencing method
This method based on the Sanger sequencing method was the most advanced tech-
nique for sequencing large genomes and was described in the early 1980s [Green,
2001]. In this method the different size fragments of DNA clones are sub-cloned into
vectors. Then fragment libraries are created and the vector DNA is isolated to be se-
quenced using chain termination method, generating redundant amounts of sequence
data from one or both ends of random fragments. Consensus sequence is deduced
from computational assembly of these redundant sequence read fragments [Staden,
1979].
The applications were limited due to increased complexity caused by the large size
of the genome and the assembly process. Therefore, before initiation of sequencing
process a physical map (overlapping genome fragments of source genome) of the
genome was created by arrangement of YAC (Yeast Artificial Chromosome) or BAC
(Bacterial Artificial Chromosomes) clones. These genome fragments were further
randomly fragmented into smaller fragments to be sequenced using shotgun method.
This process is known as hierarchical shotgun sequencing and is slower than the whole
genome shotgun sequencing method.
The main drawbacks of shotgun sequencing were the sequence gaps and misas-
semblies due to repetitive sequences. In the case of B. microti for example, the first
release of the genome contained two gaps and two chromosomes were merged in a
single contigue [Cornillot et al., 2012, Cornillot et al., 2013]. But because of the abil-
ity to generate large amounts of sequence data from full genome rapidly (500 bp per
day) for identification of conserved sequence and avoid the step of creating physical
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maps, whole genome shotgun sequencing was used primarily as the sequencing method
to sequence genomes of small bacteria, Drosophilla and eventually humans [Green,
2001], which was achieved utilizing paired-end tags strategy, increasing the sequenc-
ing efficiency. In this strategy paired ends from both the ends of DNA fragments are
sequenced [Venter et al., 2001].
This method was used to determine the sequence of canonical reference strain
Plasmodium falciparum 3D7. Some chromosomes showed gaps (mostly <2.5Kb) in the
consensus sequence after assembly. The reason for the problem caused in sequencing
and assembly process was the high A+T rich P. falciparum DNA [Gardner et al.,
2002]. The biased AT richness of the DNA causes library creation problems, as
the complexity (combination of nucleotides) of base pairs is reduced compared to
source genome, causing production of overlapping sequence. This makes the assembly
process difficult by wrong assembly of short read sequences, which leads to creation
of gaps [Carlton et al., 2015].
1.4.1.2 Next generation sequencing (NGS) techniques
The extensions of the Sanger sequencing method were the dominant sequencing tech-
niques till 2005. Some of the limitations and drawbacks of the Sanger sequencing
method were using gels or polymers as separation media, sequencing of limited num-
bers of samples in parallel and the creation of libraries by cloning onto a bacterial
host. This was time consuming and can include host biases [Morozova and Marra,
2008]. Though the first human genome was sequenced using parallel processing of
Sanger method in 2004 [IHGSC, 2004], there was a need of financially cheap sequenc-
ing methods producing high throughput results. This was the motivation for the
development of NGS techniques. The methods developed over the last 15 years have
overcome those limitations [Van Dijk et al., 2014]. This section presents the descrip-
tion of the important NGS technologies developed and commercialized by different
platforms over the world [Hall, 2007].
1.4.1.2.1 454 Pyrosequencing method
This was one of the first NGS technologies released and commercialized in 2005 by a
US based biotech company 454 Life Sciences, part of Roche Diagnostics [Margulies
et al., 2005]. This technology used the pyrosequencing technique and improved the
DNA amplification process. This reduced amplification time and removed biases due
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to amplification in a bacteria cell. This method detects the incorporation of a nu-
cleotide by a DNA polymerase in real time (also known as sequencing by synthesis
approach) and was faster than the dye-termination method as explained above [Shen-
dure and Ji, 2008].
The target DNA is sheared into small fragments, which are ligated with common
adapters and are amplified on the beads (streptavidin-coated magnetic beads) using
water in oil emulsion PCR technique. These beads are then loaded onto the Pico Titer
plate device which allows for only one bead per well (reaction chamber). The base of
this slide is attached with CDD imager to detect the light signals [Margulies et al.,
2005]. The sequencing approach was based on detection of polymerase activity by an
enzymatic luminometric inorganic pyrophosphate detection assay (ELIDA) [Nyren,
1987]. Each well is supplied with one of the four dNTPs, DNA polymerase, ATP
sulfurylase, luciferase and apyrase, and with the substrates adenosine 5’ phospho-
sulfate (APS) and luciferin. The oxyluciferyn producing visible light is produced in
two reactions, using pyrophosphate (PPi) released during polymerase activity. The
sequence of each DNA template is determined from a pyrogram, which corresponds
to the order of correct nucleotides that had been incorporated [Morozova and Marra,
2008].
This NGS technology is discontinued [Goodwin et al., 2016], but was capable of
generating 80-120 Mb of sequence in 200 to 300 bp reads in a 4 hour run [Morozova
and Marra, 2008]. The major drawbacks of this technology were low throughput,
high reagent cost, relatively high error rates in homopolymers and the shorter read
lengths which makes the assembly process difficult.
1.4.1.2.2 Illumina sequencing method
The Illumina/ Solexa sequencing technology [Bentley et al., 2008] was developed and
commercialized by Solexa in 2006, acquired by the USA based company Illumina in
2007. This technology differs from the pyrosequencing method in DNA amplification
process and sequencing by synthesis process. This technology amplifies DNA using
solid phase bridge PCR process in flow cells. Also, the real time sequence detection
is achieved using the dNTPs attached with reversible termination group and fluores-
cent dye [Chen et al., 2013]. This technology produces shorter reads, but cost for
sequencing each base is lower than the pyrosequencing method.
The large DNA to be sequenced is sheared into small fragments and each strand is
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attached with a primer sequence, index sequence and the adapter sequence [Bentley
et al., 2008]. DNA insert is achieved by isothermal amplification of the target DNA
fragment. The modified DNA strands are passed on to the flow cell, which is a glass
slide with lanes containing oligonucleotide sequences complementary to the adapters
attached to the DNA fragment. The adapters attached to the DNA fragment on
both ends are complimentary to each other. The fragments are amplified using bridge
PCR technique. The clonal amplification step increases the quality of the sequencing
signal. The double stranded fragments are denatured resulting into forward strand
and reverse strand. After the clonal amplification the reverse strands (reverse strand
of the source DNA fragment) are cleaved and washed from the flow cell. Sequencing
in each strand begins at the 3’ end. A special polymerase is used to incorporate the
nucleotides with fluorescence dye tag and 3’-reversible terminator, which blocks the
addition of other nucleotides (ddNTPs), improving detection of homo-polymers unlike
in pyrosequencing method. The 3’ group can be removed by chemical or enzymatic
hydrolysis [Canard and Sarfati, 1994]. All the nucleotides have different light emission
properties and all the four nucleotides are supplied to the flow cell in each cycle, but
only one is incorporated [Chen et al., 2013]. Therefore, number of cycles is equal to
the length of the fragment. On addition of each nucleotide, a light is emitted specific
to the added nucleotide.
Both, forward and reverse strands are sequenced and the reads are clustered based
on the index sequence of each fragment. For each sample, reads with similar base
calls are clustered, and forward and reverse reads are paired [Bentley et al., 2008].
These read sequence clusters are used for the de novo assembly process to predict the
sequence of an unknown genome or aligned to the reference genome to identify the
nucleotide variations such as SNVs and INDELs.
This approach increased the throughput by improving the amplification and se-
quencing by synthesis steps. Making the real time sequencing step independent of the
enzymatic action unlike the earlier methods, significantly decreases sequencing time
and increases sequencing capacity. Accuracy of base calling also improved because
of pair-read sequencing. Illumina sequencers are capable of producing upto 400 bp
long reads. One of the major drawbacks of high throughput technologies is short read
lengths, making the assembly process difficult [Morozova and Marra, 2008, Van Dijk
et al., 2014]. Sources of calling errors could be base substitutions caused by modified
DNA polymerase and reversible terminators or due to biased PCR reactions because
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of bias in the base composition (like AT richness in P. falciarum genome).
PCR amplification is the major source of errors. Efforts have been made to im-
prove the results by modulating the library preparation techniques [Oyola et al., 2012].
For sequencing of P. falciparum genome, better results have been shown with selec-
tive PCR conditions (specific polymerase and improved enzymes) in Illumina library
preparation, generating unbiased results and greater coverage at AT rich regions [Oy-
ola et al., 2012]. The P. falciparum genomic data used in this study, could be the
data used in the population structure description study, explained in Chapter 2 and
Chapter 3. Continuous efforts are being made to to remove the errors and optimize
the sequencing process facilitating accurate SNP detection.
1.4.1.2.3 Polony sequencing method
This sequencing technique was developed by George M Church in the same year as
pyrosequencing technique by 454 Life Sciences. One of the biggest advantage of this
technology is that the software and the protocols has been made open source [Hall,
2007]. This technology is based on sequence by ligation method and uses emulsion
PCR to amplify the signal. Using this technology, the genome of E. coli was sequenced
in 2005 [Shendure et al., 2005].
In this technique the library of randomly sheared DNA fragments is created using
rolling circle replication and emulsion PCR. The replicated circular fragments are
cleaved at 17-18 bp from T30 and ligated with two adapter sequences for hybridization
to beads on the ends of the fragments. Total length of this modified fragment is 135
bp and each strand of the fragment is amplified using emulsion PCR on a bead. These
beads are mixed with acrylamide and poured into a teflon-masked microscope slide,
covered by a coverslip which is washed with aminosaline to enable the covalent binding
because of the free hydroxyl group between the DNA templates attached to the bead
and the coverslip. This polymerization results in the formation of a monolayer of
beads in the acrylamide gel. The reagents, anchor primers and degenerated nonamers
are passed between this monolayer and the microscope slide [Shendure et al., 2005].
Each of these nonamers has specific fluorescent markers and one of the four bases (A,
T, C and G) at one of the 9 positions. Polymerase is not used and these nonamers are
selectively ligated to the anchor primer, producing a fluorescent signal corresponding
to one of the four bases. Like these seven bases from the 5’ to 3’ direction and six
bases from the 3’ end can be recovered. For each DNA fragment, a 26 bp read is
1.4. GENOMIC DATA FUNCTIONAL ANALYSIS 41
recovered (for both forward and reverse strand) [Shendure et al., 2005].
This technology was cheaper than the conventional sequencing methods and open
source platform, but the paired-reads produced were very short causing problems in
the assembly process and low accuracy due to complex amplification and nonamer
cleavage steps [Hall, 2007].
1.4.1.2.4 SOLiD sequencing method
The SOLiD (Sequencing by Oligonucleotide Ligation and Detection) technology was
commercialized by the USA based company Applied Biosystems, brand of Life Tech-
nologies and owned by Thermo Fisher Scientific corporation. This technology is based
on Polony sequencing technique as explained above and was commercialized in 2008.
This technology is based on 2 base encoding and is able to sequence around 35 bases
which is more than the polony sequencing method where only 26 bases could be
sequenced [Shendure et al., 2005].
The sheared DNA fragments (up to size 35 bp) are tagged with two adapters at
both ends. The DNA libraries are created using emulsion PCR. The PCR products
are transferred onto a glass surface. The sequencing occurs at this glass surface by
hybridization and ligation of octamer probes (one of the 16 dinucleotide known bases
+ 3 degenerated bases + 3 degenerated bases attached to fluorescent dye). There is
a cleavage site between the 5th and the 6th positions of the probe for SOLiD version
2 and between 4th and 5th for SOLiD version 1 [Mardis, 2008]. In the sequencing
reaction on this glass side, universal primers (length n) with free 5’ phosphate group
and the octamer probes are provided. The primer is annealed to the 5’ end adapter
sequence of the DNA fragment. The probe having the complimentary dinucleotide of
the first two template dinucleotides is ligated to the primer. The fluorescent signal of
the ligated probe is read and the probe is chemically cleaved at the 5th position leaving
a free phosphate group available for the next probe ligation. Ligation cycle is repeated
up to 7 times and after that the initial primer and all the ligated probes (length 5)
are denatured and removed from the reaction. A new reaction is started with a new
universal primer (length n-1) and the probes and so on [Applied Biosystems, 2016].
For each DNA fragment a sequence read of length around 35 bp is produced after
5-7 ligation events X 5 primer cycle reactions [Mardis, 2008]. Each base is sequenced
by two probes and in two different primer cycle reactions. The read is deduced from
the color space. The color peaks recorded for the fluorescence activity in the same
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way as in the Illumina sequencing technology. With the knowledge of the first base
of the DNA fragment, the full sequence can be derived by converting the color space
to base space [Mardis, 2008].
This is the only NGS technology that is based on sequencing by ligation process
and is one of the high throughput methods. It offers improved accuracy and validation
of sequencing reads as each base is sequenced twice, differentiating errors from true
variations as compared to the reference genome. The drawbacks of this technology
are shorter read lengths and long run time. Each SOLiD sequencing run produces
around 3 Gb of sequence data with an average read length of up to 35 bp in around
6-8 days [Morozova and Marra, 2008].
1.4.1.2.5 Ion Torrent sequencing method
The Ion Torrent sequencing method was developed by Jonathan Rothberg (founder
of 454) at Ion torrent systems Inc. owned by Life technologies corporation founded
in 2008. The DNA sequencing approach is similar to that of the 454 pyrosequencing
method and was commercialized in 2010. This technology directly translates chemi-
cally encoded information into digital information on a semiconductor chip [Rothberg
et al., 2011] and is improved over the other sequencing methods, as no fluorescent
detection or modified polymerase or nucleotides are used. This technology utilizes
amassively parallel semiconductor sensing device to detect the hydrogen ion released
on addition of a nucleotide. It is one of the fastest, cheapest and scalable DNA
sequencing methods [Van Dijk et al., 2014].
The library creation of the DNA to be sequenced is similar to 454 pyrosequencing.
The amplified beads containing the ssDNA fragments are added to the microarray
chips, which contain millions of reaction wells of the size close to a single bead. In
the sequencer this chip is added on top of a ion-sensitive field-effect transistor based
sensors (ISFET sensor), which are compatible with complementary metal-oxide semi-
conductor (CMOS) process to convert the chemical signal into digital signal [Rothberg
et al., 2011]. In each reaction well, PPi and hydrogen ion are released due to each
polymerase reaction and the change in the pH of the solution is recorded by the
CMOS sensor. The information about the supplied dNTP and the change in the pH
is used to determine the complementary DNA sequence. The level of change in the
pH of the solution depicts the number of nucleotides added in single reagent cycle
[Rothberg et al., 2011].
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This sequencing method provides increased accuracy of sequenced reads with fewer
errors. Not relying on the signal detection method as used in other technologies, it
increases the speed and accuracy of sequencing. Some errors can occur in reading
homopolymers. The capacity of microarray chip has increased from 10 Mb (Ion
Personal Genome Machine) to 10 Gb (ion proton sequencer). This technology is
capable of producing up to 300 million reads of length 200 bp with close to 100 gb of
data in approximately 3 hours [Frey et al., 2014].
1.4.1.2.6 PacBio sequencing methods
The PacBio DNA sequencing technology also referred to as Single Molecule Real
Time (SMRT) DNA sequencing method was developed and commercialized by a
USA based biotechnology company Pacific Biosciences. This is one of the most recent
technologies. This technology is based on sequencing by synthesis approach. This
technology does not require amplification of the DNA sequence (which helps in even
genome coverage) and instead relies on real time DNA polymerase action to complete
the strand complementary to the target strand [Liu et al., 2012].
The technologically advanced part of this sequencing process is the zero mode
waveguide (ZMW), which maintains high signal to noise ratio. In each ZMW an
active DNA polymerase and a ssDNA molecule are immobilized at the bottom. Each
SMRT cell contains thousands of ZMWs (reaction chambers), which are illuminated
from below with light having wavelength greater than the diameter of the ZMW and
not allowing the light to pass through the cylindrical waveguides. DNA polymerase
action is fast and unaltered. During polymerase action the fluorescence label is excited
and emits light which is captured on a sensor. The sequential emission of lights due to
incorporation of complementary fluorescence labeled dNTPs in real time is continuous
and enables sequencing of long reads using natural DNA synthesis process [Levene
et al., 2003].
This technology utilizes the efficiency of DNA polymerase action without any
alterations and sequences the target DNA molecule in real time. This technology is
capable of producing 50k reads of continuous long read length of 10 to 15 kb utilizing
150,000 ZMWs in approximately 4 hours [Rhoads and Au, 2015]. The drawbacks of
this technology is high fluorophore-dependent raw read error rate compared to other
technologies and high price per Mb of data. This technology is considered as the
onset of third generation sequencing technologies, which aims to further increase the
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performance and decrease the cost and complexity of DNA sequencers [Rhoads and
Au, 2015].
1.4.1.2.7 Overview of Sequencing technologies
In the above sections, the most commercialized and used next-generation sequencing
methods have been explained. The most popular and successful NGS platforms are
454, Illumina, SOLiD, Ion Torrent and PacBio [Van Dijk et al., 2014] (454 discontin-
ued). These technologies have improved the amplification step and material loss due
to selective reagents. With improved sequencers and base-calling software, long reads
have become available, which enable for de novo genome assembly and metagenomic
studies by Illumina and 454.
PacBio technology provides the longest reads and is suitable for complete genome
sequencing. Illumina offers one of the highest throughput and lowest per base calls
(HiSeq X Ten), because of improved amplification process, clustering process, reagents,
and signal detection technology. This technology can help in population genomic anal-
ysis [Van Dijk et al., 2014]. Illumina is the most effective for de novo assembly as
it offers read-pairs. The fastest sequencing platform is Ion Torrent (PGM platform)
and PacBio platforms, the latter being more expensive and more error prone. A com-
paritive study of these three platforms Ion Torrent PGM, PacBio RS and Illumina
MiSeq, has shown better results for P. falciparum genome sequencing and variant
calling Illumina sequencing platform [Quail et al., 2012]. The P. falciparum genomic
data used in this study, could be the data used in the population structure description
study, explained in Chapter 2 and Chapter 3.
New technologies are developing on assessing single molecule undergoing natural
processes [Morozova and Marra, 2008]. One of the promising sequencers made avail-
able is MinION, which is based on Oxford Nanopore technology. This technology
avoids the use of secondary signals for detecting base incorporation or hybridization.
In nanopore technology, the real-time base detection is performed by passing a ssDNA
through a protein pore with passing current. The DNA sequence is charaterized by
changes in voltage due to translocation of DNA by secondary motor proteins [Good-
win et al., 2016]. Overall, sequencing platforms are entering the third generation
of sequencing technologies and aimed at increasing throughput, avoiding amplifica-
tion bias, producing longer reads with higher consensus accuracy for haplotype and
rare mutation detection, reducing reagents and the cost to sequence the target DNA
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molecule [Liu et al., 2012].
The rapid advancement of sequencing technologies and rapid production of huge
amounts of genomic data have led to the development of bioinformatics and data
analysis tools. Algorithm and methods have been developed to remove the low quality
called bases, remove noise, assemble the short reads, data and functional analysis.
The next chapter discusses the use of NGS genomic data available at various public
databases for variant calling and functional analysis.
1.4.2 Data processing and variant recovery
In the previous section, we have seen different techniques and platforms producing
sequencing data. Over the past years, a large amount of sequencing data has been
produced for genomic studies and identification of genomic variations in the form of
single nucleotide variants (SNVs), insertions/deletions (INDELs), copy number varia-
tions (CNVs), or other structural variants (SVs). SNPs are an important category of
genetic variations and can influence disease risk and associated drug efficacy. Using
whole genome sequencing data, P. falciparum population structure based on non-
synonymous SNPs, marker SNPs have been identified in the K13 gene associated
to artemisinin resistance and SNPs are identified in background genes in South-east
Asia (SEA) [Miotto et al., 2013, Ariey et al., 2014, Miotto et al., 2015]. CNVs due
to recombination events are other important source of variation in the population.
One of the ways for identification of CNVs is genome-wide association study (GWAS)
analysis. Recently, a study by Cheeseman and colleagues [Cheeseman et al., 2016]
showed different frequencies of CNVs in different size P. falciparum populations in
Africa, South America and SEA based on microarray experiments. They provide evi-
dence for prevalence of deleterious CNVs and identify CNVs under positive selection,
including CNVs encompassing 1)Pfrh2b (reticulocyte binding-like homologue protein
2), a adhesive molecule involved in erythrocyte invasion and 2)pfmdr1 (multi drug
resistance 1), a well studied locus under strong selection [Cheeseman et al., 2016]. In
this thesis, SNVs are primarily focused for parasite population description and func-
tional analysis. This section outlines methods, techniques and tools for identification
of SNVs and databases for description of associated functions.
For processing and storing the sequencing data, specific file formats have been
created. These file formats have become standard and suitable for different algorithms
and platforms for the analysis of sequencing data. The process of variant calling can
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be divided into 4 steps: (1) quality assessment of the raw data, (2) alignment of the
reads to reference targets, (3) processing of reads after alignment for variant discovery,
and (4) genomic and functional analysis of variants. In this section we mention the
processing steps after alignment (post-processing) required and tools used to curate
the raw sequencing data from various sequencing platforms into readable format files
and make it available for genomic analysis [Dolled-Filhart et al., 2013, Bao et al.,
2014]. Only read alignments on reference genome are discussed and not de novo
assembly.
1.4.2.1 Quality assessment
The data produced from the DNA sequencer, containing the information regarding
raw sequencing reads and the quality scores is stored in FASTQ format files, which is
the standard format published by the Wellcome Trust Sanger Institute [Cock et al.,
2010]. Quality scores are the Phred-scaled scores, which gives the likelihood that the
base quality is correct. It is defined as -10log10(P), where P is the base-calling error
probability, which is based on detected signal for each base. The Phred-scaled values
are used to deal with small numbers.
In the FASTQ files information for each read is represented by 4 parts; first part
is an identifier associated with the read, second part is the sequenced read, third
part is the quality score identifier and fourth part gives the Phred-scale based quality
score associated with each base in the read, using an ASCII code [Cock et al., 2010].
For short sequences each part is in one line, but for longer sequences it can be in
more than one line. Usually the size of these files is huge. Therefore, to reduce the
processing time these files can be divided into shorter files, processed in parallel and
the results can be combined later.
The other format used for representing nucleotide or peptide sequences is FASTA
format. The first line of each sequence is the header starting with the symbol “>”
describing the sequence. Each nucleotide and peptide base is represented by one
letter and the sequence is represented by a continuous string of letters. This format
is usually used to store reference sequences [Pearson and Lipman, 1988].
To recover statistics on the raw reads several tools are available such as FastQC
[Andrews, 2010]. These methods can provide statistics regarding quality distribution
along the reads, GC content, read length distribution, duplication of sequence reads
and check for adapter. These statistics are used to determine if the raw reads needs
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to be filtered for noise. At the pre-processing step (before alignment), the bases with
very low quality score, base associated to primers and adapters can be removed. Tools
such as Cutadapt [Martin, 2011], can be used to perform for the filtering of these
raw reads [Bao et al., 2014].
1.4.2.2 Alignment
Over the years many alignment tools have been developed for the alignment of se-
quencing reads accurately and efficiently to a reference genome such as MAQ [Li et al.,
2008], BWA [Li and Durbin, 2009], Bowtie [Langmead et al., 2009], NovoAlign [Novocraft,
2016] and others. The tool to be used for the alignment of the reads depend on fac-
tors like, sequencing method used and amount and the length of the reads to be
mapped [Bao et al., 2014]. The main strategy in these programs is to reduce the false
positive matching and avoid loss of biologically important variables. Tools like BWA
and Bowtie are more fast and tools like NovoAlign are sensitive [Dolled-Filhart et al.,
2013]. These tools are mostly based on two algorithms for matching the read to the
reference genome, Burrows-Wheeler Transformation (BWT) compression techniques
and Smith-Waterman (SW) Dynamic programing algorithm. BWA and Bowtie are
based on BWT technique and are one of the most used alignment tools [Bao et al.,
2014]. Also, tools like BWA provide a mapping quality score for each assembly based
on various factors which assess the confidence and accuracy of the called base [Li
et al., 2009]. The output of of these mappers in Sequence Alignment/Map (SAM)
format files are converted to Binary Alignment/Map (BAM) format files using SAM-
tools [Li et al., 2009]. These alignment format files can further be visualized using
many online and offline tools available like ARTEMIS [Carver et al., 2012a], IGV
[Thorvaldsdottir et al., 2013] and others.
1.4.2.3 Post-processing and variant calling
After the alignment to the reference genome, these alignments are stored in Sequence
Alignment/Map (SAM) format files and the binary version Binary Alignment/Map
(BAM) format files. These files store and represent the alignment information with
11 fields providing position, orientation and mapping quality of all the aligned reads.
This information is stored in tab-delimited text format with a header section start-
ing with a symbol “@” followed by the alignment section and then the tag section
representing associated quality of the aligned read [Li et al., 2009].
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The information in these alignment files associated to the variations can be fur-
ther processed using SAMtools [Li et al., 2009]. This tool can perform tasks on
the SAM/BAM files, such as sorting, merging, indexing, removing duplicates and
retrieving information from specific regions in the genome. The variant calling can
be performed using tools like SAmtools (bcftools), GATK [McKenna et al., 2010]
and Freebayes [Garrison and Marth, 2012, Bao et al., 2014]. These tools can also
perform statistics based on the quality of reads to help in the process of filtering the
data for a specific analysis [Li et al., 2009, McKenna et al., 2010]. These variant
calling programs provide specific metrics based on base quality and coverage. In or-
der to identify reliable SNVs (Single Nucleotide Variations) accurately, the choice of
the variant calling program should be based on the quality metrics provided by each
program. The calling of SNVs can vary at different coverage levels when using these
programs, as the used statistics and algorithms of these variant calling programs is
different [Yu and Sun, 2013]. In this section we discuss the two most commonly used
variant calling programs, GATK and SAMtools (bcftools).
The NGS analysis program, GATK uses MapReduce framework to process call-
ing of variants in parallel and make the calculations fast. For genotype likelihood
estimation, GATK implements Bayesian model [McKenna et al., 2010]. GATK con-
sists of two main variant calling programs, UnifiedGenotyper and HaplotypeCaller.
UnifiedGenotyper calls SNVs and INDELs, assuming each locus as independent. Hap-
lotypeCaller performs a local de novo assembly and detects SNVs, INDELs with in-
creased accuracy. GATK learns the filters to remove low quality variants from the
data [Yu and Sun, 2013]. Therefore, base quality filter threshold is different for every
dataset.
The other program SAMtools, scans every position in the alignment files and
contains tools for manipulation of aligned reads in SAM/BAM format [Li et al.,
2009, Bao et al., 2014]. For the estimation of sequencing errors SAMtools uses a
MAQ model [Liu et al., 2013]. The mpileup tool, calculates the likelihood of each
possible genotype based on the sequence reads and calculates the consensus genotype.
This function creates a pileup format file containing information for each base in the
genome. The bcftools tool, then uses this pileup file and calls the SNVs and INDELs
based on the genotype likelihood scores. Most of the analysis is based on the analysis
of the variation in the genome compared to the reference genome. In SAMtools, the
estimation of the genotype likelihood of SNVs and INDELs is different from GATK [Yu
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and Sun, 2013]. SAMtools uses predefined base quality filter threshold to remove low
quality variants.
In the sequencing dataset, each base is assigned a Phred-scaled quality score
generated by the sequencer representing the confidence of a base call [Li et al.,
2009, McKenna et al., 2010]. These sequencer generated scores can be biased and
inaccurate. Therefore, before calling of the SNPs in the sequencing dataset, the align-
ments provided by the alignment tools are processed again by these programs. The
duplicate reads starting at the same location are removed keeping the read with the
best alignment quality score. The read sequencing quality scores are recalibrated
based on raw quality scores and allele types. The reads are realigned for accurate
detection of SNPs and INDELs. The mismatching of read alignments to the align-
ment provided by alignment tools are considered as the sequencing errors [Yu and
Sun, 2013].
After the pre-processing step, both the programs GATK and SAMtools identify
the SNPs using Bayesian framework [Webb-Robertson et al., 2005]. These programs
calculate the posterior probability of the possible genotypes and report the genotype
with highest probability as the consensus genotype. The SNP calling is based on
comparison of this consensus genotype to the reference genotype. SAMtools assigns
a phred-scaled quality score as -10log10(1-P), where P is the consensus genotype
probability [Li et al., 2009, Yu and Sun, 2013].
The genotype quality parameters and SNP quality parameters are provided in
the output variant call format (VCF) file and correct genotype is selected based on
these parameters. These programs do not report all the bases, as the internal filters
remove the bases with low mapping quality and phred-scaled quality score of the
variant (cutoff is 13 in SAMtools). This programs report more informative parameters
representing quality of a SNP, like coverage, mapping quality, allele frequency and
strand bias, which can be used for filtering the data further in order to select high
base quality SNPs with good coverage [Yu and Sun, 2013]. SAMtools and GATK
produce similar results for single-sample analysis and provide specific SNP quality
parameters [Warden et al., 2014, Yu and Sun, 2013].
1.4.2.4 Variant analysis
These tools can used to retrieve information associated to different types of variations
(SNPs, MNVs and INDELs) in a variant calling format (VCF) file [Danecek et al.,
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2011]. This file format was generated for the 1000 genome project to store variant
information. Now, this is the standard file format used to represent annotations
associated to the different variations in the genome of one or more samples. This
format is flexible, extensible, compact in size and easy to generate and parse.
The structure of this text format file consists of headers and the quality prop-
erties of each site (base/variation). The headers in the starting of the file provide
information about the VCF file version used, the criteria used to filter the data,
the commands used to generate the VCF file, description of the quality annotation
parameters, contig names and lengths and the reference file used for the assembly.
After the headers, the information and quality parameters associated to each
base/variant site is represented in eight columns detailing chromosome name (CHROM),
base position in the chromosome (POS), variant identifiers based on location or uni-
versal identifiers from the reference database (ID), reference allele on the forward
strand of the sample (REF), alternative allele on the forward strand of the sample
(ALT), phred-scale score (base quality score in SAM/BAM file)of the variant that it
is wrongly mapped (QUAL), filtering criteria passed by the variant (FILTER) if any,
quality annotations (INFO) associated to each base. The information in the INFO
column depends on different variant callers. These files also contain columns describ-
ing the annotations of the genotype of each sample. Genotype annotations for each
variant site for more than one sample can be included in a single VCF [Danecek et
al., 2011].
There are many different parameters presented in the INFO column of the VCF
files. Some of these parameters can be included or excluded at the time of VCF file
generation. The definition of some of the parameters in the INFO column and some
genotype descriptors from the VCF file produced using SAMtools mpileup function
and bcftools are the following ones (NOTE: The parameters in this manuscript are
described based on GATK tool documentation [GATK, 2016], SAMtools tool docu-
mentation [Github, 2010] and various forums, as the description of all the parameters
is not provided in articles extensively):
DP (Raw read depth): This parameter represents the unfiltered number of reads
(depth) at a particular genomic location for a sample. Minimum value of this pa-
rameter is 0. The higher the number of reads (depth), the more confidence on the
base call. For multiple samples this will represent the sum of filtered reads of all the
samples.
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VDB (Variant Distance Bias): This parameter represents the misalignment of the
reads. It checks if the variant bases occur randomly in aligned reads. Higher value
indicates greater bias and the reads within the aligned reads are distributed randomly.
AF1 (Maximum likelihood estimate of the first ALT allele frequency): This pa-
rameter estimates the frequency of the most frequent ALT allele at that location.
This parameter ranges between 0 and 1. The higher the value, the more often the
ALT allele is present in the reads at that location.
AC1 (Max-likelihood estimate of the first ALT allele count): This parameter
estimates the count of the most frequent ALT allele at that location. The higher the
value, the more often the ALT allele is present in the reads at that location.
DP4 (high-quality ref-forward bases, ref-reverse, alt-forward and alt-reverse bases):
This parameter summarizes the number of forward strands with the REF base, re-
verse strand with the REF base, forward strand with the ALT base and reverse strand
with the ALT base. The sum of these 4 values can be less than the parameter DP
(accounting for all the reads), as DP4 does not take into consideration reads with low
quality bases. The default base quality threshold for using SAMtools mpileup is 13,
i.e, the bases with base quality below 13 are not considered in DP4.
MQ (Root-mean-square mapping quality of covering reads): Mapping quality
(MAPQ) represents the score that all the reads containing the base with base quality
greater than 13 are mapped correctly, i.e., how unique is the mapped region. This
parameter (MAPQ in SAM/BAM file) depends on the aligner that is used to align
the reads and depends on the probability considered for accuracy of read alignment.
In the VCF file it is calculated as the root mean square of MAPQ of the reads at the
specific genomic location. The range of mapping quality is between 0 and 60. The
value 255 means that no mapping quality is present. Higher values indicate more
uniqueness and that the base is mapped correctly.
FQ (Phred probability of all samples being the same): This parameter measures if
the variant locus is conserved in all the samples. The positive value of this parameter
represents the Phred-scaled probability that there is more than one allele. Otherwise,
negative value represents the phred-scaled probability that all the samples have the
same allele. For a single-sample test, positive value represents heterozygous locus and
negative value represents homozygous locus.
GT (Genotype): This parameter represents the allele values separated by / (un-
phased) or | (phased). REF is represented by 0 and ALT is represented by 1. If
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heterozygous, second ALT is represented by 2 and so on. This representation is for
the diploid data. For haploid data genotype is represented by only one value (0/1/2).
In the case of using bcftools to create the VCF file, the homozygous genotype is
represented as 1/1 and heterozygous genotype is represented as 1/2 for haploid data.
PL (Phred-scaled genotype likelihood): This parameter represents the -10 log (
P ( Genotype | Data ) ) likelihoods for the genotypes of all the possible sets of REF
and ALT alleles. For a biallelic location, PL will be represented as three comma
separated values: first one is the probability that the site is homozygous for the
REF allele, second is the probability that the site is heterozygous and third is the
probability that the site is homozygous for ALT allele. These values are normalized
by subtracting the lowest PL value with all the values. The lower the value, the more
likely the kind of genotype to expect. For homozygous ALT sites in haploid data the
third value will always be 0.
GQ (genotype quality, encoded as a Phred score): In GATK, this parameter
represents the difference between the likelihoods of the two most probable genotypes.
It can be interpreted from PL as the second loWest score, i.e., the first score greater
than 0, which is the most probable. Maximum value of GQ is 99. Any value above
this threshold is still represented as 99.
Many other parameters are available [GATK, 2016, Github, 2010] and can be
recovered using different utilities and tools to be included in a VCF file [Danecek et
al., 2011].
The data size reduces a lot moving from the raw reads to the variants for analysis.
Data are filtered based on quality before the alignment process, then filtered for
accuracy during the alignment process, and then further filtered based on the quality
parameters associated to the variations under focus of analysis.
1.4.2.5 Plasmodium genome resources
In the last decade due to advancement of sequencing and assembly technologies the
quantity and quality of the sequence data have increased. Storing such data and
making them publicly available for analysis is one of the important tasks that have
been focused by the sequencing centers. In the previous section we discussed the
variant calling process for selecting significant SNPs and INDELs from the raw reads
sequenced by different sequencing platforms. SNPs are an important category of
genetic variations and can influence disease risk and associated drug efficacy. Genes
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containing non-synonymous SNPs responsible for changing the amino acid sequence
can be retrieved and annotated. The expression of these genes in different life stages
can be assessed using protein and RNA-seq data. These predicted genes and proteins
from the DNA sequencing data can be annotated using Gene Ontology (GO) terms
provided by different sequencing centers and Malaria research community. Further,
these genes can be identified in metabolic pathways and gene-gene/protein-protein
interaction networks to reveal the affected networks in upstream and downstream of
the targeted genes.
These genomic, transcriptomic and proteomic information can provide evidence
regarding the underlying metabolic pathways influenced by the genes and support
the discovery of drug targets and evolutionary population studies. There are pub-
licly available database servers for Plasmodium falciparum genome such as Euro-
pean Nucleotide Archive (ENA) [Leinonen et al., 2011a], GeneDB [Hertz-Fowler
et al., 2004, Logan-Klumpler et al., 2012], MalariaGEN [MalariaGEN, 2016c], Plas-
moDB [Bahl et al., 2003, Stoeckert et al., 2006, Aurrecoechea et al., 2009] and
STRING [von Mering et al., 2005, Szklarczyk et al., 2011, Szklarczyk et al., 2015]. In
this section we discuss the use of these databases.
1.4.2.5.1 ENA
The European Nucleotide Archive (ENA) is a publicly available archive for raw nu-
cleotide sequence, assembly information and functional annotation information [Leinonen
et al., 2011a]. It provides services for nucleotide data submission, storage, search (text
and sequence) and download. This works in collaboration with National Center for
Biotechnology Information (NCBI) and The DNA Data Bank of Japan (DDBJ) in
International Nucleotide Sequence Database Collaboration (INSDC).
This archive includes three databases: (1) Sequence Read Archive (SRA) [Leinonen
et al., 2011b], which stores raw NGS sequence data. The raw NGS data in supported
formats (ex: BAM) and associated meta-information (study, sample, experiment and
run) can be uploaded in the SRA archive. The data can also be submitted with
authorized access through SRA into European genome-phenome archive (EGA), (2)
Trace Archive, which stores the sequencing data from gel/capillary platforms and (3)
EMBL-Bank, which stores nucleotide sequences, associated biological annotation and
source of the annotation. The submitted data are diverse, such as, expressed sequence
tags, high-throughput sequences, through genomic assemblies and richly annotated
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sequence fragments [Leinonen et al., 2011a]. The data at ENA is also mirrored to
two other databases, DNA Data Bank of Japan (DDBJ) and GenBank.
ENA provides interactive web platform to retrieve data in various formats, such as
XML, HTML, FASTA, FASTQ, SAM/BAM and SRF. For each sequence a summary
page is available which provides the sequence, associated meta-information, biblio-
graphic sources, EMBL bank annotation and a graphical view of the assembly. The
sequences can be searched using descriptors in the text based search and providing
the sequence for sequence similarity search. The data can also be browsed and down-
loaded using a programmatic data access tool, which allows retrieval of information
and data using REST (Representational state transfer) URLs. The ENA browser
also provides options to download sequence, read and taxonomy data in bulk from
the databases. The ENA "Features and Qualifiers" tool provides the vocabulary for
DNA sequencing.
1.4.2.5.2 MalariaGEN
The Malaria Genomic Epidemiology Network (MalariaGEN) is a data sharing database,
which makes available genetic variation data and analysis associated to human (host),
Plasmodium (parasite) and Anopheles mosquito (vector) genome from different col-
laborative projects aimed at understanding the effects of variation on biology and
epidemiology of malaria [MalariaGEN, 2016c]. Research labs from more than 20
countries contribute in these collaborative projects. MalariaGEN resource center
(MRC) is a National Institutes of Health project funded by Wellcome Trust and
Gates Foundation.
The data comes from various studies including clinical research, epidemiology, ge-
netics, statistics, parasitology, entomology, immunology, computer science and ethics.
The data from these studies contribute to three projects on host genome variation,
four projects on parasite genome variation and one project on vector genome varia-
tion. MalariaGEN currently provides interactive tools to browse and retrieve genomic
data, variants and associated statistics (depth histogram and variant density), sam-
ple information and statistics (samples plotted on world map, mean base quality and
mean coverage), study information and list of study locations. This interactive tool is
available for two projects: (1) Anopheles Gambiae (principal vector of P. falciparum
malaria in Africa) 1000 Genome project, which aims at analyzing variations in popu-
lation of Anopheles Gambiae [MalariaGEN, 2016a] and (2) Pf3k project, which aims
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at analyzing genome variation in 3,000 P. falciparum parasite samples [MalariaGEN,
2016b]. The SNP calling in Pf3K project dataset is done using GATK haplotype
caller.
The mentioned interactive tools are included in the Panoptes web application,
which is an open source application for browsing and visualizing data. The data are
stored in simple tab-delimited files and other specific formats. The data is structured
as MySQL data tables in nested folders.
The SNPs described for defining the population structure of Plasmodium falci-
parum parasite [Manske et al., 2012, Miotto et al., 2013] and identifying the genetic
background associated to artemisinin resistance [Miotto et al., 2015] in Cambodia and
in SEA, can be recovered with the meta-information from the MalariaGEN database
server as Tab delimited tables.
1.4.2.5.3 PlasmoDB
PlasmoDB Plasmodium genomics data resource is the official and highly used database
for Plasmodium genome sequencing consortium [Bahl et al., 2003, Stoeckert et al.,
2006, Aurrecoechea et al., 2009]. This database is a project of EuPathDB (Eukary-
otic Pathogen genome database) Bioinformatic resource center (BRC), in addition to
other databases for Amoeba, Cryptosporidium, Giardia, Microsporidia, Priroplasma,
Toxoplasma, Trichomonas and Kinetoplastida. PlasmoDB provides a user friendly
data-mining interface for analysis and visualizing genomic-scale data produced by
the global malaria research community. This database provides information for 10
Plasmodium species and 13 strains based on sequencing data. The source for these
data are GeneDB, GenBank and information provided by malaria research commu-
nity. PlasmoDB provides tools for comparisons of these species and organisms. There
are two P. falciparum reference strains present in the database, 3D7 and IT.
This database presents sequence and associated annotation of P. falciparum canon-
ical reference genome strain 3D7 and other isolate strains from different Plasmodium
sequencing projects. The complete sequence of the strain 3D7 is included in Plas-
moDB since release version 4.0 (2008). The current release version is 28 (2016) and
the 3D7 reference genome sequence version 3 is available in the database server. For
this sequence, PlasmoDB provides data at genomic, transcriptomic and proteomic
levels, such as SNPs, CHIP-seq, RNA-seq, Microarray (multiple life cycle stages),
expressed sequence tags (ESTs), serial analysis of gene expression (SAGE) tags and
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protein expression data (multiple life cycle stages). SNP data are present for more
than 100 isolates and can be used for population studies [Bahl et al., 2003, Stoeckert
et al., 2006, Aurrecoechea et al., 2009].
This database server implements Genomics Unified Schema (GUS) deployed in Or-
acle and PostgreSQL (open source object-relational database developed in 1996) [Post-
greSQL, 2016]. GUS is a highly structured format to include different sequence and
expression data types [Clark et al., 2005]. This schema stores and integrates, genomic
sequences, annotation and co-expression data from different available resources. GUS
allows users to customize the query (SQL) and recover information of genes and SNPs
and associated functions and expressions for different analysis.
Information from this relational database server can be retrieved by (1) Text based
search: provide old/new SNPs ID, gene IDs, gene names or gene product names. (2)
Pre-defined query based search: select pre-defined query options. The retrieved result
can be based on a single query or a combination of different queries [Bahl et al., 2003].
In this database server, a summary page for each annotated gene can be recovered.
The genes can be visualized in the genome using the genome browser tool. For each
gene, the details such as associated annotations, IDs, predicted mRNA and protein
sequences, microarray expression results precomputed statistics based on transcrip-
tomic and proteomic data, and links to Malaria Parasite Metabolic Pathways database
and Malaria Research and Reference Reagent Resource Centre can be recovered from
the summary page. The functional annotation associated with the genomic sequences
of other species can be recovered using orthology criteria [Bahl et al., 2003].
1.4.2.5.4 GeneDB
GeneDB is a publicly available database archiving pathogen genomic sequences made
available by various sequencing centres [Hertz-Fowler et al., 2004, Logan-Klumpler
et al., 2012]. It includes data from different genome and expressed sequence tag
(EST) projects. GeneDB currently provides access to genomes of 41 organisms, which
includes completed and partial sequence annotations. This database server provides
up to date annotation of (Plasmodium) genomes, including Plasmodium falciparum
genome. This database provides the reference genomes with annotations and manual
curation.
The data are stored in PostgreSQL relational database that uses the Chado
schema [Mungall and Emmert, 2007], which allows for consistent and flexible an-
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notation of sequence features. GeneDB implements GUS [Clark et al., 2005] using
the standardized files for sequences and annotations generated by GeneDB mining
code.
This database implements a pipeline to provide automated annotation (predic-
tions) of the stored sequence data before manual curations. The manual annotations
are included from literature, other public databases and information provided by other
research institutes. The automated genome annotation pipeline includes algorithms
for selecting gene, prediction of protein features, BLAST/FASTA search against nu-
cleotide, protein databases and domain information, annotated and predicted GO
terms [Hertz-Fowler et al., 2004].
The Plasmodium curated genomes and associated annotations from this database
are shared by PlasmoDB. The user comments provided in the PlasmoDB database for
genes are accessed by GeneDB to revise the curation as well [Logan-Klumpler et al.,
2012].
GeneDB also provides genome browser tool, Artemis [Carver et al., 2012b], with
latest curation for all the genes. This tool is used for genome annotation and it is
possible to read and write to the Chado relational database schema directly.
1.4.2.5.5 Gene interaction networks
In order to determine the biological processes taking place in different subpopulations,
gene-gene interaction networks can be studied. Functional and predicted protein-
protein interactions are available based on data sources and literature [Szklarczyk D.
et al., 2015]. The interactions between the proteins can help in understanding the
function of the proteins and reveal role in metabolic pathways. The biological net-
works are data representation of protein-protein interactions, coexpression evidence
and metabolism. The nodes of the network are the proteins or the genes and the edges
could be the evidences for physical interaction or association based on experimental
data.
For identification of biological function associated to the significant genes, the
functionally grouped networks of GO terms (annotated and predicted) from Gene
Ontology (GO) consortium and pathways from KEGG and BioCarta can be recovered
using the ClueGO v2.2.4 and CluePedia v1.2.4 plugins of Cytoscape. ClueGO utilizes
updated precompiled annotation and ontologies files as the data source, to recover
annotation and pathways of provided genes. The algorithm to define the functional
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groups is: (a) create a binary matrix for genes and associated terms, (b) Using this
matrix and kappa statistics create a term-term similarity matrix, (c) create initial
functional groups based on predefined threshold of kappa score and minimum number
of terms per group to be considered (d) iteratively merge the functional groups, if
there is a certain percentage of overlap [Bindea et al., 2009]. The network is created
with nodes as the term and edges as the association based on kappa score. These
networks can be filtered based on the statistical enrichment/depletion of GO terms.
1.4.2.5.6 STRING
The Search Tool for the Retrieval of Interacting Genes/Proteins database (STRING-
DB) provides a user friendly web interface for browsing, visualization and retrieving
known and predicted interactions based on functional and physical interaction evi-
dence [von Mering et al., 2005, Szklarczyk et al., 2011, Szklarczyk et al., 2015]. It is a
collaborative project of Swiss Institute of Bioinformatics (SIB), European Molecular
Biology Laboratory (EMBL) and Center for protein research (CPR). STRING aims
at providing interaction confidence scores, comprehensive coverage (increased number
of proteins, organisms and accurate prediction methods), user friendly interface and
being a stable resource of protein networks. The current release of STRING, i.e.,
version 10 provides interaction data for 2031 organisms. STRING database is based
on protein-coding gene loci.
The interactions provided in STRING are the functional association between pro-
teins contributing to similar biological process. The sources of these interactions
can be classified into three groups, known interactions, predicted interactions and
computed interactions [Szklarczyk et al., 2015]. The source of known interaction
evidence are (1) interactions recovered from experimental data available in public
databases (Ex: Yeast2Hybrid) and (2) pathway and protein complexes information
from manually curated databases. The source of predicted interaction evidences are
(1) the genomic neighbourhood genes, (2) gene families with similar occurrence pat-
tern and (3) gene fusion events. The source for computed interaction evidences are
(1) automated literature text-mining, (2) proteins with correlated genes based on ex-
pression and (3) interactions from pre-computed protein orthology relations available
in eggNOG database (partner resource project) [Powell et al., 2014]. These interac-
tion evidences represents the sharing of biological function and is not necessarily the
physical interaction between two nodes (genes) [Szklarczyk et al., 2011]. The accu-
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racy of all the interaction evidences in STRING is validated with the interactions in
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway maps [Kanehisa and
Goto, 2000] for only the metabolism.
STRING allows the visualization and retrieval of interaction network with genes
as nodes and edges as the interaction based on the evidence from different sources.
The network can be requested for multiple protein sequences and protein names. For
single protein names and sequences all the interactions with that gene are provided
and for multiple protein namessequences interactions among the only those genes are
provided. The genes with no interaction evidence are also represented as unconnected
nodes.
Each interaction in the network is scored, and cutoff on these scores can be used
to filter data for accuracy. The STRING interaction evidence scores based on the
coexpression data are calculated as [Szklarczyk et al., 2015]:
The pipeline matches the probe identifiers and the experimental microarray ex-
pression values to the target set of genes in STRING. The expression values are
extracted from microarray gene expression experiments deposited in NCBI Gene Ex-
pression Omnibus (NCBI GEO) [Barrett et al., 2009]. For each gene, the probe values
are combined into a single vector and the expression values of all the probes are aver-
aged. The microarray expression values in these vector arrays are z-value normalized
and in order to remove redundancy the normalized expression vectors for each target
gene is correlated with other genes in the target set using Spearman’s rank correla-
tion. The gene arrays are pruned using Hobohm-2 algorithm [Hobohm et al., 1992].
This algorithm removes the mostly connected gene at each step until the there is only
one connection in the remaining gene. This array of n target genes is transformed into
n arrays per gene. The raw score for expression values is calculated as pairwise Pear-
son correlation coefficient. The correlation is calibrated with STRING benchmark,
which is that the number of functional pathway in KEGG [Kanehisa and Goto, 2000],
where pair of genes are annotated together, i.e., score cutoff on the fraction of true
functional association [Szklarczyk et al., 2015].
The raw scores for interaction evidence from neighbourhood, homology, gene fu-
sion, experimental data and text mining are calculated as sum of intergenic distances,
euclidean distance, as constant (0.99) of fusion event, uniqueness of interaction and
log-odds ratio, respectively [von Mering et al., 2005]. The combined score for all the
interaction evidences is calculated as 1 −
∏
(1 − Ki), where i is the evidence source
60 CHAPTER 1. INTRODUCTION
and K is the STRING confidence score created by benchmarking each interaction ev-
idence confidence score against the KEGG database [von Mering et al., 2005]. These
scores represent the confidence of an interaction to be true and not the strength of
the interaction.
For P. falciparum genome, the recovered interaction networks based on different
sources should be analyzed carefully, as most of the edges (interactions) have a low
interaction score. For example, in the complete interaction network of P. falciparum
based on coexpression data source, less than 10% of the interactions have a score
greater than 0.9 (range 0 to 1). This creates interaction hubs, i.e., nodes (genes) with
many edges (interactions) with low score. Therefore, the network is not scale free
and it should be curated for network based studies. The B. microti genome is not
included in the STRING database server. ————————————————–
Chapter 2
Barcoding the P. falciparum
genome
2.1 Introduction
Plasmodium falciparum malaria is one of the most severe and wide spread parasitic
disease affecting millions of humans in the world. Following the emergence and spread
of drug resistant parasites is a major challenge. The Cambodian-Thai border is recog-
nized as the epicentre of the emerging drug resistances. The resistance to earlier drugs
chloroquine [Eyles et al., 1963] and sulfadoxine-pyramethamine [Wongsrichanalai
et al., 2002] was observed in the same location as for recently emerging artemisinin re-
sistance [Ariey et al., 2014]. Molecular epidemiological studies have confirmed that the
spread of resistant parasites to these two drugs to Africa has originated from South-
east Asia [Mita et al., 2009]. The reasons supporting the emergence of multi-drug
resistance parasites in this area are unknown. Recent reports have shown existence of
artemisinin resistance and sensitive populations in Cambodia based on whole genome
sequencing [Miotto et al., 2013, Miotto et al., 2015]. Three resistant subpopulations
(KH2, KH3 and KH4), ancestral population (KH1) and one large admixed subpop-
ulation (KHA) were described using samples isolated in the time period 2007-2011.
The resistant subpopulations are associated to clinical artemisinin resistance defined
by a delayed of parasite clearance in the first 3 days of artesunate monotherapy, or
artemisinin based combination therapy (ACT) [Miotto et al., 2013], and were later
confirmed to be associated to mutations in the propeller domain of the K13 gene
(PF3D7_1343700) located on the chromosome 13 [Ariey et al., 2014]. In their report,
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Ariey and collaborators clearly showed that the prevalence of mutant k13 alleles, in-
volved in artemisinin resistance, was much higher in western Cambodian provinces
than in eastern Cambodia.
A new approach was used to identify a unique molecular barcode to follow the
diffusion of k13 alleles and allow classification of the samples into artemisinin resistant
and sensitive populations using small number of loci. Two earlier studies describing
the importance and usefulness of the barcode approach for P. falciparum genome are
(1) a 24-SNP barcode in P. falciparum nuclear genome, detected by a robust TaqMan
genotyping approach [Daniels et al., 2008]. Their analysis was performed on African
and Thai isolates and (2) a 23-SNP barcode in P. falciparum organelle (mitochondria
and apicoplast) genomes, constructed using iterative SNP detection algorithm based
on haplotypes [Preston et al., 2014]. This analysis was performed on samples from
Africa, Thailand, Cambodia and Vietnam.
At present, novel, rapid and reliable techniques based on fluorescent magnetic
beads, such as the LUMINEX technology, are available to detect specific alleles.
A rapid assay of Plasmodium typing was developed using fluorescent microspheres
[McNamara et al., 2006]. This assay combined a PCR and a ligation reaction: PCR-
LDR-FMA (PCR-based ligase detection reaction-fluorescent microsphere assay).
This chapter describes the implementation of the PCR-LDR-FMA for the de-
tection of an 11-SNPs barcode from the set of 24 SNPs described by Daniels et
al., [Daniels et al., 2008]. The evidence supporting presence of parasite subpopula-
tions was provided and intensive gene flow over Cambodia was described to assess the
spread of drug resistance. The idea was to provide evidence to support the hypothesis
that parasite population structure plays an important role in spread of k13 alleles and
artemisinine resistance from west to east Cambodia. Allele gradient analysis supports
the idea of west to east allele diffusion axis. A new subpopulation was defined, highly
prevalent in northern Cambodia and associated with in vitro mefloquine resistance
(expressed by high mefloquine IC50 values).
This work has been recently published in Malaria journal as "Plasmodium falci-
parum parasite population structure and gene flow associated to anti-malarial drugs
resistance in Cambodia" and the approach, results and discussions sections presented
in this chapter can be referred from Article 1.
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2.2 Approach and Results
The aim of implementing the barcode approach was (1) the clustering of samples
into parasite subpopulations based on a small number of loci and (2) describing gene
flow among the identified subpopulations. The loci (SNPs) were identified among
533 blood samples collected in 2010-2011 from P. falciparum malaria patients coming
from 16 health centers (11 health centers and 5 hospitals)(Article1: Additional file 1).
These health centers are located in 10 provinces located in all regions of Cambodia
(Figure 2.1). In addition to the 533 samples, 4 reference P. falciparum DNA samples
were used as a control to validate barcode detection (3D7, Dd2, HB3 and RO33;
recovered from MR4). This work was done in collaboration with Pasteur Institute of
Cambodia, Cambodia (Figure 2.2).
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Figure 2.1: Boundary map of Cambodia showing data (blood samples) collection
localities (health centres and hospitals) by Pasteur Institute of Cambodia. Cambo-
dia boundary map source: http://www.mappery.com/map-of/Cambodia-Provinces-
Outline-Map
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DNA 
Extraction 
•Source (533 blood samples from 2010-2011) 
•Location (11 Health centres and 5 Hospitals) 
PCR-LDR-FMA 
•Source set (24 SNPs defined by Daniels et al., 2008) 
•Technique (LUMINEX technology, Primer design) 
Barcoding 
•Signal analysis (LUMINEX) 
•Genotyping (11 valid SNPs in 282 genotyped samples) 
282 Barcodes 
•Specificity of 11-SNPs barcode alleles / Gene flow (Chi-squared analysis) 
•Allele diversity  at16 localities (FST analysis) 
•Clustering (Unsupervised hierarchical clustering, Proportional distance, Ward’s minimum variance method) 
•Subpopulations (Random Sampling analysis, 9 conserved groups/subpopulations) 
Drug 
Susceptibility 
•Mutations in k13 gene associated to artemisinin resistance (98 patients) 
•In vitro IC50 susceptibilities(Chloroquine, Mefloquine, Piperaquine, Quinine) 
•Drug susceptibility associated to subpopulations (Box plot, Threshold = 30 Nm) 
Results 
•West to East allele gradient axis supporting gene flow in Cambodia 
•Existence of recently emerged founder subpopulations near the border of Cambodia 
•A subpopulation in northern Cambodia carrying R539T k13 allele and susceptible to mefloquine resistance 
Figure 2.2: A flowchart briefly representing major steps of the barcoding approach and
associated results. The major steps are mentioned in boxes and associated analysis
and results obtained are described in points for each step. The final results are
mentioned in points associated to the box in grey “Results”.
2.2.1 Barcode genotyping
The genomic DNA was extracted from blood samples using DNA mini blood kit (Qi-
agen, Germany) and primary PCR was carried using FirePol R©Taq DNA Polymerase
to reach the target between 164 and 385 bp (Article 1: Method section “DNA ex-
traction and PCR amplification”). The genotyping was performed using LUMINEX
technology, which is based on polystyrene / paramagnetic microspheres to perform
multiplexed assays. The assay was designed as polymerase chain reaction (Article1:
Additional file 2) followed by ligation detection reaction (Article1: Additional file 3
and 4), followed by fluorescent microsphere-based assay (PCR-LDR-FMA) (Article
1: Method section “Ligation and detection assays” and “Hybridization and labeling
of magnetic beads”).
The 11 barcode loci were selected among 24 SNPs described by Daniels et al.,
[Daniels et al., 2008], which were detected by a robust TaqMan genotyping approach
for genotyping studies in P. falciparum African and Thai populations. Primers for the
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24 SNPs were designed using P. falciparum reference genome 3D7 version 3 (Article1:
Additional file 2). Out of the 24 SNPs only 11 SNPs could be genotyped for 282 blood
samples (Article1: Result section “Barcode of alleles for 11 variable sites”).
Around 50% of the samples were rejected due to traces of mixed infection, no
significant signal with LUMINEX for at least one barcode position and/or no ampli-
fication using PCR for at least one locus. Around 60 samples showed more than one
mentioned factor and were rejected (Article1: Additional file 7). Finally, 282 samples
among 533 blood samples were successfully genotyped at the 11 SNP loci (Article1:
Result section “Barcode of alleles for 11 variable sites”).
2.2.2 LUMINEX signal analysis
The PCR-LDA-FMA assay is a multi-step approach (Figure 2.3A). The locus is first
amplified by PCR. The Ligation detection assay (LDA) will bind two primers, one
carrying a florescent dye. The ligation is allowed only when both primer hybridized
at 100% to the PCR product. The allele specific base is located just at ligation point.
LUMINEX beads have been coupled with a primer and the allele detection is measured
after hybridization with the ligation product. The LUMINEX detection assay is based
of florescent beads with specific properties. The LUMINEX microsphere is targeted
to a specific detector in the MAGPIX apparatus. The fluorescent signal is captured
and provided as a quantitative value.
The heterogeneity of the signal measured by the MAGPIX apparatus was impor-
tant. Background noise and positive signal vary both in linearity and intensity for
each tested bead. It depends on the microsphere, but also on the used primer. We
had several examples, where the same microsphere was used for different loci. The
96-well plate inter-variability was also high. A signal analysis method was developed
based on a set of values recovered from an array of measurements. The signal was
analyzed per 96-well plate. Four control DNA (strains 3D7, Dd2, HB3 and RO33)
were introduced in our analysis on each plate to ensure that a significant number of
representative values for both the background noise and the positive signal would be
present.
The algorithm first classifies the set of signal values for one allele k between two
series, one corresponding to the signal without noise (referred to as "signal"), and the
other corresponding to the noised signal (referred to as "noise"). This classification
method minimizes the variance associated to the two series of measures, and is anal-
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ogous to the k-mean algorithm where k = 2. A test was developed to address each
measurement to the negative or positive value of the allele assuming that both series
of values are following a Gaussian distribution (Figure 2.3B). We considered two pos-
sibilities: either the signal is significantly different from the noise, or it is significantly
from the signal. We compared the two probabilities of accepting the null hypothesis
H0 whilst H0 is true. Nevertheless, if both probabilities were higher than 1-0.0027/2
(6 times the standard deviation according to the unilateral normal distribution), we
considered that the signal was uncertain. The final decision concerning uncertainties
was always given to the operator.
Allele 
PCR product 
locus 
A 
T 
Ligation assay is allowed only  
if hybridization is specific 
Primer coupled 
LUMINEX Bead 
Fluorescent dye  
=> Positive signal 
Noise, e Signal, M 
Measure, m Mµk eµk 
T T 
A. 
B. 
Fluorescent bead 
=> Control signal 
Figure 2.3: LUMINEX signal analysis. (A) Schematic representation of PCR-LDR-
FMA producing florescent signal. (B) Characterizing the obtained signal as signal
with noise and signal without noise. "Noise" is referred to signal from beads in which
ligation does not take place and "signal" is referred to signal from beads which undergo
ligation.
Decisions concerning alleles at a specific locus were taken from the analysis of two
signals, one for primer 1 and one for primer 2. In the study, primer 1 corresponds to
the reference allele found in 3D7 and primer 2 for the altered allele. Loci characterized
as mixture corresponds to polyclonal samples of P. falciparum. "Other" means that
the allele value could not be characterized at the corresponding locus based on the
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two primers used in the present analysis. In the case of BC07, we assumed that
"other" value corresponded to the third allele, which was not tested experimentally.
For the other loci that are bi-allelic, the significant absence of signal was considered
as a technical problem. "Not valid" data corresponded to experiments that either
need to be confirmed, or to DNA samples of bad quality (Figure 2.4).
Sample i  Primer 1  Primer 2  Decision 
A  Positive  Positive  Mixture 
B  Positive  Negative  Primer 1 
C  Negative  Positive  Primer 2 
D  Negative  Negative  Other 
E  Uncertain  Positive  Primer 2 
F  Uncertain  Negative  Not Valid 
G  Positive  Uncertain  Primer 1 
H  Negative  Uncertain  Not Valid 
I  Uncertain  Uncertain  Not Valid 
Figure 2.4: Possible decisions in LUMINEX signal analysis for different types of
samples. Primer 1 corresponds to the reference allele and primer 2 corresponds to
the altered allele.
2.2.3 Visual representation of allele specificity to health cen-
ters
Decision concerning alleles at a specific locus were taken from the analysis of two
signals, one for primer 1 and one for primer 2. In the study, primer 1 corresponds to
the reference allele found in 3D7 and primer 2 for the altered allele. Loci characterized
as mixture correspond to polyclonal samples of P. falciparum. "Other" means that
the allele value could not be characterized at the corresponding locus based on the
two primers used in the present analysis. In the case of BC07, we assume that "other"
value corresponds to the third allele which was not tested experimentally. For the
other loci which are bi-allelic, the significant absence of signal could be considered as
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a technical problem. "Not valid" data corresponds to experiments that either need to
be confirmed, or to DNA samples of bad quality (Figure 2.4).
It was observed that the REF (reference 3D7) and ALT (non-reference) alleles at a
specific SNP position were in an opposite quadrant (Article1: Figure 1 and Additional
file 8) for bi-allelic loci. Comparing the results with Between-Class analysis for health
centres, the specificity of alleles was determined visually (Article1: Results section
"Allele distribution associated to health centres"). This graphical results show an east
to west opposition of locations. The geographical localization of localities was not
entirely met. The localities are closer to the center and Pursat appears in an aberrant
position.
2.2.4 Gradient of alleles based on allele significance in health
centres
The correspondence analysis was used in an exploratory way and these results were
confirmed using Chi-squared statistical test (Article1: Figure 2, Additional file 1 and
Additional file 9). Chi-squared test was used to determine statistically significant (p-
value < 0.05) relationship between all the alleles and health centres (Article1: Results
section "Allele frequency gradient between localities"). In the Figure 2 of Article 1,
the allele frequencies are represented by weblogos and the red and blue color signifies
ALT and REF allele enrichment, respectively. The allele enrichment is defined as
Chi-squared test statistics component (χ2 = Σ[(Observed − Expected)2/Expected];
one component for each health centre) greater than 1 (Article1: Figure 2, Additional
file 1 and Additional file 9). Other Not significant SNP positions are colored in grey
and the barcode position 11 was not significant in any of the health centres evident
by its low variation.
Form this analysis and representation on the map of Cambodia (Article1: Figure
2 and Additional file 9), it was seen that the enriched alleles were not restricted to
a single health centre, but instead enriched in geographically close localities. Alle-
les of some of the SNPs were significantly enriched in specific regions of Cambodia
(e.g., ALT alleles for BC01, BC02, BC03, BC07 and BC08 and the REF allele for
BC04, BC05 and BC06). Also, a specific allele gradient was observed between regions
based on significant allele frequency in health centres. For example, western Cam-
bodia appeared as the starting point for the diffusion for BC02_ALT_C allele and
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northern Cambodia was associated with BC02_REF_T allele. The region of Bat-
tambang shows no significant allele frequency for this locus (Article1: Additional file
9B). Therefore, barcode allele specificity for localities could suggest the presence of
specific subpopulations with fixed allele in restricted area and overlap between these
subpopulations, or even gene flow.
2.2.5 Subpopulation structure based on barcode
In order to determine the allele diversity between samples at different locations, a
fixation index (FST ) was calculated [Charlesworth, 1998] for the 16 health centers
(Article1: Results section "Presence of fixed alleles at the border of Cambodia").
This parameter is representative of genetic differentiation. The increased value repre-
sents genetic drift within subpopulations, which could be due to bottleneck effect, or
founder effect [Whitlock, 2011]. The value ranges from 0 (no differentiation high di-
versity) to 1 (complete differentiation low diversity) for subpopulations with respect
to total population. The average FST is calculated based on average allele diversity
of 11 SNPs in subpopulations at specific locations (samples at 16 health centers) and
total population (282 samples). The allele diversity at a single barcode locus for a
specific location or total population is calculated as 1−Σp2
i
, where p is REF and ALT
allele frequency. Average allele diversity is calculated as average over all the barcode
loci. Average FST is calculated as (At − As)/At, where At is average allele diversity
in total population and As is average allele diversity at different locations.
Based on the average FST values (Article1: Figure 3), it was observed that the
localities near the border (mostly north and west) show higher FST values than the
localities at a distance from the border, i.e., subpopulations at the localities near
border could be emerging subpopulations due to founder effects with low diversity
and the subpopulations at the localities away from the border could be ancestral or
admixed populations with high diversity.
Another approach for identification of subpopulations was based on unsupervised
hierarchical clustering of the 282 genotyped samples based on 11-SNPs barcode (Arti-
cle1: Methods section "Data and statistical analysis"). The pairwise distance between
the samples was calculated as the proportion of base substitution between them over
the barcode (genetic distance [Miotto et al., 2013]). Ward’s minimum variance
method was used as the clustering method to build the dendrogram (Article1: Addi-
tional file 5A). This method minimizes the variance (square of error) in each cluster.
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The dendrogram was cut to obtain 8 clusters (k=8) based on dendrogram structure
and earlier defined subpopulations [Miotto et al., 2013] by matching the barcode. The
correspondence of the 293 samples and defined subpopulations was provided by Olivo
Miotto [Miotto et al., 2013]. Random sampling was performed in order to obtain ro-
bust results (Article1: Additional file 5B): the clustering approach was implemented
on 10,000 subsets of 230 samples each (idea was not to disrupt the structure of clus-
tering too much), randomly selected out of the 282 samples. Based on these 10,000
clustering results, pairwise distances between samples were calculated as the percent-
age of clustering results in which two samples are in the same cluster. Nine clusters
(conserved groups) G1-G9 were finally selected based on the dendrogram structure
(Additional file 5B) and association with earlier defined subpopulations [Miotto et al.,
2013]. Weblogo was used to highlight conserved alleles among health centres in G1
to G9 groups. The groups are geolocalized by the geographical centroids on the 2D
map. The coordinates for the geographical centroids are calculated as the average
of the coordinates (measured in the coordinate space of the 2D map) of the health
centres included in the group.
The significance of each group was established by comparing the average distance
of the samples to the geographical centroid within a group to the distribution of
average distance after random sampling in nine groups. The p value < 0.05 was sig-
nificant. The average distance for each group was compared to the average distances
calculated for 5000 random re-sampling of the 282 samples within the nine conserved
groups. The p value was calculated as the proportion of average values below the
average distance of the health centres to the geographical centroid for each group.
Unsupervised clustering runs based on different random subset of the 282 isolates
suggested the existence of 9 robust clusters (referred as G1-G9, size of the groups, n
= 18-44) representative of the parasite subpopulations (Article1: Figure 4). Specific
conserved groups identified in north-west area of the country and have matching
barcodes with the earlier defined founder subpopulations [Miotto et al., 2013] and no
groups corresponding to specific subpopulations (G5, G6 and G9) could be identified
near the center of the country (Article1: Results section "Identification of emerging
subpopulations in Cambodia").
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2.2.6 Anti-malarial drug susceptibilities associated to regions
and subpopulations
Out of the 282 samples, mutations in k13 gene associated with resistance to artemisinin
were questioned in 98 patients, as described earlier [Ariey et al., 2014]. From these
patients, 70% of the samples were positive for one of the k13 resistant alleles (C580Y,
R539T, Y493H, I543T, P553L, V568G and N458Y). The C580Y allele was the most
prevalent (5468 positive patients) and present in all the conserved groups (Article1:
Additional file 10) followed by R539T (968 positive patients). Barcode alleles at
BC01, BC03, BC04, BC05, BC09 and BC11 are conserved in these nine samples and
significantly associated to Trapaing Prasat HC (Article1: Figure 2 and Additional file
11).
In vitro IC50 (half maximal inhibitory concentration) susceptibilities to chloro-
quine (n = 109), mefloquine (n = 111), piperaquine (n = 103) and quinine (n =
107), were assessed in isolates with a parasitaemia > 0.1% (Article1: Results sec-
tion "Mefloquine resistance is strongly associated to northern Cambodia"). The data
was represented as a box plot and the parasites were considered to be resistant for
the median value for target drug > 30Nm. No geographical bias was observed for
Piperaquine. The susceptibility for mefloquine was highest in northern and southern
localities (Article1: Figure 5) followed by chloroquine (Article1: Additional file 12).
Two geographic loci for mefloquine resistance in Cambodia were identified, one as-
sociated to C580Y allele (south) (Article1: Additional file 10) and one associated to
R539T allele (north) (Article1: Figure 5). The samples in G4 and G8 groups show
high mefloquine IC50 values (Article1: Additional file 13) and large proportion of
G8 samples originating from Trapaing Prasat HC carried R539T mutation (Article1:
Additional file 10).
This suggests presence of recently emerging P. falciparum subpopulation in north-
ern Cambodia (supported by high FST for Trapaing Prasat HC) with mefloquine
resistance.
2.3 Discussion
A PCR-LDR-FMA technique for the mid-throughput detection of a barcode for P.
falciparum Cambodian isolates was optimized. A specific algorithm was developed for
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signal discrimination between the 23 alleles corresponding to 11 SNPs, which enabled
us to characterize 282 samples. The choice of the loci was based on both possibility
to run detection at the corresponding locus and allele frequency. We see that the fre-
quency of most of the 11 successfully genotyped SNPs is comparable to the frequency
of ESEA samples included in MalariaGEN v4 database. This information was not
available at the beginning of the project and the comparisons were performed after
the MalariaGEN data release. As, the study by Daniels et al., [Daniels et al., 2008]
included only African and Thai samples, the frequency of the alleles in the dataset is
different from the allele frequency in the MalariaGEN database (Article1: Additional
file 6). The level of genotyping failure is due to the fact that the 24 SNPs from
the Broad Institute were not selected for the DNA content of the genomic location
(Article1: Result section "Barcode of alleles from 11 variable sites"). AT richness of
the P. falciparum genome contributes to the failure. A significant amount of samples
were rejected because of mixed infections, the impossibility to design primers, lack of
PCR amplification and bad quality of the signal (Article1: Additional file 2, 3, 4 and
7). Also, bioanalysis based on genome annotation present in PlasmoDB, revealed
that some of the SNPs were in the subtelomeric regions encoding surface antigens
(Article1: Additional file 6). These SNPs might not reflect population evolution, but
more parasite-host interactions such as antigenic variation.
From the FST (fixation index) analyses we see that the regions on the border of
Cambodia are more towards fixations of alleles, i.e., genetic material is not shared,
because of low level of breeding. FST analysis (Article1: Figure 3) and gradients of
allele frequencies (Article1: Additional file 9A-J) over the country suggest gene flow
in a centripetal orientation. Crossing of subpopulations could be responsible for allele
diffusion over the country. Especially in western Cambodian sites, where the low FST
values could result from overlap between subpopulations. This likely reflects gene
flow driving the homogenization of the population.
The comparison of the 282 barcodes of 11 SNPs is made with the population
structure described by O. Miotto et al., in 2013. It has been shown in the Additional
file 6 (Article1) that all of the 24 SNPs are not present in the released MalariaGEN
dataset. Also 2 SNPs out of the 11 SNPs are not called in MalariaGEN dataset.
Therefore, these 11 SNPs were called again in the 167 BAM files recovered from
the ENA database corresponding to the 2013 study by O. Miotto (Variant calling
explained in Chapter 3). The correspondence of the 167 samples and subpopulations
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is not publicly available and was provided by O. Miotto.
The parasite population structure was defined based on individual SNPs and
global barcode analysis. The uneven distribution and specificity of alleles confirmed
the presence of subpopulations and allele gradient representing gene flow. G1, G3
and G7 are associated with C580Y k13 mutant alleles and correspond to KH2 and
KH3 subpopulations. It should be interesting to compare the barcodes in the two
subpopulations (WKH-F01 and WKH-F03) described recently in the same localities
in western Cambodia [Miotto et al., 2015] from parasites isolated later than the
present study (2011-2013).
Among the three less significant groups defined by the barcodes, G2 and G4 could
not be associated to any of the specific subpopulations described earlier. The group
G8 was associated with northern Cambodia and most of the samples were carrying
the R539T k13 allele. Allele frequencies of this group were very close to that of
the Trapaing Prasat HC, as illustrated by the Weblogos (Article1: Additional file
11). The high FST value of northern localities is in agreement with the hypothesis
of gene flow associated with R539T mutation from the north. The prevalence of
R539T k13 allele associated with increased ring stage survival and delayed parasite
clearance rates near eastern Thailand and northern Cambodia border has been shown
in recent studies (Article1: Discussion section "11-SNPs barcode successfully identifies
parasite subpopulations"). The other 3 groups G5, G6 and G9 could not be associated
to specific subpopulations and the reason cold be presence of admixed or ancestral
population, which could not be identified based on the presented 11 SNPs barcode.
The association of G1, G3 and G7 group with artemisinn resistance and presence
of C580Y k13 allele supports the diffusion of C580Y allele form western Cambodia,
as described earlier [Ariey et al., 2014]. The R539T allele was strongly associated to
a subpopulation originating from northern Cambodia and represented by G8 group.
The two groups G4 and G8 were associated to high mefloquine IC50 values (Article1:
Additional file 13). Allele frequency in G8 was close from those found in Trapaing
Prasat samples (Article1: Additional file 11), suggesting that it could be the region
of origin of these parasites. Despite the observed association between drug resistance
(artemisinin and mefloquine) and subpopulations, the present study provides no ev-
idence that drug pressure is responsible for emergence of subpopulations in western
and northern Cambodia.
The existence of subpopulation and gene flow among these subpopulations has
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been supported by the conserved group analysis (clustering approach), allele gradi-
ent analysis (Chi-squared test) and fixation index (FST ) analysis. These could be
founder subpopulations emerging from the ancestral population KH1, as defined ear-
lier [Miotto et al., 2013]. The variation in the significance of the conserved groups
towards the center of Cambodia could be related to diffusion of alleles by overlapping
subpopulations. This is supported by the presence of G2, G4 and G8 groups which
have some barcodes associated to admixed subpopulation KHA. A west to east gene
flow axis is observed, but other diffusion axis might also be present in Cambodia.
The genetic exchange between subpopulations takes place by mating, which could
be supported by human socio-economical migrations. The socio-economic scenario is
changing in Cambodia rapidly, and it will be interesting to develop a specific barcode
analysis to follow the evolution of these subpopulations in this new socio-economical
context.
These 11 SNPs are shown to be suited for identification of the recent emerging
subpopulations (KH2, KH3 and KH4), but this barcode was not able to identify the
ancestral population (KH1) and the admixed population (KHA) as defined earlier
[Miotto et al., 2013]. Reason could be the diversity of these two parasite populations.
The present study validates the possibility of LUMINEX to barcode parasites. Indeed,
a more relevant and specific set of SNPs should be analyzed for implementation of
the barcode approach.
The barcoding approach (SNP genotyping) is a way of rapid and feasible assays
for classification of isolates into subpopulations or relevant clusters. This approach is
supported by the development of multi-assay technologies. This approach can reduce
the cost and resources used for epidemiological studies compared to whole genome
sequencing approach. At health centers it can provide a means to track the parasite
development and classify patients into different classes based on parasite nature (re-
sistant, wildtype, mixed infection). One of the issues with this approach could be the
selection of barcode loci for a specific study (as in this study, a specific barcode rele-
vant to Cambodian population should be developed). Methods and techniques should
be developed to generalize the barcoding approach. These barcodes can provide rapid
results but should be combined with other results for accuracy.
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Background: Western Cambodia is recognized as the epicentre of emergence of Plasmodium falciparum multi-drug 
resistance. The emergence of artemisinin resistance has been observed in this area since 2008–2009 and molecular 
signatures associated to artemisinin resistance have been characterized in k13 gene. At present, one of the major 
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ple and jeopardizing malaria elimination programme efforts. To anticipate the diffusion of artemisinin resistance, the 
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Methods: To this end, a mid-throughput PCR-LDR-FMA approach based on LUMINEX technology was developed to 
screen for genetic barcode in 533 blood samples collected in 2010–2011 from 16 health centres in malaria endemics 
areas in Cambodia.
Results: Based on successful typing of 282 samples, subpopulations were characterized along the borders of the 
country. Each 11-loci barcode provides evidence supporting allele distribution gradient related to subpopulations 
and gene flow. The 11-loci barcode successfully identifies recently emerging parasite subpopulations in western 
Cambodia that are associated with the C580Y dominant allele for artemisinin resistance in k13 gene. A subpopula-
tion was identified in northern Cambodia that was associated to artemisinin (R539T resistant allele of k13 gene) and 
mefloquine resistance.
Conclusions: The gene flow between these subpopulations might have driven the spread of artemisinin resistance 
over Cambodia.
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Background
Plasmodium falciparum malaria is one of the most severe 
and wide spread parasitic disease affecting millions of 
humans in the world. Following the emergence and spread 
of multidrug resistant parasites is a major challenge. "e 
Cambodian–"ai border is recognized as the epicentre of 
the emerging resistances. Plasmodium falciparum clinical 
malaria resistance to chloroquine was first documented 
in 1957 [1, 2] in this area. Later, in 1967 pyrimethamine 
resistance was also reported in the same region [3, 4]. 
Molecular epidemiological studies have confirmed that the 
spread of resistant parasites to these two drugs to Africa 
has originated from Southeast Asia [5]. In 1990s, meflo-
quine resistance was consequently observed in this area 
and more recently, the emergence of artemisinin deriva-
tives resistance was observed along Cambodian-"ai 
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border [6, 7]. "e reasons supporting the emergence of 
multidrug resistance parasites in this area are unknown. 
Recently, whole genome sequencing data demonstrated 
that P. falciparum populations were highly fragmented in 
Cambodia [8, 9]. Four subpopulations (KH1, KH2, KH3 
and KH4) and one large admixed subpopulation (KHA) 
were described using samples isolated in the time period 
2007–2011 [8]. KH1 subpopulation was shown to be as the 
ancestral population. "e KH2, KH3 and KH4 subpopu-
lations were associated to clinical artemisinin resistance 
defined by a delayed of parasite clearance in the first 3 days 
of artesunate monotherapy or artemisinin-based combi-
nation therapy (ACT) [8] and were later confirmed to be 
associated to mutations in the propeller domain of the 
Kelch gene (PF3D7_1343700) located on the chromosome 
13 (k13) [6]. In their report, Ariey and collaborators clearly 
showed that the prevalence of mutant k13 alleles, involved 
in artemisinin resistance, was much higher in western 
Cambodian provinces than in eastern Cambodia [6].
In this context, the present study aimed at evaluating 
the structure of the parasite population at a country-wide 
scale. Indeed, one hypothesis is that the structure of the 
parasite population plays an important role in the spread 
of k13 mutant alleles from west to east Cambodia. "e 
parasite population structure can be assessed by following 
different genetic variations such as single nucleotide poly-
morphisms (SNPs), microsatellite repeats, insertions/dele-
tions and range of gene duplication events [10]. Several 
molecular approaches have been developed to accurately 
detect reliable SNPs in the P. falciparum genome. For 
instance, a 24-SNP barcode detected by a robust TaqMan 
genotyping approach was described by Daniels et al. [11]. 
"eir analysis was performed on African and "ai isolates. 
At present, novel, rapid and reliable techniques based on 
fluorescent magnetic beads, such as the LUMINEX tech-
nology, have been developed to detect specific alleles. A 
rapid assay of Plasmodium typing was developed using 
fluorescent microspheres [12]. "is assay combined a PCR 
and a ligation reaction: PCR-LDR-FMA (PCR-based ligase 
detection reaction-fluorescent microsphere assay).
"is paper describes the implementation of the PCR-
LDR-FMA for the detection of an 11-SNP barcode. "e 
presence of parasite subpopulations was evaluated and 
intensive gene flow over Cambodia was described to 
assess the spread of drug resistance. Of note, a new sub-
population was defined, highly prevalent in northern 
Cambodia and associated with in vitro mefloquine resist-
ance (expressed by high mefloquine IC50 values).
Methods
Plasmodium falciparum isolates and samples size
A set of 533 blood samples collected in 2010–2011 
from P. falciparum malaria patients was analysed. "ese 
samples originate from 16 health centres (11 health cen-
tres and five reference hospitals) located in 10 provinces 
in Cambodia. Isolates were grouped in four regions: 
western, southern, eastern and northern Cambodia 
(Additional file 1). Four control DNA samples were used 
to validate barcode detection (3D7, Dd2, HB3 and RO33).
DNA extraction and PCR ampli"cation
"e genomic DNA was extracted from 200  µl of blood 
using the DNA Mini blood kit (Qiagen, Germany) 
according to manufacturer’s instructions. DNA extracts 
were stored at −20  °C until use. DNA from reference 
strains 3D7, Dd2, HB3 and RO33, provided by Malaria 
Research and Reference Reagent Resource Center-MR4, 
were used as controls. Primary PCR was carried out in 
25 µL of final volume with 5 µL of DNA, 0.25 µM of each 
corresponding primers (Additional file  2), 0.2  mM of 
each deoxynucleoside triphosphate (dNTP) (Solis Bio-
dyne), 1× of reaction Buffer, 2.5  mM of MgCl2, 1.25 U 
FirePol® Taq DNA Polymerase (Solis Biodyne), with the 
following conditions: 94 °C for 15 min, then 30 cycles of 
a three step program (94 °C for 30 s, 52–55 °C for 1 min 
and 72  °C for 1  min) and final extension at 72  °C for 
10  min to reach the corresponding target between 164 
and 385 bp (Additional file 3).
"e nested PCR was performed in 25  μl containing 
0.5 μM of each primer (Additional file 2), 0.2 mM of each 
deoxynucleoside triphosphate (dNTP) (Solis Biodyne), 
1× of reaction Buffer, 2.5 mM of MgCl2, 2.5 U Taq poly-
merase (FirePol® DNA Polymerase, Solis Biodyne). 5  µl 
of the primary PCR reaction were used as the template. 
PCR conditions were: 94  °C for 15  min, then 40 cycles 
of 94  °C for 30  s, annealing temperature between 55 
and 60  °C for 1 min and 72  °C for 1 min. A final exten-
sion at 72 °C for 10 min was performed to obtain the cor-
responding fragments between 100 and 200  bp. PCR of 
valid SNPs were performed in four multiplexed reactions 
(Additional file 3).
Ligation and detection assays
Nested PCR products were pooled together in two sets 
according to microsphere combinations. One microli-
tre of the pooled PCR products were used for the ligase 
detection reaction (LDR). "e LDR was based on two 
allele-specific primers and one locus-specific probes 
(Additional file 4). "e allele-specific primers were com-
posed of two parts: the 5-prime part hybridizing with the 
MagPlex-Tag probe and the 3-primer part hybridizing 
with the PCR product. 33 different MagPlex-Tags were 
used to detect 40 alleles (Additional file 4) corresponding 
to the 20 loci which were successfully amplified by PCR 
(Additional file 3). Ligation was performed after hybridi-
zation of the locus-specific primer. Several MagPlex 
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anti-Tag probes were used twice. Locus-specific probes 
were 5′ phosphorylated and 3′ biotinylated. LDRs were 
performed in a final volume of 15  µL holding in 1× of 
Taq Ligase buffer, 10 nM of each LDR (allele- and locus-
specific primers), 4  U of Taq DNA ligase (Genesearch) 
and 1  µL of pooled Nested PCR. "ermocycling condi-
tions were carried out by denaturation of the double 
stranded DNA at 95 °C for 1 min, followed by 32 cycles at 
95 °C for 15 s and hybridization at 58.0–60 °C (Additional 
file 3) for 2 min. Quality control was performed by using 
DNA from reference strains provided by MR4. Two mul-
tiplexed reactions were used to characterize final valid 
SNPs (Additional file 3).
Hybridization and labeling of magnetic beads
A 5  µL fraction of the LDR product was poured into 
60  µL of hybridization solution TMAC buffer (3× of 
tetramethylammonium chloride [TMAC] (Sigma-
Aldrich), 3 mM of EDTA (Gibco), 50 mM Tris–HCl, pH 
8.0 (Sigma-Aldrich), 0.1  % sodium dodecyl sulfate) and 
1000 beads of each MagPlex-Tag microspheres used in 
the multiplex LDR, as described above. Beads quantifi-
cation was performed as previously described [13]. Mix-
tures were heated to 95 °C for 1 min 30 s and incubated 
at 37 °C for 35 min to allow hybridization between SNPs-
specific LDR products (Tag-probe) and bead-labeled 
anti-TAG probes. "en, 6 µL of 1:50 dilution of strepta-
vidin-R-phycoerythrin (Invitrogen) in TMAC buffer was 
added to the post-LDR mixture and incubated at 37  °C 
for 20  min in 96-well plate (Eppendorf ). PCR and LDR 
reactions were conducted in 96-well plate. "e fluores-
cence of each allele-specific LDR products was meas-
ured on a MagPix instrument with xPonent 4.2 software 
(LUMINEX).
"e measurement of the signal for an allele was decom-
posed into the signal intensity without noise and the 
background noise. Negative samples show reduced sig-
nal-to-noise ratio and positive samples show increased 
signal-to-noise ratio.  "e identification of negative and 
positive samples was based on a classification method 
which minimizes the variance associated to the two 
series of measures. "is algorithm was analogous to 
the k-mean algorithm where k =  2. A test was used to 
address each measurement to the negative or positive 
value of the allele. Negative and positive results for the 
two alleles were combined to assess barcode value at con-
sidered position. Double negative results were considered 
as positive for the third allele at BC07 barcode position 
(BC07_ALT_G allele). DNA of the four reference strains 
3D7, Dd2, HB3 and RO33 was introduced as the posi-
tive control on each 96-well plates. A set of 282 samples 
were successfully genotyped out of the 533 blood samples 
initially selected for the analysis, using an 11 positions 
barcode.
Data and statistical analysis
Comparison with the available genomic resources was 
performed after calling of the mutations from BAM files 
deposited in the ENA database for 167 samples isolated 
between 2007 and 2011. Correspondence of these iso-
lates and the earlier defined subpopulations in Cambodia 
[8] was provided by O. Miotto. Alleles for the 11 barcode 
positions and k13 locus were recovered from the VCF 
files.
Statistical analysis was performed on the 282 samples 
using R software [14]. For determining the dependency of 
the alleles of some selected genes on the locations, firstly 
the association between alleles and health centres was 
visually addressed using correspondence analysis (Fig. 1). 
Analysis was performed for the 11 barcode positions. 
Space distribution of health centres was questioned using 
Between-Class analysis. "e significance of differences 
in allele distribution was tested using Chi squared tests 
for independence. Loci presenting a p value  <0.05 were 
considered as exhibiting a significantly different distri-
bution among centres. To identify localities that account 
most for the SNP allele dependency on health centres, 
a threshold value of 1 for the Chi squared test statistics 
components was used (one component for each health 
centre, Additional file  1). Weblogos [15] were used to 
highlight conserved alleles among health centres.
Average FST (fixation index) was calculated to measure 
the extent of genetic differentiation within health cen-
tres. It was based on 11-SNPs barcode of 282 samples. 
An average allele diversity value was first calculated per 
sampling area (Hs) from the 11-SNPs barcode. It was 
then compared with the allele diversity measured for the 
282 samples (Ht) to obtain the average FST value, ranging 
from 0 (no differentiation/high diversity) to 1 (complete 
differentiation/low diversity: subpopulations fixed for dif-
ferent alleles).
To define the population structure, hierarchical clus-
tering was performed on 282 samples described by 
the 11-SNPs barcode. "e pairwise distances between 
the samples were estimated as the proportion of base 
substitutions between them over the barcode. Ward’s 
minimum variance method was used to build the den-
drogram (Additional file  5A). Random sampling was 
performed in order to obtain robust results: the cluster-
ing approach was implemented on 10,000 subsets of 230 
samples each, randomly selected out of the 282 samples. 
Based on these 10,000 clustering results, pairwise dis-
tances between samples were calculated as the percent-
age of clustering results in which two samples are in the 
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same cluster. "is distance matrix was then used to build 
a dendrogram for all 282 samples. "e number k of final 
clusters (conserved groups) was selected based on the 
dendrogram structure (Additional file 5B). "e value for 
k  =  9, 10 and 14 were producing relevant clusters, but 
on comparing the barcodes with the previously defined 
population structure [8], it was observed that the clusters 
produced on increasing k after 9 are not associated to a 
specific resistant population (KH2, KH3 and KH4) and 
instead are related to admixed population KHA and the 
mixture of other resistant subpopulations. "ese unspe-
cific clusters were localized close to centre of the coun-
try. Hence, the population structure was represented by 
nine conserved groups (G1 to G9). Weblogo was used to 
highlight conserved alleles among health centres in G1 
to G9 groups. "e groups are geolocalized by the geo-
graphical centroids on the 2D map. "e coordinates for 
the geographical centroids are calculated as the average 
of the coordinates (measured in the coordinate space of 
the 2D map) of the health centres included in the group. 
To determine the groups significantly related to geo-
graphical locations, the average distance to geographical 
centroid within a group was compared to the average dis-
tance to the geographical centroid when the 282 samples 
were randomly assigned to the nine groups. "e average 
distance for each group was compared to the average 
distances calculated for 5000 random re-sampling of the 
282 samples within the nine conserved groups. "e p 
value was calculated as the proportion of average values 
below the average distance of the health centres to the 
geographical centroid for each group.
Results
Barcode of alleles from 11 variable sites
PCR fragments were successfully amplified for 20 SNPs. 
"ere were no PCR amplification for the other four SNPs 
and were rejected. Assays for only 13 SNPs provide inter-
pretable LUMINEX signal (Additional file  3) and others 
were excluded from the assay. Out of the 13 SNPs, the 
locus #7 was abandoned due to non-reproducibility and 
non-accuracy of the detection on control DNAs and locus 
#5 was rejected because genotyping analysis revealed that 
this locus was monomorphic. Finally, 11 SNPs were vali-
dated for barcoding (BC01 to BC11). Four multiplex PCRs 
and two multiplex LDRs were set up for the LUMINEX 
detection according to their annealing temperature.
Since the work of Daniels et al. [11], the genome version 
and annotation has been improved. Databases revealed that 
23 SNPs amongst the 24 were located in a coding region 
and they are equally distributed between synonymous and 
non-synonymous mutations (Additional file 6). Five SNPs 
were located in subtelomeric regions. Genomic analysis 
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Fig. 1 Relationship between allele distribution and geographic origin of parasites in the P. falciparum Cambodian population. Correspondence 
analysis was based on 23 alleles and was conducted for 282 samples. Each reference (REF) and altered (ALT) alleles are represented. Position BC07 
had two alternative alleles. a Contribution of each allele in the distribution of the 282 samples. b Between-class analysis performed with health 
centres. Analysis was done on the same dataset as in a. Scales of the two diagrams are identical
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revealed that non detection in the locus #11 was due to 
the presence of two nearly identical copies of the rifin gene 
in which the SNP is located (Additional file 6). PlasmoDB 
v11.1 suggested that locus #15 corresponding locus was 
tri-allelic. LUMINEX data treatment was adapted for this 
locus. Locus #24 (BC11) was validated for LUMINEX geno-
typing despite its low variation in Cambodian parasite pop-
ulation (Additional file 6). Initial analysis was performed on 
533 samples, 79 were resulting from mixed infection, 183 
of the samples present no significant signal with LUMINEX 
for at least one barcode position and 50 samples could not 
be amplified using PCR for at least one locus. Among the 
251 rejected samples, 59 samples show more than one type 
of errors (Additional file 7). Finally, 282 samples among 533 
blood samples were successfully genotyped at 11 SNP loci.
Allele distribution associated to health centres
Correspondence analysis was performed using barcode 
of all the samples (Fig. 1a). Axis 1, 2 and 3 were explain-
ing 21, 16 and 12 % of the information respectively. For 
each SNP, REF (reference 3D7) and ALT (non-reference) 
alleles were in opposite quadrants except for BC07 bar-
code position which was tri-allelic. "e BC11_ALT_T 
allele was located at the centre of the representation as it 
was present in nearly all samples. Despite the low number 
of isolates with corresponding BC11_REF_G allele, corre-
spondence analysis showed association of this allele with 
eastern and southern Cambodia. Association of alleles 
with health centres was questioned using Between-Class 
analysis (Fig. 1b). Matching of relative position of health 
centres in the Between-Class analysis with their geo-
graphic position suggests that some alleles show associa-
tion with samples geographic origin. A strict opposition 
between eastern and western Cambodia was observed, 
which can be due to specific distribution of BC03 and 
BC05 alleles in samples from these areas (Fig. 1). North-
ern and southern localities present a similar distribution 
pattern in other projections (Additional file  8). Present 
analysis suggests that allele frequencies are in agreement 
with the geographic location of health centres. Pursat 
is not in a correct position in both correspondence and 
Between-class analysis. It is located in the western part 
of Cambodia and it clusters with eastern localities. "e 
discrepancy with its geographic localization could be due 
to the BC06_ALT_T and BC07 allele frequencies.
Allele frequency gradient between localities
Uneven distribution of alleles was confirmed by Chi 
squared analysis (p value  <0.05) and the allele frequen-
cies were represented using Weblogo (Fig.  2). Barcode 
BC11 was excluded from this analysis because of its low 
variation. Most important allele enrichments were high-
lighted in red and blue colors for ALT and REF alleles 
respectively, using the Chi squared values (Additional 
file  1). Allele enrichment was not restricted to a sin-
gle health centre but is often present in geographically 
close localities. Western Cambodia, including Battam-
bang, Pailin and Pursat provinces displayed significant 
enrichment of ALT alleles for BC01, BC02, BC03, BC07 
and BC08 and the REF allele for BC04, BC05 and BC06 
(Additional file 8). "e region of Kampot (Koh Slar and 
Chhouk health centres) showed strong enrichment of 
BC02_REF_T and BC04_ALT_T with a quasi-absence 
of opposite alleles (Additional files 1, 9B, D). For some 
alleles, the gradient from ALT to REF significant allele 
frequency was emphasized by the presence of health 
centres located between ALT and REF significant geo-
graphic area where no significant enrichment could 
be specified for any of the alleles. For example, western 
Cambodia appeared as the starting point for the diffusion 
of BC02_ALT_C and northern Cambodia was associ-
ated with BC02_REF_T (Additional file  9B). "e region 
of Battambang shows no significant allele frequency for 
this locus. An example for the West-East axis is observed 
for BC10 locus where the region of Pailin was associated 
with BC10_REF_G alleles whereas BC10_ALT_A allele 
was found in eastern Cambodia. Accordingly, Battam-
bang and Pursat health centres located between these 
two areas show no significant bias in allele frequency 
(Additional file  9J). "erefore, association between bar-
code alleles and localities could suggest the presence of 
specific subpopulations with fixed allele in restricted geo-
graphic distribution and overlap between these subpopu-
lations or even gene flow.
Presence of "xed alleles at the border of Cambodia
"e presence of subpopulations was confirmed using 
an average FST value calculated per health centres. High 
FST values are observed at the localities near the bor-
ders of Cambodia (Fig. 3), including Keov Seima (eastern 
Cambodia). Tasanh and Sampov Loun health centres in 
western Cambodia are associated with high FST values 
and accordingly BC02_ALT_C allele was observed to 
be fixed in Tasanh region. Similarly, BC04_ALT_T and 
BC09_ALT_C might have contributed to high FST values 
in northern localities. "e fixation of BC04_ALT_T allele 
was also observed in Kampot province (Chhouk HC).
FST analysis and gradients of allele frequencies (Addi-
tional file  9A–J) over the country suggest gene flow in 
a centripetal orientation. According to high FST values, 
the five locations Anlong Veng, Keov Seima, Sampoev 
Loun, Tasanh and Trapaing Prasat might be associated 
with parasite subpopulations. Crossing of subpopulations 
could be responsible for allele diffusion over the country. 
Especially in western Cambodian sites, where the low FST 
values could result from overlap between subpopulations. 
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"is likely reflects gene flow driving the homogenization 
of the population.
Identi"cation of emerging subpopulations in Cambodia
Results presented in sections above suggest that sub-
populations were restricted to small geographic areas. 
Unsupervised clustering runs based on different ran-
dom subset of the 282 isolates suggested the existence of 
9 robust clusters (referred as G1–G9, size of the groups, 
n  =  18–44) representative of the parasite subpopula-
tions. "e relationship between groups and health cen-
tres was established based on distance of samples to their 
geographical centroid. None of the groups had samples 
restricted to a single health centre, and most of the geo-
graphical centroids are focused in north-west area of the 
country (Fig. 4).
"e three groups G1, G3 and G7 were significantly 
associated to specific geographic area (p value  <0.05). 
"e samples in these groups were mostly isolated in 
western Cambodia, but also include samples from 
the north or from the south of the country (Addi-
tional file  10). G1 includes two samples from eastern 
Cambodia. G3 samples were originating from western 
and southern Cambodia only. G7 had two samples from 
the southern and one from northern Cambodia. Rela-
tionship with previously described Cambodian parasite 
subpopulations shows that the three groups could be 
associated with KH2 and KH3 subpopulations. Accord-
ingly, samples that have been probed, carried C580Y k13 
mutation. Weblogos were added to the analysis to illus-
trate the frequency of alleles at the 11 barcode position 
among conserved clusters (Fig. 4). In accordance with the 
results presented above (Figs. 1, 2), G1 shows conserved 
allele positions: BC01_T, BC04_A, BC05_G, BC08_A and 
BC10_G. "is genotype was very close to the two bar-
codes associated with Pailin and Ou Chra health centres. 
Group G3 weblogo was more reminiscent of Promoy HC 
barcode (Additional file 11). "e barcode analysis based 
on 11 SNPs was efficient to describe conserved subpopu-
lations that emerged recently in western Cambodia con-
comitantly with artemisinin resistance.
"e three groups G2, G4 and G8, are localized in the 
area between north-western region and the centre of the 
country (Fig. 4; Additional file 10). "e average distance 
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of these groups to the geographical centroid presents a p 
value between 0.1 and 0.3. "e two groups, G2 (n = 32) 
and G4 (n  =  27), have samples from various localities. 
Most of the samples in G2 are originating from locali-
ties in southern Cambodia and include 10 samples with 
C580Y k13 allele. "ree barcodes in this group are found 
in the admixed KHA subpopulation described earlier [8]. 
"e samples in the group G4 are mostly originating from 
localities in western Cambodia and include eight samples 
with C580Y, two samples with R539T and one sample 
with N458Y k13 allele. Two barcodes in this group are 
identified in the previously defined parasite subpopula-
tions, one barcode is found in KH4 subpopulation (also 
carrying Y493H allele) and the other is found in KHA 
subpopulation (also carrying R539T allele). "e samples 
in the group G8 (n = 44) are mostly originating from the 
localities in the north (Trapaing Prasat and Anlong Veng 
health centre) of the country and include four samples 
with C580Y and six samples with R539T k13 allele. In 
this group the 11 barcode loci are conserved in most of 
the samples and some samples have variation at BC01, 
BC03 and BC08 locus. "ree barcodes in this group are 
identified in the previously defined KH3 (shown to carry 
R539T alleles), KH1 (ancestral population) and KHA 
(admixed population with C580Y alleles) subpopulations.
"e three other groups G5, G6 and G9 are localized 
close to the centre of the country and show no signifi-
cant geographical centroid p values (0.99, 0.99 and 0.44, 
respectively). "e samples in these groups are originating 
from localities from all over the country. In the group G5 
(n = 40) only four samples are originating from the locali-
ties in the south of Cambodia. "is group includes four 
samples with C580Y, one sample with R539T, one sample 
with P553L and one sample with Y493H k13 alleles. Four 
barcodes of this group are identified in the KH subpopu-
lations, two barcodes in KH1 and two barcodes in KHA. 
"e samples in the group G6 (n = 33) are mostly coming 
from the localities in the southern and eastern regions of 
Cambodia. "is group includes six samples with C580Y, 
one sample with I543T and one sample with V568G k13 
alleles. Only one barcode of this group is identified in the 
KH3 subpopulation. "e samples in the group G9 (n = 27) 
are mostly originating from the localities in eastern and 
western regions and 4/5 tested sample are negative for k13 
allele. In this group, two barcodes are identified in the KH4 
subpopulation, two barcodes in the KHA subpopulation, 
Health centres
Cambodian Capital 
(Phnom Penh) 
0.0 – 0.05 
0.05 – 0.15 
0.15 – 0.25 
> 0.25 
12
3
4
5
6
7
8
9
11
12
10
13
14
15
16
Locali"es
1: Tasanh HC
2: Pailin RH
3: Ou Chra HC
4: Sampoev Loun RH
5: Ba#ambang RH
6: Anlong Veng RH
7: Trapaing Prasat HC
8: Veurn Say HC
9: Keov Seima HC
10: Khsim HC
11: Chhouk HC
12: Koh Slar HC
13: Takavit HC
14: Oral HC
15: Promoy HC
16: Pursat
Fig. 3 Genetic diversity (Average FST) of the P. falciparum population among health centres. The Average FST value was calculated among all indi-
viduals isolated from a specific health centre for the 11 barcode positions
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one barcode in KH1 subpopulation and one barcode in 
KH3 subpopulation. "e relationship between barcodes 
matching the KH4 subpopulation and Y493H allele was 
confirmed for seven isolates of this group.
"e map (Fig.  4) represents a gradient of distribution 
of relevant subpopulation based on barcode description 
from north-west to the centre of Cambodia emphasiz-
ing gene flow in that orientation. "e barcodes of the 
groups including samples from the north-western locali-
ties are mostly associated to the KH2 and KH3 subpopu-
lations and most of the samples carry C580Y k13 allele 
only. Moving towards the centre it is observed that the 
barcodes are associated more with the KHA, KH1 and a 
specific KH3 subpopulations in the north (G8). "e sam-
ples are mostly carrying C580Y and R539T k13 alleles 
and also a rare N458Y allele in one of the samples. "e 
groups in the centre of the country are including more 
barcodes associated to the KHA and KH1 subpopula-
tions and some barcodes matching the KH3 and KH4 
subpopulations. "e samples are shown to carry C580Y, 
R539T, Y493H and the three rare mutations P553L, 
I543T and V568G (Additional file 10). "is could suggest 
the localization of the admixed populations with high 
diversity towards the centre of the country.
Me#oquine resistance is strongly associated to northern 
Cambodia
Mutations in k13 gene associated with resistance to arte-
misinin were determined in 98 patients, as described 
earlier [6]. From these patients, 70 % of the samples were 
positive for one of the k13 resistant alleles (C580Y, R539T, 
Y493H, I543T, P553L, V568G & N458Y). Artemisinin 
resistance was more frequent in western and northern 
Cambodia (Chi squared test p < 0.01). "e mutant alleles 
Y493H, I543T, P553L, V568G, and N458Y were found 
once in the 282 isolates. "e C580Y allele was the most 
prevalent (54/68 positive patients) and was found to be 
present in all the conserved groups. "irty-seven different 
barcodes were found among these 54 samples. No asso-
ciation was found between the C580Y allele and 11-SNPs 
barcode. "e R539T was the second most frequent allele (9 
isolates over 68 positive patients) with six isolates belong-
ing to G8, two to G4 and one from G5. Four isolates were 
from northern Cambodia, three from western and two 
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from southern Cambodia. Barcodes of these nine samples 
have BC01_REF_C, BC03_ALT_A, BC04_ALT_T, BC05_
REF_G, BC09_ALT_C and BC11_ALT_T in common. All 
these alleles were significantly associated to Trapaing Pra-
sat health centre (Fig. 2; Additional file 11).
In vitro IC50 susceptibilities to chloroquine (n  =  109), 
mefloquine (n = 111), piperaquine (n = 103) and quinine 
(n  =  107), were assessed in isolates with a parasitaemia 
>0.1 % [16]. Samples were distributed among all geograph-
ical locations and clustering groups. Piperaquine showed 
no geographical bias. "e susceptibility for chloroquine 
and mefloquine were lower in eastern Cambodia (Addi-
tional file 12). High mefloquine IC50 values were found in 
isolates from Promoy, Takavit and Trapaing Prasat health 
centres (Fig. 5). Mefloquine resistant parasites in the region 
between Promoy and Takavit were mostly carrying C580Y 
allele. R539T mutant parasites had significantly high 
mefloquine IC50 values (Fig. 5) suggesting two geographic 
loci for mefloquine resistance in Cambodia, one associated 
to C580Y allele and one associated to R539T allele. Large 
proportion of G8 samples were carrying R539T alleles and 
most originating from Trapaing Prasat HC in the north. 
"e samples in G4 and G8 groups show high mefloquine 
IC50 values (Additional file 13). "e FST values are shown 
to be high for Trapaing Prasat HC (Fig.  2). "ese results 
suggest the presence of a recently emerging P. falciparum 
subpopulation in northern Cambodia.
Discussion
Implementation of 11-SNPs barcode for mid-throughput 
analysis
A PCR-LDR-FMA technique for the Mid-throughput 
detection of a barcode for P. falciparum Cambodian 
isolates was optimized. "is strategy included multiplex 
PCR and ligase detection reactions prior to hybridiza-
tion with magnetic microspheres (MagPlex-Tag probes). 
A specific algorithm was developed for signal discrimi-
nation between the 23 alleles corresponding to 11 SNPs 
which enabled us to characterize 282 samples. "e choice 
of the loci was a critical step. It was based on both pos-
sibility to run detection at the corresponding locus and 
allele frequency. In fact, the PCR-LDR-FMA required 
the design of several primers at each locus. "is was the 
main source of rejection of SNPs. Indeed, this task was 
hampered by the AT richness of P. falciparum genome. 
"e frequency of alleles in the present dataset (Addi-
tional file 6) was sometimes different from the expected 
non-reference allele frequency (NRAF). One explana-
tion could be that the study of Daniels et al. included only 
"ai samples [11]. Discrepancy was also observed with 
the MalariaGEN database. Genome annotation of P. falci-
parum is available at PlasmoDB. Bioanalysis revealed that 
some of the selected SNPs were present in genes located 
in subtelomeric regions and encoded surface antigens 
(Additional file 6). "ese regions are known to be highly 
variable and to encode surface antigens. Variation in 
these regions might not reflect population evolution, 
but more parasite-host interactions such as antigenic 
variation.
11-SNPs barcode successfully identi"es parasite 
subpopulations
"e 11-SNPs barcode analysis at a country-wide scale 
confirmed that P. falciparum population is fragmented 
into subpopulations. Evidences were given both by indi-
vidual SNPs and by global barcode analysis. "e present 
West North EastSouth
Ou Chra Pailin Trapaing
Prasat
Promoy Koh Slar Takavit Chhouk Veurn SayKhsim WT R539TC580Y
200
150
100
50
0
200
150
100
50
0
30nM
IC50
(nM)
Health centres
(***)
K13 muta"ons 
(*)
a b
Fig. 5 Distribution of mefloquine IC50 value among P. falciparum isolates in Cambodia. Box plot analysis presents median and quartiles. Meflo-
quine resistant parasite have IC50 value over 30 nM (dashed line). a Mefloquine sensitivity measured per health centres. *** A significant effect was 
observed (Kruskal–Wallis: p = 2.028e−05). b Mefloquine sensitivity measured per k13 gene alleles related to artemisinin resistance. * A significant 
effect was observed (Kruskal–Wallis: p value = 0.01695). Number of samples: C580Y: 29, WT: 15 and R539T: 8
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study covers all regions where P. falciparum is endemic 
in Cambodia. "e uneven distribution of most alleles 
confirmed the presence of subpopulations with restricted 
geographic distribution, leading us to define nine groups. 
Isolates from clustering groups G1, G3 and G7 were 
mostly located in western Cambodia. "ey were associ-
ated with the C580Y k13 mutant allele and correspond 
to the KH2 and KH3 subpopulations described earlier [6, 
8]. "ese three groups might have restricted geographic 
origin as barcode allele frequencies from health centres 
(Fig. 2) and clustering groups (Fig. 4) were similar (Addi-
tional file 11). Subpopulation in these localities have been 
shown to emerge recently and correlates with artemisinin 
resistance specific to C580Y allele. It should be interest-
ing to compare the barcodes in the two subpopulations 
(WKH-F01 and WKH-F03) described recently in the 
same localities in western Cambodia [9] from parasites 
isolated later than the present study (2011–2013).
Among the three less significant groups defined by the 
barcodes, G2 and G4 could not be associated to any of 
the specific subpopulations described earlier. "e reason 
for G2 could be the origin of samples from the area which 
was not covered by genomic analysis. In fact, high FST 
value was observed in Chhouk suggesting possible emer-
gence of subpopulation in southern Cambodia. Only five 
barcodes from these two groups were matching with the 
genotypes of defined subpopulation origin, one from 
KH4 and 4 from the admixed subpopulation KHA. "e 
group G8 was associated with northern Cambodia and 
most of the samples were carrying the R539T k13 allele. 
Allele frequencies of this group were very close to that of 
the Trapaing Prasat HC, as illustrated by the Weblogos 
(Additional file 11). "e high FST value of northern locali-
ties is in agreement with the hypothesis of gene flow 
associated with R539T mutation from the north. "e 
prevalence of R539T k13 allele associated with increased 
ring stage survival and delayed parasite clearance rates 
near eastern "ailand and northern Cambodia border 
has been shown in recent studies [17, 18].
"e 11-SNPs barcode questions the origin of sub-
populations in Cambodia. Subpopulations are expected 
to emerge at different places and at different times over 
the country. Introduction of ACT is clearly associated 
with emergence of western parasite subpopulations. "e 
origin of other subpopulations is not known. Barcode 
analysis shows that the genetic drift induced by the emer-
gence of subpopulation disappears rapidly over time, 
most likely through the presence of admixed populations. 
Unfortunately, the present 11-SNPs barcode seems less 
relevant for the characterization of populations with high 
heterogeneity such as core population KH1 and admixed 
population KHA.
Relationship between subpopulations and drug 
susceptibilities
Groups G1, G3 and G7 were associated with resistance to 
artemisinin. Resistant parasites in these groups were car-
rying the C580Y allele only (Additional file 10). "e dif-
fusion of the C580Y allele in 2010–2011 over Cambodia 
was described previously [6]. "e present study provides 
evidence that the C580Y allele can be found in all groups. 
In the group G8, though the C580Y allele is present, 
most of the samples are associated to the R539T resistant 
allele. "ree groups contains more than one k13 allele: 
G4 (N458Y, 1; R539T, 2; C580Y, 8), G5 (Y493H, 1; P553L, 
1; R539T, 1; C580Y, 4), G6 (I543T, 1; V568G, 1; C580Y, 
6) and G8 (R539T, 6; C580Y, 4). "e R539T allele was 
strongly associated to a subpopulation originating from 
northern Cambodia and represented by G8 group. "e 
two groups G4 and G8 were associated to high meflo-
quine IC50 values (Additional file  13). Interestingly, G8 
includes highest number of samples (21/28) with associ-
ated to high mefloquine IC50 values (IC50 > 30 nM). Par-
asites were genetically close according to their barcode. 
Allele frequency in G8 was close from those found in 
Trapaing Prasat samples, suggesting that it is the region 
of origin of these parasites. "is result is in agreement 
with the study by Chaorattanakawee et al., which shows 
the increase in occurrence of R539T allele from 2009 to 
2013 and association with increased mefloquine IC50 
value for R539T allele (ex vivo drug susceptibility test) 
[19]. Despite the observed association between drug 
resistance (artemisinin and mefloquine) and subpopula-
tions, the present study provides no evidence that drug 
pressure is responsible for emergence of subpopulations 
in western and northern Cambodia.
Genetic exchange between parasite subpopulations
Clustering approach provided evidence that subpopula-
tions have emerged in different parts of the country. "ey 
might have emerged from the ancestral KH1 population 
described by Miotto et al. [8]. Significance of geographi-
cal centroids shows that the most recently emerged sub-
populations could be well localized. "e decrease of the 
significance could be related to the diffusion of alleles, 
which in that case follows the west to east major axis 
(Fig. 4). Nevertheless, other gene flow axis might also be 
present over Cambodia. "is was confirmed by high FST 
values at the periphery of the country (Fig.  3). Regions 
with high FST were strongly related to forest areas which 
are mostly distributed at the border of Cambodia. Para-
site subpopulations might have encountered independ-
ent drift of mutation and selection. Parasites moving 
out of their region of origin will progressively mix their 
genetic background with other parasites. "is hypothesis 
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is supported by the presence of G2, G4 and G8 groups 
containing barcodes associated to admixed population 
KHA. Genetic exchange between subpopulations takes 
place by mating. It might be supported by human socio-
economical migrations. "e presence of this ongoing 
gene flow might have supported the eastward dispersal of 
artemisinin resistance k13 alleles after introducing ACT 
in the country. Currently, environmental factors such as 
deforestation, development of communication axes and 
global welfare are changing rapidly. It will be interesting 
to develop a specific barcode analysis to follow the evolu-
tion of these subpopulations in this new socio-economi-
cal context.
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Additional !les
Additional !le 1. Geographic distribution of samples and allele 
frequency. Blood samples from P. falciparum positive patients were 
collected from 16 health centres or hospitals covering the areas where 
parasite transmission is active. The number of valid samples (282) out 
of the total selected samples (533) is provided per health centre. The 
frequency of each allele (REF/ALT) is given for the 11 loci, which were 
positive for LUMINEX detection. The alleles with Chi squared test statistics 
components (one component for each health centre) greater than 1 
are highlighted in grey. The presence of Kelch-propeller domain altered 
allele was assessed by PCR and sequencing. The frequencies of wild type 
individuals and of the two major alleles C580Y and R539T are provided per 
location. The other alleles present at low frequency, N458Y, Y493H, I543T, 
P553L and V568G are pooled together. The drug sensitivity was measured 
routinely for patients presenting high parasitaemia (>2 %). The number of 
samples tested for IC50 measurements for chloroquine (CQ), piperaquine 
(PIP), quinine (QN), artesunate (ART), mefloquine (MF) and dihydroarte-
misinin (DHA) is provided.
Additional !le 2. Primers sequences for PCR reactions corresponding 
to 20 of the 24 SNPs selected for barcode detection and for k13 locus 
amplification.
Additional !le 3. PCR and LDR conditions. NV for not valid PCR. Eight 
LUMINEX assays were negative. Assay#7 was rejected because one allele 
only was not detected (Pos/Neg). LUMINEX detection was performed after 
microsphere hybridization and ligation reaction. ID of microspheres that 
were used for several assays are in bold.
Additional !le 4. Primer sequences for LDR (Ligation Detection reaction) 
performed.
Additional !le 5. Classification of samples into 9 conserved groups. A. 
Hierarchical clustering of the 282 valid samples based on the 11-SNPs 
barcode. The pairwise distance between the samples is calculated as the 
proportion of base substitution between them over the barcode. Ward’s 
minimum variance method was used to build the dendrogram. The den-
drogram is cut to obtain 8 clusters (k = 8). The clusters are represented 
by red rectangles. B. Hierarchal clustering of 282 samples based on the 
percentage of clustering results in which two samples are in the same 
cluster (when 8 clusters are considered). The clustering approach was 
implemented on 10,000 subsets of 230 samples each, randomly selected 
out of the 282 samples. Based on these 10,000 clustering results, pairwise 
distance between samples were calculated as the percentage of cluster-
ing results in which two samples are in the same cluster. The number 
of clusters (conserved groups) was selected based on the dendrogram 
structure. The clusters are represented by red rectangles.
Additional !le 6. Major features of the Single Nucleotide Polymorphisms 
selected for LUMINEX assay. A set 11 SNPs (highlighted in grey) has 
been selected from 24 SNPs validated by Daniels et al. [11]. NRAF value 
from three geographic areas and the global NRAF were recovered from 
MalariaGEN v4.0. Genome position was evaluated according to genome 
version 3. Subtelomere were identified based on gene composition. Valid 
SNPs are highlighted in grey. Frequency of valid alleles was calculated 
based on the data mentioned in Additional file 3. SNP ID is the column 
“Position” preceded by the tag “Pf3D7_[01-14]_v3:” in MalariaGEN and by 
the tag “NGS_SNP.Pf3D7_[01-14]_v3.” in PlasmoDB.
Additional !le 7. Number of samples rejected due to mixed infection 
(M), no significant signal with LUMINEX for at least one barcode position 
(N) and no amplification using PCR for at least one locus (X).
Additional !le 8. Relationship between allele distribution and geo-
graphic origin of parasites in the P. falciparum Cambodian population. Cor-
respondence analysis was based on 23 alleles and was conducted for 282 
samples. Each reference (REF) and altered (ALT) alleles are represented. 
Position BC07 had two alternative alleles. Left panel presented the contri-
bution of each allele in the distribution the 282 samples. Between-class 
analysis performed with health centres is presented in the right panel. 
A. Axis1-axis3 projection of the correspondence analysis. B. Axis2-axis3 
projection of the correspondence analysis.
Additional !le 9. Gene flow analysis based on uneven distribution of 
alleles in the P. falciparum population over Cambodia. The barcode is 
represented by 11 genomic positions presenting two types of allele per 
site: the reference allele which is found in 3D7 reference genome (REF) 
and the alternative allele (ALT). Over representation of one of the REF/
ALT allele in a local parasite population was evaluated using a Chi squared 
analysis. The allele was in blue for REF and dark red for ALT. The box was in 
grey when the Chi squared test statistics components (one component 
for each health centre) was less than 1. Allele distribution is presented for 
barcode position BC01 to BC10. Barcode position BC11 was not suitable 
for Chi squared analysis. Corresponding position in the barcode in sur-
rounded in red. The significant health centres which are close together 
were circled. A. Allele distribution for barcode BC01. B. Allele distribution 
for barcode BC02. C. Allele distribution for barcode BC03. D. Allele distribu-
tion for barcode BC04. E. Allele distribution for barcode BC05. F. Allele 
distribution for barcode BC06. G. Allele distribution for barcode BC07. H. 
Allele distribution for barcode BC08. I. Allele distribution for barcode BC09. 
J. Allele distribution for barcode BC10.
Additional !le 10. Sample Meta-information, barcode, associated drug 
susceptibility, associated k13 alleles and the correspondence to the KH 
subpopulations [8] (based on the matching of the barcode). The blank 
cells in the columns 21-28 and columns 29-35 means that the samples are 
not tested for drug susceptibility and k13 alleles, respectively.
Additional !le 11. Comparison of allele frequencies in health centre and 
in conserved clustering groups. A comparative analysis was illustrated 
using Weblogos sorted for health centre and clustering groups.
Additional !le 12. Distribution of IC50 value of P. falciparum isolates 
per major geographic areas. Box Plot analysis is presenting median and 
quartiles. Dashed line figure out the threshold where parasite could be 
resistant for the drug (30 nM). Parasites were originating from regions 
distributed at the four compass points in Cambodia. ANOVA test was 
significant for chloroquine and mefloquine (p value = 5.62e−5 and p 
value = 0.0408, respectively).
Additional !le 13. Distribution of mefloquine IC50 value of isolates 
associated to conserved clusters G1 to G9. Box Plot analysis is presenting 
median and quartiles. Mefloquine resistant parasites have IC50 over the 
dashed line (30 nM).
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Additional file 1. Geographic distribution of samples and allele frequency. Blood samples from P. falciparum positive patients were 
collected from 16 health centres or hospitals covering the areas where parasite transmission is active. The number of valid samples (282) 
out of the total selected samples (533) is provided per health centre. The frequency of each allele (REF/ALT) is given for the 11 loci, 
which were positive for LUMINEX detection. The alleles with Chi squared test statistics components (one component for each health 
centre) greater than 1 are highlighted in grey. The presence of Kelch-propeller domain altered allele was assessed by PCR and 
sequencing. The frequencies of wild type individuals and of the two major alleles C580Y and R539T are provided per location. The other 
alleles present at low frequency, N458Y, Y493H, I543T, P553L and V568G are pooled together. The drug sensitivity was measured 
routinely for patients presenting high parasitaemia (>2 %). The number of samples tested for IC50 measurements for chloroquine (CQ), 
piperaquine (PIP), quinine (QN), artesunate (ART), mefloquine (MF) and dihydroartemisinin (DHA) is provided. 
 
                                                         
 
ID Regions Province
Health centre HC 
or hospital RH
Valid
Samples
REF
C
ALT
T
REF
T
ALT
C
REF
G
ALT
A
REF
A
ALT
T
REF
G
ALT
A
REF
C
ALT
T
REF
C
ALT
A
ALT
G
REF
C
ALT
A
REF
A
ALT
C
REF
G
ALT
A
REF
G
ALT
T
Exp. WT C>Y R>T Other CQ PIP QN MF
1 West Battambang Tasanh HC 5 1 4 0 5 3 2 3 2 5 0 4 1 1 1 3 0 5 1 4 4 1 0 5 3 1 1 0 1 1 1 1 1
2 West Pailin Pailin RH 32 10 22 15 17 14 18 14 18 27 5 25 7 7 9 16 1 31 22 10 28 4 0 32 24 1 21 2 0 16 13 15 16
3 West Pailin Ou Chra HC 18 6 12 6 12 6 12 13 5 15 3 14 4 4 2 12 1 17 8 10 17 1 0 18 9 3 5 0 1 9 9 9 10
4 West Battambang Sampoev loun RH 5 3 2 4 1 4 1 2 3 4 1 5 0 1 3 1 0 5 1 4 2 3 0 5 3 0 2 1 0 2 2 2 2
5 West Battambang Battambang RH 7 2 5 4 3 3 4 2 5 6 1 5 2 1 1 5 2 5 1 6 4 3 0 7 1 1 0 0 0 2 2 2 2
6 North Oddar Meanchey Anlong Veng RH 11 4 7 11 0 8 3 3 8 9 2 9 2 4 4 3 1 10 2 9 7 4 0 11 3 1 2 0 0 1 1 1 1
7 North Oddar Meanchey Trapaing Prasat HC 37 25 12 33 4 15 22 2 35 32 5 30 7 5 23 9 4 33 6 31 14 23 0 37 12 3 5 4 0 20 21 20 21
8 East Rattanakiri Veurn Say HC 26 14 12 16 10 25 1 12 14 12 14 15 11 8 10 8 4 22 17 9 8 18 3 23 12 12 0 0 0 5 5 5 5
9 East Mondulkiri Keov Seima HC 7 3 4 5 2 6 1 2 5 1 6 5 2 4 3 0 1 6 1 6 1 6 0 7 2 1 0 0 1 1 1 1 1
10 East Kratie Khsim HC 15 10 5 11 4 8 7 4 11 6 9 12 3 4 4 7 3 12 6 9 8 7 0 15 7 3 3 0 1 4 5 4 5
11 South Kampot Chhouk HC 17 8 9 16 1 13 4 2 15 12 5 14 3 2 6 9 4 13 7 10 9 8 1 16 6 0 4 1 1 8 9 9 9
12 South Kampot Koh Slar HC 16 7 9 13 3 10 6 3 13 10 6 11 5 2 9 5 11 5 7 9 8 8 0 16 5 1 3 1 0 7 7 7 7
13 South Kampong Som Takavit HC 21 13 8 14 7 16 5 6 15 6 15 19 2 1 9 11 10 11 7 14 10 11 3 18 5 1 4 0 0 15 15 15 14
14 South Kampong Speu Oral HC 8 0 8 5 3 5 3 5 3 5 3 6 2 0 5 3 3 5 3 5 5 3 0 8 0 0 0 0 0 2 1 1 1
15 West Pursat Promoy HC 36 10 26 19 17 19 17 18 18 31 5 30 6 2 19 15 5 31 9 27 19 17 1 35 6 2 4 0 0 16 11 15 16
16 West Pursat Pursat 21 13 8 9 12 8 13 13 8 8 13 6 15 11 6 4 0 21 15 6 9 12 0 21 0 0 0 0 0 0 0 0 0
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Additional file 2. Primers sequences for PCR reactions corresponding to 20 of the 24 SNPs 
selected for barcode detection and for k13 locus amplification. 
 
 
ID Barcode Orientation Primary PCR Length (bp) Nested PCR Length (bp)
Forward AAAATGAAGCAGCAAAAG GATTGTGAAAATGAGAAGAGAGAAA
Reverse ATCTAATATACATTGAAGGGAATA AAAGCAATCGAACCCTTTG
Forward AAAATTCACAATGATTTAACAC AAAACAAATGGCATCCACTG
Reverse TTTTTCTGAGTAAAGATCAGC TGATAAAACCAAGAAGTCCAAGA
Forward TGGAAATACACAATTCAATG TTCCAAAACTATGTTTGCTGCT
Reverse CGAATGTTTTTCCATATTTT TGCAGTGGTACTTGTTGCTACC
Forward CCAACCAACGAACACAAATAC AGGAAAATGCTCCGGTAACT
Reverse TGGTTGACTGTTATTGGGGTA GGTTCATATTATTTGGTGACTCG
Forward TCAGGAATTTGAAGAACATT TGAAAATAATGATGAGAATGATGTC
Reverse TTTCTTTCCTCATTTCTGTT ATGTGGGGAACTATTAATGGAG
Forward TGACAAGAAAACAAAGAATG TGTGCAAGAAAAGTAGGAAATG
Reverse ATCAACAAAAGCTGATGAAT TGTGTCCCCTCTTTTTCTGT
Forward TGAATGTAATATAAATCAGGTTG CTGAAAAATCGGATGAATGG
Reverse GGCTGGAATAGATAAAATCA GGCTAGCTCAGCTTCCAAT
Forward CGAATTTAAGTACCTTAGGAAA TCACAACGTCCATATGTTGAA
Reverse TCATAAAGTTTTTATTGTCTTCA TCATTATCACCTACTTTCTGTACCA
Forward GAGGATGTATACCATTAGCTG GATGAGTTAGCAACGAAACCA
Reverse ATCATTCATATGTGGAAACA AACGTAAACCAGGAGTAAGACG
Forward GTTGTTATATCTTTTGCTATGAA AAATCCATCCTTTTATGAATGC
Reverse CGTAATGGTTTATAACTATTCTTT TGGATGTATGACAGCTTTTTCTAA
Forward ATACACTAAACGCAAAACCT CATTATGCGAATGCGATCTA
Reverse TGTTAATTCCTTTTCGATTT CGTTTATATTGCAACATTTCTTCA
Forward CAATGAATATGAATTGGATTT GATGAAAATGGAACCATTCATAG
Reverse GAACATTAAGTAAAATGTGATCC TGTTGGTCTTTTTCCTCTTCTAA
Forward TGACAAACAAGTATATAATAATAAGAG TGTTGTTGGTGAATACAATGAAA
Reverse TGTTTTAAAAGTCGTGGATA TCGTACCACCATTAACATTTTG
Forward CATAAATAAAACTTTCGCTGA TGGAATGATTTGAGCAATAGAA
Reverse ATTTTCAATATCATCTTCTTTACA AATACCCATGATATCACATTCCA
Forward ATCATCTGTATTTTGTTATTATGA AATCTTTTCCAGTTATTTTCTATCCA
Reverse GTTAGACAATTTTGCTACACTT CATGGGGGTATGTAATTTGG
Forward TCACAAACAAATAACAATGAA AAAAGCAATTCCACAAGAACC
Reverse ACATGTTTTGGACCATCTAC CTGGTGTTTCCTTTTTATTTGG
Forward ATCGCATGTAGATTAATATGG AAGAAAATTAAAGAGCATGAATCG
Reverse AAGGAGCTTCTGTAATACTATTTT CATAAGAACTGCTTCCATCTCC
Forward AATATATCTGTATTTGCTAACATGA 288 TGTGTTTTATTTTTAGTGTGAGCTTT 119
Reverse TGTAACAAGGAATGACAAAA AGAGGATATCCAATAGGGTGCT
Forward TGTAACAGAAGAAGATTACACG 246 CAATAATGAAAGGTATTCAAACCA 158
Reverse TATCAGCATAATTCGATAAGTG TACTTCTTCACACATATCAAAATCG
Forward CGATTTAATTACTGTTTTGAGA AACAAATCATCAATTAAGTCATCC
Reverse TTGGTTTACAATTAGTTCTAGC TGAGGAATAGGTTCATATGCTG
Forward CGGAGTGACCAAATCTGGGA GCCAAGCTGCCATTCATTTG
Reverse GGGAATCTGGTGGTAACAGC GCCTTGTTGAAAGAAGCAGA
Assay#23
Assay#24
241 149
Assay#10
Assay#11
Assay#12
Assay#13
Assay#14 NA
113
242 130
BC06 385 161
BC05 287 158
NA NA
NA
NA
NA
NA
NA
NA
NA
Assay#15
114
Assay#1
Assay#2
Assay#3
Assay#4
Assay#5
Assay#6
Assay#7
Assay#8
Assay#9
241 136
248 149
BC07
BC08
BC09
BC10
Assay#22
149
285 164
298 148
250
297
164
BC02 120
176
103
215
BC01 273 124
148
292 111
NA
NA
NA
NA
BC04
Kelch NA 2097 849
NA
NA
NA
NA
NA
NA
168Assay#16
Assay#17
Assay#18
Assay#19
Assay#20
Assay#21
BC11 233
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
BC03
NA
350
247
200
NA
NA
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Additional file 3. PCR and LDR conditions. NV for not valid PCR. Eight LUMINEX assays 
were negative. Assay#7 was rejected because one allele only was not detected (Pos/Neg). 
LUMINEX detection was performed after microsphere hybridization and ligation reaction. ID 
of microspheres that were used for several assays are in bold. 
 
 
 
 
 
 
 
 
 
 
 
 
 
ID
Primary 
PCR 
Nested
PCR 
LDR MTAG_ID
LUMINE
X
Barcode  PCR LDR
Assay #1 55 60 58-60 22/25 Neg NA NA NA
Assay #2 55 60 58-60 26/27 Neg NA NA NA
Assay #3 52 59 59 28/29 Pos BC01 1 1
Assay #4 55 58 59 33/34 Pos BC02 2 1
Assay #5 55 58 59 35/36 Pos Neg NA NA
Assay #6 56 60 58-60 38/39 Neg NA NA NA
Assay #7 53 58 58-60 42/43 Pos/Neg NA NA NA
Assay #8 52 58 60 44/45 Pos BC03 3 2
Assay #9 52 58 59 12/13 Pos BC04 3 1
Assay #10 52 58 58-60 14/15 Neg NA NA NA
Assay #11 52 59 58-60 18/19 Neg NA NA NA
Assay #12 52 59 59 20/21 Pos BC05 1 1
Assay #13 52 59 59 30/37 Pos BC06 1 1
Assay #14 Neg NA NA NA NA NA NA NA
Assay #15 52 55 59 46/47 Pos BC07 4 1
Assay #16 52 58 59 48/51 Pos BC08 3 1
Assay #17 Neg NA NA NA NA NA NA NA
Assay #18 Neg NA NA NA NA NA NA NA
Assay #19 52 55 59 52/53 Pos BC09 4 1
Assay #20 52 58 60 12/13 Pos BC10 3 2
Assay #21 Neg NA NA NA NA NA NA NA
Assay #22 52 58 58-60 14/15 Neg NA NA NA
Assay #23 52 58 58-60 26/27 Neg NA NA NA
Assay #24 52 55 60 28/78 Pos BC11 4 2
Tm (
0
C) Multiplex
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Additional file 4. Primer sequences for LDR (Ligation Detection reaction) performed. 
 
 
Part 1 Part 2
REF  MTAG-A022  CAAACAAACATTCAAATATCAATC GATAAAAATGTAGGTGATGTAAAAGATG
ALT  MTAG-A025  CTTTCTTAATACATTACAACATAC GATAAAAATGTAGGTGATGTAAAAGATA
REF  MTAG-A026 TACATTCAACACTCTTAAATCAAA GCTTTCCTATCAACCGTTTCC
ALT  MTAG-A027 TAACTTACACTTAACTATCATCTT GCTTTCCTATCAACCGTTTCT
REF  MTAG-A028  CACTTAATTCATTCTAAATCTATC TTTCAAATGTTATTTTCAACTATGTTAAGTAAC 
ALT  MTAG-A029  TACTACTTCTATAACTCACTTAAA TTTCAAATGTTATTTTCAACTATGTTAAGTAAT 
REF  MTAG-A033  ACTACTTATTCTCAAACTCTAATA GAAAAAAATAATTTGAACAATAAAACTTATAATAA 
ALT  MTAG-A034  ACTTATTTCTTCACTACTATATCA GAAAAAAATAATTTGAACAATAAAACTTATAATAG 
REF  MTAG-A035 CATCTTCATATCAATTCTCTTATT TGATGTTCATATTCACAATGATCAAC
ALT  MTAG-A036 ATTAAACAACTCTTAACTACACAA TGATGTTCATATTCACAATGATCAAG
REF  MTAG-A038 ATTCAATACTATCTAACACTTACT GGATGTTATTAAAAATGAAGAGAAGCATAG
ALT  MTAG-A039 ACAAATATCTAACTACTATCACAA GGATGTTATTAAAAATGAAGAGAAGCATAC 
REF  MTAG-A042 CACTACACATTTATCATAACAAAT AAGGAGATAGTGTTGGGGGC
ALT  MTAG-A043 AACTTTCTCTCTCTATTCTTATTT AAGGAGATAGTGTTGGGGGT
REF  MTAG-A044  TCATCACTTTCTTTACTTTACATT TGATGAAAGCCACCGAACTC
ALT  MTAG-A045  TACACAATATTCATCATAACTAAC TGATGAAAGCCACCGAACTT 
REF  MTAG-A012  CATAATCAATTTCAACTTTCTACT CCATCATATAAATATTTCTATATTCCATTAGCT
ALT  MTAG-A013  CAAATACATAATCTTACATTCACT CCATCATATAAATATTTCTATATTCCATTAGCA
REF  MTAG-A014 AATTTCTTCTCTTTCTTTCACAAT TACGTAATGTTGTCTTAAGCCCG 
ALT  MTAG-A015 TACTTCTTTACTACAATTTACAAC TACGTAATGTTGTCTTAAGCCCA
REF  MTAG-A018 ACACTTATCTTTCAATTCAATTAC AAATGAAAGAAGTGATGCAACAATTTGAT
ALT  MTAG-A019 ATACTTTACAAACAAATAACACAC AAATGAAAGAAGTGATGCAACAATTTGAC
REF  MTAG-A020  CTTTCTCATACTTTCAACTAATTT AATGGAAAATTTTGATGATATTTTATTAAG
ALT  MTAG-A021  TCAAACTCTCAATTCTTACTTAAT AATGGAAAATTTTGATGATATTTTATTAAA
REF  MTAG-A030  CTTAACATTTAACTTCTATAACAC AAATAACAATGAACATCATCATGATG
ALT  MTAG-A037  TACAACATCTCATTAACATATACA AAATAACAATGAACATCATCATGATA
REF
ALT
REF  MTAG-A046  TTAAACAATCTACTATTCAATCAC AAATTCAAATTATGTTCACAGGAATAAAC
ALT  MTAG-A047  TCTCTTTAAACACATTCAACAATA AAATTCAAATTATGTTCACAGGAATAAAA
REF  MTAG-A048  AATCAACACACAATAACATTCATA ACCTTCCATATCTAAAAAAACTTCATTC
ALT  MTAG-A051  CAATTTACATTTCACTTTCTTATC ACCTTCCATATCTAAAAAAACTTCATTA
REF
ALT
REF
ALT
REF  MTAG-A052  TTCTTCATTAACTTCTAATCTTAC CCTACATTAAATGAAAATGAAAACGTTA
ALT  MTAG-A053  TTAACAACTTATACAAACACAAAC CCTACATTAAATGAAAATGAAAACGTTC
REF  MTAG-A012  CATAATCAATTTCAACTTTCTACT CAAAATATCAACAAGAAAAACATAATTACTC
ALT  MTAG-A013  CAAATACATAATCTTACATTCACT CAAAATATCAACAAGAAAAACATAATTACTT
REF
ALT
REF  MTAG-A014 AATTTCTTCTCTTTCTTTCACAAT GTAAATATTTTAGTGAAGATTATTTTTGGACT
ALT  MTAG-A015 TACTTCTTTACTACAATTTACAAC GTAAATATTTTAGTGAAGATTATTTTTGGACC
REF  MTAG-A026 TACATTCAACACTCTTAAATCAAA AACAAAATGGATGATTTCGTATATACA
ALT  MTAG-A027 TAACTTACACTTAACTATCATCTT AACAAAATGGATGATTTCGTATATACC
REF  MTAG-A028  CACTTAATTCATTCTAAATCTATC AATTAGAAAATACACAAAATTATCAAAAAAG
ALT  MTAG-A078  TTTACAAATCTAATCACACTATAC AATTAGAAAATACACAAAATTATCAAAAAAT
Assay#10
Assay#11
Assay#12 BC05
Assay#7
Assay#8
Assay#9 BC04
NA
BC03
Assay#13 BC06
Assay#14
Assay#15 BC07
NA
Assay#19 BC09
Assay#20 BC10
Assay#16 BC08
Assay#17
Assay#18
NA
NA
Assay#21
Assay#22
Assay#23
Assay#24 BC11
NA
NA
NA
[Phos] AATTGAAAATTTAAAAAATGTTATTGTTTC [BtnTg]
LDR PRIMER
Conserved PrimerMicrosphere ID
NA
[Phos]AAAATCATAGACAAAAAAAAAACAGTTTC[BtnTg]
[Phos]AAAATGATAAGCTTTTTCGTGATGA[BtnTg]
NA NA NA NA
NA NA NA NA
[Phos]CTCCCAAACCATCTGAAGGT[BtnTg]
AlleleBarcode
NA
NA
[Phos]TGCTGGAGGAGTTGTTTGTT[BtnTg]
[Phos]GATGCAAATAATCTTGATAAAGTATATGG[BtnTg]
[Phos]CATGAACGAGTCACCAAATAATATG[BtnTg]
[Phos]TGAAAATGAAAAAGAATTATCTTCATATAAT[BtnTg]
[Phos]GTTCAGTTATTCCAAATAATTTTTGTAATAA[BtnTg]
NA NA NA NA
NA NA NA
ID
NA
NA
NA
NA
Assay#4 BC02
Assay#5
Assay#6
Assay#1
Assay#2
Assay#3 BC01
[Phos]CAAGCTAATATAGGTCCATTGTGTATT[BtnTg]
[Phos]CATATAATGAAGAAAATTTATTAGGAAAGA[BtnTg]
[Phos]TTAGCCTTCACAGTTGTAATGTTATCT[BtnTg]
[Phos]CACCCGAACTAAATCGCTCC[BtnTg]
[Phos]TAAGAAACATTTTAATATTTTACAGAAAAAGAGG[BtnTg]
[Phos]ATTGCTACATGCATTATACAAAATCC[BtnTg]
[Phos]AAATTCTTAGGAAGCTTTTTTCCAAG[BtnTg]
[Phos]ATATTTATGGATGAACATTATATTAATAAAGATAT[BtnTg]
[Phos]TTTAGTGATACCATACCTAATTTAAGTAGAGAAG[BtnTg]
[Phos]GATCGTGCCGCACAACGA[BtnTg]
[Phos] TTGGATGAAATTTCTTGATGAATATAA [BtnTg]
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Additional file 5. Classification of samples into 9 conserved groups. A. Hierarchical 
clustering of the 282 valid samples based on the 11-SNPs barcode. The pairwise distance 
between the samples is calculated as the proportion of base substitution between them over 
the barcode. Ward’s minimum variance method was used to build the dendrogram. The 
dendrogram is cut to obtain 8 clusters (k = 8). The clusters are represented by red 
rectangles. B. Hierarchal clustering of 282 samples based on the percentage of clustering 
results in which two samples are in the same cluster (when 8 clusters are considered). The 
clustering approach was implemented on 10,000 subsets of 230 samples each, randomly 
selected out of the 282 samples. Based on these 10,000 clustering results, pairwise distance 
between samples were calculated as the percentage of clustering results in which two 
samples are in the same cluster. The number of clusters (conserved groups) was selected 
based on the dendrogram structure. The clusters are represented by red rectangles. 
 
A. 
 
B. 
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Assay SNP ID# WAF WSEA ESEA NRAF ID freq Type REF ALT Mutant Chrom. Loc. Genes Gene ID (new) Position Gene Name
1 Pf_01_000130573 0.701 0.438 0.560 0.615 NV NV NSY C T A168T 1 core PFA0145c PF3D7_0102900 130339 aspartate--tRNA ligase 
2 Pf_01_000539044 0.949 0.768 0.816 0.898 NV NV SYN G A S173 1 sub PFA0670c PF3D7_0113900 537322 Plasmodium exported protein (hyp8)
3 Pf_02_000842803 0.333 0.403 0.543 0.349 BC01 0.56 SYN C T N1004 2 sub PFB0935w PF3D7_0220800 842805 cytoadherence linked asexual protein 
4 Pf_04_000282592 0.160 0.359 0.398 0.266 BC02 0.36 NSY T C N233S 4 core PFD0250c PF3D7_0405100 276127 Sec24 subunit b (SEC24b) 
5 Pf_05_000931601 0.305 0.001 0.002 0.157 NV NV NSY C G P7739A 5 core PFE1120w PF3D7_0522400 931606 conserved Plasmodium protein
6 Pf_06_000145472 0.341 0.421 0.524 0.387 NV NV NSY C G S1104T 6 core PFF0175c PF3D7_0603600 145475 conserved Plasmodium protein
7 Pf_06_000937750 NA NA NA NA NV NV SYN A G G300 6 core PFF1105c PF3D7_0623000 937752 chorismate synthase (CS) 
8 Pf_07_000277104 0.102 0.429 0.289 0.250 BC03 0.4 SYN G A L2389 7 core MAL7P1.19 PF3D7_0704600 221722 ubiquitin transferase, putative 
9 Pf_07_000490877 0.363 0.658 0.601 0.333 BC04 0.65 SYN A T A233 7 core PF07_0040 PF3D7_0709700 435497 lysophospholipase, putative 
10 Pf_07_000545046 0.530 0.711 0.571 0.518 NV NV SYN C T P435 7 core PF07_0047 PF3D7_0711000 489666 AAA family ATPase, CDC48
NA NA NA NA NV NV SYN T C D73 7 core MAL7P1.57 PF3D7_0713000 602559
NA NA NA NA NV NV SYN T C D76 4 sub PFD0134c(p) PF3D7_0402700 163280
12 Pf_07_000671839 0.470 0.616 0.365 0.520 BC05 0.3 NSY G A S692N 7 core MAL7P1.65 PF3D7_0713500 616459 conserved Plasmodium protein,
13 Pf_07_000683772 0.418 0.419 0.404 0.335 BC06 0.21 NSY C T G3129S 7 core PF07_0053 PF3D7_0713900 628392 conserved Plasmodium protein,
14 Pf_07_000792356 0.264 0.366 0.308 0.274 NV NV SYN A C P203P 7 core PF07_0070 PF3D7_0716900 736978 drug metabolite transporter, putative 
NA NA NA NA 0.4 NSY C A Q584K
NA NA NA NA 0.41 NSY C G Q584E
16 Pf_08_000613716 0.233 0.439 0.856 0.459 BC08 0.81 NSY C A F2558L 8 core PF08_0089 PF3D7_0812100 612596 conserved Plasmodium protein
17 Pf_09_000634010 0.413 0.357 0.300 0.416 NV NV NSY C T S61N 9 core PFI0725c PF3D7_0914800 634019 GINS complex subunit Psf3, putative 
18 Pf_10_000082376 0.0004 0 0 0.0004 NV NV intergenic A T - 10 sub NV NV 82375 conserved Plasmodium protein
19 Pf_10_001403751 NA NA NA NA BC09 0.6 NSY A C T1106P 10 core PF10_0344 PF3D7_1035300 1402510 glutamate-rich protein (GLURP) 
20 Pf_11_000117114 0.158 0.589 0.531 0.384 BC10 0.43 NSY G A S597F 11 sub PF11_0037 PF3D7_1102500 119497 Plasmodium exported protein (PHISTb)
21 Pf_11_000406215 0.473 0.729 0.661 0.646 NV NV NSY A C N1036H 11 core PF11_0108 PF3D7_1110200 408600 pre-mRNA-processing factor 6
22 Pf_13_000158614 NA NA NA NA NV NV SYN T C T35 13 core MAL13P1.15 PF3D7_1303000 158412 conserved Plasmodium protein
23 Pf_13_001429067 0.0001 0.995 0.999 0.396 NV NV NSY T G N3191T 13 core MAL13P1.176 PF3D7_1335300 1429067 reticulocyte binding protein 2+
24 Pf_14_000755729 0.0003 0.820 0.958 0.426 BC11 0.98 NSY G T R736I 14 core PF14_0177 PF3D7_1417800 755731 DNA replication factor MCM2
11 Pf_07_000657939 rifin (RIF)
Daniel et al. , 2008 MalariaGEN v4.0 Study Mutation Genome information
PF3D7_0731500 1359804 erythrocyte binding antigen-17515 Pf_07_001415182 BC07 7 sub MAL7P1.176
Additional file 6. Major features of the Single Nucleotide Polymorphisms selected for LUMINEX assay. A set 11 SNPs (highlighted in grey) 
has been selected from 24 SNPs validated by Daniels et al. [11]. NRAF value from three geographic areas and the global NRAF were 
recovered from MalariaGEN v4.0. Genome position was evaluated according to genome version 3. Subtelomere were identified based on 
gene composition. Valid SNPs are highlighted in grey. Frequency of valid alleles was calculated based on the data mentioned in Additional 
file 3. SNP ID is the column “Position” preceded by the tag “Pf3D7_[01-14]_v3:” in MalariaGEN and by the tag “NGS_SNP.Pf3D7_[01-
14]_v3.” in PlasmoDB. 
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Additional file 7. Number of samples rejected due to mixed infection (M), no significant 
signal with LUMINEX for at least one barcode position (N) and no amplification using PCR 
for at least one locus (X). 
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Additional file 8. Relationship between allele distribution and geographic origin of parasites 
in the P. falciparum Cambodian population. Correspondence analysis was based on 23 
alleles and was conducted for 282 samples. Each reference (REF) and altered (ALT) alleles 
are represented. Position BC07 had two alternative alleles. Left panel presented the 
contribution of each allele in the distribution the 282 samples. Between-class analysis 
performed with health centres is presented in the right panel. A. Axis1-axis3 projection of the 
correspondence analysis. B. Axis2-axis3 projection of the correspondence analysis. 
 
A. 
 
B. 
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Additional file 9. Gene flow analysis based on uneven distribution of alleles in the P. 
falciparum population over Cambodia. The barcode is represented by 11 genomic positions 
presenting two types of allele per site: the reference allele which is found in 3D7 reference 
genome (REF) and the alternative allele (ALT). Over representation of one of the REF/ALT 
allele in a local parasite population was evaluated using a Chi squared analysis. The allele 
was in blue for REF and dark red for ALT. The box was in grey when the Chi squared test 
statistics components (one component for each health centre) was less than 1. Allele 
distribution is presented for barcode position BC01 to BC10. Barcode position BC11 was not 
suitable for Chi squared analysis. Corresponding position in the barcode in surrounded in 
red. The significant health centres which are close together were circled. A. Allele 
distribution for barcode BC01. B. Allele distribution for barcode BC02. C. Allele distribution 
for barcode BC03. D. Allele distribution for barcode BC04. E. Allele distribution for barcode 
BC05. F. Allele distribution for barcode BC06. G. Allele distribution for barcode BC07. H. 
Allele distribution for barcode BC08. I. Allele distribution for barcode BC09. J. Allele 
distribution for barcode BC10. 
 
A. 
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B. 
  
 
 
C. 
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D. 
 
 
 
E. 
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G. 
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H. 
 
 
 
I. 
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Clustering
Sample IPC No. Year Site ID field Region
Health centre 
or Hospital District Province SNP1 SNP2 SNP3 SNP4 SNP5 SNP6 SNP7 SNP8 SNP9 SNP10 SNP11 CQ PIP QN ART MF DHA BM AQ C580Y R539T Y493H I543T P553L V568G N458Y Conserved Clusters
ENA 
Accession Region
KH 
Subpopulation
3503 1023503 2010 2 PLPF010 West Ou Chra HC Pailin Pailin T C A A G C C A A G T 1 0 0 0 0 0 0 1
3522 1023522 2010 2 CP080 West Pailin RH Pailin Pailin T C A A G C C A A G T 1 0 0 0 0 0 0 1
5035 1125035 2011 2 KH004_030 West Pailin RH Pailin Pailin T C A A G C G A A A T 100 36 2.92 35 4.79 8.3 60 1 0 0 0 0 0 0 1
3268 1023268 2010 2 PL030 West Ou Chra HC Pailin Pailin T C A A G C G A A G T 1 ERS024146 WKH KH2
3498 1043498 2010 4 ORPF018 South Oral HC Oral Kampong Speu T C A A G C G A A G T 1 ERS024146 WKH KH2
3575 1023575 2010 2 P016 West Battambang RH Battambang Battambang T C A A G C G A A G T 669 85.4 993 5.5 98.7 8.76 1 ERS024146 WKH KH2
4375 1124375 2011 2 KH004_017 West Pailin RH Pailin Pailin T C A A G C G A A G T 1 0 0 0 0 0 0 1 ERS024146 WKH KH2
4954 1124954 2011 2 06PF033 West Tasanh HC Samlot Battambang T C A A G C G A A G T 1 0 0 0 0 0 0 1 ERS024146 WKH KH2
5208 1125208 2011 2 PLPF009 West Ou Chra HC Pailin Pailin T C A A G C G A A G T 25 39.3 88 0.63 9.3 0.6 34.5 8 1 0 0 0 0 0 0 1 ERS024146 WKH KH2
3652 1023652 2010 2 PLPF018 West Ou Chra HC Pailin Pailin T C A A G T G A A G T 151.54 29.9 358.55 2.29 44.81 2.95 1 0 0 0 0 0 0 1
4357 1124357 2011 2 KH004_015 West Pailin RH Pailin Pailin T C A A G T G A A G T 1 0 0 0 0 0 0 1
3918 1183918 2011 8 FTP132 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey T C A T G C G C A G T 0.61 30.82 0.77 0 0 0 0 0 0 0 1
5149 1165149 2011 6 04PF037 East Veurn Say HC Veurn Say Rattanakiri T C G A A C G A C G G 66 21 115 0.3 31 0.49 18.3 11 0 0 0 0 0 0 0 1
4221 1134221 2011 3 05PF013 West Promoy HC Veal Veng Pursat T C G A G C A A C G T 326 404 1.1 96 0.57 1 ERS032018 WKH KH3
4358 1114358 2011 1 07PF004 West Sampovloun RH Sampovloun Battambang T C G A G C A A C G T 1 ERS032018 WKH KH3
3653 1043653 2010 4 ORPF034 South Oral HC Oral Kampong Speu T C G A G C A C A G T 138.11 26.55 468.56 1.81 70.43 1.11 1
4271 1134271 2011 3 05PF024 West Promoy HC Veal Veng Pursat T C G A G C C A C G T 365 72.2 642 1.68 95.6 1.36 13 72 1
4287 1124287 2011 2 KH004_010 West Pailin RH Pailin Pailin T C G A G C G A A G T 85.93 58.11 242.39 1.24 24.94 1.27 49.26 42.67 1 0 0 0 0 0 0 1
4288 1124288 2011 2 KH004_011 West Pailin RH Pailin Pailin T C G A G C G A A G T 274 548 1.2 22 0.61 98 1 0 0 0 0 0 0 1
4417 1124417 2011 2 KH004_021 West Pailin RH Pailin Pailin T C G A G C G A A G T 1
5100 1125100 2011 2 KH004_033 West Pailin RH Pailin Pailin T C G A G C G A A G T 27 32 89 0.6 10 0.44 24 1 0 0 0 0 0 0 1
5016 1135016 2011 3 VVPF017 West Promoy HC Veal Veng Pursat T C G A G C G A C A T 1
3272 1023272 2010 2 PL033 West Ou Chra HC Pailin Pailin T C G A G C G A C G T 232.1 69.4 140.9 3.3 12.9 5.7 1 ERS032638 WKH KH2
3277 1023277 2010 2 PL036 West Ou Chra HC Pailin Pailin T C G A G C G A C G T 167.7 59.6 194.9 1.1 25 1.9 0 0 0 0 0 0 0 1 ERS032638 WKH KH2
4124 1134124 2011 3 05PF002 West Promoy HC Veal Veng Pursat T C G A G C G A C G T 81 123 0.6 27.3 0.4 11.8 164 1 ERS032638 WKH KH2
4167 1134167 2011 3 05PF006 West Promoy HC Veal Veng Pursat T C G A G C G A C G T 166 290 0.72 103 0.5 58 57 1 ERS032638 WKH KH2
4273 1134273 2011 3 05PF026 West Promoy HC Veal Veng Pursat T C G A G C G A C G T 39 0.94 18 0.13 1 ERS032638 WKH KH2
4349 1124349 2011 2 KH004_014 West Pailin RH Pailin Pailin T C G A G C G A C G T 66 117 0.34 39.3 0.31 1 0 0 0 0 0 0 1 ERS032638 WKH KH2
4645 1124645 2011 2 06PF030 West Tasanh HC Samlot Battambang T C G A G C G A C G T 1 ERS032638 WKH KH2
5089 1135089 2011 3 VVPF024 West Promoy HC Veal Veng Pursat T C G A G C G A C G T 1 ERS032638 WKH KH2
5131 1135131 2011 3 VVPF031 West Promoy HC Veal Veng Pursat T C G A G C G A C G T 1 ERS032638 WKH KH2
3780 1033780 2010 3 VVPF059 West Promoy HC Veal Veng Pursat T T A A G C G A A G T 1 ERS032009 WKH KHA
4613 1164613 2011 6 04PF012 East Veurn Say HC Veurn Say Rattanakiri T T G A A C G A A G G 0 0 0 0 0 0 0 1
4842 1194842 2011 9 10PF032 South Chhouk HC Chhouk Kampot T T G A G C A A A G T 1
3587 1043587 2010 4 ORPF032 South Oral HC Oral Kampong Speu T T G A G C A A C G T 1
3791 1043791 2010 4 ORPF045 South Oral HC Oral Kampong Speu T T G A G C A A C G T 1
3861 1183861 2011 8 M085 North Anlong Veng RH Anlong Veng Oddar Meanchey T T G A G C C A C G T 1 ERS028715 WKH KH2
4021 1184021 2011 8 FTP139 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey T T G A G C C A C G T 1 ERS028715 WKH KH2
4469 1184469 2011 8 M091 North Anlong Veng RH Anlong Veng Oddar Meanchey T T G A G C C A C G T 1 0 0 0 0 0 0 1 ERS028715 WKH KH2
4673 1184673 2011 8 M094 North Anlong Veng RH Anlong Veng Oddar Meanchey T T G A G C C A C G T 1 ERS028715 WKH KH2
975_F NA 2010 3 NIH West Pursat Pursat Pursat T T G A G C C A C G T 1 ERS028715 WKH KH2
3296 1023296 2010 2 P011 West Battambang RH Battambang Battambang T T G A G C G A C G T 1 ERS032003 WKH KH2
4133 1134133 2011 3 05PF003 West Promoy HC Veal Veng Pursat T T G A G C G A C G T 589 517 0.25 20 0.3 1 ERS032003 WKH KH2
4256 1134256 2011 3 05PF021 West Promoy HC Veal Veng Pursat T T G A G C G A C G T 842 105 2308 0.32 73 0.35 21.4 52 1 ERS032003 WKH KH2
Genotype (Barcode) IC50 Kelch (K13  gene) alleles Data from O. Miotto et al.  , 2013 [8]Sample Information
Additional file 10 . Sample Meta-information, barcode, associated drug susceptibility, associated k13 alleles and the correspondence to 
the KH subpopulations [8] (based on the matching of the barcode). The blank cells in the columns 21-28 and columns 29-35 means that 
the samples are not tested for drug susceptibility and k13alleles, respectively. 
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3269 1023269 2010 2 PL031 West Ou Chra HC Pailin Pailin C T G A A C G A C G T 2
3630 1023630 2010 2 CP070 West Pailin RH Pailin Pailin C T G A A T G A C G T 144 31.8 217.5 1.8 54 2.67 0 0 0 0 0 0 0 2
4798 1194798 2011 9 10PF028 South Chhouk HC Chhouk Kampot C T G A G C G A C G T 2
4233 1134233 2011 3 05PF014 West Promoy HC Veal Veng Pursat C T G T A C A A C G T 514 50.1 1147 3.22 128 1.38 63.3 185 1 0 0 0 0 0 0 2
4381 1194381 2011 9 10PF002 South Chhouk HC Chhouk Kampot C T G T A C A A C G T 315 39 625 0.33 66 0.4 2
4822 1164822 2011 6 04PF022 East Veurn Say HC Veurn Say Rattanakiri C T G T A C A C A G G 0 0 0 0 0 0 0 2
4129 1144129 2011 4 02PF177 South Takavit HC Kampong Seila Kampong Som C T G T A C G A C G G 748 79.4 1321 2.5 1.3 1 0 0 0 0 0 0 2
4148 1144148 2011 4 02PF188 South Takavit HC Kampong Seila Kampong Som C T G T A C G A C G T 129 36 500 0.58 100 0.34 26.9 71 2 ERS024143 WKH KHA
4238 1134238 2011 3 05PF018 West Promoy HC Veal Veng Pursat C T G T A C G A C G T 2 ERS024143 WKH KHA
4240 1144240 2011 4 02PF204 South Takavit HC Kampong Seila Kampong Som C T G T A C G A C G T 280 83.9 1051 2.16 194 1.65 23.2 78 2 ERS024143 WKH KHA
4250 1144250 2011 4 02PF206 South Takavit HC Kampong Seila Kampong Som C T G T A C G A C G T 2 ERS024143 WKH KHA
4268 1144268 2011 4 02PF207 South Takavit HC Kampong Seila Kampong Som C T G T A C G A C G T 191 76 597 1.6 98 1.19 2 ERS024143 WKH KHA
4350 1134350 2011 3 05PF036 West Promoy HC Veal Veng Pursat C T G T A C G A C G T 2 ERS024143 WKH KHA
4383 1194383 2011 9 10PF04 South Chhouk HC Chhouk Kampot C T G T A C G A C G T 86 62 551 0.7 64 1.3 1 0 0 0 0 0 0 2 ERS024143 WKH KHA
4492 1114492 2011 1 07PF005 West Sampovloun RH Sampovloun Battambang C T G T G C G A A G T 1 0 0 0 0 0 0 2 ERS024150 WKH KHA
3944 1183944 2011 8 FTP134 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T G T G C G A C G T 1 0 0 0 0 0 0 2
4527 1194527 2011 9 01PF057 South Koh Slar HC Chhouk Kampot C T G T G C G A C G T 226 49 751 0.93 73 0.46 140 57 1 0 0 0 0 0 0 2
3811 1083811 2010 8 M078 North Anlong Veng RH Anlong Veng Oddar Meanchey C T G T G C G C C G T 2 ERS028713 WKH KHA
4407 1194407 2011 9 10PF009 South Chhouk HC Chhouk Kampot C T G T G T G C C G T 706 56 287 0.31 17 0.22 14 178 2
4170 1124170 2011 2 06PF007 West Tasanh HC Samlot Battambang T C G T G C G A C G T 0 0 0 0 0 0 0 2
4747 1194747 2011 9 01PF062 South Koh Slar HC Chhouk Kampot T T A T A C G C C G T 2
4548 1194548 2011 9 10PF019 South Chhouk HC Chhouk Kampot T T G T A C G A C G T 1 0 0 0 0 0 0 2
4762 1194762 2011 9 10PF026 South Chhouk HC Chhouk Kampot T T G T A C G A C G T 2
3515 1043515 2010 4 ORPF023 South Oral HC Oral Kampong Speu T T G T A C G C A G T 2
4210 1144210 2011 4 02PF200 South Takavit HC Kampong Seila Kampong Som T T G T A C G C A G T 161 37 511 0.32 79 0.28 24.2 73 1 0 0 0 0 0 0 2
4159 1144159 2011 4 02PF190 South Takavit HC Kampong Seila Kampong Som T T G T A C G C C G T 336 71 636 1.06 174 0.74 1 0 0 0 0 0 0 2
5146 1195146 2011 9 01PF073 South Koh Slar HC Chhouk Kampot T T G T A T G C A G T 297 38 434 0.49 58 0.61 15 59 2
3340 1023340 2010 2 P012 West Battambang RH Battambang Battambang T T G T G C G A C G T 2
3814 1083814 2010 8 M080 North Anlong Veng RH Anlong Veng Oddar Meanchey T T G T G C G A C G T 2
4036 1184036 2011 8 FTP142 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey T T G T G C G A C G T 1 0 0 0 0 0 0 2
4744 1194744 2011 9 10PF025 South Chhouk HC Chhouk Kampot T T G T G C G C A G T 65 151 56 34 52 2
5107 1195107 2011 9 01PF072 South Koh Slar HC Chhouk Kampot T T G T G C G C C G T 68 51 405 0.3 55 0.5 2
3773 1023773 2010 2 PLPF023 West Ou Chra HC Pailin Pailin C C A A G C G A C G T 2.31 3.48 0 0 0 0 0 0 0 3
4322 1134322 2011 3 05PF031 West Promoy HC Veal Veng Pursat T C A A G C A A C A G 138 66 397 1.05 106 0.87 42 3
4234 1134234 2011 3 05PF015 West Promoy HC Veal Veng Pursat T C A A G C A A C A T 338 40 841 0.69 124 0.56 45.9 114 3
4235 1134235 2011 3 05PF017 West Promoy HC Veal Veng Pursat T C A A G C A A C A T 184 42 644 0.74 87 0.46 100 78 1 0 0 0 0 0 0 3
4257 1134257 2011 3 05PF022 West Promoy HC Veal Veng Pursat T C A A G C A A C A T 284 47 881 0.49 117 0.33 50.1 113 1 0 0 0 0 0 0 3
4258 1134258 2011 3 05PF023 West Promoy HC Veal Veng Pursat T C A A G C A A C A T 159 67 462 1.48 156 1.15 3
4274 1134274 2011 3 05PF027 West Promoy HC Veal Veng Pursat T C A A G C A A C A T 3
3670 1023670 2010 2 CP078 West Pailin RH Pailin Pailin T C A A G C A A C G T 3 ERS025100 WKH KH3
4339 1124339 2011 2 06PF021 West Tasanh HC Samlot Battambang T C A A G C A A C G T 830 58 661 0.8 50 0.6 113.6 187 3 ERS025100 WKH KH3
4844 1124844 2011 2 PLPF003 West Ou Chra HC Pailin Pailin T C A A G C A A C G T 104 57 128 0.91 10 1.47 3 ERS025100 WKH KH3
947_F NA 2010 3 NIH West Pursat Pursat Pursat T C A A G C A A C G T 3 ERS025100 WKH KH3
4142 1144142 2011 4 02PF185 South Takavit HC Kampong Seila Kampong Som T C A A G C A C C A T 169 52 105 0.55 35 0.52 3
4174 1144174 2011 4 02PF194 South Takavit HC Kampong Seila Kampong Som T C A A G C A C C A T 143 63 256 0.33 64 0.26 16 103 3
3274 1023274 2010 2 PL034 West Ou Chra HC Pailin Pailin T C A A G C G A C G T 146.7 63.1 242.5 4.9 31.1 7.5 0 0 0 0 0 0 0 3 ERS024130 WKH KH2
5160 1125160 2011 2 KH004_034 West Pailin RH Pailin Pailin T C A A G C G A C G T 148 50 0.21 9.9 0.3 4.3 83 1 0 0 0 0 0 0 3 ERS024130 WKH KH2
3511 1043511 2010 4 ORPF021 South Oral HC Oral Kampong Speu T C A T G C A A C A T 154 4.3 2.3 3
4396 1194396 2011 9 01PF039 South Koh Slar HC Chhouk Kampot T T A A G C A C C G T 179 42 373 0.19 25 0.1 13 59 0 0 0 0 0 0 0 3
4811 1194811 2011 9 01PF064 South Koh Slar HC Chhouk Kampot T T A A G C A C C G T 3
3889 1183889 2011 8 FTP130 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C C A A G T A A C G T 0 0 0 0 0 0 0 4
3970 1123970 2011 2 PLPF029 West Ou Chra HC Pailin Pailin C C A T G C G C C G T 1.55 87.57 0.61 1 0 0 0 0 0 0 4
4359 1124359 2011 2 KH004_016 West Pailin RH Pailin Pailin C C A T G T A C C G T 0 1 0 0 0 0 0 4
965_F NA 2010 3 NIH West Pursat Pursat Pursat C C A T G T C A C G T 4 ERS032255 WKH KH4
3631 1023631 2010 2 PLPF017 West Ou Chra HC Pailin Pailin C T A A G T G A C G T 0 0 0 0 0 0 1 4
5049 1185049 2011 8 M099-D0 North Anlong Veng RH Anlong Veng Oddar Meanchey C T A T A T G A A G T 4
3834 1183834 2011 8 M081 North Anlong Veng RH Anlong Veng Oddar Meanchey C T A T G C A A C G T 4
4404 1124404 2011 2 KH004_020 West Pailin RH Pailin Pailin C T A T G C A A C G T 190 45 832 0.79 107 0.61 0 1 0 0 0 0 0 4
4611 1184611 2011 8 FTP175 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C A C C G T 4
4200 1134200 2011 3 05PF008 West Promoy HC Veal Veng Pursat C T A T G C G A A A T 278 62 357 0.22 83 0.21 10.4 83 4
4255 1124255 2011 2 KH004_005 West Pailin RH Pailin Pailin C T A T G C G A A G T 1 0 0 0 0 0 0 4
4279 1124279 2011 2 08PF009 West Ou Chra HC Pailin Pailin C T A T G C G A A G T 458 86 654 0.9 61.4 1.08 4
4605 1124605 2011 2 KH004_024 West Pailin RH Pailin Pailin C T A T G C G A A G T 76 49 439 0.7 42 0.98 49.8 27.5 1 0 0 0 0 0 0 4
4617 1124617 2011 2 KH004_025 West Pailin RH Pailin Pailin C T A T G C G A A G T 1 0 0 0 0 0 0 4
3504 1023504 2010 2 CP063 West Pailin RH Pailin Pailin C T A T G C G A C A T 4
3890 1183890 2011 8 FTP131 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C G A C G T 229.03 46.52 816.64 1 0 0 0 0 0 0 4
4024 1184024 2011 8 FTP133 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C G A C G T 4
4707 1184707 2011 8 FTP184 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C G A C G T 4
4784 1154784 2011 5 03PF005 East Khsim HC Snoul Kratie C T A T G C G A C G T 1 0 0 0 0 0 0 4
4785 1154785 2011 5 03PF006 East Khsim HC Snoul Kratie C T A T G C G A C G T 4
4953 1154953 2011 5 03PF008 East Khsim HC Snoul Kratie C T A T G C G A C G T 4
5075 1155075 2011 5 03PF010 East Khsim HC Snoul Kratie C T A T G C G A C G T 35.95 36.69 74.74 1.44 74.03 1.2 24.5 28.23 1 0 0 0 0 0 0 4
3841 1123841 2011 2 R030 West Battambang RH Battambang Battambang C T A T G C G C C G T 4 ERS024133 WKH KHA
4581 1194581 2011 9 01PF059 South Koh Slar HC Chhouk Kampot C T A T G T A C A G T 4
3792 1023792 2010 2 PLPF024 West Ou Chra HC Pailin Pailin C T A T G T C A C G T 4
4326 1124326 2011 2 KH004_012 West Pailin RH Pailin Pailin C T A T G T G A A G T 4
3276 1023276 2010 2 PL035 West Ou Chra HC Pailin Pailin T T A A G T G A C G T 1 0 0 0 0 0 0 4
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4209 1144209 2011 4 02PF199 South Takavit HC Kampong Seila Kampong Som C C A A G C A C C A T 5
4138 1144138 2011 4 02PF181 South Takavit HC Kampong Seila Kampong Som C C A T A C A C C G T 201 55 416 0.37 43 0.41 17.5 121 5
4218 1134218 2011 3 05PF012 West Promoy HC Veal Veng Pursat C C A T G C A C C A T 322 50 742 0.96 192 0.54 62 104 5 ERS025276 WKH KHA
5060 1195060 2011 9 01PF069 South Koh Slar HC Chhouk Kampot C C A T G C A C C A T 112 31 292 0.6 60 0.6 0 1 0 0 0 0 0 5 ERS025276 WKH KHA
4208 1144208 2011 4 02PF198 South Takavit HC Kampong Seila Kampong Som C C G T A C A C C G T 152 45 539 0.47 58 0.6 20.8 85 0 0 0 0 0 0 0 5
3445 1023445 2010 2 CP066 West Pailin RH Pailin Pailin C C G T G C A A C G T 170 30.1 238 1.8 46.5 1.8 1 0 0 0 0 0 0 5
5048 1195048 2011 9 10PF053 South Chhouk HC Chhouk Kampot C C G T G T A C C A T 65 31 323 0.46 60 0.55 23.9 29 0 0 0 0 1 0 0 5
5106 1195106 2011 9 01PF071 South Koh Slar HC Chhouk Kampot C C G T G T A C C A T 72.03 33.45 527.85 0.34 40.02 0.38 69.84 25.56 5
4390 1124390 2011 2 06PF026 West Tasanh HC Samlot Battambang C C G T G T C A C A T 0 0 1 0 0 0 0 5
4930 1164930 2011 6 04PF031 East Veurn Say HC Veurn Say Rattanakiri C T G T G T C C C A T 0 0 0 0 0 0 0 5 ERS025282 NEKH KH1
937_F NA 2010 3 NIH West Pursat Pursat Pursat T C A A A T A A C A T 5 ERS028704 WKH KH1
3306 1023306 2010 2 R025 West Battambang RH Battambang Battambang T C A T G T A C C A T 119.7 31.9 214.1 4.8 25.9 4.85 5 ERS023744 WKH KHA
3312 1023312 2010 2 R026 West Battambang RH Battambang Battambang T C A T G T G A C A T 5
4107 1154107 2011 5 03PF011 East Khsim HC Snoul Kratie T C G A A C A A C A T 5
3815 1123815 2011 2 CP078 West Pailin RH Pailin Pailin T C G A A T A A C G T 863 93.3 890 1.15 134 0.84 1 0 0 0 0 0 0 5
4280 1124280 2011 2 08PF011 West Ou Chra HC Pailin Pailin T C G T A C A A A G T 284 56 456 1.47 59 1.08 5
4993 1164993 2011 6 12PF006 East Kaev Seima HC Kaev Seima Mondulkiri T C G T A C C C C A T 5
4897 1164897 2011 6 12PF004 East Kaev Seima HC Kaev Seima Mondulkiri T C G T A T A A A G T 5
4211 1144211 2011 4 02PF201 South Takavit HC Kampong Seila Kampong Som T C G T A T A C C G T 5
4310 1154310 2011 5 03PF018 East Khsim HC Snoul Kratie T C G T A T C C C G T 126 44 473 0.41 33 0.19 3.8 60 5
4353 1154353 2011 5 03PF020 East Khsim HC Snoul Kratie T C G T A T C C C G T 0 0 0 0 0 0 0 5
4647 1184647 2011 8 FTP178 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey T C G T A T G A C G T 5
4665 1184665 2011 8 FTP181 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey T C G T A T G A C G T 5
5065 1135065 2011 3 05PF081 West Promoy HC Veal Veng Pursat T C G T A T G A C G T 0 0 0 0 0 0 0 5
3393 1023393 2010 2 CP076 West Pailin RH Pailin Pailin T C G T G C A A A G T 1 0 0 0 0 0 0 5
4282 1124282 2011 2 KH004_009 West Pailin RH Pailin Pailin T C G T G C A A A G T 217 103 511 1.09 60 0.9 1 0 0 0 0 0 0 5
4337 1124337 2011 2 KH004_013 West Pailin RH Pailin Pailin T C G T G C A A A G T 5
3592 1063592 2010 6 RTKPF033 East Veurn Say HC Veurn Say Rattanakiri T C G T G T A A A A T 5
5054 1165054 2011 6 04PF034 East Veurn Say HC Veurn Say Rattanakiri T C G T G T A C C A T 0 0 0 0 0 0 0 5
4444 1164444 2011 6 04PF003 East Veurn Say HC Veurn Say Rattanakiri T C G T G T C A A A T 0 0 0 0 0 0 0 5
4445 1164445 2011 6 04PF004 East Veurn Say HC Veurn Say Rattanakiri T C G T G T C A A A T 0 0 0 0 0 0 0 5
3586 1043586 2010 4 ORPF031 South Oral HC Oral Kampong Speu T T A T A T A C C A T 5
4604 1164604 2011 6 12PF002 East Kaev Seima HC Kaev Seima Mondulkiri T T G A A T A A C A T 5
4765 1164765 2011 6 04PF018 East Veurn Say HC Veurn Say Rattanakiri T T G A A T A A C G T 0 0 0 0 0 0 0 5
4212 1144212 2011 4 02PF202 South Takavit HC Kampong Seila Kampong Som T T G A A T G A C A G 5
3489 1043489 2010 4 ORPF017 South Oral HC Oral Kampong Speu T T G A A T G A C A T 5
3963 1183963 2011 8 FTP137 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey T T G T A T A C A A T 270.8 58.4 294.43 0.64 47.74 1.12 5
4515 1184515 2011 8 FTP172 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey T T G T A T A C A A T 5
5213 1165213 2011 6 04PF044 East Veurn Say HC Veurn Say Rattanakiri T T G T G T A C C A T 5
4458 1194458 2011 9 01PF054 South Koh Slar HC Chhouk Kampot T T G T G T C C A A T 5
5099 1155099 2011 5 03PF013 East Khsim HC Snoul Kratie C C G T A C G A A A T 15 61 0.87 38 0 0 0 0 0 0 0 6
4783 1154783 2011 5 03PF004 East Khsim HC Snoul Kratie C T A T A C A A A A T 6
4912 1164912 2011 6 12PF005 East Kaev Seima HC Kaev Seima Mondulkiri C T A T A C C A C A T 6
4599 1154599 2011 5 03PF002 East Khsim HC Snoul Kratie C T G A A C G A A A T 6
3599 1063599 2010 6 RTKPF036 East Veurn Say HC Veurn Say Rattanakiri C T G A A C G A C A T 6
5069 1165069 2011 6 04PF036 East Veurn Say HC Veurn Say Rattanakiri C T G T A C A A A A T 6
3616 1023616 2010 2 R028 West Battambang RH Battambang Battambang C T G T A C C A C A T 0 0 0 0 0 0 0 6
4994 1164994 2011 6 12PF007 East Kaev Seima HC Kaev Seima Mondulkiri C T G T A C C A C A T 6
4127 1144127 2011 4 02PF175 South Takavit HC Kampong Seila Kampong Som C T G T A C G A A A T 167 47.5 592 0.8 101.9 0.69 16.6 62 1 0 0 0 0 0 0 6
4180 1144180 2011 4 02PF196 South Takavit HC Kampong Seila Kampong Som C T G T A C G A A A T 346 46.8 890 2.15 108 2.42 6
4236 1134236 2011 3 05PF016 West Promoy HC Veal Veng Pursat C T G T A C G A A A T 6
4249 1124249 2011 2 KH004_004 West Pailin RH Pailin Pailin C T G T A C G A A A T 237 107 795 1.29 63 1.3 1 0 0 0 0 0 0 6
4328 1184328 2011 8 FTP150 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T G T A C G A A A T 206 21 218 0.8 67 1.1 62 40 6
4839 1194839 2011 9 01PF066 South Koh Slar HC Chhouk Kampot C T G T A C G A A A T 1 0 0 0 0 0 0 6
4354 1154354 2011 5 03PF021 East Khsim HC Snoul Kratie C T G T A T A A A A T 1 0 0 0 0 0 0 6
5150 1165150 2011 6 04PF038 East Veurn Say HC Veurn Say Rattanakiri C T G T A T C A A A T 70 33 234 0.51 32 0.45 18.8 12.3 0 0 0 0 0 0 0 6 ERS028696 WKH KH3
4443 1164443 2011 6 04PF002 East Veurn Say HC Veurn Say Rattanakiri C T G T A T G A A A T 0 0 0 0 0 0 0 6
3347 1023347 2010 2 PLPF004 West Ou Chra HC Pailin Pailin T C G A A C C A A A T 6
4914 1164914 2011 6 04PF029 East Veurn Say HC Veurn Say Rattanakiri T C G A A C C A A A T 64 33 152 0.37 41 0.32 11.1 19 0 0 0 0 0 0 0 6
4158 1144158 2011 4 02PF191 South Takavit HC Kampong Seila Kampong Som T C G T A C C A A A T 412 54 531 0.65 136 0.53 6
4840 1194840 2011 9 01PF067 South Koh Slar HC Chhouk Kampot T T A T A C A A A A T 6
4875 1194875 2011 9 10PF039 South Chhouk HC Chhouk Kampot T T A T A C A A A A T 6
4903 1164903 2011 6 04PF027 East Veurn Say HC Veurn Say Rattanakiri T T A T A C C A C A T 6
4916 1154916 2011 5 03PF007 East Khsim HC Snoul Kratie T T A T A C C A C A T 47 29 137 0.13 13.5 0.24 5.4 30 6
4984 1154984 2011 5 03PF009 East Khsim HC Snoul Kratie T T A T A C C A C A T 0 0 0 1 0 0 0 6
4748 1164748 2011 6 12PF003 East Kaev Seima HC Kaev Seima Mondulkiri T T G A A C C A C A T 0 0 0 0 0 1 0 6
5020 1115020 2011 1 07PF008 West Sampovloun RH Sampovloun Battambang T T G A A C C A C A T 202.47 39.95 805.52 1.93 136.14 1.47 63.31 47.61 1 0 0 0 0 0 0 6
4259 1124259 2011 2 KH004_006 West Pailin RH Pailin Pailin T T G T A C C A A A T 340.45 201.75 1018.19 0.39 4.59 0.45 10.89 17.1 1 0 0 0 0 0 0 6
4179 1144179 2011 4 02PF195 South Takavit HC Kampong Seila Kampong Som T T G T A C G A A A T 353 83 857 1.22 156 1.73 6
4843 1194843 2011 9 10PF033 South Chhouk HC Chhouk Kampot T T G T G C G A A A G 6
4766 1194766 2011 9 10PF027 South Chhouk HC Chhouk Kampot T T G T G C G A A A T 200 67 171 0.5 20 0.3 33 60 6
5067 1195067 2011 9 10PF055 South Chhouk HC Chhouk Kampot T T G T G C G A A A T 67 36 140 0.3 19 0.3 11.2 28.9 6
4485 1164485 2011 6 04PF005 East Veurn Say HC Veurn Say Rattanakiri T T G T G T G A A A T 6
4313 1134313 2011 3 05PF029 West Promoy HC Veal Veng Pursat T C A T G T A A A G T 7
4495 1124495 2011 2 KH004_023 West Pailin RH Pailin Pailin T T A A G T C A A G T 356 58 537 0.78 48 0.57 1 0 0 0 0 0 0 7 ERS025258 WKH KHA
4656 1124656 2011 2 KH004_028 West Pailin RH Pailin Pailin T T A T G C A A A G T 131 42 234 0.71 71 0.6 43.8 34.3 7
3527 1023527 2010 2 CP079 West Pailin RH Pailin Pailin T T A T G C C A A G T 1 0 0 0 0 0 0 7 ERS032243 WKH KH2
4157 1134157 2011 3 05PF005 West Promoy HC Veal Veng Pursat T T A T G C C A A G T 178 35 458 0.41 71 0.23 8.3 71 0 0 0 0 0 0 0 7 ERS032243 WKH KH2
5036 1125036 2011 2 KH004_031 West Pailin RH Pailin Pailin T T A T G C C A C G T 7
4168 1134168 2011 3 05PF007 West Promoy HC Veal Veng Pursat T T A T G T A A A G T 1 0 0 0 0 0 0 7
4216 1134216 2011 3 05PF010 West Promoy HC Veal Veng Pursat T T A T G T A A A G T 7
4239 1134239 2011 3 05PF019 West Promoy HC Veal Veng Pursat T T A T G T A A A G T 7
915_F NA 2010 3 NIH West Pursat Pursat Pursat T T A T G T C A A A T 7
3629 1023629 2010 2 CP065 West Pailin RH Pailin Pailin T T A T G T C A A G T 7 ERS023736 WKH KH2
5066 1195066 2011 9 10PF054 South Chhouk HC Chhouk Kampot T T A T G T C A A G T 1 0 0 0 0 0 0 7 ERS023736 WKH KH2
916_F NA 2010 3 NIH West Pursat Pursat Pursat T T A T G T C A A G T 7 ERS023736 WKH KH2
986_F NA 2010 3 NIH West Pursat Pursat Pursat T T A T G T C A A G T 7 ERS023736 WKH KH2
4281 1124281 2011 2 KH004_008 West Pailin RH Pailin Pailin T T G T A C C A A G T 1 0 0 0 0 0 0 7
5145 1125145 2011 2 PLPF008 West Ou Chra HC Pailin Pailin T T G T G C C A A G T 163.34 30.17 142.39 0.51 28.14 0.53 37.71 10.06 7
4751 1184751 2011 8 FTP185 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey T T G T G C C A C G T 7 ERS025393 NEKH KH1
4395 1194395 2011 9 01PF038 South Koh Slar HC Chhouk Kampot T T G T G C C C A G T 7
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4149 1144149 2011 4 02PF189 South Takavit HC Kampong Seila Kampong Som C T A T G C A A C A T 264 62 467 0.54 169 2.11 42.4 93 8 ERS024144 WKH KH3
4253 1134253 2011 3 05PF020 West Promoy HC Veal Veng Pursat C T A T G C A A C A T 8 ERS024144 WKH KH3
4338 1134338 2011 3 05PF034 West Promoy HC Veal Veng Pursat C T A T G C A A C A T 8 ERS024144 WKH KH3
4356 1134356 2011 3 05PF038 West Promoy HC Veal Veng Pursat C T A T G C A A C A T 8 ERS024144 WKH KH3
4438 1184438 2011 8 FTP157 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C A A C A T 211 37 698 0.87 154 0.56 25.1 84 8 ERS024144 WKH KH3
4440 1184440 2011 8 FTP159 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C A A C A T 346 37 577 0.59 79 0.78 65 79 8 ERS024144 WKH KH3
4441 1184441 2011 8 FTP160 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C A A C A T 546 39 763 0.79 142 0.54 117 88 8 ERS024144 WKH KH3
4462 1184462 2011 8 FTP162 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C A A C A T 49 0.62 87 0.6 31 47 0 1 0 0 0 0 0 8 ERS024144 WKH KH3
4466 1184466 2011 8 FTP163 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C A A C A T 209 99 2049 1.09 138 1.09 8 ERS024144 WKH KH3
4467 1184467 2011 8 FTP164 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C A A C A T 223 55 934 1.38 176 1.04 8 ERS024144 WKH KH3
4507 1184507 2011 8 FTP170 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C A A C A T 83 44 347 0.78 35 0.69 41 35.9 8 ERS024144 WKH KH3
4649 1184649 2011 8 FTP180 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C A A C A T 175 47 199 1.25 96 0.85 31.9 47 8 ERS024144 WKH KH3
4675 1184675 2011 8 FTP182 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C A A C A T 95 37 294 1.14 93 0.8 51.3 36.2 8 ERS024144 WKH KH3
4685 1184685 2011 8 FTP161 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C A A C A T 8 ERS024144 WKH KH3
4703 1184703 2011 8 FTP183 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C A A C A T 149 52.7 292 1.12 98.5 1.35 40.8 0 1 0 0 0 0 0 8 ERS024144 WKH KH3
4763 1184763 2011 8 FTP187 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C A A C A T 192 56.3 395 0.52 75.8 0.44 37.3 64.7 8 ERS024144 WKH KH3
4877 1184877 2011 8 FTP191 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C A A C A T 8 ERS024144 WKH KH3
5093 1195093 2011 9 10PF059 South Chhouk HC Chhouk Kampot C T A T G C A A C A T 82 33 327 0.95 60 0.73 48.7 39 0 1 0 0 0 0 0 8 ERS024144 WKH KH3
5138 1185138 2011 8 FTP197 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C A A C A T 41 57 284 0.6 40 0.6 0 1 0 0 0 0 0 8 ERS024144 WKH KH3
5192 1185192 2011 8 FTP199 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C A A C A T 8 ERS024144 WKH KH3
5202 1115202 2011 1 07PF009 West Sampovloun RH Sampovloun Battambang C T A T G C A A C A T 125 34 627 1.47 79 1.23 36.7 34.5 0 1 0 0 0 0 0 8 ERS024144 WKH KH3
967_F NA 2010 3 NIH West Pursat Pursat Pursat C T A T G C A A C A T 8 ERS024144 WKH KH3
4286 1184286 2011 8 FTP148 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T A T G C C A C A T 231 92 579 1.21 126 1.08 41.2 73 0 1 0 0 0 0 0 8
4701 1194701 2011 9 10PF024 South Chhouk HC Chhouk Kampot C T A T G C C C C A T 8
4442 1164442 2011 6 04PF001 East Veurn Say HC Veurn Say Rattanakiri C T G A G C A A C A T 8
4879 1164879 2011 6 04PF025 East Veurn Say HC Veurn Say Rattanakiri C T G T G C A A A A T 8
4323 1114323 2011 1 07PF002 West Sampovloun RH Sampovloun Battambang C T G T G C A A C A T 8
5061 1195061 2011 9 01PF070 South Koh Slar HC Chhouk Kampot C T G T G C A A C A T 62 30 471 0.44 23 0.41 24 40 8
5092 1195092 2011 9 10PF058 South Chhouk HC Chhouk Kampot C T G T G C A A C A T 45 34 144 0.32 37 0.56 24.7 37 1 0 0 0 0 0 0 8
5211 1165211 2011 6 12PF009 East Kaev Seima HC Kaev Seima Mondulkiri C T G T G C A A C A T 285.01 648.16 1318.53 0.63 17.12 0.67 4.45 78.16 0 0 0 0 0 0 0 8
4580 1194580 2011 9 01PF058 South Koh Slar HC Chhouk Kampot T T G T A C A C C A T 8
3597 1063597 2010 6 RTKPF034 East Veurn Say HC Veurn Say Rattanakiri T T G T G C A A C A T 8 ERS028702 WKH KH1
3842 1183842 2011 8 M083 North Anlong Veng RH Anlong Veng Oddar Meanchey T T G T G C A A C A T 8 ERS028702 WKH KH1
3862 1183862 2011 8 M086 North Anlong Veng RH Anlong Veng Oddar Meanchey T T G T G C A A C A T 8 ERS028702 WKH KH1
4327 1184327 2011 8 FTP149 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey T T G T G C A A C A T 558 67 376 0.52 41 0.48 26.4 155 1 0 0 0 0 0 0 8 ERS028702 WKH KH1
4391 1184391 2011 8 FTP151 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey T T G T G C A A C A T 767 66 1113 0.39 105 0.61 100 206 8 ERS028702 WKH KH1
4612 1184612 2011 8 FTP176 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey T T G T G C A A C A T 8 ERS028702 WKH KH1
5019 1185019 2011 8 FTP195 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey T T G T G C A A C A T 71 33 178 0.25 23 0.3 12.1 83.1 1 0 0 0 0 0 0 8 ERS028702 WKH KH1
5118 1185118 2011 8 M103 North Anlong Veng RH Anlong Veng Oddar Meanchey T T G T G C A A C A T 1 0 0 0 0 0 0 8 ERS028702 WKH KH1
932_F NA 2010 3 NIH West Pursat Pursat Pursat T T G T G C A A C A T 8 ERS028702 WKH KH1
4934 1134934 2011 3 VVPF012 West Promoy HC Veal Veng Pursat T T G T G C A C C A T 8 ERS025263 WKH KHA
4935 1134935 2011 3 VVPF013 West Promoy HC Veal Veng Pursat T T G T G C A C C A T 8 ERS025263 WKH KHA
4936 1134936 2011 3 VVPF014 West Promoy HC Veal Veng Pursat T T G T G C A C C A T 8 ERS025263 WKH KHA
827_F NA 2010 3 NIH West Pursat Pursat Pursat C C A A A T C A A G T 9 ERS023741 WKH KH4
832_F NA 2010 3 NIH West Pursat Pursat Pursat C C A A A T C A A G T 9 ERS023741 WKH KH4
838_F NA 2010 3 NIH West Pursat Pursat Pursat C C A A A T C A A G T 9 ERS023741 WKH KH4
973_F NA 2010 3 NIH West Pursat Pursat Pursat C C G A A C A A A A T 9 ERS028714 WKH KH1
954_F NA 2010 3 NIH West Pursat Pursat Pursat C C G A A C A A A G T 9 ERS017705 WKH KHA
5188 1165188 2011 6 04PF042 East Veurn Say HC Veurn Say Rattanakiri C C G A A C G A A A T 9
5152 1165152 2011 6 04PF040 East Veurn Say HC Veurn Say Rattanakiri C C G A A C G A A G T 68 35.6 130 0.29 19.7 0.37 9.6 13.3 9 ERS028718 WKH KHA
5159 1165159 2011 6 04PF041 East Veurn Say HC Veurn Say Rattanakiri C C G A A C G A A G T 36 29.4 162 0.45 14 0.4 6.1 9.5 0 0 0 0 0 0 0 9 ERS028718 WKH KHA
4746 1194746 2011 9 01PF061 South Koh Slar HC Chhouk Kampot C C G A A T A A A A T 1 0 0 0 0 0 0 9
818-2_F NA 2010 3 NIH West Pursat Pursat Pursat C C G A A T G A A A T 9 ERS032686 WKH KH4
962_F NA 2010 3 NIH West Pursat Pursat Pursat C C G A A T G A A A T 9 ERS032686 WKH KH4
964_F NA 2010 3 NIH West Pursat Pursat Pursat C C G A A T G A A A T 9 ERS032686 WKH KH4
966_F NA 2010 3 NIH West Pursat Pursat Pursat C C G A A T G A A A T 9 ERS032686 WKH KH4
5151 1165151 2011 6 04PF039 East Veurn Say HC Veurn Say Rattanakiri C C G A G C A A A A T 9
4749 1184749 2011 8 M095-D0 North Anlong Veng RH Anlong Veng Oddar Meanchey C T A T A T C A A A T 57 35 228 0.46 28 0.49 11.2 12.3 0 0 0 0 0 0 0 9 ERS025267 WKH KH3
189-4_F NA 2010 3 NIH West Pursat Pursat Pursat C T A T A T C A A A T 9 ERS025267 WKH KH3
993_F NA 2010 3 NIH West Pursat Pursat Pursat C T A T A T C A A A T 9 ERS025267 WKH KH3
4561 1164561 2011 6 04PF010 East Veurn Say HC Veurn Say Rattanakiri C T G A A T C A A G T 9
4776 1154776 2011 5 03PF003 East Khsim HC Snoul Kratie C T G A G C A A A G T 0 0 0 0 0 0 0 9
4130 1144130 2011 4 02PF178 South Takavit HC Kampong Seila Kampong Som C T G A G C A C A A G 9
4147 1144147 2011 4 02PF187B South Takavit HC Kampong Seila Kampong Som C T G A G C A C A A T 9
4790 1164790 2011 6 04PF019 East Veurn Say HC Veurn Say Rattanakiri C T G A G C C A A G T 9
4340 1154340 2011 5 03PF019 East Khsim HC Snoul Kratie C T G A G C G C A G T 150 50 472 0.69 76 0.38 44.8 86 9
3624 1033624 2010 3 VVPF044 West Promoy HC Veal Veng Pursat C T G A G T G C A A T 9
4198 1184198 2011 8 FTP145 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T G T G T C A A G T 531 82 546 0.43 69 0.75 0 0 0 0 0 0 0 9
4214 1184214 2011 8 FTP146 North Trapaing Prasat HC Trapaing Prasat Oddar Meanchey C T G T G T C A A G T 399 66.5 478 0.57 47.2 0.85 42.3 9
959_F NA 2010 3 NIH West Pursat Pursat Pursat T T A A A T C A A A T 9
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Additional file 11. Comparison of allele frequencies in health centre and in conserved 
clustering groups. A comparative analysis was illustrated using Weblogos sorted for health 
centre and clustering groups. 
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Additional file 12. Distribution of IC50 value of P. falciparum isolates per major geographic 
areas. Box Plot analysis is presenting median and quartiles. Dashed line figure out the 
threshold where parasite could be resistant for the drug (30 nM). Parasites were originating 
from regions distributed at the four compass points in Cambodia. ANOVA test was 
significant for chloroquine and mefloquine (p value = 5.62e−5 and p value = 0.0408, 
respectively). 
 
 
 
Additional file 13. Distribution of mefloquine IC50 value of isolates associated to conserved 
clusters G1 to G9. Box Plot analysis is presenting median and quartiles. Mefloquine resistant 
parasites have IC50 over the dashed line (30 nM). 
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Chapter 3
Functional analysis of Pf
subpopulations
3.1 Introduction
This chapter describes another approach for description of P. falciparum population
structure and identification of molecular markers and pathways supporting artemisinin
resistance. At the beginning of this project the meta-information about parasite pop-
ulation structure described earlier [Miotto et al., 2013] in Cambodia was not available.
Therefore, we decide to describe again the population structure and make associa-
tions with the artemisinin resistance molecular markers. Other contributing factors
for using this dataset was the time period of early emergence of artemisinin resis-
tance (2008-2011). The barcoding approach was suitable for subpopulation and gene
flow analysis. This approach is aimed at functional analysis of the polymorphisms
recovered in whole genome sequencing data.
The recently identified molecular markers, the mutations in the BTB/POZ do-
main and propeller domain of the kelch 13 gene (k13), have proven to be impor-
tant targets for identifying resistant isolates and following resistance. In addition
to the three dominant mutations identified by Ariey and colleagues (C580Y, R539T
and Y493H) [Ariey et al., 2014], more mutations have been identified in Cambodia
[Miotto et al., 2015] and adjoining countries like Myanmar [Tun et al., 2015]. This
raises concern, as previous spreads of earlier antimalarial drug resistances to Africa
caused millions of death. Understanding the mechanism associated to transmission
and acquisition of resistance is very important to contain the resistance by identi-
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fying new drug targets. Furthermore, the non-synonymous SNPs identified (based
on GWAS analysis) in ferredoxin (fd), apicoplast ribosomal protein S10 (arps10 ),
multidrug resistance protein 2 (mdr2 ) and chloroquine resistance transporter (crt)
were shown to be associated to mutations in k13 and were described as background
mutations [Miotto et al., 2015]. Even after the identification of molecular marker and
associated studies, the mechanism underlying artemisinin resistance is not known.
One of the possible pathways associated to artemisinin resistance has been recently
described by Mbengue and colleagues [Mbengue et al., 2015] based on experimental
data. They showed that the production of phosphatidylinositol-3-phosphate (PI3P)
by phosphatidylinositol-3-kinase (PI3K) and artemisinin interaction is essential for
parasite growth (elevated levels of PI3P when going from ring to schizont stage). In
the case of mutated k13 (C580Y), the binding of k13 to PI3K (inhibitory action)
and polyubiquitination of PI3K does not take place, keeping the level of PI3P always
high, allowing the parasite to mature. Therefore, PI3K was described as an important
target for understanding the mechanism.
Apart from the identified molecular markers and possible pathways associated to
artemisinin resistance, understanding the parasite population structure is also impor-
tant. Fragmentation of P. falciparum population structure was shown by Miotto and
colleagues [Miotto et al., 2013] based on whole genome sequencing analysis and con-
firmed by the analyses in the previous chapter. The description of ancestral popula-
tion, founder populations and admixed subpopulation based on chromosome walking
analysis, provides an insight into understanding the emergence of parasite resistant
subpopulations. Emerging of resistance subpopulations in varied localities in Cambo-
dia was also made evident by the barcoding approach [Dwivedi et al., 2016] described
above.
The main objective of this study was the functional annotation of the polymor-
phisms associated to artemisinin resistance in P. falciparum resistant and sensitive
subpopulations. Major part of this work was to develop pipelines and utilize the
available bioinformatics tools to recover the list of SNPs and identify potential genes
in artemisinin resistant populations that could be targeted for understanding the
artemisinin resistant mechanism.
The whole parasite genome data from four localities in Cambodia was post-
processed. A variant calling pipeline was implemented based on sequencing quality
signal parameters to recover non-synonymous SNPs for description of parasite pop-
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ulation structure (Article2: Figure S13). The population structure was identified
using two approaches, unsupervised hierarchical clustering based on the called SNPs
followed by association studies and the network based stratification method using
protein interaction network based on coexpression data. One method is based on the
significant SNPs discovered in the defined subpopulations and the other method is
based on the significant genes in the network. The interest of performing such a dou-
ble analysis is of course to test the robustness of results: processing such big datasets
is always likely to give significant results, but finding concordant information from
different sources of information is much more reassuring. Indeed, both approaches
provide quite similar results suggesting the robustness of the functional evidence. The
classification of isolates based on interaction network has not been performed earlier
for P. falciparum genomic data. Three gene sets were focused on, significant genes in
KH1.2 common with ART-R subpopulations, ART-R subpopulations specific genes
and resistance background specific genes. Functional annotation of these three gene
sets based on GO terms and functional groups of GO terms revealed PI3K-K13 in-
teraction pathway and suggested E3 mediated autophagy pathway could be playing
an essential role in acquisition of artemisinin resistance.
This work questions the emergence of subpopulations and acquisition of artemisinin
resistance. In further sections, the approaches and major results are explained briefly
and the complete manuscript provided in the last section should be referred. This
manuscript will be submitted soon.
3.2 Approach and Results
3.2.1 Data Acquisition
The dataset used in this study is the same as the one on which the P. falciparum
population structure in Cambodia was described earlier [Miotto et al., 2013]. The
samples are isolated from 4 locations in Cambodia. The whole genome sequencing
data was recovered from ENA database server as BAM files. The sequencing was done
using Illumina Genome Analyzer II and the alignment was performed using BWA
tool [Manske et al., 2012, Miotto et al., 2013]. Only 167 BAM files (Article2: Table
S4) were successfully recovered out of the 293 isolates used by Miotto and colleagues
(Article 2: Supplementary material section “Data acquisition”). The genomes were
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aligned using 3D7 reference genome version 2. The data originated from four regions
in Cambodia, Pailin, Pursat and Tasanh in West and Ratanakiri in east. The 167
BAM files were converted to VCF files using SAMtools v 0.1.19 and the SNPs were
extracted using the following procedure:
samtools sort "BAMfilename".bam s"BAMfilename"
samtools index s"BAMfilename".bam
samtools mpileup −uf PfalciparumGenomic_PlasmoDB5.5.fasta s"BAMfilename"
| bcftools view −vcg − > "BAMfilename".vcf
vcftools − − keep − INFO − all − − vcf "BAMfilename".vcf − − remove − indels
− − out s"BAMfilename"snp.vcf − − recode
1: Tasanh HC  
2: Pailin RH  
3: Pursat 
4: Ratanakiri 
1 
2 
4 
3 
WTSI sample collection 
location 
Cambodian Capital  
(Phnom Penh)  
Localities 
Figure 3.1: Boundary map of Cambodia showing data (blood samples) collection
localities by Wellcome Trust Sanger Institute. Cambodia boundary map source:
http://www.mappery.com/map-of/Cambodia-Provinces-Outline-Map
3.2.2 Data filtering
This analysis is focused on non-synonymous SNPs in the coding region of the genome
in at least one of the isolates and does not take insertion/deletion (INDELs) muta-
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tions into consideration. The approach was to select SNPs with strong ALT signal
and avoid false positive SNPs. The data was filtered for noise based on two param-
eters: mapping quality (MQ) and ALT allele frequency (DA), which is analogous to
Non-Reference Allele Frequency (NRAF) (Article2: Supplementary material section
“Filtering data for noise”). As it is known that the mapping quality decreases to-
wards the chromosome ends, we randomly remove around 100 kb from the beginning
and end of each chromosome. When visualizing the MQ values over the genome with
and without the chromosome ends, a clear threshold at 29 is observed (Article2: Fig-
ure S14). Therefore, MQ >29 was used as one of the filtering criteria. Moreover,
to identify true SNPs, the approach was to select SNPs with high ALT frequency.
We used the parameter DP4, which accounts for number of reads having ref/non-ref
(ALT) allele in forward/reverse strand. We calculated the ALT frequency (this term
is referred to as DA in the manuscript) and on the frequency density plot, we put a
threshold where the distribution of low quality SNPs and high quality SNPs intersect,
which is at about 0.7 (Article2: Figure S15). Therefore, DA > 0.7 was considered
as the second filtering criteria. Filtering the data based on these two parameters
provides 247783 SNPs in 167 isolates, i.e., genome positions with reliable ALT alleles
in at least one isolate. Also, the SNPs with Minor Allele Frequency (MAF) less than
0.01796 were removed (Article2: Figure S16). Therefore, a set of 111701 SNPs was
recovered in 167 isolates. The isolate bias towards a given chromosome was checked
by plotting the number of filtered SNPs in an isolate as a function of number of fil-
tered SNPs in a chromosome for each chromosome. No isolate was rejected from the
analysis.
3.2.3 Different genome versions
The data by Miotto and colleagues was aligned on 3D7 reference genome version
2 and to get the correspondence with the genome version 3, we performed BLAST
(Article2: Supplementary material section “Correspondence between different genome
version”). For some of the chromosomes, short alignments were recovered, so BLAST
was performed on specific regions of these chromosomes to recover the alignment.
Around 3000 unmapped SNPs were removed and a list of 108596 SNPs was obtained.
Realignment of the sequence reads was not done on the 3D7 reference genome
version 3, as the FASTQ files were not available and the process was time consuming.
The idea was to rapidly recover the list of potential SNPs for population structure
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analysis.
3.2.4 Removing uncertain SNPs
Uncertain SNPs are defined as loci with a possibility of more than one ALT allele.
The loci representing uncertain SNPs in some of the isolates were removed when
uncertainty was too important to be resolved, or substituted with ALT allele of highest
frequency or the REF allele based on the uncertain SNP frequency in the 167 isolates
(Article2: Supplementary material section “Removing uncertain SNPs and correcting
errors”). Around 2% SNPs were removed and 17% were substituted in at least one
isolate. Therefore, 106538 SNPs were recovered after this step. Figure S17, shows
the global scenario used to remove and substitute uncertain SNPs. This approach is
not very stringent and removes a very small proportion of SNPs compared to the full
dataset. The memory of these SNPs is kept and can be included in the analysis if
required.
3.2.5 Genome annotation
The recovered SNPs were annotated using VCF-annotator Perl script (developed
at the Broad Institute, Cambridge, MA)(Article2: Supplementary material section
“Annotation of the recovered SNPs”). The GFF3 (General Feature Format version
3) format annotation file corresponding to 3D7 reference genome version 2 was recov-
ered from Ensemble release version ASM276v1.21. Also, the regions containing the
genes with description such as CLAG, DBL, Rifin, hyp, Stevor, GARP, RESA, VAR,
PfEMP, Surfin, PHIST, KAH and EMP in a consecutive organization, were consid-
ered as telomeric regions and were removed from the analysis (Article2: Table S5).
Therefore, finally a set of 21257 SNPs in 167 isolates was recovered for population
study. This set is referred to as IBC dataset. The recovered genome annotation was
validated in the PlamoDB genome browser.
3.2.6 Validation of IBC dataset
The IBC dataset was validated by comparison with other publically available dat-
sets, PlasmoDB (Asian strains) and MalariaGEN (Asian and African strains) by
considering the common SNPs between the datasets (Article2: Figure S18) and the
distribution of SNPs in the coding region of the genome (Article2: Figure S19 and
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Table 6). The overlap between IBC dataset and MalariaGEN dataset, as well as
IBC and PlasmoDB is better than overlap between those two previously published
datasets. The use of this pipeline and analysis of a big dataset seems to stabilize
the results and reduce the false positives in the recovered list of SNPs. (Article2:
Supplementary material section “Validation of IBC dataset”).
3.2.7 Clustering
A similar clustering pipeline was used, as described in the chapter above (Article1).
Samples were divided into 8 subpopulations (Article2: Figure 1) instead the 5 sub-
populations described earlier [Miotto et al., 2013] (Article2: Supplementary material
section “Clustering”). The number of clusters was decided based on presence of k13
alleles and correspondence with the KH subpopulations, which were provided by O.
Miotto .
The subpopulations KH2 and KH3 were already described by Miotto and are the
donor populations for the most dominant allele C580Y, but in our dataset the KH2
subpopulation could be robustly divided into two subpopulations KH2.1 and KH2.2.
KH4 is known to be the donor population for the Y493H allele. We denoted KH5
a new subpopulation, which was not described earlier and which was highlighted by
our analysis. All the isolates in this subpopulation carry one of the three K13 alleles,
which are mutually exclusive. R539T is the dominating allele followed by C580Y and
Y493H alleles. Hence, we consider KH5 as a donor population for R539T allele of the
k13 gene. The ART sensitive (ART-S) subpopulation KH1 described as the ancestral
population [Miotto et al., 2013] was also divided into two robust subpopulations,
KH1.1 and KH1.2. None of the isolates in these two subpopulations carried any of
the three K13 mutations and all the corresponding isolates originate from Ratanakiri
in eastern Cambodia (one isolate from Tasanh in western Cambodia). KH1.1 is one
of the largest subpopulations and KH1.2 is the smallest subpopulation. The other
dominating subpopulation is the admixed subpopulation KHA with around 52% of
the ART resistant isolates and 48% ART sensitive isolates (Article2: Result and
Discussion section “Description of P. falciparum subpopulations”).
As done in the barcoding chapter, to perform an additional robustness study of
the clusters, 1000 hierarchical clustering were performed for 150 isolates randomly
selected from the 167 isolates and the frequency of samples being in a specific sub-
population (for k = 8) was calculated. Out of the 167 isolates only 9 isolates were
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observed to be not specifically associated with a particular subpopulation and can
be included either in one of the subpopulations (KH2.1, KH3, KH5 and KH1.1), or
the admixed subpopulation KHA. The remaining 158 isolates always clustered in the
same subpopulation.
3.2.8 Significant SNPs and genes
SNPs significantly associated to each subpopulation were identified using one-tailed
Fisher exact test (Article2: Supplementary Material section “Significant SNPs and
Genes”). For each SNP, ALT allele frequency in each subpopulation was compared to
the ALT allele frequency in KH1.1 subpopulation (considered as the ancestral pop-
ulation). Benjamini-Hochberg method was used to correct the p-values for multiple
comparisons. All the SNPs with a corrected p-value lower than 0.05 were considered
as significant and the genes containing these significant SNPs were defined as the
significant genes (Article 2: Table S7).
3.2.9 Information from gene interaction networks and gene
ontology
A new approach was used to understand the underlying metabolic pathways associ-
ated to artemisinin resistance. Gene-gene interaction networks based on coexpression
data were recovered from STRING v10 (Article2: Supplementary material section
“Gene interaction network and gene ontology”). Only, the interactions with scores
greater than 50% were kept. Maximum expression in blood stage based on microar-
ray transcriptomic data was recovered from PlasmoDB and the genes were classified
on the coexpression network into different blood stage forms (Article2: Figure S1)
using Cytoscape. This analysis has not been done before and provides a very clear
description of coexpressed genes in different blood stage forms (Article2: Table S8).
In order to verify the expression of genes associated with the K13 gene (PF13_0238)
in the described blood stages, the genes co-expressed with K13 gene were represented
on the coexpression interaction network. In the full network, starting from the K13
gene the neighboring genes were marked then the neighbors of neighbor genes and so
on until the major part of the network (representative of blood stages) was marked.
It was observed that the genes associated with the K13 gene were mostly expressed
in the ring stage and schizogony stage part of the network (Article2: Figure 2).
3.2. APPROACH AND RESULTS 117
For identification of biological function associated to the significant genes, the
functionally grouped networks of GO terms and pathways were recovered and stud-
ied for each subpopulation using the ClueGO v2.2.4 and CluePedia v1.2.4 plugins
of Cytoscape (Article2: Supplementary material section “Gene interaction network
and gene ontology”). For the functional annotation of the significant genes in each
subpopulation, GO terms were also recovered from PlasmoDB v13.
3.2.10 Network based description
Apart from the hierarchical clustering method for classification of subpopulations
based on SNPs, efforts were made to classify the samples based on interactions among
significant genes in a network. This approach can be used to reveal the part of the
networks or pathways, which are more connected and are affected the most in case of
mutations (Article2: Supplementary material section “Network based subpopulation
description”).
In the first approach the subpopulations were clustered based on presence or
absence of the interaction in the interaction network with evidence from all the
sources available in STRING v10. This analysis revealed that the KH1.2 popula-
tion (artemisinin sensitive subpopulation) clusters with the resistant subpopulations,
suggesting that it might have acquired the resistance background, but not completely
(K13 alleles absent).
To validate this a new approach was implemented, that has never been imple-
mented on P. falciparum genome before (Article2: Supplementary material section
“Network based subpopulation description”). The population structure of 167 par-
asite isolates was also questioned using the method of Network Based Stratifica-
tion [Hofree et al., 2013], which clusters the isolates together having diffusion paths
associated to mutated genes in similar network regions. Full P. falciparum interac-
tion network recovered from STRING v10. All interaction prediction sources were
considered. The results were obtained for the top 10% highest interaction scores. The
mutated genes were propagated to the neighbourhood network (network smoothing)
and based on the node score matrix of the resulting diffusion network for each iso-
late, clustering was performed using non-negative matrix factorization (NMF) method
[Lee and Seung, 1999]. Consensus clustering was performed by selecting 80% mutated
genes and 80% isolates 100 times randomly and iterating NMF clustering 10 times.
The consensus clustering between samples was estimated as the percentage of co-
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clustering results in which they are in the same cluster when the dendrogram is cut
to obtain 8 groups (to make the comparison easy with the 8 KH sub-populations).
This consensus clustering matrix was normalized and then used to build a dendro-
gram for all 167 isolates using Euclidean distance matrix and ward minimum variance
method in R. This method provides clustering of the isolates based on interacting sig-
nificant genes in a network. The clustering was very similar to the clustering obtained
from unsupervised hierarchical clustering approach. Some of the samples were clus-
tered in different subpopulations (Article2: Figure S2). Also, the description of KHA
subpopulation was different. Some of the sensitive isolates in KHA clustered with
KH1.1 and some clustered with resistant subpopulations. This suggests that due to
crossing between or among subpopulations, some ART sensitive samples in the KHA
subpopulation have acquired resistance background and some sensitive KHA samples
have not acquired the resistant background (Article2 : Result and Discussion section
“Description of P. falciparum subpopulations”). Also, when modulating K to obtain
2-8 clusters, it was observed that KH1.2 clusters with KH4 (Y493H donor subpop-
ulation). This could suggest the presence of P. falciparum parasite subpopulations
with specific genetic background in Cambodia before the introduction of ART.
3.2.11 Analysis of the genes associated with artemisinin re-
sistance
The analysis was focused on three gene sets primarily obtained at the intersection of
significant genes (set of genes containing the significant SNPs) in the resistance sub-
populations. These three gene sets are: (a) 168 significant genes having at least one
significant SNP in all the resistant subpopulations (KH2.1, KH2.2, KH3, KH4, KH5)
and the subpopulation KH1.2, (Article2: Figure S5, S6 and Table S1) (b) 97 signifi-
cant genes having at least one significant SNP in all the resistant subpopulations only
(Article2: Figure S7, S8 and Table S2)and (c) 57 significant genes having at least one
significant SNP in all the resistant subpopulations and admixed subpopulation KHA,
but no significant SNP in the subpopulation KH1.2 (Article2: Figure S10, S11 and
Table S3). There can be different SNPs in the same gene in different subpopulations.
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3.3 Discussion
The variant calling approach developed during this study, is reproducible, reliable and
extendible. The filtering approach implemented on the recovered variations at differ-
ent levels helps in recovering good quality SNPs in the coding region and reduces false
positive SNP detection. The techniques implemented to remove uncertainties from
certain SNPs are not very stringent and can differ for different studies. Only a small
amount of SNPs are removed and can be included in the analyses if required. The
results are validated in comparison with publically available dataset based on genomic
structure and detectable SNPs. The overlap between IBC dataset and MalariaGEN
dataset, as well as IBC and PlasmoDB is better than overlap between those two
previously published datasets.
The pairwise distance calculated is similar to the genetic distance used earlier [Miotto
et al., 2013]. The clustering recovered using Ward’s minimum variance method based
on the 21257 SNPs overlaps significantly with the population description by Miotto.
The correspondence between the isolates and subpopulations is not publicly avail-
able. The clustering was validated with O. Miotto in personal communication. Also,
due to the mapping of 3D7 reference genome version 2 and 3, the mutations in K13
could be recovered and associated with recovered clusters (subpopulations). These
mutations were not recovered in the earlier analysis, as this region in the reference
genome version 2 is not correctly mapped. In this work we are able to associate the
P. falciparum population structure with the molecular marker of artemisinin resis-
tance. The distribution of K13 Kelch mutations and the KH sub-populations shows
the specificity of genetically defined sub-populations to the geographical locations.
The other clustering approach used to structure the population was the network
based stratification method based on interactions among significant genes in a net-
work, which clusters the isolates together having diffusion paths associated to mutated
genes in similar network regions. This approach can be used to reveal the part of the
networks or pathways which are more connected and are affected the most in case
of mutations. This approach provides a tool to exploit the metabolic and protein
interaction data available. This method was implemented in collaboration with the
present postdoc in the team Bioinformatics and system biology of cancer at IRCM.
This method validated the clusters and suggested the associations of isolates among
subpopulations are robust. Indeed, around 9 isolates were misplaced in this approach
compared to the hierarchical clustering method, but the important point is that the
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samples were either misplaced from or to the KHA subpopulation, which could sug-
gest the crossing of founder subpopulations and KHA admixed subpopulation and the
acquisition of resistance background or specific background associated to the founder
populations. This finding also supports one of the hypotheses of my work that ad-
mixed subpopulation might be responsible for transmission resistant background by
crossing (also mentioned in the barcoding approach). This approach can be imple-
mented on other available interaction networks and metabolic pathways.
Based on both the clustering approaches samples were classified into more specific
subpopulations and provides an important insight regarding the genetic background
of the subpopulations, as in the case of KH1.2. Though KH1.2 is a small population
(n=5), but it is observed to be robust based on both, significant SNPs and gene-gene
interactions in the coexpression network.
One of the important results is the mapping of blood stage data recovered from
PlasmoDB on the coexpression network (Article2: Figure S1). It clearly shows dis-
tinct parts of the network representing coexpression at ring, trophozoite and sch-
izont. The approach of marking the neighbor interacting genes on this network shows
strong association of K13 with the genes expressed in ring and schizont stage. This
is in agreement with the strong homology between Kelch and KEAP1 human gene
[Paloque et al., 2016]. This analysis suggests that studying the co-expression network
is relevant for analysis of background genes in the context of ART resistance.
The background mutations described recently associated with K13 alleles were
also assessed. It was seen that the most significant background mutation in fer-
rodoxin gene is not always present with the k13 mutations (in case of KH3). In
some cases, different mutations in the five defined background genes are significant in
different subpopulations, suggesting specificity (Article2: Result and Discussion sec-
tion “Subpopulation associated genetic background”). There are 57 mutations found
significant in all the ART-R subpopulations, suggesting that the fixation of one mu-
tation in the population is the results of selection among subpopulations rather than
de novo acquisition after drug pressure. These results could suggest that the selection
was performed on subpopulations and not on the ancestral population.
We define three gene sets based on the population structure: (1) significant genes
common in KH1.2 and ART-R subpopulations, (2) genes specific to ART-R subpop-
ulations and (3) the resistance background ART-R and KHA subpopulations. The
distribution of 168 genes in all compartments of the coexpression network suggests
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a common background of all the subpopulations differentiating from the ancestral
population KH1.1. The analysis of all ART-R subpopulations significant genes (265
genes) reveal GO terms associated with cell signalization, gene expression at DNA,
RNA and post-translation level, RNA metabolism (tRNA and mRNA modification,
. . . ) and organella related functions (Article2: Figure S4). These functions are con-
served in the two sets KH1.2 specific and ART-R specific, but not completely.
The 97 genes emphasize the presence of Phosphodiestarase 1 (PDE1) involved
in regulation of cGMP concentration (Article2: Result and discussion section “De-
scription of ART-R subpopulation genetic background”). Genes in the same GO
term functional group as k13 are associated with polyubiquitination (E3-like protein
MAL7P1.19 and RPN10 proteasome subunit), signal transduction (PI3K PFE0765w),
autophagy (Atg7, Atg18) and regulation of protein activity (Serine/threonine phos-
phatase PFD0505c) (Article2: Figure S8). Figure S9 shows that major components
of the 97 gene set have been kept in KHA isolates (Article2: Result and Discussion
section “Artemisinin resistance background associated pathways”). This suggests
that KHA background was acquired by crossing of parasites from various populations
either ancestral, resistant or admixed population that existed before.
Overlapping gene set of KHA significant genes and ART-R specific genes (57
genes), identified two protein kinases PI3K and ARK2, and suggested autophagy
as one of the pathways associated with artemisinin resistance (Article2: Result and
discussion section “Artemisinin resistance background associated pathways”). Also,
the presence of mutations in Atg7 and Atg18 suggest that autophagy could be a key
pathway in the acquisition of artemisinin resistance. Despite the presence of PI3K in
the final 57 gene set, mutations in PI3K were not systematically associated with k13
resistant alleles. Further studies will define how P. falciparum is able to manage ring
stage arrest after oxidative stress induced by artemisinin.
We try to explain the transmission and existence of subpopulation with an Emer-
gence Selection and Diffusion model, where the subpopulations emerge from ances-
tral population with a common background. Resistant alleles are selected in these
subpopulations and the transmission takes place by crossing over with the admixed
population KHA.
There is a strong need to analyze more genomic data from varied locations in
the same country to understand the stated hypotheses completely. Also data from
different countries should be analyzed to verify the generality of this model. The
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geographical and socio-economic scenario of Cambodia is changing due to undergo-
ing development initiatives, which could strongly influence the parasite population
structure in Cambodia. Therefore, for following the evolution and movement of these
populations, genomic data in different time periods is required.
The admixed sub-population can be considered as the major threat for transmis-
sion and acquisition of artemisinin resistant allele because of ability to cross with in
and with other subpopulations. Specific methods should be implemented for under-
standing the dynamics of admixed subpopulation.
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Abstract:  
Plasmodium falciparum malaria is one of the most widespread parasitic infections in humans and 
remains a leading global health concern. Malaria elimination efforts are threatened by the 
emergence and spread of resistance to artemisinin-combination therapies (ACTs), the front-line 
treatments of Malaria. The first case of clinical artemisinin resistance was observed in Cambodia 
which is identified as the epicenter of anti-malarial drug resistance. Recent studies have provided 
evidence for parasite population fragmentation in Cambodia. However, promising molecular 
markers and possible pathways associated with artemisinin drug resistance have been identified, 
the underlying molecular mechanisms of resistance remain unknown. We evaluated the genomic 
data of early emergence of artemisinin resistance (2008-2011) in Cambodia, through 
characterization of 167 isolates using a panel of 21257 SNPs. Eight subpopulations were 
identified and 57 background genes have been linked to artemisinin resistance and characterize 
the 167 isolates into eight subpopulations based on 21257 SNPs. We provide an extended list of 
57 background genes. Functional analysis of artemisinin resistance subpopulations put into 
picture the role of PI3K pathway in artemisinin resistance and highlights the link between 
mitophagy and acquisition of artemisinin drug resistance.  
 
One Sentence Summary:  
The association of artemisnin resistant subpopulations background genes with the redox 
metabolism appears as a key factor for the acquisition of tolerance to drugs. 
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Introduction: 
Malaria is one of the most widespread parasitic infections in the world affecting humans. The 
ongoing WHO malaria elimination program aimed at eradicating malaria, is hindered by the 
emergence of resistance to the front line-treatment, Artemisinin Combination therapy (ACT). 
Resistance to artemisinin is identified as delayed parasite clearance, which could evolve into 
complete resistance to the drug. At present, there are no anti-malarial molecules which can 
replace artemisinin for the treatment of Malaria. Understanding the process and pathways 
underlying artemisinin drug resistance is crucial to the identification of new drug targets and 
containment of drug resistance. Cambodia in Southeast Asia (SEA) has been considered as the 
epicenter of emergence of anti-malarial drug resistance. The first clinical case of artemisinin 
treatment failure was reported in Pailin near western Cambodia-Thailand border [Dondorp et al., 
2009], which is the same location where resistance to the anti-malarial drugs chloroquine [Eyles 
et al., 1963] and sulfadoxin-pyramethamine [Wongsrichanalai et al., 2002] was observed. 
Epidemiological models suggest that the spread of resistance parasites to these two antimalarial 
drugs to Africa, originated from Southeast Asia [Mita et al., 2009]. Recently, the spread or 
emergence of artemisinin resistant parasites has been reported in neighboring countries of 
Cambodia [Kyaw et al., 2015, Wang et al., 2015, Miotto et al., 2015], Leading to efforts amid to 
understand the resistance process, and to the identification of molecular markers associated with 
artemisinin resistance. Recent reports have shown the high fragmentation of P. falciparum 
parasite populations in Cambodia [Manske et al., 2012, Miotto et al., 2013, Dwivedi et al., 
2016]. Miotto et al., [Miotto et al., 2013] , have shown the presence of P. falciparum parasite 
ancestral population (KH1), founder subpopulations (KH2, KH3 and KH4) associated with 
clinical artemisinin resistance and admixed subpopulation (KHA) in Cambodia based on analysis 
of 293 full genome sequences from time period 2008-2011. The founder subpopulations were 
associated with mutations in the propeller domain of the Kelch gene (PF3D7_1343700) located 
on chromosome 13 (C580Y, Y493H, R539T) and fixation of these mutations in western 
Cambodia has been shown [Ariey et al., 2014]. Furthermore, analysis of non-synonymous SNPs 
identified mutations in the ferredoxin (fd), apicoplast ribosomal protein S10 (arps10), multidrug 
resistance protein 2 (mdr2) and chloroquine resistance transporter (crt) genes associated with 
mutations in K13 and were described as background mutations. Although, these promising 
molecular markers have been described, the underlying molecular artemisinin drug resistance 
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pathway is still unknown. Recently, Mbengue and colleagues have described a possible pathway 
associated with artemisinin drug resistance mechanism based on experimental evidence 
[Mbengue et al., 2015]. They show that the production of phosphatidylinositol-3-phosphate 
(PI3P) by phosphatidylinositol-3-kinase (PI3K) and interaction with artemisinin is essential for 
parasite growth (elevated levels of PI3P when going from ring to schizont stage). In the case of 
mutated K13 (C580Y), the binding of K13 to PI3K (inhibitory action) and polyubiquitination of 
K13 does not take place, keeping the level of PI3P always high and allowing thus the parasite to 
mature. Therefore, PI3K was described as an important target for understanding the mechanism.  
In this context, the present study is aimed at evaluating the structure of the parasite population at 
a country-wide scale to support one of the hypotheses that the P. falciparum parasite population 
structure plays an important role in transmission and acquisition of K13 mutant alleles among 
subpopulations. In the present study, we use the genomic dataset on which the population 
structure was described earlier [Miotto et al., 2013] to evaluate the early emergence of 
artemisinin resistance (2008-2011) in Cambodian parasite population. In total, 21257 non-
synonymous SNPs were called again based on the quality of sequencing signal parameters. The 
P. falciparum population structure in Cambodia is described using unsupervised hierarchical 
clustering method and network based stratification method [Hofree et al., 2013] using 
coexpression data. The 167 successfully recovered isolates were characterized into more specific 
subpopulations (8 subpopulations compared to 5 subpopulations described earlier [Miotto et al., 
2013]). We provide an extended list of 57 background genes associated with artemisinin 
resistance. Together these data suggest that emergence of P. falciparum subpopulations took 
place independently, followed by selection of artemisinin resistance parasites among 
subpopulations and the transmission of the resistant alleles and acquisition of artemisinin 
resistance background genes through admixed subpopulation KHA, as hypothesized earlier 
[Dwivedi et al., 2016]. This process of selection is tightly associated with the PI3K kinase and 
signalization pathways mediated by PDE1 and ARK2 enzymes.  
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Results and Discussion: 
Description of P. falciparum subpopulations 
The definition of parasite subpopulations in Cambodia was based on SNPs called among P. 
falciparum genome sequences from 2008-2011. These genome sequences were submitted by the 
Wellcome Trust Sanger Institute in the ENA database server and originate from three locations 
in western Cambodia (Pursat, Pailin and Tasanh) and one location in eastern Cambodia 
(Ratanakiri). A specific variant calling pipeline was described to select the SNPs based on the 
sequencing signal parameters. Analysis focused on early instance of ART resistance emergence 
in Cambodia. The 21257 non-synonymous SNPs in the coding region of the genome recovered 
from the variant calling pipeline to classify 167 parasite genome sequences into different 
subpopulations in Cambodia. Hierarchal clustering of these parasite isolates revealed 8 
subpopulations, refining further the previously described structure of P. falciparum parasite 
population in Cambodia [Miotto et al., 2013]. Isolates carrying one of the three dominant K13 
alleles C580Y, Y493H and R539T found in our dataset are referred to as ART resistant isolates 
and the five subpopulations, of which nearly all the isolates were carrying the K13 alleles are 
referred to as artemisinin resistant (ART-R) subpopulations (Fig. 1). The subpopulations KH2 
and KH3 are the donor populations for the most dominant allele C580Y (the isolates in KH2 are 
classified into two subpopulations KH2.1 and KH2.2). One isolate in KH2.2 does not carry any 
of the three K13 alleles. KH4 is the donor population for the Y493H allele. KH5 is a new 
subpopulation which was not described earlier, with all the isolates in this subpopulation 
carrying one of the three K13 alleles which are mutually exclusive. R539T is the dominating 
allele followed by C580Y and Y493H alleles. Hence, KH5 is considered to be a donor 
population for R539T allele of the K13 gene. Two KH5 isolates match with a barcode that is 
associated with mefloquine resistance as well [Dwivedi et al, 2016]. The ART sensitive (ART-S) 
subpopulation KH1 described as the ancestral population [Miotto et al., 2013] was classified into 
two subpopulations, KH1.1 and KH1.2. None of the isolates in these two subpopulations carry 
any of the three K13 alleles and all the isolates originate from Ratanakiri in eastern Cambodia 
(one isolate from Tasanh in western Cambodia).  KH1.1 is one of the largest subpopulations and 
KH1.2 is the smallest subpopulation. The other dominant subpopulation is the admixed 
subpopulation KHA with around 52% of the ART resistant isolates and 48% ART sensitive 
isolates.  
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The parasite population structure in Cambodia was also confirmed using Network based 
stratification method [Hofree et al., 2013] based on the P. falciparum gene-gene interaction 
network (mainly co-expression data) provided by STRING v10 [Szklarczyk et al., 2015] (Fig. 
S1). The isolates were clustered using non-negative matrix factorization (NMF) method [Lee & 
Seung, 1999]. The classification of most of the samples into subpopulations is similar to the 
classification based on hierarchal clustering of 21257 SNPs (Fig. S2). Only admixed 
subpopulation KHA was different. Out of the 58 isolates in this subpopulation, 20 isolates were 
clustering with other subpopulations. Out of the 28 ART sensitive KHA isolates, 18 isolates 
clustered with KHA, 5 isolates clustered with ART-R subpopulations and 5 isolates clustered 
with ART-S subpopulation KH1.1. This suggests that due to crosses between or among parasite 
subpopulations, some ART sensitive samples in the KHA subpopulation may have acquired 
background alleles and some sensitive KHA samples may have not acquired the resistant 
background. The description of the other subpopulations was similar to the description in the 
previous approach. Changing the dendrogram cut-off threshold to obtain 2 to 8 clusters, led to 
the observation that the KH1.2 ART-S subpopulation is robust and the isolates clustered with 
isolates of ART-R populations but not with the other ART-S subpopulation KH1.1. This 
suggests the presence of P. falciparum parasite subpopulations with specific genetic backgrounds 
in Cambodia before the introduction of ART. 
 
Subpopulation associated genetic background 
In order to probe metabolic differences between different parasite subpopulations, SNPs and 
genes found to be associated with artemisinin resistance were described by comparing the ALT 
frequency of SNPs in a specific subpopulation to the ALT frequency in the KH1.1 
subpopulation. The genes carrying the significant SNPs were defined as significant genes. The 
ART sensitive ancestral population KH1.1 was considered as the reference as it has more REF 
significant alleles than ALT significant ones. The mapping of Kelch gene in the gene-gene 
interaction network from STRING v10 based on the co-expression data showed a strong 
relationship between the genes co-expressed in the ring and schizont forms of the erythrocyte 
stage (Fig. 2). This is in agreement with the strong homology between Kelch and KEAP1 human 
gene [Paloque et al., 2016]. Analysis of the co-expression network is therefore highly relevant 
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for analysis of background genes in the context of ART resistance. ART-R subpopulations have 
265 significant genes in common. A set of 168 significant genes were found in common with the 
KH1.2 ART-S subpopulation (Table S1). The 168 genes were distributed in most of 
compartments of the co-expression network deduced from STRING and confirmed the presence 
of a common background for all subpopulations emerging from the ancestral population KH1.1 
(Fig. S3).  
Significant GO terms were recovered using PlasmoDB v10. ClueGO was used to recover 
function groups of GO terms. The full 265 significant genes displayed GO terms associated with 
cell signaling, gene expression post-translation regulation, RNA metabolism (tRNA and mRNA 
modification, …) and organelle related functions (Fig. S4). The 168 gene set GO annotation 
functional groups showed conserved enrichment for organelle functions (AMA1, PfMDR2 or 
exosomal protein RRP6) and gene expression (Fig. S5). About 60 genes encode integral 
membrane proteins, (many of which are of unknown function (38/61)) and surface antigens such 
as msp1 and some specific var genes (Fig. S6). Several genes are associated with cell signaling 
in the 168 gene set and significant numbers of these are protein kinases. The PfMDR2 gene is 
associated with the background D484I mutation, which was present in KH1.2 ART-S 
subpopulation. The ARP10 (apicoplast ribosomal protein S10) encoding gene was found to carry 
two different mutations V127M and D128H, which were significantly associated with ART-R 
and admixed subpopulations, whereas KH1.2 had only D128H mutation.  
 
Description of ART-R subpopulation genetic background  
To assess the ART-R subpopulations specific set of 97 genes (Table S2), we removed the 168 
gene set found in common with KH1.2 ART-S subpopulation from the total of 265 genes. GO 
terms enrichment for the cell signaling pathway showed less connections with protein kinase 
activity, but highlighted the presence of Phosphodiestarase 1 (PDE1) involved in regulation of 
cGMP concentration. (Fig. S7 and S8). The gene carries 3 mutations found in the KH1.1 
ancestral population, but only S506L was fixed in all the ART-R subpopulations. New GO terms 
associated with apicoplast highlighted the presence of genes related to organelles, including the 
ferredoxin background gene. About half of the proteins associated with the GO term “integral 
component of the membrane” had at least another GO term in other functional categories 
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including PDE1, apicoplast associated RAP-like protein, fatty acid biosynthesis and 
polyubiquitination. Genes in the same GO term functional group as K13 were associated with 
polyubiquitination (E3-like protein MAL7P1.19 and RPN10 proteasome subunit), signal 
transduction (PI3K PFE0765w), autophagy (Atg7, Atg18) and regulation of protein activity 
(Serine/threonine phosphatase PFD0505c). Background mutations associated with PfCRT and 
ferredoxin (fd) were found to be significant in all ART-R and admixed subpopulations. 
Interestingly the ferredoxin D193Y background mutation was not always associated with the 
K13 mutation in the KH3 subpopulation. In our dataset, PfCRT was associated with 13 
mutations including the two background mutations N326S and I356T. KH1.2 had no significant 
PfCRT mutations. An additional R371I mutation was found in ART-R and the admixed 
subpopulation KHA. In addition to these three PfCRT mutations, KH4 isolates carry one more 
significant mutation T256I. 
According to these observations, resistance to artemisinin appears as a selection process among 
parasites from subpopulations. In the case of K13, different subpopulations carry different 
alleles. The K13 gene was found to be significant in donor populations where only one K13 
mutation was present (p value = 3.92E
-11
), but also in KH5 (p value = 1.0296E
-4
) where all the 3 
different exclusive mutations were present. KH5 is a donor for R539T mutations as it is absent in 
other subpopulations except KHA. The K13 gene is the only gene where mutually exclusive 
mutations associated with subpopulation are found. There are 57 mutations found significant in 
all the ART-R subpopulations, suggesting that the fixation of one mutation in the population is 
the results of selection among subpopulations than de novo acquisition after drug pressure. 
Altogether, these results suggest that selection was performed on daughter subpopulations and 
not on the ancestral population. The mutation in the fd gene was not present in all isolates of 
KH3 subpopulation displaying the most dominant C580Y allele, emphasizing the relationship 
between initial genetic drift during the emergence of subpopulations and the selection process 
performed afterwards.  
 
Artemisinin resistance background associated pathways 
Emergence of K13 mutations in Cambodia was tightly related to the presence of subpopulations 
like KH2, KH3, KH4 and KH5, which provides an appropriate background for acquisition of 
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artemisinin resistance. In the admixed subpopulation KHA, 20 isolates out of the 58 isolates had 
no K13 allele and these isolates are referred to as the KHA sensitive isolates (KHAs). Out of the 
5 background genes mentioned above, the fd gene was the only significant gene in the KHA 
subpopulation when compared to the total population of 167 isolates. When KHA was compared 
with the ancestral population KH1.1 as reference, the number of significant genes increased to 
467. Overlap between the 97 gene set and 467 gene set interaction networks based on co-
expression data shows that the genes are conserved in all the compartments of the network. GO 
terms functional group analysis confirms that major components of the 97 gene set have been 
conserved in KHA isolates (Fig. S9). The KHA specific 467 gene set was similar to that of ART-
R 265 gene set in terms of GO annotation. This suggests that KHA background was acquired 
through crossing of parasites from various populations either ancestral, resistant or from a pre-
existing admixed population. 
The main hypothesis in this study is that artemisinin resistance is acquired by diffusion. The 
artemisinin resistance genetic background can be defined as the intersection between ART-R 
subpopulation background genes and the KHA significant genes. The significant genes of the 
KH1.2 subpopulation were removed from this set to yield a final list of 57 genes (Table S3). The 
K13 gene and two other known background genes fd and PfCRT are part of this artemisinin 
resistance specific gene set (Fig. S10 and S11). A lipid kinase PI3K and a protein kinase ARK2 
could be identified. The PI3K-K13 interaction has been evaluated by Mbengue and colleagues 
[Mbengue et al., 2015] and the ARK2 serine/threonine protein kinase was recently listed among 
the high priority malaria targets for novel drugs [Spitzmüller et al., 2013]. We also identified the 
phosphodiesterase (PDE1) as an important protein involved in signal transduction. PDE1 activity 
is expected to regulate cGMP concentration in the parasite. These cyclic nucleotide molecules 
are second messengers regulating specific kinases, which are expected to play a major role in cell 
cycle control and differentiation. Only one mutation in PDE1 (S506L) was significantly 
associated with ART-R subpopulations, but it was also present in the ancestral population KH1.1 
(7/45).  
The mutations in the K13 gene associated with artemisinin resistance are very specific, mutually 
exclusive, and absent in the isolates of the ancestral population. The K13 gene is expected to 
work as a part of E3-like protein complex interacting with the target proteins through the kelch 
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domain. Polyubiquitination of PI3K kinase mediated by K13 was described experimentally 
[Mbengue et al., 2015], but the E3-like ubiquitin ligase domain containing K13 is expected to 
have many more targets. Nothing is known about the other potential targets. Furthermore, the 
PI3K itself is a protein being involved in cell signaling pathways. The presence of mutations in 
Atg7 and Atg18 suggest that autophagy could be participating in the acquisition of artemisinin 
resistance. Atg18 is a member of pre-autophagosomal structure (PAS) and is recruited by Atg9 at 
PI3P rich regions of the ER membrane (Fig. 3). Both PI3K and Atg18 are proteins with unique 
organization in Plasmodium species among Apicomplexa and most orthologues are found in 
plants. These proteins play an important role in the reduction of accumulation of ROS associated 
with mitochondria. Mitophagy, a response to oxidative stress, is also associated with cell cycle 
arrest and is essential for the cell to reduce its metabolic activity under stress. Interestingly, it has 
been suggested that artemisinin leads to E3-dependent mitophagy after targeting the 
mitochondria [Wang et al., 2010]. Connection with cell cycle arrest is present in the 57 gene set, 
evident by the presence of ARK2 (soluble serine/threonine kinase) and PDE1. Best orthologues 
are found in plants, but the nuclear localization signal found in A. thaliana is absent. ARK2 was 
found to be highly expressed in schizont stage of the blood stage cycle. PDE1 might regulate the 
activity of cGMP dependent protein kinase PKG (PF14_0436), playing an essential role during 
the late schizont stage and gametogenesis. The role of these two enzymes in modulating the cell 
cycle during ring stage remains unknown.  
Human KEAP1 protein involved in oxidative stress is the only model that could correlate with 
the function of K13. KEAP1 is involved in the sequestration of the transcription factor NRF2, 
but no orthologues of NRF2 could be found in P. falciparum. Interestingly, KEAP1 interacts 
with the protein poly-ubiquitination system, as an E3 subunit. This study suggests a link between 
autophagy in P. falciparum and acquisition of artemisinin resistance. Mutations in the PI3K 
enzyme were already present in the ancestral population and four of them have been fixed in the 
ART-R subpopulations (Fig. S12). Despite the presence of PI3K in the final 57 gene set, 
mutations in PI3K were not systematically associated with K13 resistant alleles. This could 
suggest that the mitophagy is one among several pathways associated with artemisinin 
resistance. Ferrodoxin (fd) was also suggested to interact with artemisinin. Our findings will set 
the xxx for future studies aimed to define how P. falciparum is able to manage ring stage arrest 
after oxidative stress induced by artemisinin.  
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The process of emergence of artemisinin resistance could be summarized in an Emergence 
Selection Diffusion model (ESD). This model is very close to the population shifting balance 
theory described by Wright. This work describes the emergence of subpopulation with common 
genetic background. The parasites among these subpopulations accumulated a large amount of 
mutations compared to the ancestral population KH1.1. Small populations are known to enable 
genetic drift. A large number of subpopulations in Cambodia have been previously described 
[Dwivedi et al., 2016], but little is known about the phenomenon responsible for the existence of 
these subpopulations. Emergence of K13 resistant alleles was only observed in the genetic 
background of these subpopulations and alleles were clearly associated with specific 
subpopulations. We suggest that artemisinin resistant parasites were selected among 
subpopulations. The diffusion of K13 allele was later observed through the admixed population 
KHA after crossing. The association of background genes with the redox metabolism appears as 
a key factor for the acquisition of tolerance to drugs. Mutations associated with oxidative stress 
pathways could be either the result of environmental parameters or intrinsic consequence of 
genetic drift in parasites with low fitness. According to the described ESD model, KHA parasites 
appear to be responsible for the diffusion of artemisinin resistance and some of these parasites 
will have better fitness in a new environment, where artemisinin combined therapies (ACTs) are 
systematically used. Health operators should be aware about the specific risk associated with the 
KHA parasites.  
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Fig. 1. Dendrogram representing the classification of 167 parasite isolates into 8 clusters (k = 8). 
The pairwise distance between two samples is calculated as the proportion of base substitution 
between them over the genome. Ward’s minimum variance method is used as the metric to build 
the dendrogram. Different clusters (subpopulations) are represented with different colors. The 
barplot on the left represents the number of isolates in each locality and the colors represent the 
type of K13 mutation present. “Green” represents ART-S isolates. “Red”, “Yellow” and “Blue” 
color represents isolates with C580Y, Y493H and R539T K13 mutations, respectively. The 
barplot on the right represents the number of isolates in each locality and the colors represent the 
associated subpopulation to each isolate. 
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Fig. 2. Flowchart showing the first, second and third neighbouring genes of the K13 gene in the 
interaction network based on co-expression data recovered from STRING v10. The unconnected 
nodes are not considered in this analysis. The force directed layout is used to plot the network. 
The genes are colored according to the maximum expression stage data [Le Roch et al., 2003] 
recovered from PlasmoDB. The genes highlighted in “yellow” color are the first, second and 
third neighbour genes of the K13 gene, shown using four networks in clockwise orientation. The 
neighbour genes are marked using Cytoscape v3.2.1. 
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Fig. 3. Schematic representation of the K13 gene targets and associated pathways.  The 
interaction with the transcription factor is based on KEAP1 model in humans. PI3K-K13 
interactions were identified experimentally. In addition to AKT signalization pathway our study 
suggests the involvement of PI3K kinase in autophagy pathway. MAL7P1.108 encodes 
phosphoinositide binding protein suggesting presence of other pathways regulated in artemisinin 
resistance background. 
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Supplementary Materials: 
 
Materials and Methods: 
 
Data Acquisition 
 
The genome sequencing data of Cambodian parasite isolates was recovered from the ENA 
(European Nucleotide Archive) database server. This dataset was submitted by the Wellcome 
Trust Sanger Institute and is the same data that was used to define the artemisinin resistant 
parasite population structure in Cambodia [Manske M. et al., 2012][Miotto O. et al., 2013]. 
Out of 293 full genome sequences from 2008-2011 due to new generation sequencing (NGS) 
techniques, 86 files submitted in raw SRF (Sequence Read Format) were not recovered as the 
procedure to convert SRF to BAM (Binary Sequence Alignment/Mapping) or VCF (Variant 
Calling Format) is not well established and 40 BAM files were corrupted or empty when 
converted to VCF. Therefore, 167 genome sequences were recovered successfully 
(Supplementary Table4) in BAM format and converted to much readable VCF v4.1 files 
[Danecek P. et al., 2011] using SAMtools v0.1.19 [Li H. et al., 2009]. The canonical strain 
Plasmodium falciparum 3D7 was used as the reference genome. The reference genome in 
FASTA file format was recovered from the PlasmoDB Plasmodium Genomics resource 
database. The reference genome used is the version 5.5 of the PlasmoDB release, which is P. 
falciparum genome sequence version 2. The 167 genome sequences originate from four 
locations: Pailin (14 sequences), Tasanh (26 sequences) and Pursat (81 sequences) in western 
Cambodia and Ratanakiri (46 sequences) in eastern Cambodia. 
 
Filtering data for noise 
 
A reliable variant calling pipeline was established for the identification of significant SNPs 
(Supplementary Figure S13). This analysis is focussed on non-synonymous SNPs in the 
coding region of the genome in at least one of the isolates and does not take insertion/deletion 
(INDELs) mutations into consideration. The single nucleotide polymorphism (SNP) data was 
filtered for noise based on the signal parameters provided in the VCF (v4.1) files. For 
identification of the thresholds of these parameters to filter the data, at first around 100kb 
were removed from starting and end of each chromosome corresponding to genome version 
2. These 100kb regions at the extremity of P. falciparum chromosomes encode for multi-gene 
families, most of them encoding putative surface antigens (VAR, Rifin, Stevor etc.). An 
average value for all the signal parameters over the 167 genome isolates was calculated for 
each SNP. Average quality values for each SNP were defined as sum of the values in 
different isolates over the number of isolates having a non-reference allele. When the average 
quality values per position were plotted along the genome, a clear threshold in the mapping 
quality (MQ) parameter was observed at 29 (Supplementary Figure S14). Removing 
chromosome ends removed most of the signal below the score 29. Therefore, mapping 
quality score higher than 29 was considered as one of the filtering criteria. Many SNPs 
showed MQ ≤ 29 in the coding core of chromosome 4 and 7, as internal VAR gene clusters 
are present in these chromosomes. No other quality parameters plotted along the genome, 
with or without the telomeric regions showed any change in distribution on which a 
significant threshold could be defined. In order to select the SNPs with high quality (as 
described in VCF v4.1) non-reference (non-REF) signal, DP4, the parameter accounting for 
high-quality forward strand REF bases, reverse strand REF bases, forward strand non-REF 
bases and reverse strand non-REF bases for a specific position was analysed. To account for 
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the percentage of non-REF signal (referred to as DA in the manuscript), a histogram showing 
frequency density of proportion of non-REF alleles (forward strand non-REF bases + reverse 
strand non-REF bases) over the sum of all alleles (DP4) was plotted. To choose a quality 
threshold on the DA value we studied its distribution. It appeared to be a mix of two 
distributions: on the left low quality SNPs and on the right high quality SNP. We chose 0.7 as 
it seems to be the intersection between those two distributions and selected SNPs with DA 
higher than 0.7 (Supplementary Figure S15). Therefore, DA score ≥ 0.7 was considered as 
the second filtering criteria to include SNPs with high quality non-REF allele calls. Around 
20,000 SNPs were recovered for each isolate after implementing these filtering criteria (from 
13470 to 23022 SNPs). There were 247783 SNPs having a non-REF allele in at least one of 
the 167 Cambodian parasite genomes. In order to remove the SNPs with rare allele 
frequencies in the population, non-reference allele frequency (NRAF) was calculated for each 
SNP (Supplementary Figure S16a). MAF was defined as the minimum of NRAF and 1-
NRAF [Manske M. et al., 2012][Amato R. et al., 2016]. All the SNPs with a minor allele 
frequency (MAF) less than 0.01796 were removed from the analysis (Supplementary Figure 
S16b). This filter removed SNPs with non-REF frequency of 1, 2, 165, 166 and 167 (SNPs 
with REF allele in all the isolates were not focussed). After applying the three filters, 111701 
unique SNPs were recovered in 167 Cambodian isolates.  
 
Correspondence between different genome versions 
 
Mapping of the SNP coordinates between genome version 2 and 3 was done, as the new 
publicly available datasets are based on reference genome version 3. P. falciparum 3D7 
reference FASTA file was recovered from PlasmoDB release v10, as genome version 3 is 
used for alignment in this release. BLAST (Basic Local Alignment Search Tool) was 
implemented from NCBI (National Centre for Biotechnology Information) platform to match 
the two versions. The mega BLAST was performed for each chromosome separately. For the 
chromosomes 4, 7, 8, 10 and 13 very short lengths of alignments were obtained depicting 
major changes in the genomic sequence between version 2 and 3. Therefore, alignments were 
obtained by defining specific regions in these chromosome sequences. Mapping for 
approximately all SNPs in all chromosomes were recovered. In overall, 3105 unmapped 
SNPs in the recovered data were removed from the analysis. BLAST was done for each 
chromosome keeping genome version 2 (PlasmoDB release version 5.5) as reference and 
version 3 (PlasmoDB release version 10) as query. Therefore, we obtain a list of 108596 
SNPs. 
 
Removing uncertain SNPs and correcting errors 
  
After filtering the data and removing the unmapped SNPs, the uncertainties were treated. 
SNPs with more than one ALT (non-REF) allele for a specific isolate were considered as 
uncertainties. These uncertainties were removed or substituted with REF or ALT allele based 
on the frequency of uncertainties in the isolates. SNPs having the uncertain ALT allele 
frequency higher than 40% were removed (830 SNPs). Some of the SNPs with low frequency 
uncertain ALT alleles were substituted with either most frequent ALT or REF allele and 
included in the analysis. For the case where SNPs have only one ALT allele in most of the 
isolates and uncertain ALT allele in some isolates, the uncertain allele was substituted with 
the ALT value (16859 SNPs). For the other case where SNPs have more than one ALT allele 
for different isolates, the uncertain ALT alleles were substituted with the most frequent ALT 
allele. The ALT alleles with the frequency 1.5 times the frequency of same allele at random, 
are considered as the most frequent ALT allele for SNP (1772 SNPs). In the case of uncertain 
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ALT allele frequency less than 5% and no majority ALT allele, the uncertain ALT allele was 
substituted with the REF allele (54 SNPs). All the other cases were removed from the 
analyses (1228 SNPs). Therefore, 106538 unique SNPs were recovered in 167 Cambodian 
isolates with 18683 modified SNPs (Supplementary Figure S17).     
 
Annotation of the recovered SNPs 
 
To describe the distribution of the SNPs over the genome, the 167 strains were annotated 
using VCF-annotator Perl script (developed at the Broad Institute, Cambridge, MA). A GFF3 
(General Feature Format version 3) format annotation file is required as an input file for 
running the VCF annotator. The GFF3 file was recovered from Ensembl database server. The 
Ensembl release version ASM276v1.21 corresponds to the P. falciparum genome sequence 
version 2. The annotation shows that the SNPs are mostly in CDS, introns, exons and 
5pUTR. 3pUTR are rarely described in P. falciparum annotation data files used. To 
determine the coordinates of the telomeric regions more precisely than earlier, where 100kb 
were removed from starting and end of chromosomes, the chromosomes corresponding to 
genome version 3 (PlasmoDB release version 11) were visualized using the genome browser 
provided by PlasmoDB. The regions containing the genes with description such as CLAG, 
DBL, Rifin, hyp, Stevor, GARP, RESA, VAR, PfEMP, Surfin, PHIST, KAH and EMP in a 
consecutive organization, were considered as telomeric regions. The gene location in the 
coding region was determined and chromosome end coordinates were recovered 
(Supplementary Table5). Finally, after providing annotation information and the information 
describing the SNPs in telomeric regions, analysis was focused only on non-synonymous 
SNPs in the coding region of the gene. Therefore, we obtained a dataset containing 21257 
non-synonymous SNPs. This dataset is referred to as IBC dataset in this manuscript and is 
used for parasite population study in Cambodia. There are 3714 modified SNPs (as described 
in the section above) in the set of these 21257 SNPs. 
 
Validation of IBC dataset 
 
To validate the recovered 21257 SNPs after filtering, correcting and annotating the 167 
parasite genome sequences, the distribution of SNPs over the genome was compared to the 
distribution of SNPs in publicly available datasets. This comparison is the control for the 
genomic structure of the recovered variant set. The two datasets used for comparison are: (1) 
PlasmoDB dataset (release version 10) containing Asian isolates (Indochina, Thailand, 
Vietnam and SEA) and (2) MalariaGEN dataset (release version 1.0) containing African and 
Asian isolates. These datasets are outsourced, but annotated and mapped similarly to IBC 
dataset. IBC dataset was also compared to these two datasets by considering the common 
SNPs present in the data sets. There is an overlap of 4597 and 5478 SNPs out of 21257 SNPs 
with PlasmoDB (Asian isolates) and MalariaGEN dataset, respectively (Supplementary 
Figure S18). The reason for the mismatch of SNPs can be different sample sizes of the 
datasets (167 IBC isolates compared with 7 PlasmoDB isolates), sequencing of samples at 
different times and regions (PlasmoDB isolates) and different variant calling criteria 
(MalariaGEN isolates). Also, the number of SNPs was accounted for in coding and non-
coding regions in all the three datasets for comparison. The specifications in the CDS (coding 
DNA sequence) region of the genome were reported and it was observed that the distribution 
of SNPs (Synonymous SNPs, Non-Synonymous SNPs, Non-sense SNPs and Read through 
SNPs) in the coding region is similar in all these three datasets (Supplementary Figure S19). 
The number of SNPs in the coding region after removing the SNPs in the chromosome ends 
for PlasmoDB (Asian isolates) and MalariaGEN (African and Asian isolates) are 8987 and 
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55093, respectively (Supplementary Table6). Hence, the overlap between IBC dataset and 
MalariaGEN dataset, as well as IBC and PlasmoDB is better than overlap between those two 
previously published datasets. The use of this pipeline and analysis of a big dataset seems to 
stabilize the results and reduce the false positives in the recovered list of SNPs. 
 
Clustering 
 
To describe the parasite population structure in Cambodia, unsupervised hierarchical 
clustering was performed on the IBC dataset (all the statistical analysis is performed in R 
v3.0.1 and v3.2.3). The pairwise distance between two isolates was estimated as the 
proportion of base substitution between them over the whole set of recovered SNPs. Ward 
minimum variance method was used as a metric to build the dendrogram. The 
correspondence between previously described parasite subpopulations in Cambodia [Miotto 
O. et al., 2013] and the 167 isolates were recovered from the Sanger Institute. Eight 
subpopulations were described based on the hierarchal clustering results: KH1.1, KH1.2, 
KH2.1, KH2.2, KH3, KH4, KH5 and KHA (Fig. 1). In order to choose the optimal number of 
clusters in the dendrogram, the value of k was set to 2 to 10 and the clusters obtained at k = 8 
overlapped both, clusters based on different k13 alleles and the previously described KH 
subpopulations. By further increasing the k, only the admixed subpopulation KHA was 
further divided into small subpopulations, which was not really interesting. Hence, this result 
cross-checks the biological evidence.  
To perform an additional robustness study of the clusters, 1000 hierarchical clustering were 
performed for 150 isolates randomly selected from the 167 isolates and the frequency of 
samples being in a specific subpopulation (for k = 8) was calculated. Out of the 167 isolates 
only 9 isolates were observed to be not specifically associated with a particular subpopulation 
and can be included either in one of the subpopulations (KH2.1, KH3, KH5 and KH1.1) or 
the admixed subpopulation KHA. The remaining 158 isolates always clustered in the same 
subpopulation. 
Significant SNPs and Genes 
To describe the metabolic pathways and functions associated with different subpopulations, 
significant genes were recovered based on significant SNPs. For each subpopulation 
significant SNPs were defined using one-tailed Fisher-exact test, by comparing the ALT 
allele frequency of each SNP in each subpopulation to the to the ALT allele frequency in 
artemisinin sensitive population KH1.1 which is considered as the ancestral population from 
which other subpopulations are derived [Miotto O. et al., 2013]. Accordingly, there are much 
less significant SNPs (43 SNPs / 21257 SNPs) observed in KH1.1 subpopulation (45 isolates) 
when compared to the total population (167 isolates). This shows that the isolates in KH1.1 
are closer to the reference genome than the isolates in other subpopulations (based on 21257 
SNPs). Only the SNPs with ALT allele increased frequency in a particular subpopulation 
were considered. Benjamini-Hochberg method was used to correct the p-values from multiple 
comparisons. All the SNPs with a corrected p-value lower than 0.05 were considered as 
significant and the genes containing these significant SNPs were defined as the significant 
genes (Supplementary Table7). 
Gene interaction networks and gene ontology 
In order to determine the biological processes taking place in different subpopulations, gene-
gene interaction networks were studied. The interaction network data were recovered from 
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STRING v10 which provides functional and predicted protein-protein interactions from other 
publicly available data sources and literature [Szklarczyk D. et al., 2015]. Networks based on 
co-expression data for all the significant genes in each subpopulation were recovered. Only 
edges with a STRING confidence score for co-expression higher than 0.5 were considered for 
the analysis. The networks were imported and analysed in Cytoscape v3.2.1 [Shannon P. et 
al., 2003]. Also, the complete P. falciparum interaction network based on co-expression data 
(confidence score ≥ 0.5) was recovered from STRING v10 database. Out of the 5777 genes 
identified in the genome of P. falciparum (PlasmoDB release v28), only 3875 genes have co-
expression interaction confidence score greater than 0.5. Out of these 3875 genes, 33 genes 
do not have interactions with the major interaction network and are not considered in this 
analysis. The 3842 genes were classified into six parasite blood stage forms (early ring, late 
ring, early trophozoite, late trophozoite, early schizogony and late schizogony) 
(Supplementary Figure S1). These genes were classified according to the maximum 
expression stage, which was based on microarray transcriptomic data of the study by Le Roch 
et al., [Le Roch KG. et al., 2003], available in PlasmoDB server (“Pf-iRBC+Spz+Gam Max 
Exp Timing” column). The genes maximum expressed in merozoite blood stage form of the 
parasite were not focussed (711 genes). Also, 138 genes were not classified into any blood 
stage according to the maximum expression stage data [Le Roch KG. et al., 2003].The 
remaining 2993 genes were majorly distributed into ring and trophozoite and followed by 
schizont blood stage (Supplementary Table8). 
In order to verify the expression of genes associated with k13 gene (PF13_0238) in the 
described blood stages, the genes co-expressed with k13 gene were represented on the 
interaction network (Supplementary Figure S1). In the full network, starting from k13 gene 
the next adjacent genes were marked until the major parts of the networks (representative of 
blood stages) were marked. This can be visualised as one step diffusion of signal from the 
starting node k13 to other nodes of the interaction network. It was observed that the third 
neighbour genes (three diffusion steps) of the k13 gene were mostly expressed in the ring 
stage and schizogony stage part of the network (Fig. 2).   
For identification of biological function associated to the significant genes, the functionally 
grouped networks of GO terms and pathways were recovered and studied for each 
subpopulation using the ClueGO v2.2.4 and CluePedia v1.2.4 plugins of Cytoscape. The 
algorithm to define the functional groups is: (a) create a binary matrix for genes and 
associated terms, (b) Using this matrix and kappa statistics create a term-term similarity 
matrix, (c) create initial functional groups based on predefined threshold of kappa score and 
minimum number of terms per group to be considered (d) iteratively merge the functional 
groups, if there is a certain percentage of overlap [Bindea G. et al., 2009]. The network is 
created with nodes as the term and edges as the association based on kappa score. All the 
default conditions of the ClueGO plugin were used. Right-sided hypergeometric test 
(enrichment) was used as the statistical test and Benjamini-Hochberg method was used to 
correct p-values. The GO terms associated to the significant genes for each subpopulation 
were also recovered from PlasmoDB release v13.  
Network based subpopulation description 
To describe the population structure based on the functional background, hierarchical 
clustering was performed on the subpopulations based on the presence and absence of edges 
in the interaction network from STRING v10. All the interactions among significant genes of 
each subpopulation above the STRING medium combined confidence score (0.4) from 
different sources were considered for this analysis (Neighbourhood, Gene Fusion, Co-
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occurrence, Co-expression, Experiments, Databases and Text-mining). This approach groups 
the subpopulations with similar functional background. The presence and absence of edges 
was treated as binary data, 1 if the edge is present and 0 if the edge is absent among 
significant genes in a specific subpopulation. Binary (Jaccard) distance matrix and Ward 
minimum variance method were used to build the dendrogram. The hierarchical clustering 
was performed with and without the KHA to analyse the effect of admixture subpopulation 
on the population structure (Supplementary Figure S20).  
The population structure of 167 parasite isolates was also questioned using the method of 
Network Based Stratification [Hofree M. et al., 2013] which clusters the isolates together 
having diffusion paths associated to mutated genes in similar network regions. The list of 
mutated genes for each isolate was projected on the full P. falciparum interaction network 
recovered from STRING v10. Other prediction sources than co-expression data such as co-
occurrence, gene fusion, databases, experimental evidence, text-mining and neighbourhood 
were also considered for the full P. falciparum interaction network. The results were obtained 
for top 10% gene-gene interactions based on combined confidence score provided by 
STRING database. The mutated genes were propagated to the neighbourhood network 
(network smoothing) and based on the node score matrix of the resulting diffusion network 
for each isolate, clustering was performed using non-negative matrix factorization (NMF) 
method [Lee D.D. & Seung H.S., 1999]. Consensus clustering was performed by selecting 
80% mutated genes and 80% isolates 100 times randomly and iterating NMF clustering 10 
times. The consensus clustering between samples was estimated as the percentage of co-
clustering results in which they are in the same cluster when the dendrogram is cut to obtain 8 
groups (to make the comparison easy with the 8 KH sub-populations). This consensus 
clustering matrix was normalized and then used to build a dendrogram for all 167 isolates 
using Euclidean distance matrix and ward minimum variance method in R. Some of the 
isolates are clustered in different clusters when compared to the clustering results based on 
21257 SNPs. There are 10 isolates (isolate index: 9, 70, 91, 103, 112, 134, 148, 151, 160, 
162) that were in the KHA subpopulation according to clustering results based on 21257 
SNPs, but according to clustering based on network based stratification these isolates are 
clustered in other resistant and sensitive subpopulations. Also one isolate (isolate index: 156) 
is classified in KH2.2 which was in classified in KH2.1 earlier and one isolate (isolate index: 
61) is classified in KH2.1 which was classified in KH3 in the earlier method (Supplementary 
Figure S2). All the other 155 isolates completely overlaps with the clusters observed 
previously. This dendrogram was cut at different thresholds (k ϵ (2, 8)) to verify the closeness 
of different isolates and compare it with the hierarchical clustering results based on 21257 
SNPs and absence/presence of interacting edges in network based on significant genes of 
different subpopulations.  
Analysis of the genes supporting artemisinin resistance 
The analysis was focused on three gene sets primarily obtained at the intersection of 
significant genes (set of genes containing the significant SNPs) in the resistance 
subpopulations. These three gene sets are: (a) 168 significant genes having at least one 
significant SNP in all the resistant subpopulations (KH2.1, KH2.2, KH3, KH4, KH5) and the 
subpopulation KH1.2, (b) 97 significant genes having at least one significant SNP in all the 
resistant subpopulations only and (c) 57 significant genes having at least one significant SNP 
in all the resistant subpopulations and admixed subpopulation KHA, but no significant SNP 
in the subpopulation KH1.2. There can be different SNPs in the same gene in different 
subpopulations. These three sets were chosen to focus on the genes contributing to 
artemisinin resistance.  
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Supplementary Figures: 
 
 
Fig. S1. Plasmodium falciparum gene-gene interaction network based on co-expression data 
showing maximum expression of genes in the six parasite blood stage forms. The co-
expression interaction network was recovered from STRING v10 database. The edges 
connecting the genes, have the co-expression evidence score greater than 0.5. The force 
directed layout is used to plot the network. The genes are classified into different blood stage 
based on the maximum expression data [Le Roch KG. et al., 2003] recovered from 
PlasmoDB server. The interaction network is plotted using Cytoscape v3.2.1. The 
unconnected genes are not included in the analyses. The nodes in “white” color are either 
expressed  maximally in merozoite blood stage form or are unclassified.  
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Fig. S2. Hierarchical clustering of 167 isolates based on the network based stratification 
method [Hofree M. et al., 2013]. Interaction network was recovered from STRINGv10 and 
interaction evidence from all the sources was used. Only top 10% of the interactions were 
included in the analysis. Similarity matrix was computed using consensus clustering, which 
was performed by selecting 80% mutated genes and 80% isolates 100 times randomly and 
iterating NMF clustering 10 times. This similarity matrix was then used to build a 
dendrogram for all 167 isolates using Euclidean distance matrix and ward minimum variance 
method in R. Colors for different clusters were assigned by comparison with the hierarchical 
clustering result based on 21257 SNPs (Supplementary FigureS6). (A) Hierarchical clustering 
showing different clusters in different colors. The isolate classified in different clusters in two 
approaches (SNP based and Network based) are pointed with black triangles. (B) 
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Hierarchical clustering showing different clusters and corresponding subpopulation names. 
The colors of the triangles correspond to the classification of the isolate based on 21257 
SNPs. 
 
 
Fig. S3. Network representation of overlapping gene sets associated to ART-R 
subpopulations (set of 265 genes) and the ART-S subpopulation KH1.2 common resistance 
background (set of 168 genes). The networks for the two gene sets based on coexpression 
data are recovered from STRING v10. The edges connecting the genes, have the co-
expression evidence score greater than 0.5. The nodes and edges in “red” color represent the 
interaction network based on coexpression for ART-R subpopulations gene set. The nodes 
and edges in “white” color represent the interaction network based on coexpression for ART-
S sunpopulation KH1.2 common resistance background gene set. For the ART-R 
subpopulation specific gene set, out of the 265 genes only 173 genes are used for overlap and 
for the KH1.2 common resistance background gene set, out of 168 only 146 genes are used 
for overlap. Other genes (nodes) are removed either because of no interactions (before/after 
overlap) or STRING confidence score below 0.5. The representation of overlapping 
coexpression network is done in Cytoscape v 3.2.1 using the DyNet Analyzer plugin.  
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Fig. S4. The functionally grouped networks of GO terms and pathways for ART-R 
subpopulation specific gene set (265 genes). This network represents the associations 
between the GO terms based on the similarity of the genes (refer Material and Method 
section ”Gene interaction networks and gene ontology”). The nodes represent the GO terms 
and the edges are the associations based on kappa score, which is also used for defining 
functional groups. Each functional group is represented with the most significant GO term in 
the functional group. The “Triangles” represent the metabolic pathways, “Ellipse” represents 
the GO terms associated biological processes, “Hexagon” represents the GO terms associated 
to cellular component and the “Rectangles” represent the GO terms associated to Molecular 
functions. Different colors signify different GO terms functional groups. Nodes with more 
than one color represents the GO terms included in more than one functional group. Different 
parts of the network are marked with general annotation terms. The network of GO terms 
functional group is built in Cytoscape v3.2.1 using the plugin ClueGO v 2.2.4. 
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Fig. S5. The functionally grouped networks of GO terms and pathways for ART-S 
subpopulation KH1.2 common resistance background gene set (168 genes). This network 
represents the associations between the GO terms based on the similarity of the genes (refer 
Material and Method section ”Gene interaction networks and gene ontology”). The nodes 
represent the GO terms and the edges are the associations based on kappa score, which is also 
used for defining functional groups. Each functional group is represented with the most 
significant GO term in the functional group. The “Triangles” represent the metabolic 
pathways, “Ellipse” represents the GO terms associated biological processes, “Hexagon” 
represents the GO terms associated to cellular component and the “Rectangles” represent the 
GO terms associated to Molecular functions. Different colors signify different GO terms 
functional groups. Nodes with more than one color represents the GO terms included in more 
than one functional group. The network of GO terms functional group is built in Cytoscape 
v3.2.1 using the plugin ClueGO v 2.2.4. 
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Fig. S6. The functionally grouped networks of GO terms and pathways with associated genes 
for ART-S subpopulation KH1.2 common resistance background gene set (168 genes).  This 
network represents the associations between the GO terms based on the similarity of the 
genes (refer Material and Method section ”Gene interaction networks and gene ontology”). 
The nodes represent the GO terms and the edges are the associations based on kappa score, 
which is also used for defining functional groups. Each functional group is represented with 
the most significant GO term in the functional group. The “Triangles” represent the metabolic 
pathways, “Ellipse” represents the GO terms associated biological processes, “Hexagon” 
represents the GO terms associated to cellular component and the “Rectangles” represent the 
GO terms associated to Molecular functions. Different colors signify different GO terms 
functional groups. Nodes with more than one color represents the GO terms included in more 
than one functional group. Different parts of the network are marked with general annotation 
terms. The network of GO terms functional group with associated genes is built in Cytoscape 
v3.2.1 using the plugins ClueGO v 2.2.4 and CluePedia v 1.2.4 . 
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Fig. S7. The functionally grouped networks of GO terms and pathways for ART-R 
subpopulations specific gene set (97 genes). This network represents the associations between 
the GO terms based on the similarity of the genes (refer Material and Method section ”Gene 
interaction networks and gene ontology”). The nodes represent the GO terms and the edges 
are the associations based on kappa score, which is also used for defining functional groups. 
Each functional group is represented with the most significant GO term in the functional 
group. The “Triangles” represent the metabolic pathways, “Ellipse” represents the GO terms 
associated biological processes, “Hexagon” represents the GO terms associated to cellular 
component and the “Rectangles” represent the GO terms associated to Molecular functions. 
Different colors signify different GO terms functional groups. Nodes with more than one 
color represents the GO terms included in more than one functional group. The network of 
GO terms functional group is built in Cytoscape v3.2.1 using the plugin ClueGO v 2.2.4. 
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Fig. S8. The functionally grouped networks of GO terms and pathways with associated genes 
for ART-R subpopulations specific gene set (97 genes). This network represents the 
associations between the GO terms based on the similarity of the genes (refer Material and 
Method section ”Gene interaction networks and gene ontology”). The nodes represent the GO 
terms and the edges are the associations based on kappa score, which is also used for defining 
functional groups. Each functional group is represented with the most significant GO term in 
the functional group. The “Triangles” represent the metabolic pathways, “Ellipse” represents 
the GO terms associated biological processes, “Hexagon” represents the GO terms associated 
to cellular component and the “Rectangles” represent the GO terms associated to Molecular 
functions. Different colors signify different GO terms functional groups. Nodes with more 
than one color represents the GO terms included in more than one functional group. Different 
parts of the network are marked with general annotation terms. The region with genes closely 
associated to k13 gene (PF13_0238) based on GO terms are marked with a circle. Genes are 
also associated to autophagy (PF11_0271 and PF10_0126). The network of GO terms 
functional group with associated genes is built in Cytoscape v3.2.1 using the plugins ClueGO 
v 2.2.4 and CluePedia v 1.2.4 . 
 
 
 
 
 
3.4. ARTICLE 2 153
 
Fig. S9. Comparison of GO terms functional groups between the admixed subpopulation 
KHA specific genes (467 genes) and the ART-R subpopulation specific genes (97 genes). 
The conserved functional groups are matched by black lines. This network represents the 
associations between the GO terms based on the similarity of the genes (refer Material and 
Method section ”Gene interaction networks and gene ontology”). The nodes represent the GO 
terms and the edges are the associations based on kappa score, which is also used for defining 
functional groups. Each functional group is represented with the most significant GO term in 
the functional group. The “Triangles” represent the metabolic pathways, “Ellipse” represents 
the GO terms associated biological processes, “Hexagon” represents the GO terms associated 
to cellular component and the “Rectangles” represent the GO terms associated to Molecular 
functions. Different colors signify different GO terms functional groups. Nodes with more 
than one color represents the GO terms included in more than one functional group. The 
network of GO terms functional group is built in Cytoscape v3.2.1 using the plugin ClueGO 
v 2.2.4. 
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Fig. S10. The functionally grouped networks of GO terms and pathways for artemisinin 
resistance background gene set (57 genes), obtained by overlapping KHA specific genes (467 
genes) and ART-R subpopulations specific genes (97 genes). This network represents the 
associations between the GO terms based on the similarity of the genes (refer Material and 
Method section ”Gene interaction networks and gene ontology”). The nodes represent the GO 
terms and the edges are the associations based on kappa score, which is also used for defining 
functional groups. Each functional group is represented with the most significant GO term in 
the functional group. The “Triangles” represent the metabolic pathways, “Ellipse” represents 
the GO terms associated biological processes, “Hexagon” represents the GO terms associated 
to cellular component and the “Rectangles” represent the GO terms associated to Molecular 
functions. Different colors signify different GO terms functional groups. Nodes with more 
than one color represents the GO terms included in more than one functional group. The 
network of GO terms functional group is built in Cytoscape v3.2.1 using the plugin ClueGO 
v 2.2.4. 
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Fig. S11. The functionally grouped networks of GO terms and pathways with associated 
genes for artemisinin resistance background gene set (57 genes), obtained by overlapping 
KHA specific genes (467 genes) and ART-R subpopulations specific genes (97 genes). This 
network represents the associations between the GO terms based on the similarity of the 
genes (refer Material and Method section ”Gene interaction networks and gene ontology”). 
The nodes represent the GO terms and the edges are the associations based on kappa score, 
which is also used for defining functional groups. Each functional group is represented with 
the most significant GO term in the functional group. The “Triangles” represent the metabolic 
pathways, “Ellipse” represents the GO terms associated biological processes, “Hexagon” 
represents the GO terms associated to cellular component and the “Rectangles” represent the 
GO terms associated to Molecular functions. Different colors signify different GO terms 
functional groups. Nodes with more than one color represents the GO terms included in more 
than one functional group. The network of GO terms functional group is built in Cytoscape 
v3.2.1 using the plugin ClueGO v 2.2.4. 
 
 
 
 
 
156 CHAPTER 3. FUNCTIONAL ANALYSIS OF PF SUBPOPULATIONS
 
Fig. S12. Domain structure of kelch protein (k13), Phospatidylinositol 3-kinase (PI3K), 
cGMP-specific phosphodiesterase (PDE1), Serine/threonine protein kinase (ARK2), 
Autophagy related protein (Atg18 and Atg7) marked with all the mutations found in the IBC 
dataset. The figure was generated using Pfam server either using UNIPROT accession 
number or by direct submission of the amino acid sequence. Amino acid mutations in “red” 
color are the significant mutations observed in different subpopulations. 
 
Fig. S13. Variant (SNP) Calling Pipeline. This flowchart describes the 4 major steps of the 
pipeline to call significant SNPs for the population study. The numbers on the left of the 
flowchart are the number of SNPs kept at each step. The steps taken at each step to select 
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relevant SNPs are mentioned on the right side of the flowchart with all the associated 
information. 
(A) 
 
(B) 
 
Fig. S14. The Mapping quality (MQ: Root-mean-square mapping quality of covering reads) 
values (x-axis) averaged over 167 isolates for each SNP (y-axis) plotted along the genome. 
The average quality value for each SNP is calculated as the ∑values in different isolates / 
number of isolates showing that SNP. The red dotted vertical lines represent the last SNP in 
each chromosome and the blue dotted horizontal line represents the MQ value 29. (A) 
Average MQ values of all the unique SNPs along the full genome. (B) Average MQ values of 
all the unique SNPs in the coding core. SNPs in 100kb region at the starting and end of all the 
14 chromosomes removed. 
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Fig. S15. Histogram showing the density of SNPs for DA (∑non-REF alleles / ∑DP4) averaged 
over 167 isolates for each SNP. This figure represents the density of SNPs with a density 
function fitted on the histogram (red line) and the minima of the curve after DA ≥ 0.5 (dotted 
blue line). All the SNPs above the threshold DA ≥ 0.7 were included in the analyses. 
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Fig. S16. Histogram representing frequency of 247783 SNPs for non-reference allele 
frequency (NRAF) score and minor allele frequency (MAF) score. (A) shows the frequency 
of SNPs for NRAF score. The small zoomed version of the histogram shows the NRAF 
values 1, 2, 165, 166 and 167 which were not include in the analyses (marked with red 
triangles). (B) shows the frequency of SNPs for MAF scores. The SNPs with the MAF value 
below the threshold of 0.01796 (blue dotted line) correspond to the NRAF values which were 
not included in the analyses.  
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Fig. S17. Criteria and statistics of SNPs with uncertain ALT alleles in the isolates. Uncertain 
SNPs are defined as the SNPs with more than one ALT allele in at least one of the 167 
isolates. (A) shows the histogram of uncertain ALT allele frequency. All the SNPs with 
uncertain ALT allele frequency greater than 40% (dotted blue line at 0.4) were removed from 
the analyses. (B) represents a schematic diagram of different cases considered for SNPs with 
uncertainties and the decision of substitution taken. Uncertainties were substituted with the 
most frequent ALT value or REF value in around 17% of the SNPs at this step. (C) represents 
the pie chart with percent of certain SNPs, substituted SNPs and removed SNPs.     
 (A)                                                               (B) 
        
(C) 
 
Fig. S18. Venn diagrams showing the comparison of IBC dataset with other two datasets 
used in the analysis. (A) and (B) shows the Venn diagrams representing the overlap of 
common coding region non-synonymous SNPs between IBC dataset and PlasmoDB Asian 
isolates (release version 10) and MalariaGEN African and Asian isolates (release version 
1.0), respectively. (C) shows the Venn diagram representing the overlap of common coding 
region non-synonymous SNPs between IBC dataset, PlasmoDB Asian isolates and 
MalariaGEN African and Asian isolates and IPG Cambodian isolates. Total number of SNPs 
are mentioned in bracket. 
 
162 CHAPTER 3. FUNCTIONAL ANALYSIS OF PF SUBPOPULATIONS
 
Fig. S19. Pie chart representing the number of synonymous SNPs, non-synonymous SNPs, 
non-sense SNPs and read through SNPs in the coding region recovered in IBC, PlasmoDB 
(Asian isolates) and MalariaGEN database. The PlasmoDB (Asian isolates) and MalariaGEN 
data were annotated and mapped similarly to IBC dataset. The distribution of SNPs in the 
coding region is very similar in all the three databases. 
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Fig. S20. Hierarchal clustering of subpopulations based on interactions recovered from 
STRING v10. Interactions among significant genes of each subpopulation from all the 
sources above the confidence score of 0.4 were included in the analyses. The presence and 
absence of interactions in the network were treated as binary data. Binary (Jaccard) distance 
matrix and Ward’s minimum variance method were used to build the dendrogram. (A) 
Hierarchal clustering of all the subpopulations. (B) Hierarchal clustering of the 
subpopulations after excluding the admixed subpopulation KHA from the analyses.    
 
 
 
 
 
164 CHAPTER 3. FUNCTIONAL ANALYSIS OF PF SUBPOPULATIONS
Supplementary Tables: 
Table S1. List of all the significant genes specific to KH1.2 resistant background (168 
genes). These genes have at least one significant SNP (refer Material and Method section 
“Significant SNPs and Genes”) in ART-S subpopulation KH1.2 and all the ART-R 
subpopulations. This list provides PLasmoDB gene ID, product description of the gene, 
associated old ID and the Uniprot ID recovered from PlasmoDB v 11. 
Gene ID Product Description Old ID UniProt ID 
PF3D7_0103600 ATP-dependent RNA helicase, putative PFA0180w NA 
PF3D7_0104100 conserved Plasmodium membrane protein, unknown function PFA0205w NA 
PF3D7_0104300 ubiquitin carboxyl-terminal hydrolase 1, putative (UBP1) PFA0220w NA 
PF3D7_0105700 asparagine-rich antigen Pfa35-2 PFA0280w NA 
PF3D7_0207300 serine repeat antigen 8 (SERA8) PFB0325c O96162 
PF3D7_0209000 6-cysteine protein (P230) PFB0405w P68874 
PF3D7_0211700 tyrosine kinase-like protein, putative (TKL1) PFB0520w O96197 
PF3D7_0212400 conserved Plasmodium membrane protein, unknown function PFB0555c O96204 
PF3D7_0307900 conserved Plasmodium protein, unknown function PFC0335c O77320 
PF3D7_0310500 DEAD box helicase, putative PFC0440c O77360 
PF3D7_0313900 conserved Plasmodium protein, unknown function PFC0580c O97257 
PF3D7_0314700 zinc finger protein, putative PFC0610c O97260 
PF3D7_0316200 conserved Plasmodium protein, unknown function PFC0705c O77393 
PF3D7_0317200 cdc2-related protein kinase 4 (CRK4) PFC0755c O77385 
PF3D7_0404300 conserved Plasmodium protein, unknown function PFD0207c Q8I1Y6 
PF3D7_0405300 6-cysteine protein (LISP2) PFD0260c Q8I1X6 
PF3D7_0405400 pre-mRNA-processing-splicing factor 8, putative (PRPF8) PFD0265w Q8I1X5 
PF3D7_0412400 erythrocyte membrane protein 1, PfEMP1 (VAR) PFD0615c Q9U0G6 
PF3D7_0417400 conserved Plasmodium protein, unknown function PFD0840w C0H4B0 
PF3D7_0418000 conserved Plasmodium protein, unknown function PFD0872w C0H4B3 
PF3D7_0419400 conserved Plasmodium protein, unknown function PFD0940w Q8I1P3 
PF3D7_0419900 phosphatidylinositol 4-kinase, putative PFD0965w NA 
PF3D7_0420000 zinc finger protein, putative PFD0970c Q8I1N9 
PF3D7_0420300 transcription factor with AP2 domain(s) (ApiAP2) PFD0985w Q8I1N6 
PF3D7_0421700 conserved Plasmodium protein, unknown function PFD1030c C0H4B8 
PF3D7_0422200 erythrocyte membrane-associated antigen PFD1045c Q8IFP4 
PF3D7_0504800 conserved Plasmodium protein, unknown function PFE0235c C0H4C4 
PF3D7_0505000 conserved Plasmodium membrane protein, unknown function PFE0245c C0H4C6 
PF3D7_0506500 conserved Plasmodium protein, unknown function PFE0320w C0H4C9 
PF3D7_0508900 conserved Plasmodium protein, unknown function PFE0440w Q8I414 
PF3D7_0511500 RNA pseudouridylate synthase, putative PFE0570w Q8I3Z1 
PF3D7_0513200 conserved Plasmodium protein, unknown function PFE0655w Q8I3X5 
PF3D7_0519500 carbon catabolite repressor protein 4, putative (CCR4) PFE0980c Q8I3R5 
PF3D7_0520800 conserved Plasmodium protein, unknown function PFE1045c Q8I3Q3 
PF3D7_0522400 conserved Plasmodium protein, unknown function PFE1120w C0H4F8 
PF3D7_0525500 WD repeat-containing protein, putative PFE1270c Q8I3L0 
PF3D7_0526600 conserved Plasmodium protein, unknown function PFE1325w Q8I3J9 
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PF3D7_0530700 conserved Plasmodium protein, unknown function PFE1535w Q8I3G1 
PF3D7_0603800 centrosomal protein CEP76, putative (CEP76) PFF0185c C6KSN6 
PF3D7_0604000 conserved Plasmodium protein, unknown function PFF0195c C6KSN8 
PF3D7_0606600 conserved Plasmodium protein, unknown function PFF0325c C6KSR4 
PF3D7_0609000 conserved Plasmodium protein, unknown function PFF0445w C6KST7 
PF3D7_0613800 transcription factor with AP2 domain(s) (ApiAP2) PFF0670w C6KSY0 
PF3D7_0615400 ribonuclease, putative PFF0745c C6KSZ5 
PF3D7_0616600 conserved Plasmodium protein, unknown function PFF0805c C6KT07 
PF3D7_0619800 conserved Plasmodium membrane protein, unknown function PFF0965c C6KT38 
PF3D7_0623800 tyrosine kinase-like protein, putative (TKL4) PFF1145c C6KT74 
PF3D7_0703000 conserved Plasmodium protein, unknown function PF07_0010 Q8IC40 
PF3D7_0703200 conserved Plasmodium protein, unknown function PF07_0012 Q8IC38 
PF3D7_0703800 conserved Plasmodium protein, unknown function PF07_0014 Q8IC32 
PF3D7_0703900 conserved Plasmodium membrane protein, unknown function MAL7P1.15 Q8IC31 
PF3D7_0710200 conserved Plasmodium protein, unknown function PF07_0042 Q8IBY8 
PF3D7_0711200 conserved Plasmodium protein, unknown function MAL7P1.35 Q8IBX8 
PF3D7_0712600 erythrocyte membrane protein 1, PfEMP1 (VAR) PF07_0051 Q8IBW9 
PF3D7_0712900 erythrocyte membrane protein 1, PfEMP1 (VAR) MAL7P1.56 Q8IBW7 
PF3D7_0713000 rifin (RIF) MAL7P1.57 Q8IBW6 
PF3D7_0713100 Pfmc-2TM Maurer's cleft two transmembrane protein (MC-2TM) MAL7P1.58 Q8IBW5 
PF3D7_0713200 RESA-like protein MAL7P1.59 Q8IBW4 
PF3D7_0713900 conserved Plasmodium protein, unknown function PF07_0053 C0H4M8 
PF3D7_0718000 dynein heavy chain, putative MAL7P1.89 C0H4N5 
PF3D7_0721000 conserved Plasmodium membrane protein, unknown function PF07_0086 Q8IBP1 
PF3D7_0722200 rhoptry-associated leucine zipper-like protein 1 (RALP1) MAL7P1.119 Q8IBN1 
PF3D7_0722300 ubiquitin carboxyl-terminal hydrolase, putative MAL7P1.120 Q8IBN0 
PF3D7_0723700 metallo-hydrolase/oxidoreductase, putative PF07_0100 Q8IBL6 
PF3D7_0724700 conserved Plasmodium protein, unknown function MAL7P1.134 C0H4P2 
PF3D7_0725100 conserved Plasmodium membrane protein, unknown function MAL7P1.138 Q8IBK0 
PF3D7_0726400 conserved Plasmodium membrane protein, unknown function MAL7P1.146 C0H4P4 
PF3D7_0727100 conserved Plasmodium protein, unknown function MAL7P1.149 C0H4P6 
PF3D7_0728100 conserved Plasmodium membrane protein, unknown function PF07_0118 Q8IBH6 
PF3D7_0801900 conserved Plasmodium protein, unknown function MAL8P1.154 C0H4R0 
PF3D7_0804000 cactin homolog, putative PF08_0124 Q8IAN8 
PF3D7_0804500 conserved Plasmodium membrane protein, unknown function MAL8P1.139 Q8IAP1 
PF3D7_0809200 asparagine-rich antigen Pfa55-14 (pfa55-14) PF08_0102 Q8IAS8 
PF3D7_0809600 peptidase family C50, putative MAL8P1.113 C0H4T3 
PF3D7_0810800 
hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase 
(PPPK-DHPS) PF08_0095 Q8IAU3 
PF3D7_0818700 DNA helicase, putative MAL8P1.65 C0H4V8 
PF3D7_0820200 phosphatidylglycerophosphate synthase (PGPS) MAL8P1.58 Q8IB37 
PF3D7_0820900 conserved Plasmodium protein, unknown function MAL8P1.54 Q8IB43 
PF3D7_0826100 E3 ubiquitin-protein ligase, putative MAL8P1.23 Q8IB94 
PF3D7_0827600 conserved Plasmodium protein, unknown function MAL8P1.18 Q8IBA8 
PF3D7_0903300 conserved Plasmodium membrane protein, unknown function PFI0160w C0H517 
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PF3D7_0910200 conserved Plasmodium protein, unknown function PFI0495w Q8I350 
PF3D7_0911600 conserved Plasmodium protein, unknown function PFI0565w C0H534 
PF3D7_0914000 pseudouridylate synthase, putative PFI0685w Q8I312 
PF3D7_0919700 pyridoxal 5'-phosphate dependent enzyme class III, putative PFI0965w Q8I2V6 
PF3D7_0919800 TLD domain-containing protein PFI0970c Q8I2V5 
PF3D7_0919900 regulator of chromosome condensation, putative PFI0975c Q8I2V4 
PF3D7_0920400 conserved Plasmodium protein, unknown function PFI1000w Q8I2U9 
PF3D7_0922800 conserved Plasmodium protein, unknown function PFI1120c C0H552 
PF3D7_0923400 conserved Plasmodium protein, unknown function PFI1150w Q8I2S2 
PF3D7_0924500 conserved Plasmodium membrane protein, unknown function PFI1205c C0H557 
PF3D7_0926100 protein kinase, putative PFI1280c Q8I2P8 
PF3D7_0930300 merozoite surface protein 1 (MSP1) PFI1475w Q8I0U8 
PF3D7_1004200 WD repeat-containing protein, putative PF10_0045 Q8IJZ5 
PF3D7_1014800 conserved Plasmodium protein, unknown function PF10_0145 Q8IJP7 
PF3D7_1021100 conserved Plasmodium protein, unknown function PF10_0205 Q8IJJ2 
PF3D7_1021700 conserved Plasmodium membrane protein, unknown function PF10_0211 Q8IJI6 
PF3D7_1024900 conserved Plasmodium protein, unknown function PF10_0243 Q8IJF5 
PF3D7_1025500 conserved Plasmodium protein, unknown function PF10_0250 Q8IJE8 
PF3D7_1035300 glutamate-rich protein (GLURP) PF10_0344 Q8IJ56 
PF3D7_1035700 duffy binding-like merozoite surface protein (DBLMSP) PF10_0348 Q8IJ52 
PF3D7_1036300 merozoite surface protein (DBLMSP2) PF10_0355 Q8IJ45 
PF3D7_1104900 calcium/calmodulin-dependent protein kinase, putative PF11_0060 Q8IIV3 
PF3D7_1106700 dna2/nam7 helicase family member, putative PF11_0078 Q8IIT6 
PF3D7_1107300 polyadenylate-binding protein-interacting protein 1, putative (PAIP1) PF11_0086 Q8IIS9 
PF3D7_1111000 tRNA m5C-methyltransferase, putative PF11_0116 Q8IIQ2 
PF3D7_1121800 petidase, M16 family PF11_0226 Q8IIE8 
PF3D7_1125800 kelch protein, putative PF11_0268 Q8IIA6 
PF3D7_1130700 structural maintenance of chromosome protein, putative PF11_0317 Q8II57 
PF3D7_1133400 apical membrane antigen 1 (AMA1) PF11_0344 Q7KQK5 
PF3D7_1147000 sporozoite asparagine-rich protein (SLARP) PF11_0480 Q8IHP9 
PF3D7_1203400 transporter, putative PFL0170w Q8I611 
PF3D7_1206300 conserved Plasmodium protein, unknown function PFL0315c Q8I5Y2 
PF3D7_1208100 conserved Plasmodium protein, unknown function PFL0405w Q8I5W6 
PF3D7_1211200 conserved Plasmodium protein, unknown function PFL0555c Q8I5T8 
PF3D7_1216600 cell traversal protein for ookinetes and sporozoites (CelTOS) PFL0800c Q8I5P1 
PF3D7_1219300 erythrocyte membrane protein 1, PfEMP1 (VAR) PFL0935c Q8I5L5 
PF3D7_1302900 conserved Plasmodium protein, unknown function PF13_0015 Q8IET6 
PF3D7_1303800 conserved Plasmodium protein, unknown function MAL13P1.19 Q8IES7 
PF3D7_1305300 conserved Plasmodium protein, unknown function MAL13P1.26 C0H5A0 
PF3D7_1306500 MORN repeat protein, putative MAL13P1.32 C0H5A3 
PF3D7_1308400 conserved Plasmodium protein, unknown function MAL13P1.39 C0H5A6 
PF3D7_1313800 conserved Plasmodium membrane protein, unknown function MAL13P1.70 C0H5B3 
PF3D7_1318900 conserved Plasmodium protein, unknown function PF13_0103 Q8IEC7 
PF3D7_1324300 conserved Plasmodium membrane protein, unknown function MAL13P1.133 Q8IE74 
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PF3D7_1326600 conserved Plasmodium protein, unknown function PF13_0148 C0H5D9 
PF3D7_1330500 conserved Plasmodium protein, unknown function PF13_0164 Q8IE21 
PF3D7_1344300 conserved protein, unknown function MAL13P1.405 C0H5H1 
PF3D7_1346400 conserved Plasmodium protein, unknown function MAL13P1.234 C0H5H6 
PF3D7_1347900 conserved Plasmodium protein, unknown function MAL13P1.239 Q8IDM0 
PF3D7_1349500 conserved Plasmodium protein, unknown function MAL13P1.249 Q8IDK4 
PF3D7_1350700 N6-adenine-specific methylase, putative MAL13P1.255 C0H5I0 
PF3D7_1356800 serine/threonine protein kinase, putative (ARK3) MAL13P1.278 Q8IDD4 
PF3D7_1358000 patatin-like phospholipase, putative MAL13P1.285 Q8IDC5 
PF3D7_1359600 conserved Plasmodium protein, unknown function MAL13P1.295 C0H5J2 
PF3D7_1359700 conserved Plasmodium protein, unknown function MAL13P1.296 C0H5J3 
PF3D7_1362700 conserved Plasmodium protein, unknown function MAL13P1.313 C0H5K2 
PF3D7_1366300 conserved Plasmodium protein, unknown function MAL13P1.333 Q8ID45,Q8ID46 
PF3D7_1366400 rhoptry protein RHOP148 (RHOP148) PF13_0348 Q8ID44 
PF3D7_1402800 conserved Plasmodium protein, unknown function PF14_0029 Q8IM62 
PF3D7_1405900 RNA-binding protein, putative PF14_0056 Q8IM35 
PF3D7_1408700 conserved Plasmodium protein, unknown function PF14_0084 Q8IM09 
PF3D7_1411000.1 conserved Plasmodium protein, unknown function PF14_0108 Q8ILY5 
PF3D7_1411000.2 conserved Plasmodium protein, unknown function PF14_0108 NA 
PF3D7_1412400 conserved Plasmodium protein, unknown function PF14_0123 Q8ILX0 
PF3D7_1414500 atypical protein kinase, ABC-1 family, putative (ABCk2) PF14_0143 Q8ILV0 
PF3D7_1417400 rap guanine nucleotide exchange factor, putative, pseudogene (EPAC) PF14_0173 NA 
PF3D7_1422400 conserved Plasmodium protein, unknown function PF14_0214 Q8ILM9 
PF3D7_1422700 conserved Plasmodium protein, unknown function PF14_0217 Q8ILM6 
PF3D7_1430300 acid phosphatase, putative PF14_0282 Q8ILG1 
PF3D7_1433400 conserved Plasmodium membrane protein, unknown function PF14_0315 Q8ILC9 
PF3D7_1434500 dynein-related AAA-type ATPase, putative PF14_0326 Q8ILB9 
PF3D7_1442600 TRAP-like protein (TREP) PF14_0404 Q8IL45 
PF3D7_1442700 conserved Plasmodium protein, unknown function PF14_0405 Q8IL44 
PF3D7_1447900 multidrug resistance protein 2 (MDR2) PF14_0455 Q8IKZ6 
PF3D7_1448500 conserved Plasmodium protein, unknown function PF14_0463 Q8IKY8 
PF3D7_1449400 crossover junction endonuclease MUS81, putative (MUS81) PF14_0470 Q8IKY1 
PF3D7_1449700 exosome complex exonuclease RRP6 (RRP6) PF14_0473 Q8IKX8 
PF3D7_1450800 conserved Plasmodium protein, unknown function PF14_0483 Q8IKW8 
PF3D7_1451200 conserved Plasmodium protein, unknown function PF14_0487 Q8IKW4 
PF3D7_1457900 conserved Plasmodium protein, unknown function PF14_0552 Q8IKQ1 
PF3D7_1460900.1 apicoplast ribosomal protein S10, putative (ARPS10) PF14_0581 NA 
PF3D7_1460900.2 apicoplast ribosomal protein S10, putative (ARPS10) PF14_0581 Q8IKM3 
PF3D7_1461800 conserved Plasmodium protein, unknown function PF14_0588 Q8IKL6 
PF3D7_1462400 conserved Plasmodium protein, unknown function PF14_0594 Q8IKL0 
PF3D7_1464500 conserved Plasmodium membrane protein, unknown function PF14_0613 Q8IKJ2 
PF3D7_1467600 conserved Plasmodium protein, unknown function PF14_0644 Q8IKG1 
PF3D7_1470100 conserved Plasmodium protein, unknown function PF14_0668 Q8IKD7 
PF3D7_1474000 probable protein, unknown function PF14_0708 Q8IK98 
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PF3D7_1474200 conserved Plasmodium membrane protein, unknown function PF14_0710 Q8IK96 
 
Table S2. List of all the significant genes specific to ART-R subpopulations (97 genes). 
These genes have at least one significant SNP (refer Material and Method section 
“Significant SNPs and Genes”) in all the ART-R subpopulations and no significant SNP in 
ART-S subpopulation KH1.2. This list provides PLasmoDB gene ID, product description of 
the gene, associated old ID and the Uniprot ID recovered from PlasmoDB v 11. 
Gene ID Product Description Old ID UniProt ID 
PF3D7_0107500 lipid/sterol:H+ symporter PFA0375c NA 
PF3D7_0108300 conserved Plasmodium protein, unknown function PFA0410w NA 
PF3D7_0212500 conserved Plasmodium protein, unknown function PFB0560w O96205 
PF3D7_0213900 conserved Plasmodium protein, unknown function PFB0630c O96219 
PF3D7_0214300 conserved Plasmodium protein, unknown function PFB0650w O96223 
PF3D7_0217900 conserved Plasmodium protein, unknown function PFB0835c O96259 
PF3D7_0302500 cytoadherence linked asexual protein 3.1 (CLAG3.1) PFC0120w O77310 
PF3D7_0309200 serine/threonine protein kinase, putative (ARK2) PFC0385c O77328 
PF3D7_0317300 conserved Plasmodium protein, unknown function PFC0760c O77384 
PF3D7_0409600 replication protein A1, large subunit (RPA1) PFD0470c Q9U0J0 
PF3D7_0410300 protein phosphatase PPM1, putative (PPM1) PFD0505c Q9U0I5 
PF3D7_0411000 conserved Plasmodium protein, unknown function PFD0545w Q9U0H8 
PF3D7_0412300 phosphopantothenoylcysteine synthetase, putative PFD0610w Q9U0G7 
PF3D7_0420700 erythrocyte membrane protein 1, PfEMP1 (VAR) PFD0995c Q8IFQ6 
PF3D7_0504700 centrosomal protein CEP120, putative (CEP120) PFE0230w Q8I455 
PF3D7_0508700 
pre-mRNA-processing ATP-dependent RNA helicase PRP5, 
putative (PRP5) PFE0430w Q8I416 
PF3D7_0515300 phosphatidylinositol 3-kinase (PI3K) PFE0765w Q8I3V5 
PF3D7_0525200 conserved Plasmodium protein, unknown function PFE1255w Q8I3L3 
PF3D7_0526000 RAP protein, putative PFE1295c Q8I3K5 
PF3D7_0607700 conserved Plasmodium protein, unknown function PFF0380w C6KSS5 
PF3D7_0609700 conserved Plasmodium protein, unknown function PFF0480w C6KSU4 
PF3D7_0612800 6-cysteine protein (P12p) PFF0620c C6KSX1 
PF3D7_0613300 rhoptry protein ROP14 (ROP14) PFF0645c C6KSX6 
PF3D7_0615900 conserved Plasmodium protein, unknown function PFF0770c C6KT00 
PF3D7_0703400 conserved Plasmodium protein, unknown function PF07_0013 Q8IC36 
PF3D7_0704600 E3 ubiquitin-protein ligase (UT) MAL7P1.19 C0H4K6 
PF3D7_0707200 conserved Plasmodium protein, unknown function MAL7P1.207 C0H4L9,Q8IAJ8 
PF3D7_0709000 chloroquine resistance transporter (CRT) MAL7P1.27 Q8IBZ9 
PF3D7_0712800 erythrocyte membrane protein 1, PfEMP1 (VAR) MAL7P1.55 Q8IBW8 
PF3D7_0716700 conserved Plasmodium protein, unknown function PF07_0069 Q8IBT3 
PF3D7_0717700 serine--tRNA ligase, putative PF07_0073 Q8IBS3 
PF3D7_0720700 phosphoinositide-binding protein, putative MAL7P1.108 Q8IBP4 
PF3D7_0723900 conserved Plasmodium protein, unknown function MAL7P1.126 Q8IBL4 
PF3D7_0724100 conserved Plasmodium protein, unknown function MAL7P1.129 Q8IBL1 
PF3D7_0804700 conserved Plasmodium protein, unknown function PF08_0122 Q8IAP3 
PF3D7_0807800 26S proteasome regulatory subunit RPN10, putative (RPN10) PF08_0109 Q8IAR6 
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PF3D7_0808000 conserved Plasmodium protein, unknown function MAL8P1.124 C0H4S9 
PF3D7_0809400 conserved Plasmodium protein, unknown function PF08_0101 Q8IAS9 
PF3D7_0812900 probable protein, unknown function MAL8P1.97 Q8IAW4 
PF3D7_0816300 conserved Plasmodium protein, unknown function MAL8P1.80 C0H4U8 
PF3D7_0817600 conserved Plasmodium protein, unknown function PF08_0058 Q8IB11 
PF3D7_0903400 DEAD/DEAH box helicase, putative PFI0165c Q8I3B4 
PF3D7_0908200 conserved Plasmodium protein, unknown function PFI0395w Q8I369 
PF3D7_0909100 conserved Plasmodium membrane protein, unknown function PFI0440w C0H528 
PF3D7_0910000 SET domain protein, putative (SET4) PFI0485c Q8I352 
PF3D7_0912000 conserved Plasmodium protein, unknown function PFI0585c Q8I332 
PF3D7_0912600 conserved Plasmodium protein, unknown function PFI0615w Q8I326 
PF3D7_0916400 conserved Plasmodium protein, unknown function PFI0805w C0H539 
PF3D7_0917400 conserved Plasmodium protein, unknown function PFI0850w Q8I2X9 
PF3D7_0920000 long chain fatty acid elongation enzyme, putative (ELO3) PFI0980w C0H545 
PF3D7_0921600 tetratricopeptide repeat family protein, putative PFI1060w Q8I2T7 
PF3D7_1005500 regulator of nonsense transcripts, putative PF10_0057 Q8IJY4 
PF3D7_1008100 conserved Plasmodium protein, unknown function PF10_0079 Q8IJW2 
PF3D7_1012700 NLI interacting factor-like phosphatase, putative (NIF4) PF10_0124 Q8IJR8 
PF3D7_1012900 autophagy-related protein 18, putative (ATG18) PF10_0126 Q8IJR6 
PF3D7_1015000 FAD synthetase, putative PF10_0147 Q8IJP5 
PF3D7_1018000 tRNA pseudouridine synthase, putative PF10_0175 Q8I715 
PF3D7_1023100 dynein heavy chain, putative PF10_0224 Q8IJH4 
PF3D7_1110400 asparagine-rich antigen PF11_0111 Q8IIQ7 
PF3D7_1114900 conserved Plasmodium protein, unknown function PF11_0158 Q8IIL3 
PF3D7_1117200 conserved Plasmodium protein, unknown function PF11_0178 Q8IIJ5 
PF3D7_1126100 autophagy-related protein 7, putative (ATG7) PF11_0271 Q8IIA3 
PF3D7_1128900 conserved Plasmodium protein, unknown function PF11_0300 Q8II74 
PF3D7_1140700 conserved Plasmodium protein, unknown function PF11_0418 Q8IHV8 
PF3D7_1141100 conserved Plasmodium protein, unknown function PF11_0422 Q8IHV4 
PF3D7_1146600 CCAAT-box DNA binding protein subunit B (NFYB) PF11_0477 Q8IHQ2 
PF3D7_1209500.1 cGMP-specific phosphodiesterase (PDE1) PFL0475w Q8I5V4 
PF3D7_1209500.2 cGMP-specific phosphodiesterase (PDE1) PFL0475w NA 
PF3D7_1211900 non-SERCA-type Ca2+ -transporting P-ATPase (ATP4) PFL0590c Q8I5T3 
PF3D7_1219400 
erythrocyte membrane protein 1 (PfEMP1), pseudogene 
(VAR) PFL0940c NA 
PF3D7_1220400 
debranching enzyme-associated ribonuclease, putative 
(DRN1) PFL0980w Q8I5K9 
PF3D7_1308200 carbamoyl phosphate synthetase (cpsSII) PF13_0044 Q8IEN3 
PF3D7_1312800 conserved Plasmodium protein, unknown function PF13_0072 Q8IEJ4 
PF3D7_1318100 ferredoxin, putative MAL13P1.95 Q8IED5 
PF3D7_1318300 conserved Plasmodium protein, unknown function PF13_0101 Q8IED3 
PF3D7_1322400 conserved Plasmodium protein, unknown function MAL13P1.125 Q8IE91 
PF3D7_1328500 alpha/beta-hydrolase, putative PF13_0153 Q8IE45 
PF3D7_1339700 conserved Plasmodium protein, unknown function MAL13P1.202 Q8IDT8 
PF3D7_1343700 kelch protein K13 (K13) PF13_0238 Q8IDQ2 
PF3D7_1347200 nucleoside transporter 1 (NT1) PF13_0252 Q8IDM6 
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PF3D7_1351200 conserved Plasmodium protein, unknown function MAL13P1.258 Q8IDI7 
PF3D7_1368800 DNA repair endonuclease, putative (ERCC4) MAL13P1.346 Q8ID22 
PF3D7_1406200 conserved Plasmodium protein, unknown function PF14_0059 Q8IM32 
PF3D7_1407600 conserved Plasmodium protein, unknown function PF14_0073 Q8IM18 
PF3D7_1412700 AAA family ATPase, putative PF14_0126 Q8ILW7 
PF3D7_1417600 conserved Plasmodium protein, unknown function PF14_0175 Q8ILR9 
PF3D7_1420400 glycine--tRNA ligase (GlyRS) PF14_0198 Q8ILP6 
PF3D7_1423500 conserved Plasmodium protein, unknown function PF14_0226 Q8ILL7 
PF3D7_1426700 phosphoenolpyruvate carboxylase (PEPC) PF14_0246 Q8ILJ7 
PF3D7_1429900 ADP-dependent DNA helicase RecQ (WRN) PF14_0278 Q8ILG5 
PF3D7_1433800 conserved Plasmodium protein, unknown function PF14_0319 Q8ILC5 
PF3D7_1448000 
U3 small nucleolar RNA-associated protein 12, putative 
(UTP12) PF14_0456 Q8IKZ5 
PF3D7_1452600 conserved Plasmodium protein, unknown function PF14_0501 Q8IKV0 
PF3D7_1459100 GTP-binding protein, putative PF14_0564 Q8IKP0 
PF3D7_1460500 conserved Plasmodium protein, unknown function PF14_0577 Q8IKM7 
PF3D7_1461100 conserved Plasmodium protein, unknown function PF14_0583 Q8IKM1 
PF3D7_1466200 conserved Plasmodium protein, unknown function PF14_0631 Q8IKH4 
PF3D7_1468500 derlin-1 (DER1-1) PF14_0653 Q8IKF2 
 
Table S3. List of all the significant genes specific to artemisinin resistance background (57 
genes). These genes have at least one significant SNP (refer Material and Method section 
“Significant SNPs and Genes”) in all the ART-R subpopulations, in the admixed 
subpopulation KHA and no significant SNP in ART-S subpopulation KH1.2. This list 
provides PLasmoDB gene ID, product description of the gene, associated old ID and the 
Uniprot ID recovered from PlasmoDB v 11. 
Gene ID Product Description Old ID UniProt ID 
PF3D7_0108300 conserved Plasmodium protein, unknown function PFA0410w 
 
PF3D7_0217900 conserved Plasmodium protein, unknown function PFB0835c O96259 
PF3D7_0309200 serine/threonine protein kinase, putative (ARK2) PFC0385c O77328 
PF3D7_0317300 conserved Plasmodium protein, unknown function PFC0760c O77384 
PF3D7_0515300 phosphatidylinositol 3-kinase (PI3K) PFE0765w Q8I3V5 
PF3D7_0525200 conserved Plasmodium protein, unknown function PFE1255w Q8I3L3 
PF3D7_0526000 RAP protein, putative PFE1295c Q8I3K5 
PF3D7_0612800 6-cysteine protein (P12p) PFF0620c C6KSX1 
PF3D7_0613300 rhoptry protein ROP14 (ROP14) PFF0645c C6KSX6 
PF3D7_0703400 conserved Plasmodium protein, unknown function PF07_0013 Q8IC36 
PF3D7_0709000 chloroquine resistance transporter (CRT) MAL7P1.27 Q8IBZ9 
PF3D7_0716700 conserved Plasmodium protein, unknown function PF07_0069 Q8IBT3 
PF3D7_0717700 serine--tRNA ligase, putative PF07_0073 Q8IBS3 
PF3D7_0720700 phosphoinositide-binding protein, putative MAL7P1.108 Q8IBP4 
PF3D7_0723900 conserved Plasmodium protein, unknown function MAL7P1.126 Q8IBL4 
PF3D7_0724100 conserved Plasmodium protein, unknown function MAL7P1.129 Q8IBL1 
PF3D7_0807800 
26S proteasome regulatory subunit RPN10, putative 
(RPN10) PF08_0109 Q8IAR6 
PF3D7_0808000 conserved Plasmodium protein, unknown function MAL8P1.124 C0H4S9 
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PF3D7_0809400 conserved Plasmodium protein, unknown function PF08_0101 Q8IAS9 
PF3D7_0817600 conserved Plasmodium protein, unknown function PF08_0058 Q8IB11 
PF3D7_0908200 conserved Plasmodium protein, unknown function PFI0395w Q8I369 
PF3D7_0912000 conserved Plasmodium protein, unknown function PFI0585c Q8I332 
PF3D7_0912600 conserved Plasmodium protein, unknown function PFI0615w Q8I326 
PF3D7_0916400 conserved Plasmodium protein, unknown function PFI0805w C0H539 
PF3D7_0920000 long chain fatty acid elongation enzyme, putative (ELO3) PFI0980w C0H545 
PF3D7_0921600 tetratricopeptide repeat family protein, putative PFI1060w Q8I2T7 
PF3D7_1005500 regulator of nonsense transcripts, putative PF10_0057 Q8IJY4 
PF3D7_1008100 conserved Plasmodium protein, unknown function PF10_0079 Q8IJW2 
PF3D7_1012700 NLI interacting factor-like phosphatase, putative (NIF4) PF10_0124 Q8IJR8 
PF3D7_1012900 autophagy-related protein 18, putative (ATG18) PF10_0126 Q8IJR6 
PF3D7_1018000 tRNA pseudouridine synthase, putative PF10_0175 Q8I715 
PF3D7_1126100 autophagy-related protein 7, putative (ATG7) PF11_0271 Q8IIA3 
PF3D7_1140700 conserved Plasmodium protein, unknown function PF11_0418 Q8IHV8 
PF3D7_1209500.1 cGMP-specific phosphodiesterase (PDE1) PFL0475w Q8I5V4 
PF3D7_1209500.2 cGMP-specific phosphodiesterase (PDE1) PFL0475w 
 
PF3D7_1211900 non-SERCA-type Ca2+ -transporting P-ATPase (ATP4) PFL0590c Q8I5T3 
PF3D7_1219400 
erythrocyte membrane protein 1 (PfEMP1), pseudogene 
(VAR) PFL0940c 
 
PF3D7_1220400 
debranching enzyme-associated ribonuclease, putative 
(DRN1) PFL0980w Q8I5K9 
PF3D7_1312800 conserved Plasmodium protein, unknown function PF13_0072 Q8IEJ4 
PF3D7_1318100 ferredoxin, putative MAL13P1.95 Q8IED5 
PF3D7_1318300 conserved Plasmodium protein, unknown function PF13_0101 Q8IED3 
PF3D7_1322400 conserved Plasmodium protein, unknown function MAL13P1.125 Q8IE91 
PF3D7_1328500 alpha/beta-hydrolase, putative PF13_0153 Q8IE45 
PF3D7_1343700 kelch protein K13 (K13) PF13_0238 Q8IDQ2 
PF3D7_1347200 nucleoside transporter 1 (NT1) PF13_0252 Q8IDM6 
PF3D7_1368800 DNA repair endonuclease, putative (ERCC4) MAL13P1.346 Q8ID22 
PF3D7_1406200 conserved Plasmodium protein, unknown function PF14_0059 Q8IM32 
PF3D7_1407600 conserved Plasmodium protein, unknown function PF14_0073 Q8IM18 
PF3D7_1412700 AAA family ATPase, putative PF14_0126 Q8ILW7 
PF3D7_1423500 conserved Plasmodium protein, unknown function PF14_0226 Q8ILL7 
PF3D7_1429900 ADP-dependent DNA helicase RecQ (WRN) PF14_0278 Q8ILG5 
PF3D7_1433800 conserved Plasmodium protein, unknown function PF14_0319 Q8ILC5 
PF3D7_1448000 
U3 small nucleolar RNA-associated protein 12, putative 
(UTP12) PF14_0456 Q8IKZ5 
PF3D7_1452600 conserved Plasmodium protein, unknown function PF14_0501 Q8IKV0 
PF3D7_1459100 GTP-binding protein, putative PF14_0564 Q8IKP0 
PF3D7_1460500 conserved Plasmodium protein, unknown function PF14_0577 Q8IKM7 
PF3D7_1466200 conserved Plasmodium protein, unknown function PF14_0631 Q8IKH4 
PF3D7_1468500 derlin-1 (DER1-1) PF14_0653 Q8IKF2 
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Table S4. List of all the isolates used for the analysis. This list provides the index of the 
sample, ENA accession number, locality, year of data collection, Sample ID, Study ID and 
the name of the file to be downloaded from the ENA database server. This list is sorted in 
alphabetic order of localities in Cambodia. This publication uses data and the meta 
information from the MalariaGEN Plasmodium falciparum Community Project as described 
in Genomic epidemiology of artemisinin resistant malaria, eLife, 2016 (DOI: 
10.7554/eLife.08714). 
Index 
Accession 
Number 
Country Locality Year Sample ID Study Filename 
147 ERS010516 Cambodia Pailin 2007 PH0021-C 1012 5696_1_nonhuman 
154 ERS032008 Cambodia Pailin 2008 PH0444-C 1031 6263_5_nonhuman#1 
155 ERS032025 Cambodia Pailin 2008 PH0447-C 1031 6263_6_nonhuman#6 
156 ERS032637 Cambodia Pailin 2009 PH0223-CW 1031 6345_4_nonhuman#2 
157 ERS031999 Cambodia Pailin 2009 PH0229-C 1031 6263_4_nonhuman#4 
158 ERS024124 Cambodia Pailin 2008 PH0121-CW 1031 6007_1_nonhuman#2 
159 ERS024125 Cambodia Pailin 2008 PH0122-CW 1031 6007_1_nonhuman#3 
160 ERS024126 Cambodia Pailin 2008 PH0123-CW 1031 6007_1_nonhuman#4 
161 ERS024127 Cambodia Pailin 2008 PH0124-CW 1031 6007_1_nonhuman#5 
162 ERS024128 Cambodia Pailin 2008 PH0125-CW 1031 6007_2_nonhuman#1 
163 ERS024130 Cambodia Pailin NA NA NA 6007_2_nonhuman#3 
164 ERS024133 Cambodia Pailin 2008 PH0130-CW 1031 6007_3_nonhuman#1 
165 ERS024135 Cambodia Pailin 2008 PH0132-CW 1031 6007_3_nonhuman#3 
166 ERS024136 Cambodia Pailin 2008 PH0133-CW 1031 6007_3_nonhuman#4 
72 ERS023736 Cambodia Pursat 2010 PH0238-C 1044 6297_1_nonhuman#2 
73 ERS023737 Cambodia Pursat 2010 PH0239-C 1044 6297_1_nonhuman#3 
74 ERS023741 Cambodia Pursat 2010 PH0243-C 1044 6297_1_nonhuman#7 
75 ERS023742 Cambodia Pursat 2010 PH0244-C 1044 6297_1_nonhuman#8 
76 ERS023743 Cambodia Pursat 2010 PH0245-C 1044 6297_1_nonhuman#9 
77 ERS023744 Cambodia Pursat 2010 PH0246-C 1044 6222_8_nonhuman#3 
78 ERS023745 Cambodia Pursat 2010 PH0247-C 1044 6222_8_nonhuman#4 
79 ERS023746 Cambodia Pursat 2010 PH0248-C 1044 6222_8_nonhuman#5 
80 ERS023747 Cambodia Pursat 2010 PH0249-C 1044 6222_8_nonhuman#6 
81 ERS023748 Cambodia Pursat 2010 PH0250-C 1044 6222_8_nonhuman#7 
82 ERS023749 Cambodia Pursat 2010 PH0251-C 1044 6222_8_nonhuman#8 
83 ERS023750 Cambodia Pursat 2010 PH0252-C 1044 6222_8_nonhuman#9 
84 ERS032249 Cambodia Pursat 2010 PH0284-C 1044 6345_3_nonhuman#2 
85 ERS032246 Cambodia Pursat 2010 PH0285-C 1044 6345_2_nonhuman#11 
86 ERS032683 Cambodia Pursat 2010 PH0286-CW 1044 6345_7_nonhuman#12 
87 ERS025100 Cambodia Pursat 2010 PH0294-C 1044 6280_1_nonhuman 
88 ERS032018 Cambodia Pursat NA NA NA 6263_5_nonhuman#11 
89 ERS032243 Cambodia Pursat 2010 PH0302-C 1044 6345_2_nonhuman#8 
90 ERS032686 Cambodia Pursat 2010 PH0303-CW 1044 6345_8_nonhuman#3 
91 ERS032255 Cambodia Pursat 2010 PH0304-C 1044 6345_3_nonhuman#8 
92 ERS032014 Cambodia Pursat 2010 PH0306-C 1044 6263_5_nonhuman#7 
93 ERS032687 Cambodia Pursat 2010 PH0308-CW 1044 6345_8_nonhuman#4 
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94 ERS025262 Cambodia Pursat 2010 PH0321-C 1044 6222_1_nonhuman#1 
95 ERS025263 Cambodia Pursat 2010 PH0322-C 1044 6222_1_nonhuman#2 
96 ERS025265 Cambodia Pursat 2010 PH0324-C 1044 6222_1_nonhuman#4 
97 ERS025266 Cambodia Pursat 2010 PH0325-C 1044 6222_1_nonhuman#5 
98 ERS025257 Cambodia Pursat 2010 PH0326-C 1044 6468_8_nonhuman#2 
99 ERS025267 Cambodia Pursat 2010 PH0327-C 1044 6222_1_nonhuman#6 
100 ERS025268 Cambodia Pursat 2010 PH0328-C 1044 6222_1_nonhuman#7 
101 ERS025269 Cambodia Pursat 2010 PH0329-C 1044 6222_1_nonhuman#8 
102 ERS025258 Cambodia Pursat 2010 PH0330-C 1044 6468_8_nonhuman#3 
103 ERS025271 Cambodia Pursat 2010 PH0332-C 1044 6222_1_nonhuman#10 
104 ERS025259 Cambodia Pursat 2010 PH0333-C 1044 6468_8_nonhuman#4 
105 ERS025272 Cambodia Pursat 2010 PH0334-C 1044 6222_2_nonhuman#1 
106 ERS025273 Cambodia Pursat 2010 PH0335-C 1044 6222_2_nonhuman#2 
107 ERS025274 Cambodia Pursat 2010 PH0336-C 1044 6222_2_nonhuman#3 
108 ERS025275 Cambodia Pursat 2010 PH0337-C 1044 6222_2_nonhuman#4 
109 ERS025276 Cambodia Pursat 2010 PH0338-C 1044 6222_2_nonhuman#5 
110 ERS028696 Cambodia Pursat 2010 PH0453-C 1044 6263_1_nonhuman#1 
111 ERS028697 Cambodia Pursat 2010 PH0454-C 1044 6263_1_nonhuman#2 
112 ERS028698 Cambodia Pursat 2010 PH0455-C 1044 6263_1_nonhuman#3 
113 ERS028699 Cambodia Pursat 2010 PH0456-C 1044 6263_1_nonhuman#4 
114 ERS032688 Cambodia Pursat 2010 PH0457-CW 1044 6345_8_nonhuman#5 
115 ERS032689 Cambodia Pursat 2010 PH0458-CW 1044 6345_8_nonhuman#6 
116 ERS032690 Cambodia Pursat 2010 PH0459-CW 1044 6345_8_nonhuman#7 
117 ERS028700 Cambodia Pursat 2010 PH0460-C 1044 6263_1_nonhuman#5 
118 ERS028701 Cambodia Pursat 2010 PH0461-C 1044 6263_1_nonhuman#6 
119 ERS028702 Cambodia Pursat 2010 PH0462-C 1044 6263_1_nonhuman#7 
120 ERS028703 Cambodia Pursat 2010 PH0463-C 1044 6263_1_nonhuman#8 
121 ERS032691 Cambodia Pursat 2010 PH0464-CW 1044 6345_8_nonhuman#8 
122 ERS032692 Cambodia Pursat 2010 PH0465-CW 1044 6345_8_nonhuman#9 
123 ERS028704 Cambodia Pursat 2010 PH0466-C 1044 6263_1_nonhuman#9 
124 ERS032693 Cambodia Pursat 2010 PH0467-CW 1044 6345_8_nonhuman#10 
125 ERS028705 Cambodia Pursat 2010 PH0468-C 1044 6263_1_nonhuman#10 
126 ERS032694 Cambodia Pursat 2010 PH0469-CW 1044 6345_8_nonhuman#11 
127 ERS028706 Cambodia Pursat 2010 PH0470-C 1044 6263_2_nonhuman#1 
128 ERS028707 Cambodia Pursat 2010 PH0471-C 1044 6263_2_nonhuman#2 
129 ERS028708 Cambodia Pursat 2010 PH0472-C 1044 6263_2_nonhuman#3 
130 ERS028709 Cambodia Pursat 2010 PH0473-C 1044 6263_2_nonhuman#4 
131 ERS032695 Cambodia Pursat 2010 PH0474-CW 1044 6345_8_nonhuman#12 
132 ERS028710 Cambodia Pursat 2010 PH0475-C 1044 6263_2_nonhuman#5 
133 ERS028712 Cambodia Pursat NA NA NA 6263_2_nonhuman#7 
134 ERS028713 Cambodia Pursat 2010 PH0478-C 1044 6263_2_nonhuman#8 
135 ERS032696 Cambodia Pursat 2010 PH0479-CW 1044 6468_8_nonhuman#7 
136 ERS028714 Cambodia Pursat 2010 PH0480-C 1044 6263_2_nonhuman#9 
137 ERS028715 Cambodia Pursat 2010 PH0481-C 1044 6263_2_nonhuman#10 
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138 ERS028716 Cambodia Pursat 2010 PH0482-C 1044 6263_3_nonhuman#1 
139 ERS032697 Cambodia Pursat 2010 PH0483-CW 1044 6468_8_nonhuman#8 
140 ERS028717 Cambodia Pursat 2011 PH0484-C 1044 6263_3_nonhuman#2 
141 ERS028718 Cambodia Pursat 2011 PH0485-C 1044 6263_3_nonhuman#3 
142 ERS028719 Cambodia Pursat 2011 PH0486-C 1044 6263_3_nonhuman#4 
143 ERS028722 Cambodia Pursat 2011 PH0487-C 1044 6263_3_nonhuman#7 
144 ERS028723 Cambodia Pursat 2011 PH0488-C 1044 6263_3_nonhuman#8 
145 ERS028724 Cambodia Pursat 2011 PH0489-C 1044 6263_3_nonhuman#9 
146 ERS028725 Cambodia Pursat 2011 PH0490-C 1044 6263_3_nonhuman#10 
149 ERS028720 Cambodia Pursat 2009 PH0047-Cx 1044 6263_3_nonhuman#5 
150 ERS028721 Cambodia Pursat 2009 PH0051-Cx 1044 6263_3_nonhuman#6 
151 ERS017705 Cambodia Pursat 2010 PH0206-C 1044 5756_1_nonhuman 
152 ERS017706 Cambodia Pursat 2010 PH0209-C 1044 5788_1_nonhuman 
153 ERS017707 Cambodia Pursat 2010 PH0212-C 1044 5764_7_nonhuman 
167 ERS032258 Cambodia Pursat NA NA NA 6345_3_nonhuman#11 
11 ERS025277 Cambodia Ratanakiri 2010 PH0339-C 1044 6222_2_nonhuman#6 
12 ERS025278 Cambodia Ratanakiri 2010 PH0340-C 1044 6222_2_nonhuman#7 
13 ERS025279 Cambodia Ratanakiri 2010 PH0341-C 1044 6222_2_nonhuman#8 
14 ERS025280 Cambodia Ratanakiri 2010 PH0342-C 1044 6222_2_nonhuman#9 
15 ERS025281 Cambodia Ratanakiri 2010 PH0343-C 1044 6222_2_nonhuman#10 
16 ERS025260 Cambodia Ratanakiri 2010 PH0344-C 1044 6468_8_nonhuman#5 
17 ERS025282 Cambodia Ratanakiri 2010 PH0345-C 1044 6222_3_nonhuman#1 
18 ERS025283 Cambodia Ratanakiri 2010 PH0346-C 1044 6222_3_nonhuman#2 
19 ERS025284 Cambodia Ratanakiri 2010 PH0347-C 1044 6222_3_nonhuman#3 
20 ERS025285 Cambodia Ratanakiri 2010 PH0348-C 1044 6222_3_nonhuman#4 
21 ERS025286 Cambodia Ratanakiri 2010 PH0349-C 1044 6222_3_nonhuman#5 
22 ERS025287 Cambodia Ratanakiri 2010 PH0350-C 1044 6222_3_nonhuman#6 
23 ERS025288 Cambodia Ratanakiri 2010 PH0351-C 1044 6222_3_nonhuman#7 
24 ERS025289 Cambodia Ratanakiri 2010 PH0352-C 1044 6222_3_nonhuman#8 
25 ERS025290 Cambodia Ratanakiri 2010 PH0353-C 1044 6222_3_nonhuman#9 
26 ERS025291 Cambodia Ratanakiri 2010 PH0354-C 1044 6222_3_nonhuman#10 
27 ERS025376 Cambodia Ratanakiri 2010 PH0355-C 1044 6222_4_nonhuman#1 
28 ERS025377 Cambodia Ratanakiri 2010 PH0356-C 1044 6222_4_nonhuman#2 
29 ERS025378 Cambodia Ratanakiri 2010 PH0357-C 1044 6222_4_nonhuman#3 
30 ERS025379 Cambodia Ratanakiri 2010 PH0358-C 1044 6222_4_nonhuman#4 
31 ERS025380 Cambodia Ratanakiri 2010 PH0359-C 1044 6222_4_nonhuman#5 
32 ERS025381 Cambodia Ratanakiri 2010 PH0360-C 1044 6222_4_nonhuman#6 
33 ERS025382 Cambodia Ratanakiri 2010 PH0361-C 1044 6222_4_nonhuman#7 
34 ERS025383 Cambodia Ratanakiri 2010 PH0362-C 1044 6222_4_nonhuman#8 
35 ERS025384 Cambodia Ratanakiri 2010 PH0363-C 1044 6222_4_nonhuman#9 
36 ERS025385 Cambodia Ratanakiri 2010 PH0364-C 1044 6222_4_nonhuman#10 
37 ERS025386 Cambodia Ratanakiri 2010 PH0365-C 1044 6222_5_nonhuman#1 
38 ERS025387 Cambodia Ratanakiri 2010 PH0366-C 1044 6222_5_nonhuman#2 
39 ERS025388 Cambodia Ratanakiri 2010 PH0367-C 1044 6222_5_nonhuman#3 
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40 ERS025389 Cambodia Ratanakiri 2010 PH0368-C 1044 6222_5_nonhuman#4 
41 ERS025390 Cambodia Ratanakiri 2010 PH0369-C 1044 6222_5_nonhuman#5 
42 ERS025391 Cambodia Ratanakiri 2010 PH0370-C 1044 6222_5_nonhuman#6 
43 ERS025392 Cambodia Ratanakiri 2010 PH0371-C 1044 6222_5_nonhuman#7 
44 ERS025393 Cambodia Ratanakiri 2010 PH0372-C 1044 6222_5_nonhuman#8 
45 ERS025394 Cambodia Ratanakiri 2010 PH0373-C 1044 6222_5_nonhuman#9 
46 ERS025395 Cambodia Ratanakiri 2010 PH0374-C 1044 6222_5_nonhuman#10 
47 ERS025396 Cambodia Ratanakiri 2010 PH0375-C 1044 6222_6_nonhuman#1 
48 ERS025397 Cambodia Ratanakiri 2010 PH0376-C 1044 6222_6_nonhuman#2 
49 ERS025398 Cambodia Ratanakiri 2010 PH0377-C 1044 6222_6_nonhuman#3 
50 ERS025399 Cambodia Ratanakiri 2010 PH0378-C 1044 6222_6_nonhuman#4 
51 ERS025400 Cambodia Ratanakiri 2010 PH0379-C 1044 6222_6_nonhuman#5 
52 ERS025261 Cambodia Ratanakiri 2010 PH0380-C 1044 6468_8_nonhuman#6 
53 ERS025401 Cambodia Ratanakiri 2010 PH0381-C 1044 6222_6_nonhuman#6 
54 ERS025402 Cambodia Ratanakiri 2010 PH0382-C 1044 6222_6_nonhuman#7 
55 ERS025403 Cambodia Ratanakiri 2010 PH0383-C 1044 6222_6_nonhuman#8 
56 ERS025404 Cambodia Ratanakiri 2010 PH0384-C 1044 6222_6_nonhuman#9 
1 ERS032003 Cambodia Tasanh 2008 PH0407-C 1031 6263_4_nonhuman#8 
2 ERS032638 Cambodia Tasanh 2008 PH0409-CW 1031 6345_4_nonhuman#3 
3 ERS032015 Cambodia Tasanh 2008 PH0411-C 1031 6263_5_nonhuman#8 
4 ERS032005 Cambodia Tasanh 2008 PH0412-C 1031 6263_4_nonhuman#10 
5 ERS032022 Cambodia Tasanh 2008 PH0413-C 1031 6263_6_nonhuman#3 
6 ERS032017 Cambodia Tasanh 2008 PH0415-C 1031 6263_5_nonhuman#10 
7 ERS032009 Cambodia Tasanh 2008 PH0418-C 1031 6263_5_nonhuman#2 
8 ERS032639 Cambodia Tasanh 2008 PH0420-CW 1031 6345_4_nonhuman#4 
9 ERS032010 Cambodia Tasanh 2008 PH0421-C 1031 6263_5_nonhuman#3 
10 ERS032640 Cambodia Tasanh 2008 PH0422-CW 1031 6345_4_nonhuman#5 
57 ERS024138 Cambodia Tasanh 2008 PH0139-CW 1031 6007_4_nonhuman#1 
58 ERS024139 Cambodia Tasanh 2008 PH0140-CW 1031 6007_4_nonhuman#2 
59 ERS024140 Cambodia Tasanh 2008 PH0141-CW 1031 6007_4_nonhuman#3 
60 ERS024141 Cambodia Tasanh 2008 PH0142-CW 1031 6007_4_nonhuman#4 
61 ERS024142 Cambodia Tasanh 2008 PH0143-CW 1031 6007_4_nonhuman#5 
62 ERS024143 Cambodia Tasanh 2008 PH0144-CW 1031 6007_5_nonhuman#1 
63 ERS024144 Cambodia Tasanh 2008 PH0145-CW 1031 6007_5_nonhuman#2 
64 ERS024145 Cambodia Tasanh 2008 PH0146-CW 1031 6007_5_nonhuman#3 
65 ERS024146 Cambodia Tasanh 2008 PH0147-CW 1031 6007_5_nonhuman#4 
66 ERS024147 Cambodia Tasanh 2008 PH0148-CW 1031 6007_5_nonhuman#5 
67 ERS024148 Cambodia Tasanh 2008 PH0149-CW 1031 6007_6_nonhuman#1 
68 ERS024149 Cambodia Tasanh 2008 PH0150-CW 1031 6007_6_nonhuman#2 
69 ERS024150 Cambodia Tasanh 2008 PH0151-CW 1031 6007_6_nonhuman#3 
70 ERS024151 Cambodia Tasanh 2008 PH0152-CW 1031 6007_6_nonhuman#4 
71 ERS024152 Cambodia Tasanh 2008 PH0153-CW 1031 6007_6_nonhuman#5 
148 ERS024137 Cambodia Tasanh 2008 PH0138-CW 1031 6007_3_nonhuman#5 
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Table S5. Chromosome end coordinates. This table represents the coordinates at the start 
(column 2) and the coordinates at the end (column 3) for each chromosome (column 1) that is 
not included in the analysis. The size of different chromosomes as in P. falciparum 3D7 
genome version 3 (PlasmoDB release version 11) is mentioned in column 4.   
Chromosome 
Positions at the starting 
of a Chromosome 
not included 
Positions at the ending 
of a Chromosome 
not included 
Chromosome 
Length (bp) 
Chromosome 1 1 – 117000 481500 - 640851 640851 
Chromosome 2 1 – 120000 783000 - 947102 947102 
Chromosome 3 1 – 135000 1002000 -1067971 1067971 
Chromosome 4 1 – 174000 1067000 - 1200490 1200490 
Chromosome 5 1 – 49000 1297000 - 1343557 1343557 
Chromosome 6 1 – 74000 1293000 - 1418242 1418242 
Chromosome 7 1 – 91000 1320000 - 1445207 1445207 
Chromosome 8 1 – 90000 1296000 - 1472805 1472805 
Chromosome 9 1 – 127000 1380000 - 1541735 1541735 
Chromosome 10 1 – 112000 1515000 - 1687656 1687656 
Chromosome 11 1 – 138000 1934000 - 2038340 2038340 
Chromosome 12 1 – 98000 2130000 - 2271494 2271494 
Chromosome 13 1 – 129000 2808000 - 2925236 2925236 
Chromosome 14 1 – 71000 3129000 - 3291936 3291936 
 
Table S6. Distribution of SNPs in the CDS region accounted for the 4 datasets: IBC, 
PlasmoDB Asian isolates and MalariaGEN African and Asian isolates. Account of 
synonymous SNPs, non-Synonymous SNPs, non-sense SNPs and read through SNPs in the 
CDS region of the genome. Column 2 represents total number of SNPs after filtering the data 
and removing unmapped SNPs, but including the SNPs in the chromosome ends. The 
percentage of SNPs out of the total number of SNPs (column 2) is shown in bold letters for 
all the 3 datasets.  
Dataset 
Total 
SNPs 
Synonymous 
(SYN) SNPs 
Non-
Synonymous 
(NSYN) SNPs 
Nonsense 
(NON) SNPs 
Read through 
(RTH) SNPs 
IBC 56565 
15992 
(28.27%) 
40316 
(71.27%) 
243 
(0.43%) 
14 
(0.02%) 
PlasmoDB 
(Asian isolates) 
17004 
4951 
(29.11%) 
11965 
(70.36%) 
59 
(0.35%) 
29 
(0.17%) 
MalariaGEN 85490 
26818 
(31.37%) 
58419 
(68.33%) 
244 
(0.28%) 
9 
(0.01%) 
 
Table S7. Number of significant SNPs and the number of significant genes in each 
subpopulation compared to ancestral KH1.1 artemisinin sensitive subpopulation. Significant 
SNPs were described using one tailed Fisher-exact test. For each SNP the ALT frequency in 
each subpopulation was compared to the ALT frequency in KH1.1 (45 isolates) to calculate 
the p-value. SNPs with p-value ≤ 0.05 were considered as significant and the genes 
containing these SNPs are considered as the significant genes in each subpopulation.    
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Subpopulations 
Number of 
isolates 
Number of 
Significant SNPs 
Number of 
Significant Genes 
KH1.2 5 1361 823 
KH2.1 11 1620 938 
KH2.2 22 2312 1125 
KH3 12 1495 859 
KH4 9 1891 978 
KH5 14 1612 900 
KHA 49 740 493 
 
Table S8. Number of genes in P. falciparum gene-gene interaction network with maximum 
expression in different parasite blood stage forms. This table is based on the co-expression 
interaction network (confidence score ≥ 0.5) recovered from STRING v10 database server. 
The unconnected nodes (genes) were not considered in the analysis. The maximum 
expression data is based on the transcriptomic study by Le Roch et al., [Le Roch KG. et al., 
2003] and is recovered from PlasmoDB. Data for early and late forms of the three blood stage 
ring, trophozoite and schizogony is available. Some of the genes are not classified in the 
interaction network. 
Gene Classification Number of Genes 
Ring 
Early 702 
1043 
Late 341 
Trophozoite 
Early 548 
1082 
Late 534 
Schizogony 
Early 391 
868 
Late 477 
Merozoite 711 
Unclassified 138 
Total 3842 
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Chapter 4
Variant calling in B. microti
genome
4.1 Introduction
The apicomplexan intra-erythrocytic parasite B. microti is an emerging pathogen
and main cause of human babesiosis, endemic in USA. It is transmitted by ticks
and by blood transfusion from asymptomatic B. microti infected humans. If not
diagnosed and treated properly, the infection could lead to severe symptoms and
could also cause death [Vannier et al., 2015]. In many cases inappropriate treatment
is provided, because of confusion with lyme disease and P. falciparum malaria. There
are still gaps in complete knowledge of the B. microti genome structure and not much
is known about the proteome, drug targets, population structure and epidemiology
of this parasite. There is not much information available about the genetic factors
involved in pathogenesis and ability to infect human.
Recently, efforts have been made to sequence the nuclear genome and organelle
genomes of B. microti, which lead to confirmation of the taxonomic position of B.
microti [Cornillot et al., 2012, Cornillot et al., 2013]. Understanding the genetic
structure of B. microti started with analysis of organelle genomes. In 2014, the
apicoplast genome of the reference R1 isolate was the last part of the genetic material
to be sequenced. I was involved in the apicoplast genome comparison with genomes
of closely related species. It was observed that the B. microti apicolast metabolic
functions are conserved among Apicomplexa and that the apicoplast can be targeted
for feasible therapies for the treatment of human babesiosis. The main objectives to
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sequence the apicoplast genome was to make it available for the population studies
and provide a complete reference genome for genome-wide analysis. This work was
published as “Sequence and Annotation of the Apicoplast Genome of the Human
Pathogen Babesia microti” in the PLOS One journal.
The lack of knowledge concerning B. microti diversity in the context of pathogen-
esis and host-pathogen interactions makes it difficult to understand the impact on its
virulence, transmission to humans, and disease diagnosis and therapy. Also, there is
lack of genetic diversity data, continuous in vitro cultures for parasite propagation
and tools to identify gene function in microbial development and virulence.
After the complete genome sequencing and annotation of the reference B. microti
R1 isolate genome, the idea was to sequence more genomes to better understand the
drug susceptibilities of B. microti and define the population structure of B. microti
in USA. B. microti reference genome (R1) was sequenced using Sanger methods to
produce long reads. The sequencing of 7 new B. microti isolates was initiated and was
aimed to proceed on the analysis, as was done in the case of P. falciparum (Chapter
3). The development of multiplexing approach decreased the genome sequencing price
drastically. In above chapters we presented work on understanding P. falciparum
population structure based on genomic data, and the idea was to proceed in the same
way for B. microti.
The next project focused on sequencing seven B. microti isolates and resequencing
of R1 isolate. I was involved in calling of variants, describing population structure in
USA and identification of potential genes with significant variations, which could help
in understanding the infection and population structure, as in the case of Plasmod-
ium falciparum in Cambodia (explained in Chapter 2 and Chapter 3). Sequencing
analysis was combined with transcriptomic analysis, and the secretome was shown
to be different from those reported in malaria parasites. This information could be
used for development of specific assay for detection of B. microti infection, as well as
for antibody-based targeted therapy. This work is under review process and I briefly
explain the parts of the projects that I was involved in and the problematic faced in
section 4.3.
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4.2 The Apicoplast genome
4.2.1 Approach
The nuclear genome and mitochondrial genome were described earlier [Cornillot
et al., 2012, Cornillot et al., 2013] and were used in the description of apicoplast
genome (Article3: Materials and Methods section). The sequencing technique used
was primer walking. PCR amplification was performed on complete genomic DNA
and the primers were designed based on the sequencing of apicoplast contigs from the
assembly of full genome [Cornillot et al., 2012]. Pair-end reads were obtained for at
least two PCR products (Article3: Table S1).
Artemis and BLAST were used for genome annotation. Genome comparisons for
B. bovis, Chromera, P. falciparum, T. parva, T. gondii and B. microti R1 strain were
performed using Mauve and ACT with manual curations. The genetic maps were
visualized using CGView and GenomeVx (Article3: Materials and Methods section).
4.2.2 Results
The sequence and assembly of the apicoplast genome revealed a circular molecule
of 28.7 kbp, making it the smallest apicoplast genome to date (Article3: Figure 1).
The AT richness is about 86% and coding density of about 98%. It encodes rRNAs,
18 ribosomal proteins, elongation factor, 3 subunits of RNA polymerase, chaperone
proteins, 24 tRNAs, 140 amino acids and 5 hypothetical proteins (Article3: Result
section “Sequence analysis of the circular apicoplast genome of B.microti”). The
annotation was consistent with the annotation of nuclear genome [Cornillot et al.,
2012, Cornillot et al., 2013]. Analysis of ribosomal proteins and RNAs revealed
significant similarity with other Apicomplexa.
There are four gene clusters found in common with other compared apicomplexan
parasites (Article3: Figure 2, S1 and S2) and the chloroplast genome of the Chromera
algae (Article3: Result section “B. microti carries the minimal apicoplast genome of
apicomplexa”). The hotspot of recombination was identified in the region between
cluster1 and cluster 2 (Article3: Figure 3 and Figure 4). Also, the difference in size
of apicoplast genome between the compared organisms could be due to the lack of
duplicated genes in B. microti. Specific genes in different clusters were conserved in
different organisms and duplication and recombination events were identified (Arti-
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cle3: Figure 5, Figure6 and Figure S3). This comparative analysis shows the various
rearrangements during various stages of apicoplast evolution (Article3: Figure 7),
whereas, loss of genes associated to photosynthesis occurred in early stages of the
apicoplast evolution. Based on this analysis, it is suspected that B. microti could
contain the core apicoplast organization of Apicomplexa.
4.2.3 Conclusion
The apicoplast genome encodes genes associated to transcription and translation
events and lacks genes associated with metabolic functions. The nuclear encoded
proteins are predicted to play an important role in parasitic life cycle in the erythro-
cytic stages of vectors. The apicoplast and nuclear encoded genes could be possible
drug targets for developing novel and feasible therapies. This study identifies the
markers of B. microti evolution among other Apicomplexa (Article3: Figure 7). Also,
the information concerning the major rearrangement events and lack of gene duplica-
tion can be used for population studies. Sequencing and annotation of the B. microti
apicoplast genome completes the full genome of B. microti to be used as a reference.
The apicoplast genome was recently used by Giovanna Capri and colleagues at Yale
University to assess USA B. microti population structure (work under review).
4.2.4 Article 3
Sequence and Annotation of the Apicoplast Genome of
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Abstract
The apicomplexan intraerythrocytic parasite Babesia microti is an emerging human pathogen and the primary cause of
human babesiosis, a malaria-like illness endemic in the United States. The pathogen is transmitted to humans by the tick
vector, Ixodes scapularis, and by transfusion of blood from asymptomatic B. microti-infected donors. Whereas the nuclear
and mitochondrial genomes of this parasite have been sequenced, assembled and annotated, its apicoplast genome
remained incomplete, mainly due to its low representation and high A+T content. Here we report the complete sequence
and annotation of the apicoplast genome of the B. microti R1 isolate. The genome consists of a 28.7 kb circular molecule
encoding primarily functions important for maintenance of the apicoplast DNA, transcription, translation and maturation of
organellar proteins. Genome analysis and annotation revealed a unique gene structure and organization of the B. microti
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Introduction
Human babesiosis is an emerging infectious disease caused by a
select group of intraerythrocytic protozoan parasites defining a
new clade in the Apicomplexan phylum distinct from those
encompassing Plasmodium species, Theileria species or Babesia
bovis [1]. Most babesiosis infections in humans are caused by
Babesia microti and are transmitted by Ixodes ticks, the vectors
responsible for transmission of several other pathogens including
Borrelia, Anaplasma and Ehrlichia species. Human babesiosis is
endemic in northeastern and northern midwestern United States
but has also been reported in Europe, Asia, Africa, Australia and
South America [2,3]. Depending on their immune status and age,
patients with human babesiosis can experience mild, moderate or
severe illness with the latter possibly leading to multi-organ system
failure and death. In the United States, the mortality rate
approaches 9% in hospitalized patients and ,20% in immuno-
compromised hosts [3,4]. As a result babesiosis has been
recognized as an emerging health threat [5], and since 2011 has
been designated as a nationally notifiable disease by the Center for
Disease Control [6].
The ability of B. microti to invade and multiply within human
red blood cells, and the lack of effective tools for large-scale
screening of blood for B. microti infection from asymptomatic
donors make this parasite a major risk to the national blood supply
[7,8]. Accordingly, B. microti is now considered the most
commonly reported transfusion-transmitted pathogen in the
United States [5], and the number of documented cases of
acquired infections by transfusion has substantially increased over
the years [9]. Although babesiosis therapy, which consists of
combination of atovaquone and azithromycin or clindamycin and
quinine [10], is considered generally effective, adverse events and
disease failure and relapse can occur in some patients.
Recent efforts aimed to probe the diversity, pathogenicity and
metabolism of B. microti and to identify new markers and targets
for diagnosis and therapy of human babesiosis have led to the
completion of the first genomic sequence of a clinical clone named
R1 [11]. Subsequently Whole Genome maps of two B. microti
strains R1 and Gray were reported [12]. These genomic analyses
revealed that the genome of B. microti is less than 7Mbp, making it
the smallest nuclear genome among apicomplexa [11]. Phyloge-
netic analyses placed B. microti in a new lineage among
apicomplexan parasites distinct from B. bovis and Theileria
species [11]. The genome effort has also revealed that the parasite
has two DNA-containing organelles, the mitochondria and the
apicoplast. The apicoplast is a non-photosynthetic plastid that
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plays an essential role in parasite development and survival
[13,14]. Genetic and biochemical studies in malaria and related
parasites have shown that this organelle hosts important metabolic
and housekeeping processes, which are critical for parasite survival
within host cells (reviewed in [15]). Some of these pathways exist in
B. microti and are significantly different from their host
counterparts thereby offering new opportunities for the develop-
ment of selective therapies for treatment of human babesiosis [11].
While the linear mitochondrial genome of B. microti has been
fully characterized by two independent studies [12,16], the
apicoplast genome of this parasite remained partially assembled
due to its high A+T content and to its low representation. Here we
report the completion of the genomic sequence of the apicoplast of
the B. microti R1 isolate. We show that this genome consists of a
28.7 kb circular molecule, which encodes genes involved in
maintenance of the apicoplast DNA, transcription, translation
and maturation of organellar proteins. Sequence analysis of the B.
microti apicoplast genome and genome comparisons revealed that
major gene alterations and rearrangements occurred in the
apicoplast genomes during the evolution of piroplasms.
Materials and Methods
Sequencing, assembly and annotation of the apicoplast
genome
Genomic DNA used to complete the sequence of the R1
apicoplast genome was previously described [11,12]. The
apicoplast genome sequence was obtained by primer walking
using long PCR reactions. PCR amplification was performed using
total genomic DNA and primers designed following sequencing of
apicoplast genome contigs obtained after the first genome
assembly [11]. Sequencing was performed on both strands and
from at least two PCR products using specific primer pairs (Table
S1 in File S1). The complete sequence of the apicoplast genome
was deposited in the European Nucleotide Archive with Accession
Number LK028575. Genome annotation was performed using
Artemis (https://www.sanger.ac.uk/resources/software/artemis/)
[17] and BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Pre-
diction of tRNA genes was performed using tRNAscanSE 1.21
(http://lowelab.ucsc.edu/tRNAscan-SE/) with the following pa-
rameters: search mode: ‘‘default’’, and source: ‘‘Mito/Chloro-
plast’’ [18]. Genetic maps were obtained using CGView (http://
stothard.afns.ualberta.ca/cgview_server) [19] and GenomeVx
(http://wolfe.ucd.ie/GenomeVx) [19]. Genome comparisons
were performed using Mauve (http://gel.ahabs.wisc.edu/mauve)
[20] and edited using ACT (https://www.sanger.ac.uk/resources/
software/act) [21]. Manual editing to correct the above automated
analyses was completed on a gene-by-gene basis as needed. The
following entries were used for comparative analyses:
AAXT01000007 (B. Bovis), HM222968 (Chromera), fusion of
X95275 (IRA) and X95276 (IRB) (P. falciparum),
AAGK01000009 (T. parva), U87145 (T. gondii). Phylogenetic
analyses were performed using Phylogeny.fr with default options
[22]. TMpred (http://www.ch.embnet.org/software/
TMPRED_form.html) and Pfam (http://pfam.sanger.ac.uk/)
were used for transmembrane domain and motif predictions
[23,24].
Results and Discussion
Sequence analysis of the circular apicoplast genome of B.
microti
Previous efforts aimed to sequence the nuclear and organellar
genomes of B. microti identified several contigs representing
partial sequences of the apicoplast genome of this parasite. In
order to generate a complete sequence of the apicoplast genome,
we performed primer walking using total genomic DNA and
specific primers derived from the complete sequencing of the
individual contigs. Sequencing and assembly revealed that the
apicoplast genome of B. microti is composed of a circular molecule
of 28.7 kbp. It is the smallest apicoplast genome found in
apicomplexan parasites. The genome is 86% A+T rich and has
a coding density of over 98%. It encodes SSU and LSU rRNAs,
18 ribosomal proteins, an EF-Tu elongation factor, three subunits
of the RNA polymerase, 2 copies of the ClpC chaperone, 24
tRNAs and five hypothetical proteins ranging in size between 49
(Hyp-E) and 140 amino acids (Hyp-A) (Fig. 1). All genes encoded
in the apicoplast genome of B. microti are transcribed in the same
orientation (Fig. 1). AUG or AUA serve as initiators for 18 and 13
of the 31 codon sequences (CDSs), respectively, and are preceded
by an A-rich region that may play an important role in the
recruitment of the ribosome. Consistent with this unusual
translation initiation, a single Met-itRNA with an UAU anticodon
was found in the apicoplast genome. Termination codons used in
the CDSs of apicoplast genome include UAA (25 of the 31 CDSs)
and UGA (6 of the 31 CDSs). This finding is consistent with the
annotation of the B. microti nuclear genome, which identified an
apicoplast targeting motif in the RF2 release factor [11]. No UAG
stop codons were found in the apicoplast genome of B. microti
consistent with the lack of an apicoplast targeting sequence in the
RF1 release factor encoded by the nuclear genome [11].
The majority of CDSs in the apicoplast genome of B. microti do
not overlap, and only four coding sequences were found to overlap
over one to three codons, making the start of one CDS part of the
stop codon of the previous CDS. tRNAscanSE analyses identified
24 tRNAs. In addition to the Met-itRNA, other tRNAs with a U
at the first position of the anticodon have been found but the
Wobble pairing U - G represents less than 1% of codons in the B.
microti apicoplast genome. Half of the tRNAs known to decode
codons ending with a U or a C were not detected by tRNAscanSE;
these tRNAs might have a sequence that is too divergent from
others to be recognized by tRNAscanSE. Similar to P. falciparum,
CGU is the only codon found in the B. microti apicoplast genome
used for arginine in the CGN group.
Detailed analysis of the ribosomal proteins and RNAs predicted
from the B. microti apicoplast genome revealed significant
similarity with other apicomplexa. The genome encodes proteins
of the small (11 rps proteins) and large (7 rpl proteins) ribosomal
subunits. Additional ribosomal proteins are encoded by the
nuclear genome and targeted to the apicoplast [11]. Association
of nuclear and apicoplast encoded ribosomal proteins with 16S-
and 23S-like rRNA molecules may form the apiRibosome of B.
microti. No 5S ribosomal RNA-encoding rff gene could be found
in the B. microti apicoplast genome. This finding suggests that the
apicoplast ribosomes of B. microti are independent of 5S rRNA or
that the apicoplast can either import 5S RNA from the cytoplasm,
as was previously shown for mammalian mitochondria [25,26], or
expresses a gene with a sequence highly divergent from known rff
genes. Noteworthy, whereas the chloroplast genome of Chromera
expresses an rff gene, no rff genes were found in the apicoplast
genomes of all apicomplexan parasites sequenced to date.
Annotation of the apicoplast genome of B. microti revealed 5
hypothetical coding sequences (hypA–E). The encoded proteins do
not share significant homology with any protein in available
databases and do not contain any recognizable functional
domains. Examination of the apicoplast genomes of other
apicomplexan parasites shows the presence of unknown but
dissimilar proteins in the same genomic regions. Whether these
Apicoplast Genome of B. microti
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CDSs are expressed or are an artifact of annotation remains to be
determined.
B. microti carries the minimal apicoplast genome of
apicomplexa
Four gene clusters in the B. microti apicoplast genome were
found to be in a synteny with those found in other apicomplexan
parasites (Fig. 2 and Figures S1 and S2 in File S1) as well as the
chloroplast genomes of Chromera algae [27]. Cluster 1 includes
genes encoding ribosomal proteins and the EF-Tu elongation
factor (Fig. 3). Similar to the gene organization found in Theileria
parva, Toxoplasma gondii and Babesia bovis, Cluster 1 of the
apicoplast genome of B. microti lacks the rpl23 gene. This gene is
present in Chromera and Plasmodium species between rpl2 and
rpl4 genes but was lost during the evolution of the apicoplast in
most apicomplexa. Two copies of the rps8-hypA genes encoding
S8 ribosomal protein and a hypothetic protein (Hyp-A) are found
in the Cluster, whereas no rps13-like gene could be found in this
genome. In Chromera sp., rps13 is located between rps5 and
rpl36, whereas in most apicomplexan parasites, this region
contains a gene with unknown function or lacks a CDS as in the
case in T. gondii (Fig. 3).
Cluster 1 of the B. microti apicoplast genome is surrounded by
10 tRNA genes on the side adjacent to Cluster 4 and 2 tRNA
genes for Gln(UUG) and Trp(CCA) on the side adjacent to Cluster
2 (Fig. 4). Interestingly, in T. parva the junction between Cluster 1
and Cluster 2 contains two more tRNA genes for Lys(UUU) and
Cys(GCA), whereas in B. bovis this region lacks tRNA regions.
Unlike B. microti, the junction between Cluster 1 and Cluster 2 in
T. parva and B. bovis contains several putative CDSs of unknown
function some of which are identical copies of the same CDS
(Tp020 and Tp021 in T. parva) and (Bb210 and Bb200, and
cluster Bb200–Bb190 and Bb180–Bb170). The duplicated CDSs
found in T. parva do not share homology with those found in B.
bovis (Fig. 4). Altogether, these data suggest that the region
between Clusters 1 and 2 might be a hot spot of recombination,
and that major recombination events involving of regions adjacent
to Cluster 1 may have taken place during the evolution of
piroplasmida (Fig. 4). Furthermore, the lack of duplicated genes in
B microti may account for the differences we see in size between
these organisms.
Cluster 2 of the B. microti apicoplast genome consists primarily
of ClpC chaperones (Fig. 5). Similar to B. bovis and T. parva, the
ClpC gene of B. microti is duplicated with both copies containing
the AAA_2 ATPase domain (Fig. 4 and Fig. S3 in File S1). The
region of Cluster 2 adjacent to Cluster 3 contains a Ser(UGA)
tRNA and three hypothetical proteins (Hyp-C, Hyp-D and Hyp-
E) (Fig. 1). The position of the Ser(UGA) tRNA is conserved in
other apicomplexan parasites including T. parva (Fig. 4), P.
falciparum and T. gondii (Fig. 5).
Figure 1. Graphical circular map of the apicoplast genome of B. microti R1 isolate. The map was designed using CGview and GenomeVx.
From outside to center: coding sequence (CDS), % G+C, GC skew and base coordinates. hypA-E refer to five hypothetical protein encoding genes
found in the apicoplast genome of B. microti.
doi:10.1371/journal.pone.0107939.g001
Apicoplast Genome of B. microti
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Similar to B. bovis, P. falciparum and T. parva no rpl11
ribosomal gene was found in the B. microti apicoplast genome
(Fig. 2 & 5). This finding suggests that either the ribosomes of these
parasites do not require the L11 protein or that protein translation
in the apicoplast of these parasites involves an rpl11-like gene
radically divergent from that found in T. gondii, and prokaryotes
and located on a different site in the apicoplast genome or possibly
encoded by the nuclear genome. Because of the conserved gene
order rpl11-clpC in Chromera, and T. gondii, the loss of the rpl11
gene in the apicoplast genomes of parasites within the Class
Aconoidasida (which includes Haemosporida and Piroplasmida)
Figure 2. Schematic representation of gene clusters in the apicoplast genomes of various apicomplexan parasites. Comparison was
performed using Mauve and BLAST analyses. The red and blue bars between chromosomal DNA sequences represent highly conserved regions in the
forward and reverse directions respectively. Only highly conserved and syntenic regions were included in the present analysis. tRNA genes are
marked by *.
doi:10.1371/journal.pone.0107939.g002
Figure 3. Gene organization of cluster 1 in the apicoplast genomes of B. microti (R1), B. bovis (T2Bo), P. falciparum (3D7), T. gondii and
T. parva (Mugaga) and the chloroplast genome of Chromera sp. (CCMP3155). Light grey boxes represent highly divergent genes. White
boxes corresponds to genes restricted to one species.
doi:10.1371/journal.pone.0107939.g003
Apicoplast Genome of B. microti
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might be linked to the rearrangement of the tRNA region adjacent
to the clpC gene.
Cluster 3 of the B. microti apicoplast genome includes the
‘‘RNApol cluster’’ and contains in addition to the RNA
polymerase genes (rpoB, rpoC1, rpoC2.1 and rpoC2.2), the gene
encoding the S2 ribosomal protein, rps2 (Fig. 1 and 2). In B.
microti as well as other apicomplexa, the alpha subunit of RNA
polymerase (rpoA) gene is encoded by the nuclear genome,
whereas in algae chloroplast genomes the gene encoding is present
on cluster 1 (Fig. 3). Orientation of Cluster 3 genes in B. microti,
T. parva and B. bovis is opposite to that found in P. falciparum
and T. gondii, suggesting an inversion event that took place early
during the evolution of piroplasmida (Fig. 2). Such an event might
be responsible for the loss of the sufB gene in piroplasmida.
Cluster 4 of the apicoplast genome of B. microti includes rDNA
genes. This region consists of a single set of ssu and lsu genes,
Figure 4. Schematic representation of the DNA regions surrounding cluster 1 in B. microti R1, B. bovis T2Bo and T. parva Mugaga. A
line connecting the two ends of Cluster 1 indicate possible recombination events accounting for differences found in the gene organization and size
between apicoplast genomes of piroplasmida.
doi:10.1371/journal.pone.0107939.g004
Figure 5. Domain structure and organization of Cluster 2 genes in B. microti and other apicomplexan parasites. A. Comparison of ClpC
domain structure between B. microti, P. falciparum, T. gondii and Chromera sp. B. microti apicoplast genome encodes two ClpC proteins that lack the
N-terminus part as revealed by Pfam and TMpred predictions. Other apicomplexan ClpC structures have been obtained from Pfam database using
UNIPROT accession numbers. Two PfamA domains are found in ClpC proteins of apicomplexa: AAA_2 (ATPase catalytic function) and ClpB_D2-small
(conserved C-terminal domain). Light grey boxes indicate regions of low complexity. Transmembrane domains were predicted by Pfam only for T.
gondii ClpC proteins (TM). B. Gene organization of cluster 2. The tRNA genes of cluster 2, which are conserved in all three apicoplast genomes are in
bold. Three putative genes, C, D and E present at 39 end of B. microti cluster 2 have no significant homologies with each other and lack homologs in
other parasites.
doi:10.1371/journal.pone.0107939.g005
Apicoplast Genome of B. microti
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which are transcribed in the same orientation (Fig. 6). In
Chromera sp., T. gondi and P. falciparum apicoplast genomes,
this cluster consists of two sets of ssu and lsu genes in opposite
orientation (Fig. 6). Gene content and gene order in this cluster
Figure 6. Organization and evolution of the rDNA region in the apicoplast genome of B. microti and other apicomplexa. A.
Phylogenetic analysis based on ssu and lsu genes. The tree was obtained using the maximum-likelihood method with (Bootstrap over 90%). Genomic
organization of rDNA regions in the apicoplast or chloroplast genomes is given on top of each branch. B. Gene organization of the rDNA regions. The
tRNA genes that are present in all apicomplexan genomes are shown in bold. Scale bar represents the number of substitutions per site.
doi:10.1371/journal.pone.0107939.g006
Figure 7. Summary of the evolution of the organization of the apicoplast genome in apicomplexan parasites. The unweighted tree
was built using raw data from Figure S2 in File S1. The branch supporting the clade piroplasmida is associated with several major genomic
rearrangements. *: events that occurred twice in the apicoplast evolution; +: rearrangement, duplication and insertion events observed in B bovis and
T. parva involving distinct genes.
doi:10.1371/journal.pone.0107939.g007
Apicoplast Genome of B. microti
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differ between species. In Chromera, the ssu and lsu genes are in
the same orientation and separated by a CDS; in Toxoplasma and
Plasmodium the ssu and lsu genes are in opposite orientation; and
in B. bovis, 2 ssu genes are located upstream of the lsu gene and all
three genes are transcribed in the same orientation. Unlike B.
microti and T. parva, a second Thr(UGU) tRNA exists between
the ssu and lsu genes in B. bovis (Fig. 6). This gene organization is
likely the result of duplication events that occurred in the rDNA
region during the evolution of B. bovis.
Comparison of different apicoplast genomes shows that major
rearrangements took place during the various stages of apicoplast
evolution (Fig. 7). While the loss of genes involved in photosyn-
thesis represent a major early event in the evolution of the
apicoplast, deletion of sufB, inversion of the RNApol region,
reorganization of the rDNA region and duplication of the clpC
gene represent important events that occurred during the early
evolution of piroplasma. B. microti apicoplast genome carries these
modifications but shows no DNA expansion (duplication of small
regions) as is the case in B. bovis and T. parva. This suggests that
B. microti may harbor the core apicoplast genome organization of
apicomplexa.
Conclusion
We have completed the sequencing and assembly of the
apicoplast genome of B. microti. Our studies revealed that this
28.7 kb circular genome encodes a simple machinery devoted
primarily to the transcription and translation events occurring
within this organelle. The genome lacks genes associated with
metabolic functions but harbors five genes encoding small
hypothetical proteins whose function remains unknown. Our
analysis of the apicoplast genome of B. microti complements our
prior annotation of the nuclear genome of this pathogen, which
identified several genes encoding structural and regulatory
proteins and enzymes harboring an apicoplast targeting motif
[11]. These nuclear encoded proteins are predicted to control
important metabolic functions during the parasite life cycle in
mammalian red blood cells and the tick vector. The potent activity
of drugs such as azithromycin and clindamycin [28] against B.
microti indicates that the apicoplast plays an essential role during
the parasite intraerythrocytic life cycle. Targeting the apicoplast-
and nuclear-encoded functions important for apicoplast mainte-
nance and replication may help identify and design novel, potent
and safer therapies for the treatment of human babesiosis.
Supporting Information
File S1 Figure S1: Multiple alignment of apicoplast genomes
from B. microti and other apicomplexan parasites using Mauve.
Apicoplast genomes are laid out horizontally with colored blocks
representing homologous regions. Gene synteny and BLAST
analysis were used to define gene clusters. Figure S2: Major
genomic rearrangements revealed by comparing apicoplast
genomes of various apicomplexan parasites. Red and blue areas
represent conserved syntenic regions in the forward and reverse
directions, respectively. Figure S3: Domain structure of ClpC
proteins encoded by the apicoplast genome of piroplasmida. The
apicoplast genomes of the Babesia bovis T2Bo, Babesia microti R1
and Theileria parva Mugaga encode two ClpC proteins containing
a conserved ATPase domain (PfamA AAA_2 domain) and several
transmembrane domains predicted using TMPred (TM). The
figure was generated using Pfam server either using UNIPROT
accession number or by direct submission of the amino acid
sequence. Regions of low complexity are represented in blue.
PfamB domains are represented by horizontal lines. Table S1:
Primers used to assemble and sequence the B. microti apicoplast
genome. Coordinates are given according to the sequence
available at accession number LK028575. Primer orientation: w
for Watson strand and c for Crick strand.
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Table S1: Primers used to assemble and sequence the B.microti apicoplast genome. 
Coordinates are given according to the sequence available at accession number LK028575. Primer 
orientation: w for Watson strand and c for Crick strand. 
Name  Sequence       Begin End  Strand 
!"#$%$& & ''()**(**)*)'')***))'*)*)))())(& & & & +,+& +-+& .&
/"0+1234)& *'()(*'*(')*'**)***)***)((*))**))'**))*((& & 5+6& 566& 7&
.28+1##9& ()***))*'*'''**')'))()')**)'***(*'*)(& & & +6:$& +6-;& .&
<),5=>?;@3& *)*)()'''())''')))*()*'*& & & & & ,:A;& ,6-5& 7&
)),=4$:@B& )(*))'(()((*())')))((*& & & & & 6--$& 6-$,& 7&
)),=4$:@BB& ()***(*))*')(*)())*)*()(**& & & & 6;56& 6C$-& 7&
<),5=>?;@B& ))'*')*)**'*)'*()**)')))*')& & & & 6C$-& 6;5:& .&
)),=4$:@3& ****'))*)(**)()))))**''*')**& & & & ;5;C& ;5:-& .&
<)$-=D+,@3& ))))(*)'*))*)*)***(**((*((**& & & & CAC6& C5-$& 7&
'28+E1B&& '')')*(()(()(()())((&&& & & & & AA:,& AA;$&&& 7&
<)$-=D+,@33& )*(()(()(()())((*))& & & & & AA:C& AA;6& 7&
<)$-=D+,@BB& ****)''**'*''*''*'')&& & & & & AA;C& AA:A& .&
<)$-=D+,@DF*& *))**())''***))(*)(**& & & & & 5;+;& 5;,;& 7&
.28+1!"#,& *)*)**')((*)((***))*))(**)))*))*)()*'))))(**(& 5C6+& 5C56& 7&
<)$-=D+,@B& )'**)**)))''*)''*())*)*)*)&& & & & 5CC:& 5C-5& .&
3>D+1DGH8& **)*)*')))))(****(()*'))*)*')*'))(*'))**)())*'& +--:$& +--AC& 7&
(/",%+& & *))(******)*(('*)))(**'****((*)))*))(*& & & +++:,& +++A-& 7&
(/",%$& & ))**))****)*)'**)***)''))))())'***)('')&& & +++5$& +++6:& .&
65:A%+& & )*))*())())'(*)**))))*()()))****)'***)())(*)(*& ++C-6& ++C6-& 7&
(/",%,& & ())))))*)))*)*))))()))))(*)**()'''))**))()& & +$+$C& +$+;A& 7&
(/",%:& & )'**)*)))******))*)*))(*)*)*)*))*'**))**(((*& & +$$--& +$+6C& .&
65:A%+& & )*))*())())'(*)**))))*()()))****)'***)())(*)(*& +$:C-& +$6+6& 7&
(/",%,& & ())))))*)))*)*))))()))))(*)**()'''))**))()& & +$A5,& +$5,,& 7&
(/",%:& & )'**)*)))******))*)*))(*)*)*)*))*'**))**(((*& & +$5;6& +$5$:& .&
(/",1>3):& '*)*)(*))()*))**))))***))*)'''*)*'& & & +,+:+& +,+-A& .&
(/",1#IJ+%+& )))**)*)**)***)))))**)'(()***))*))')(*& & & +,:--& +,:,C& 7&
(/",1>3),& ''***)'')(*)*)))')**)*)'*****))*)******)**'*)'& & +,6;A& +,6$,& .&
(/",1>3)+& ((*))*))))')(()*((*(*(()**)(()(*& & & +,AC+& +,5-$& 7&
(/",1#IJ+%$& )*'*'*)))*'*)**))*)))***))****)'))''***& & & +:-6;& +:-+A& .&
(/",1>3)5& **)****)*))***))))****)')'**)*((*)*)((*& & & +:,-,& +:,:+& 7&
(/",1>3)+-& )))))*))*))))*)*)*))***)))))*)''*)*)'')& & +:,C-& +:,,$& .&
(/",1#IJ$%+& )))***(*))))))*(*)()**))*))())()))*))))& & +:6:,& +:6A+& 7&
(/",1>3)C& ***())***)*)))*()****())'')')*())()*()(& & +:A$:& +:CA;& .&
(/",1>3)$& )**)****))(****'**)*))*(()*(*)()(**& & & +6--C& +6-:+& 7&
(/",1#IJ$%$& **))**'****)''*'**)*)('**()***))*(**& & & +6$+A& +6+A,& .&
(/",1>3)A& **))****)**)**')***)**''*)*)*******)')'')& & +66CC& +66,C& .&
65$5%+& & **))*(**(****)'')*()*'*)*)*()''*)*)(*)''*)')& & +;$C-& +;$$C& .&
KB*+1LGH8& ''*(*))'*)')(*)''*'*)''*(**)**))))))'*)*'**'& & +;A56& +;A6$& .&
))5=4+$1KB*M&&&***)*))''*()*))))))((***)*(*'*)''*''**'&& & +C+5-&& +C+6$& .&
))5=4+$@B$& ))))*(('*)*('')((*(& & & & & +C$;,& +C$A+& 7&
))5=4+$@B3+& *(*))*))*)''*('*''& & & & & & +C,AA& +C,C+& .&
))5=4+$@B,& ))'*()))*)()*)((***(& & & & & +CAC6& +CA5:& 7&
))5=4+$@B3$& '*)**)**)(*(**)')**())& & & & & +A-;;& +A-:6& .&
))5=4+$@33$& (*)(**(()**)*)*(*((& & & & & +A;-;& +A;$:& 7&
))5=4+$@3,& ''*((*((*('(''& & & & & & +AC;6& +AC6$& .&
))5=4+$@33,& ())*****)))*)())**()*(& & & & & +5-;+& +5-A$& 7&
))5=4+$@3$& )*)'*)))()***)'')')))*)*'& & & & & +5,$A& +5,-:& .&
'L".%+& & **(******))*))*()*)***(()*))*)())*(*()& & & +56$,& +56;-& 7&
'L".%$& & *)*)(*)**))*))*)'****))))()(**)*))*))*))**)))(& +5;C;& +5C$+& 7&
'L".,& & **'***')*')*'*)')(()(*& & & & & $-,C5& $-:--& 7&
(/"$%+& & )(')***()***()()*'**)(*))*)*(((**& & & $++:$& $++C:& 7&
(/"$1#IJ+%+& **)))))*))))))**)*')**))'*))))))))))& & & $+6A-& $+;+6& 7&
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(/"$%$& & ****(**())***)*****)**())*)*(****)**& & & $$+$6& $$-5-& .&
!"G<,& & (**)))*)*(**)**(*)***(*& & & & & $$$5A& $$$C;& .&
(/"$1#IJ+%$& ****))))*))***')'**)**())()(*(***& & & $$:;C& $$:,6& .&
!"G<%+& & )*(')*****())''')*))()''''*)'& & & & $,--:& $$5C;& .&
!"G<%$& & ***)**)'))*)'')()*())*)(()))**)*)'))& & & $,+$,& $,-AA& .&
!"G'%$& & *)**)(**((**)*'**))***)('*)**)*)')*(& & & $6C$6& $6C;-& 7&
!"G'%+& & ()')*)*))*)*)*)'*(*))**')**)))**'*())'& & & $6A$$& $6A65& 7&
A:6$%+& & ))))))))(*'))***)*)')))*)*')'))*& & & $;$$+& $;$6$& 7&
(/"+%$& & ))*)**)*))))))))*)()*)((()*()****()& & & $C$-+& $C$,6& 7&
(/"1+%+&& )*)*)**(**()(*)**)(*)***))*))*)))'')& & & $C,$6& $C$5-& .&
!"#$%+& & ))**)*))))*))*'*)*)'')*'')()*''*& & & & $C5;,& $C5,$& .&
/"0+1!"#$& ')'****'')*())()*))))))*))))(***))*(**))**'*(&& $A$;6& $A$$+& .&
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4.3 Nuclear genome of 7 isolates
4.3.1 Approach and Results
The main focus of this study was the host-parasite interaction to identify targets for
development of novel diagnosis assays and therapies for the treatment of babesiosis.
In this study combination of RNAseq data, genomic variation data and antigenicity
data was used for the identification of factors potentially involved in pathogenesis.
High-throughput genome sequencing of 7 B. microti isolates (Table 4.1) and re-
sequencing of R1 isolate was performed using whole genome shotgun sequencing plat-
form by the colleagues at Yale and Maryland University. The reads were aligned
to the reference B. microti R1 genome using BWA tool. All nucleic acid material
was obtained from the intra-erythrocytic life cycle stages of parasite propagated in
rodents (Mice and Golder Syrian hamsters). RNAseq data was generated for six of
the isolates using Illumina HiSeq2000 sequencer and the RNAseq reads were mapped
onto the genome sequence with Bowtie.
 R1 ATCC 30222 ATCC 
PRA-99 
Bm1438 GI Naushon GreenwichYale
_Lab_Strain_1 
(Lab_Strain_1) 
Nan_Hs_2011
_N11-50 
(N11-50) 
Specimen 
Source Species 
 
Homo 
sapiens 
Thamnomys 
surdaster 
Homo 
sapiens 
Homo 
sapiens 
Homo 
sapiens 
 Ixodes 
scapularis 
Peromyscus 
leucopus 
Homo sapiens 
Species Source 
Common Name 
 
 
Human Forest mouse Human Human Human 
Black-
legged deer 
tick 
White-footed 
mouse 
Human 
Specimen 
Collection Date 
2002 1950 1973 2014 1981 1986 Unknown 2011 
Specimen 
Collection 
Location 
 
 Rennes, 
France 
 Congo 
Kinshasa, 
Zaire 
Nantucket 
Island, MA 
Nantucket 
Island, MA 
Nantucket 
Island, MA 
Naushon 
Island, MA 
Greenwich, CT 
Nantucket 
Island, MA 
Laboratory Host 
(DNA) 
 
Gerbil 
Golden Syrian 
Hamster 
C3H SCID 
mouse 
C3H SCID 
mouse 
Golden 
Syrian 
Hamster 
Golden 
Syrian 
Hamster 
C3H SCID 
mouse 
Golden Syrian 
Hamster 
Laboratory Host 
a 
(RNA) 
 
 
N/A 
Golden Syrian 
Hamster 
C3H SCID 
mouse 
N/A 
Golden 
Syrian 
Hamster 
Golden 
Syrian 
Hamster 
C3H SCID 
mouse 
C3H SCID 
mouse 
 
Table 4.1: Metadata for seven sequenced B. microti isolates
The re-sequencing of R1 genome and sequencing of the 7 isolates confirmed the
smallest size of the genome among other apicomplexan with increased gene den-
sity [Cornillot et al., 2012, Cornillot et al., 2013].
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4.3.1.1 Variant Calling
The SNPs and small INDELs were called from the whole genome sequencing data after
alignment, using SAMtools and GATK. Two different approaches were considered for
calling variants. First variant calling approach is based on the parameters used to
filter the data at Maryland University, which are DP (Raw read Depth), QUAL (Base
quality score), SB (similar to DP4 in SAMtools; accounting for the reads of each
allele in each strand) and MQ0 (Count of all reads with mapping quality as 0). These
parameters were trained for the choice of the correct filtering threshold. SNPs that
passed the filter were attributed to non-coding or coding regions using VCFannotator
(http://sourceforge.net/projects/vcfannotator) in the context of the reference genome
re-annotation. This approach recovers a list of 1490 possible variation sites, where
more than 95% were single point mutations. INDELs were analyzed differently from
SNPs and all were kept for further analysis.
When the Sanger sequencing of PCR products was performed for six identified loci:
BBM_01g00985, BBM_02g04060, BBM_02g04280, BBM_03g00885, BBM_03g04060,
BBM_04g09150, none of the variation described in the VCF files in these regions
could be confirmed experimentally. Analysis was done on the 8 strains for loci
BBM_02g04280 and BBM_03g04060 and on R1 only for the four other loci. This
confirmed the need of a specific and stringent variant calling method to avoid false
positive variations.
In the second variant calling approach all the quality parameters made available
by GATK UnifiedGenotyper were analyzed for the signal (as in the case of P. fal-
ciparum described in Chapter 3) and correspondence with training mutations. The
histogram of several parameter including the ABHom (At a specific locus reads with
ref allele over all reads), DP (Raw read depth) and MQ (Mapping quality) value were
constructed per isolate for each SNP positions. These parameters are different from
the parameters used in the variant calling in P. falciparum genome, as the signal is
different due to different genome structure and due to different tool to call variants
(GATK instead of SAMtools). The ABHom parameter evaluating homozygosis at a
locus provided valid information over the threshold of 0.85. Also, SNPs above the
MQ value over 58 were kept. DP had no impact after these two thresholds were
chosen, but in some isolates at some loci, DP could be equal to zero and these loci
were identified as uncovered region. We found 889 (588 single point mutations, 301
insertions/deletions) highly reliable variants in the nuclear genome after analysis of
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the eight sequences due to NGS technologies. Apart from the SNPs and INDELs,
260 microsatellites (12 fully characterized polymorphic loci) were also identified by
colleagues at Maryland University using Tandem Repeat Finder (TRF) tool.
It was observed that the R1 isolate is very different from other isolates, based
on the genes having the mutations. The average pairwise difference between each
isolate and the R1 is 588 SNPs, corresponding to a frequency of 0.9 SNPs/10Kb. The
majority of the variable positions were found to be R1-specific, all other genomes
being mutated. Furthermore, 54 SNP and 58 INDELs were unique to one of the
isolates. Nine sequencing errors were found in the R1 reference genome (1 SNP and
8 INDELs present in all isolates including re-sequenced R1). The two R1 sequences
had 27 INDELs differences, which were also present in some of the other isolate (3
being unique to re-sequenced R1). These 27 loci might be errors but could also be
mutations hotspots. Only 20% of all INDELs are in CDS and nearly half of them
are in-frame mutations. The distribution of INDELs, non-synonymous, read-through
and non-sens SNPs was not strictly uniform across the genome. They are 205 genes
carrying these mutations. Most contain one variable sites, but 27 genes combined
contain nearly one thirds (79/257) of protein affecting mutations (Table 4.2 and 4.3).
 R1 ATCC 30222 ATCC PRA-
99 
Bm1438 GI Naushon GreenwichYale
_Lab_Strain_1 
(Lab_Strain_1) 
Nan_Hs_2011_
N11-50 
(N11-50) 
Genome data 
gDNA shearing 
size (bp) 
500 241 271 500 240 255 416 303 
No. gDNA reads 
 
49,000,00
0 
427,433,106 463,798,222 
43,500,
000 
103,455,108 93,165,064 77,047,792 108,523,562 
SRA accession 
 
 SRP026017 SRP026029  SRP026012 SRP026015 SRP026028 SRP026025 
Genome assembly 
accession 
N/A JGVA00000000 JGUZ00000000 N/A JGUY00000000 JGUX00000000 JGUW00000000 JGUV00000000 
Assembly length 
(bp) 
N/A 6,630,005 6,346,114 N/A 6,878,190 6,438,007 6,800,559 6,361,046 
No. Contigs in 
assembly 
N/A 234 82 N/A 140 131 250 131 
Longest contig in 
assembly 
N/A 597,968 619,241 N/A 598,171 366,459 542,955 350,809 
Overlaps R1 
reference genome 
(%) 
N/A 98.42 98.79 N/A 98.41 98.31 98.90 98.43 
Transcriptome data 
mRNA shearing 
size (nucl) 
N/A 286 286 N/A 285 286 288 289 
No. RNAseq reads N/A 37,307,396 49,921,782 N/A 43,424,650 48,312,516 52,747,716 56,886,026 
SRA accession 
 
N/A SRS566271 SRS566154 N/A SRS566158 SRS566212 SRS566229 SRS566414 
 
Table 4.2: Genome and transcriptome data generated for B. microti isolates.
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  Non coding region coding region Unique * 
Isolate 
Total  
count 
Inter- 
genic 
Intronic 
5’UTR 
3’UTR 
Syn. 
Non- 
syn. Indel x3 Other 
Unique 
ALT 
Unique 
REF 
R1 27 17 2 0 2 3 3 0 3 Tab. 9 
ATCC_30222 130 55 24 4 5 18 10 14  40 0 
ATCC_PRA-99 121 56 25 2 2 14 9 13  7 0 
GI 116 58 18 2 2 14 9 13 12 0 
Greenwich_Lab_Strain_1 78 29 13 2 3 10 7 14 15 6 
Nan_Hs_2011_N11-50 130 62 21 2 5 13 15 12  21 0 
Naushon 119 61 17 2 3 9 9  18 5 0 
Bm1438 89 42 22 2 3 14 6 0 9 1 
Total 262 117 41 6 10 34 21 33 112 - 
 
  Non coding region coding region Unique 
Isolate 
Total  
count 
Inter- 
genic 
Intronic 
5’UTR 
3’UTR 
Syn. 
Non- 
syn. Indel x3 Other 
Unique 
ALT 
Unique 
REF 
R1 618 156 91 42 161 159 6 3 0 618 
 
A. 
B. 
Table 4.3: A. Localization of 262 polymorphic positions relative to R1 reference
genome, among seven B. microti isolates. B. Localization of 618 R1-specific muta-
tions.
4.3.1.2 Clustering
Unsupervised hierarchical clustering was performed for 7 samples based on 12 vari-
able microsatellites. The pairwise distance between the samples was calculated as
the proportion of base substitutions between them over the number of variable mi-
crosatellites, i.e. for pair of isolates (number of pairwise differences) / (total number
of variable sites). Unsupervised hierarchical clustering was also performed based on
differentially expressed genes. Pairwise distance among 6 isolates was calculated as
the Euclidean distance. The Ward minimum variance method was used as a metric to
build the dendrogram in R for both approaches. Conserved nodes were identified be-
tween the two clustering results (Figure 4.1). The clustering based on recovered SNPs
and INDELs did not provide consistent results, even after removing the chromosome
ends.
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Differentially expressed genes High variable microsatellites 
GI 
PRA-99 
Naushon 
Nan 
Greenwich 
ATCC_3222 
R1 
GI 
PRA-99 
Naushon 
Nan 
Greenwich 
ATCC_3222 
Euclidian  
distance 
0        0.2 
Euclidian  
distance 
0         2 
* 
* 
* 
*: conserved nodes 
Figure 4.1: Comparison of unsupervised hierarchical clustering dendrogram based on
the recovered differentially expressed genes and microsatellites. For microsatellites,
pairwise distance between the isolates is calculated as proportion of base substitutions
between them over all substitutions and for differentially expressed genes it is calcu-
lated as the Euclidean distance. Wards minimum variance method is implemented in
R for building the dendrogram. Conserved nodes are represented with a “*”.
4.3.1.3 Secretome analysis
The secretome of B. microti is defined as a set of proteins predicted to be secreted
outside the infected cell. The membrane proteome consists of proteins predicted to
be located in the surface of the parasite and the infected host cell. All the analyses
were performed with the new version of the B. microti genome annotation.
Intracellular proteins involved in cellular or nuclear trafficking were characterized
based on orthology. A set of 547 genes 835 P. falciparum (MPMP database) genes
encoding intracellular proteins were characterized based on orthology, which included
components of the acidocalcisome, clathrine, COP1, COP2, ER, Exocytosis, Golgi,
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intracellular membrane, cellular traffic, nuclear pore, nucleus, PTEX, Rab, secretion,
vacuolar. The orthology between B. microti and P. falciparum was defined by reverse
BLAST analysis and identified 2118 matches. Proteins were characterized based on
the new annotation, the former annotation [Cornillot et al., 2012], and annotation of
P. falciparum orthologues.
The mitochondrial proteome was predicted using TargetP and MitoFates. The
orthology between B. microti and P. falciparum identified a list of 206 B. microti pu-
tative mitochondrial polypeptides. The intracellular proteins and the proteins with
low probability (<0.55 for TargetP and <0.385 for MitoFates) in the two tools used
were removed from this analysis and based on the intersection among the three pre-
dicting methods, 446 proteins were identified. Finally, 35 more genes with known
mitochondrial function were included in the final set of true annotated proteins (Fig-
ure 4.2A).
Apicoplast targeted proteins. The apicoplast proteome was predicted following
a similar process. First, PATS prediction was used to characterize a first set of
putative apicoplast proteins. Out of the set of 350 proteins, 97 intracellular proteins
were removed. Second, TargetP predicted 125 putative chloroplast protein using plant
parameters. Using the same approach as for the mitochondrial genome, 78 proteins
with low probability and 19 intracellular proteins were removed. Orthology identified
215 B. microti putative targets to the apicoplast, around 60 of these orthologues
intracellular proteins. The control set of apicoplast proteins was encoded by 29 genes
having words apicoplast or chloroplast in their annotation. The IF2 initiation factor
and CPN60 HSP proteins were also added to the list. Eight known apicoplast proteins
were not detected by any of the approaches (Figure 4.2B).
At the initial step, the secretome was predicted using TargetP and TMHMM
(http://www.cbs.dtu.dk/services/TMHMM/) programs. A total of 680 secreted pro-
teins and 196 membrane proteins were identified using this approach and 118 of the
680 proteins of the secretome predicted by TargetP had more than one transmem-
brane domain. These proteins seem to not require an obvious signal peptide to be
targeted to the ER. All predicted proteins were then subjected to additional filters
to exclude proteins predicted to be residents of the apicoplast or the mitochondria
or targeted to other cellular compartments within the parasite. Using these criteria,
it was shown that the secretome of B. microti is composed of 196 proteins and the
membrane proteome of 205 proteins. Most of these proteins are hypothetical proteins.
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96 proteins are in common between secretome and organelles (Figure 4.2C).
A. 
 
B. 
 
C. 
 
Figure 4.2: Secretome prediction approach. (A) Venn diagrams illustrating overlap
between prediction methods for mitochondria proteins. (B) Venn diagrams illustrat-
ing overlap between prediction methods for mitochondria proteins. (C) Venn dia-
grams illustrating overlap between prediction for mitochondria proteome, apicoplast
proteome and secretome.
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4.3.1.4 Differential expression analysis
To identify differentially expressed genes among different samples, differential gene
expression was evaluated using two approaches. In the first approach, the ratio of
the normalized expression level over the median was computed for each gene. A ratio
was considered to be significant if > 3 (up-regulated) or smaller than 1/3 (down-
regulated). A set of 403 differentially expressed genes were identified (Figure 4.3)
with this method. A second approach was used to evaluate host dependent differential
expression using edgeR and DEseq2 methods. RNAseq data was generated for four
isolates grown in golden Syrian hamster and for two isolates grown in SCID mice.
The full set of 3618 genes (including tRNA and rRNA) was screened. Genes with
less than 4.26 reads were eliminated (70 genes). Because the sizes of the libraries
varied between samples, the “Relative Log Expression” (RLE) normalization method
was used. This method is implemented in edgeR and DESeq2 packages, which differ
in their estimation of the statistical dispersion per gene. The edgeR method was
used with exact test and tagwise estimation of the statistical dispersion, and a set of
75 differentially expressed genes were identified. The DEseq2 approach was more lax
than DEseq and resulted in a set of 107 differentially expressed genes. Of the 59 genes
predicted to be differentially expressed by the two methods, 57 were protein-coding
genes. The intersection of the first (403) and second approach (57) provides a set of
50 protein-coding genes that are differentially expressed.
One of the observations of this study was the huge genetic variation difference
between the R1 strain and the other seven strains. In the end, combining RNAseq
data, genomic variation data and antigenicity data two antigens were identified, which
could be interesting for host-parasite interaction and were never characterized before.
These proteins can be targeted for novel B. microti diagnosis assay. A link between
BMN2 gene family differential expression and variation could be observed (Figure
4.4).
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Figure 4.3: Heatmap of the log-transformed relative expressions of 403 genes consid-
ered as differentially expressed with at least one method. The distance between genes
is the Euclidean distance and the distance between isolates is 1-Pearson correlation
coefficient. In both cases, Ward metrics is used to obtain to dendrogram.
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Figure 4.4: Comparison of levels of expression of genes carrying at least one mutation.
Number of isolates where gene expression is 3x different from the median for the 6
tested isolates. § Number of mutations found in CDS, intron, 5’UTR and 3’UTR. (A)
Loci with R1-specific mutations (n=383). (B) Loci with non-R1-specific mutations
(n=105).
4.3. NUCLEAR GENOME OF 7 ISOLATES 207
4.3.2 Discussion
Although the re-sequencing of R1 strain and sequencing of 7 isolates have provided
an improved understanding of the genomic structure of B. microti genome, the popu-
lation structure of the B. microti parasite could not be well established based on the
recovered variations. One of the biggest factors contributing to this was the selection
of samples. The sampling of parasites was not relevant to the study, as the samples
were originating from very diverse locations and different time periods (Figure 4.1).
Also, the number of sequenced samples was very small and due to the paucity of
mutation no conclusions on the relationship between isolates could be drawn. A bias
was introduced by the fact that these parasite were isolated and amplified in animals.
The Bm1438 was sequenced after one passage only in SCID mice. On the other hand,
the R1 isolate was re-sequenced after about 30 passages in animals. The sequencing
technologies have been evolving rapidly and genome trapping and amplification was
developed only a short time after the analysis was started. These techniques enable
isolation of DNA of B. microti from ticks, blood of infected rodents, or even infected
humans. A very small amount of DNA is required, which combined with amplification
can provide very good results. For this study the B. microti parasite was propagated
in rodent vectors (SCID mouse, Hamster or Gerbil). For studying the characteri-
zation of population structure and identifying molecular markers a large amount of
DNA is required, which is more feasible with parasite cultures.
The genomic diversity observed in this analysis of 7 genomes (around 900 SNPs
and INDELs) was less compared to the 21257 SNPs identified in the 167 samples in
the case of P. falicparum (Chapter 3). One of the reasons could be low transmission
rate of B. microti due to tick, rodent and human niche, i.e., the overlapping of these
three different organism populations. For example, studies showing bottleneck of tick
population due to reduced dear population [Goetherd and telford 2014].
Another reason could be less possibility of infection. The possibility of infection
reduces as the transmission cycle depends on only one tick bite [Brunner and Ostfeld,
2008] in each life stage (nymph, larva, adult), unlike mosquitoes with a 3-4 day feeding
cycle in case of P. falciparum malaria. Therefore, this results into less recombination
leading to less diversity.
A specific DNA dataset of increased number of parasite isolates from the endemic
regions in USA is required for following the population dynamics of B. microti and for
calling of variants identifying the genetic background and possible molecular markers.
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A recent study by Lemieux and colleagues [Lemieux et al., 2016], summarizes
the results of sequencing isolates, mostly coming from the US. They confirm the
little number of variation existing in B. microti US isolates. They identify four
major groups of parasites, one corresponding to western part of the US and three
corresponding to eastern part of the US. Among these three eastern groups, one
group is called REF, which encompass the R1 isolate and is a small group. The two
other groups correspond to Nantucket islands isolates and to New England mainland
isolates. Authors conclude of a bottleneck effect, explaining the little variation in
B. microti US isolates with a common ancestor originating approximately 200 years
ago. These results were confirmed by Giovanna and colleagues study, which has been
submitted recently. The position of R1 as an outgroup and of the two other clade
from north-east US is confirmed by Lemieux study [Lemieux et al., 2016]. Two other
isolates GI and PRA99 (Peabody, also identical to Gray strain) are common between
Lemieux and this study.
In GPI proteome, six genes were differentially expressed and two were presenting
host-dependent differential expression. BMGPI9 (member of BMN1 family) was the
most variable protein and was associated with chromosome ends. GPI proteins are
often antigens and in fact among them BmSA1 was highly variable and confirmed as a
good antigen for B. microti detection. But we saw one mutation in ATCC3022 isolate
(C->T, non-synonymous) and all the other US isolates (C->G, non-synonymous),
which were different from R1. Additionally, two antigens were found in the secretome
using protein array. These two genes are among the top 10 most expressed genes.
Surprisingly, they show some mutations.
The genetic patterns reported here can help in better understanding of B. mi-
croti pathogenesis and mode of transmission, and may contribute to improve disease
diagnosis and control.
Chapter 5
General Discussion
Methods to understand epidemiology provides vast opportunities for exploring the
genome and identification of genomic variations. These variations can play an es-
sential role in identification of drug targets and understanding parasite population
dynamics. Identification of reliable variations is an essential step of this approach.
One of the major steps of the parasite population description approach discussed in
this thesis, is the identification of SNPs. My PhD focuses on the post-processing
of genome sequencing data, identification of reliable variations in the genome, de-
scription of population structure, identification of significant genes and functional
annotation of the genome and the target genes. The main motivation was to un-
derstand the emergence of parasite populations and transmission and acquisition of
drug resistance in Cambodian P. falciparum isolates. This work provides important
insights about the role of parasite population structure in acquisition and transmis-
sion of drug resistance in the case of P. falciparum malaria in Cambodia (Article
1 and Article 2) and the choice of sample set for identification of population struc-
ture in the case of B. microti Babesiosis in USA. Most of the approaches developed
during the PhD were for the P. falciparum genomic dataset. These approaches were
implemented on the B. microti genomic dataset, as an application of the pipeline.
The pipeline developed to call variants from the aligned reads in the beginning
of the project, forms the basis of population structure description and functional
analysis of identified genes. The most important step was the selection of the dataset
to follow the artemisinin resistance of P. falciparum parasites in Cambodia and B.
microti divergence in USA.
The genomic data used by Miotto and colleagues [Manske et al., 2012, Miotto
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et al., 2013] for epidemiology studies, was a good choice, as most of the isolates were
from western localities, which is considered the epicenter of drug resistance. The data
from one locality in eastern Cambodia (Ratanakiri) was a good control, as artemisinin
resistance was not found at that time in this region. In fact, none of the isolates were
associated with clinical artemisinin resistance. The other contributing factor for the
choice of this dataset was the time period of isolation of parasite genome, 2008-2011,
which represents the early period of emergence of artemisinin resistance.
In the case of B. microti it was observed that the sampling was not significant to
carry out a population study, as the samples were very less in number (only 7), and
were from very different locations (even outside USA), and were cultured in different
time periods (1950-2014) and the hosts was not the same for the isolates. The study of
B. microti population has also been facing an unexpected dearth of genetic diversity.
5.1 Post-Processing of genome sequencing data
The sequence data by Wellcome Trust Sanger Institute coming from four locations in
Cambodia was made available in sequence alignment format (SAM/BAM) for most
of the 293 samples and in SRF format for some of the samples. SRF files were not
recovered, as the process to convert to VCF was not well defined and was time con-
suming. The SNPs used for population description and the correspondence between
the isolates and the defined subpopulations were not available at the beginning of
the project [Manske et al., 2012, Miotto et al., 2015]. The lack of sample meta-
information lead to redefining the population structure. The choice of variants to
study population structure is crucial.
The approach focused on calling variants based on the quality of the sequenced
data. For conversion of BAM to VCF and calling of variants, SAMtools mpileup and
bcftools programs were used. The other variant calling tools like GATK could have
been used. There is no documentation suggesting the use of one tool over the other
for calling variants in haploid data, but some discussion forums and reviews state that
for the single sample haploid data analysis both the tools provide similar results [Yu
and Sun, 2013]. In SAMtools the variant calling is done considering haploid data as
diploid data, so the genotype information could be wrong, but the variant calling is
unaffected. In the scope of this study, as the variant calling is validated and show
robust results, it would be interesting to use other tools and compare the results
5.1. POST-PROCESSING OF GENOME SEQUENCING DATA 211
for establishing the specificity of the variant calling tool for P. falciparum haploid
genomic data.
For assessing the quality of the data and avoiding any associated bias, analyses
of the quality parameters for filtering the data for noise is an essential step. We see
that different parameters were identified for the threshold to filter the data in the
case of P. falciparum and B. microti. Therefore, it is very essential to analyze the
data quality for each dataset, represented in different quality parameters, and not
depend only on predefined thresholds or parameters for filtering the data. One of the
issues in parameter analyses was the definition of the quality parameters in literature.
Some of the parameters, predefined filters and associated thresholds are not defined
clearly making it important to understand the tool completely before using it for the
analyses of the data.
The approach of analyzing the sequences based on the signal parameters and
filtering the data for noise results in improved identification of true positive variations.
This is validated by comparison with other publicly available datasets and by the
presence of marker SNPs such as mutations in K13 kelch domain [Ariey et al., 2014]
and the associated background genes [Miotto et al., 2015].
The techniques implemented to remove uncertainties (more than one possible ALT
allele at a given loci for some samples) from the recovered data are not very stringent
and can differ for different studies. The approach was developed for conserving most
of the information. Therefore, only loci with high frequency of uncertainties were
removed (2%) and the loci with low frequency were substituted (17%). Also, rare
mutations were removed from the analysis, as the great number of them can create
bias in the population structure analysis. A large number of rare mutations (SNPs)
are expected in the ancestral population compared to the founder populations, due
to high diversity. Though after establishing the population structure based on the
frequent mutations, methods should be developed and implemented to analyze the
rare mutations in different populations.
The sequential approach used to select the SNPs and provide associated meta-
information such as genomic annotation and correspondence with different reference
genome versions was used to build a database (Chapter 3) following the database
scheme shown in Figure 5.1:
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Figure 5.1: UML representation of genome variant meta-model. SNPs and short
INDELs can be called after NGS sequencing. Reads are aligned on a reference genome.
The meta-model focus on Single nucleotide polymorphisms (SNPs). When no reads
cover the reference, information is not available. Strain single base (SSD) is the
instance of the SNP after filtering of VCF data files. The meta-model suggest to
create a permanent ID for the variable position: Single base mutation. The SNP is
related to the reference genome. Annotation is second layer of genetic information
that can be used and is independent from the reference genome.
The reliability of the obtained 21257 SNPs is validated by comparison with pub-
licly available dataset based on SNP distribution over the genome (the annotation
was validated in the genome browser manually), common SNPs. The overlap between
IBC dataset and MalariaGEN dataset, as well as IBC and PlasmoDB is better than
overlap between those two previously published datasets. Other important result
contributing to the reliability of the IBC set is the robustness of the clusters obtained
from unsupervised hierarchical clustering and population classification based on the
gene interaction in a network.
The meta-model was used to translate genetic information from raw BAM files
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based on P. falciparum version 2 to the new version 3. To obtain the correspondence
between P. falciparum genome version 2 and 3 BLAST was performed and was shown
to be relevant in this work based on comparison with the SNPs and genes identified
in PlasmoDB genome version 3. As a validation step, it will be interesting to redo
the read alignment mapping to genome version 3 and compare the results.
Therefore, the variant calling approach was shown to be reliable by validation
with external sources, extendible to other genomes and reproducible. This approach
is different from the variant calling approach used at MalariaGEN, where reads were
aligned using BWA, SNPs were called using SAMtools pileup and SNPs were filtered
based on consensus quality, SNP quality, mapping quality, coding/non-coding regions,
depth, degree of uniqueness and level of heterozygosity [Manske et al., 2012].
The variant calling pipeline produced more reliable results in P. falciparum genome
and was applied on the B. microti genomic set. Threshold had to be increased accord-
ing to the signal analysis and threshold was defined by a set of long read sequencing
on control PCR products. The density of mutations (0.9 variants / 10 kbp) recov-
ered was more than one order of magnitude lower as compare to the P. falciparum.
A specific DNA dataset of increased number of parasite isolates from the endemic
regions in USA was extracted directly from ticks or infected blood and sequenced for
following the population dynamics of B. microti by our colleague Giovana Capri from
the department of Molecular Microbiology and Immunology at Yale University. The
same variant calling conditions were used and she confirmed our observations. The
low level of genetic diversity in the USA B. microti populations could be explained
by a bottleneck effect on tick population due to reduced deer population in New
England [Goethert and Telford, 2014]. This work is under submission.
5.2 Population structure definition
In the case of P. falciparum understanding the existence of population and trans-
mission of alleles is necessary for containment of drug-resistant malaria. The first
approach used to identify the structure of P. falciparum subpopulations in Cambodia
was the Barcoding approach, developed in collaboration with Pasteur Institute of
Cambodia, where all the experiments were performed. The main objectives were to
identify genetic flow among the P. falciparum parasite subpopulations in Cambodia.
This approach highlights the scope and importance of barcoding samples for classi-
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fication into parasite population with a specific trait. This approach validates the
possibility of LUMINEX assay to barcode parasites. The LUMINEX signal analysis
approach developed in the lab proved to be useful for identification of samples with
true signal, which could help in sample validation to reject samples with increased
noise. The choice of 11 SNPs from the 24 SNPs [Daniels et al., 2008] is able to track
the emerging subpopulations in Cambodia, though the 24 SNPs were identified in
African and Thai isolates. The barcode based on these 11 SNPs is unable to identify
highly variable ancestral and admixed populations. Only around 50% of the assays
could provide interpretable signal and 50% of the Cambodian samples were rejected
due to traces of mixed infection, no significant signal with LUMINEX for at least one
barcode position and/or no amplification using PCR for at least one locus.
The allele gradient analysis (Chi-squared test) and allele diversity analysis (FST ),
suggested existence of specific subpopulations and underlying gene flow. The sub-
population structure was made evident by the unsupervised hierarchical clustering
approach. The barcodes of the samples could be identified in the set of 21257 SNPs
and correspondence with Miotto population classification was provided (Article 1:
Methods section "Data and statistical analysis"). The conserved groups (subpopula-
tions) could not be identified towards the centre of the country. This could suggest
presence of admixed population. Also, gene flow on west to east axis was determined
from allele gradient analysis. This analysis contributes to support one of the hypothe-
ses that admixed populations are responsible for transmission of resistant alleles. This
signifies the importance of barcoding samples due to which artemisinin resistant and
sensitive populations could be identified. This application provides future scope in
identification of patients with artemisinin resistance parasitic infection at an early
stage based on these barcode markers.
Also, as it was shown in the population structure described based on 21257 SNPs
(Article 2), that there is a specific donor population for R539T k13 allele in the west
(data from 2008-2011). A subpopulation carrying R539T allele was identified in this
area and in the north (data from 20010-2011). Barcode allele 2 was shown to have
gradient from western Cambodia to northern Cambodia. These three results suggest a
scenario of gene flow between subpopulations and acquisition of artemisinin resistant
alleles. The population in the north was associated with mefloquine resistance and
artemsinin resistance and the results are supported by recent studies stating the
presence of R539T allele at the northern border of Cambodia [Talundzic et al., 2015,
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Ye et al., 2016].
Barcoding approach holds great potential for performing similar analysis with
accuracy using relevant and specific gene sets to the population under study. Adapting
the same approach for identification of B. microti parasite structure and gene flow
among subpopulations will be interesting.
The Cambodian P. falciparum population structure was also defined based on
the 167 samples isolated by the Wellcome Trust Sanger Institute. The hierarchi-
cal clustering approach was validated by comparison with the population structure
described earlier. There was a good overlap with 85% matching classification. As
different SNPs and classification methods are used for identification of clusters, this
was expected [Manske et al., 2012, Miotto et al., 2013]. We classified samples into
more specific subpopulations based on hierarchical clustering and identified a small
artemisinin sensitive subpopulation with resistant background (KH1.2). Also the dif-
ference between the two subpopulations carrying C580Y allele only (KH2 and KH3)
is made evident by showing that KH3 does not carry the mutation in ferrodoxin
(fd) gene for all the samples carrying C580Y mutations. This is the only subpopula-
tion with mutation in fd not present with k13 allele. Therefore, this classification is
an important feature of the subpopulation structure. The reason these populations
could not be identified earlier could be different SNPs (genome version 2) and use of
principle component analysis (PCA) for recovering the population structure. PCA
is an effective tool for population classification among diverse samples from different
countries [Manske et al., 2012], but could produce overlapping populations for the
data from single country. The region of Cambodia is a low transmission region and
thus the identification of specific founder populations are possible and the structure
is conserved. In high transmission region such as Africa, more admixed populations
are expected and identification of specific populations such as KH1.1 and KH1.2 is
not possible.
The other approach implemented on the IBC (21257 SNPs; 167 samples) dataset
was the network based stratification method [Hofree et al., 2013]. This method was
developed for tumor patient classification and has not been implemented before for
P. falciparum genome analyses. It aims at classifying the samples together based on
the diffusion pathway of the target genes in an interaction network. The gene-gene
interaction network was recovered from STRING v10 database server. This approach
enables hierarchical clustering based on the target genes of each sample and provides
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a way of including gene-gene/protein-protein interaction networks based on exper-
imental data into hierarchical clustering analysis. The classification obtained from
this clustering approach, clusters the samples with similar underlying genetic net-
work. This classification confirmed the overlapping genetic background of KH1.2
subpopulation with the resistant subpopulations, suggesting that this population has
acquired the resistant background in accordance with the emergence, selection and
diffusion model (Article 3). This approach shows good overlap with the clustering
obtained from unsupervised hierarchical clustering method, which shows the reliabil-
ity of the variant calling approach and the IBC dataset. Some of the samples are
misclassified, but are displaced into or out of the KHA subpopulation. This supports
one of the major hypotheses that the transmission of resistance alleles is due to the
admixed subpopulation’s ability of crossing with other subpopulations and crossing
within subpopulation.
Network based methods is also an important way of exploring associated func-
tions. But the choice and nature of the network is of great importance. The network
recovered from STRING v10 for P. falciparum based on interactions supported by
various sources, is not a scale free network and can produce biased clustering. We
tried to keep only top 10% of the interactions in the analysis to remove most of the
edges, but still the network is not completely scale free. This suggests that rele-
vant network and sources of information should be taken into consideration before
implementing network based approaches.
5.3 Functional analysis
Other networks used in this study are the functional groups of Gene Ontology terms
recovered using Cytoscape plugin ClueGO and CluePedia. These tools provide in-
teraction networks for the targeted genes at the level of GO terms. This can be
used to understand the overlapping and connection of different functions. The GO
terms available in public database are not accurate and should be dealt with care.
Additional analyses should be accompanied as verification steps.
Three gene sets in the IBC dataset analysis were described for understanding the
underlying mechanism of emergence of subpopulation and acquisition of an artemisinin
resistance background. First, we focused on the significant genes identified in KH1.2
population common with the significant genes identified in artemisinin resistant pop-
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ulations (168 genes). This gene set represents the resistant background acquired by
KH1.2 subpopulation. A second gene set contains the significant genes specific to
the resistant subpopulations (97 genes). The third gene set is the overlap of admixed
subpopulation significant genes with resistant subpopulations significant gene sets (57
genes), signifying the resistant background.
The results based on the recovered functions from the functional groups analysis,
GO terms and these three gene sets, showed that the resistant population has acquired
a similar background and that the KHA background was acquired by crossing of
parasites from various populations either ancestral, resistant or admixed population
that existed before. This suggests the scenario where the subpopulations emerge from
ancestral population with a common background, resistant alleles are selected in these
subpopulations and the transmission takes place by crossing over with the admixed
population KHA.
Based on functional analysis, an autophagy pathway is suspected to be one of
the pathways in P. falciparum playing an essential role in acquisition of artemisinin
resistance. Association with ferredoxin was also confirmed. The proposed model of
PI3K-K13 interaction was supported by the presence of mutations in PI3K, but the
mutations were not systematically associated with K13 resistant alleles. The results
point towards a stress response of the parasite [Mbengue et al., 2015].
This work is not able to describe the underlying pathway, but it successfully pro-
vides new techniques, new targets and new models to be considered for understanding
the underlying artemisinin resistance transmission and acquisition pathway.
For complete functional annotation of the target genes in the P. falciparum genome,
there is a strong need to analyze more genomic data from varied locations. Also data
from different countries should be analyzed to verify the generality of the stated
model. The geographical and socio-economic scenario of Cambodia is changing due
to undergoing development initiatives, which could strongly influence the parasite
population structure in Cambodia. Therefore, to follow the evolution and movement
of these populations, genomic data in different time periods is required.
In the case of the B. microti genome, a secretome gene set could be identified.
Based on the reverse-phase analysis to investigate immune-proteome properties of B.
microti, two antigens potentially associated to host response were identified. This
could suggest that B. microti has evolved the survival and host-interaction mech-
anism. Improved datasets and planned approaches to sample relevant isolates is
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required.
In conclusion, the genome-wide sequencing data due to NGS technologies has
tremendously helped in epidemiological studies and revealed different aspects of par-
asite biology. Methods and techniques developed to define population structure
are helpful in understanding the epidemiology of the parasite. The two approaches
used, barcode approach and variant calling approach, not only verify the previously
described results, but also provide a further understanding of pathways and pro-
cesses involved in population structure evolution, and acquisition and transmission of
artemisinin resistant alleles. Though NGS data analysis has shown to be a powerful
tool for parasite population structure description, the barcode approach (SNP chip)
can be used to identify the recently emerging founder parasite populations and also
the parasites evading the vaccination trials. NGS data analysis is efficient for under-
standing the genomics, but methods and strategies should be developed to overcome
certain limitations of sequencing and alignment errors, reproducibility, predicted an-
notations, integration of different data types and missing meta-information. As in this
work, NGS data analysis provided insight of artemisinin action mechanism, but inte-
gration of other biological information and validation is required to fully understand
the underlying artemisinin resistant mechanisms.
5.4 Significance of population structure for public
health
The analysis of both the genomes P. falciparum an B. microti was focussed on the
emergence of new parasites. This is one of the general problems faced by public health
institutions. Global warming and globalization have contributed to the emergence of
new pathogens everywhere in the world. Understanding the complete phenomenon
of emergence is difficult, as it is the result of parameters that remains unclear and
also due to lack of genetic markers to characterize these organisms. The present
study shows that the use of whole genome sequencing data for the description of the
population structure. In the case of B. microti, the parasite population structure
could not be identified, but recent two population studies performed at genome scale
prove the relevancy of this approach.
Emergence of artemisinin resistant parasites to ACT is a major problem world-
wide. Artemisinin resistant parasites have emerged in the same region, where chloro-
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quine and pyrimethamine resistance had emerged earlier. We show that resistant
parasites all come from subpopulations existing at the border of the country. The
diffusion of K13 alleles took place through the admixed population, which can be
considered as the major factor being responsible for the spread of the resistance. The
Emergence, Selection and Diffusion (ESD) model is very close to the population shift-
ing balance theory and helps to identify parasites that need to be targeted by public
health policies. The first approach should be the identification of the geographic ar-
eas, where crossing between subpopulations takes place. It is now too late to search
for the origin of KHA parasites. The C580Y allele is now fixed in the western P. fal-
ciparum Cambodian population. It is now essential to identify the route of diffusion
to other countries from Cambodia. The second approach should be identification of
the correlation with the vector (mosquito species) population that would preferen-
tially transmit the admixed parasite. This study has not been able to identify the
external factors that favour the emergence of subpopulation and selecting a specific
background that is strongly related to stress response.
B. microti population study confirmed that all USA isolates are very close to each
other. The three sub-populations described in northern America have diverged for
several thousands of years, but the diversity among sample is low. This phenomenon
can result from a bottleneck effect, which may have helped the emergence of parasites
that can infect humans. The USA is facing a continuous increase in the number of
babesiosis cases since the early seventies. It is becoming the first pathogen transmitted
by blood transfusion. No reliable and cheap detection assay exist for blood donors
and blood samples. B. microti is endemic only in small geographic areas in the
USA and it is present only when ticks are active. Furthermore, most infected people
are asymptomatic. The main focus of this study has been the identification of new
protein markers of babesiosis. The BmSA1/BmG9/BmGPI18 protein was the most
promising molecule. Our genomic survey has identified two new potential markers
that are members of the secretome.
Despite decreased cost and an increase in feasibility, full genome sequencing cannot
be systematically used for clinical analysis. The development of LUMINEX assay was
a test to develop new low cost genotyping approaches. Results were promising, but
more tests will be necessary before it can become a routine technology. Several studies
are done to identify more SNPs in K13, but it is also important to identify new genes
and alleles associated to resistance, through LUMINEX methods, and identify new
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underlying mechanisms supporting artemisinin resistance. Public health institutions
should bring into practice, two approaches to follow emergence of pathogen, one
based on routine identification of pathogens and another survey based on full genome
sequencing to follow the evolution of population structure.
The work presented in this thesis was the opportunity to explore new areas of
research and technology in the field of population dynamics and variant analysis. I
will be glad to continue to explore these areas and hopefully contribute in a significant
way.
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